<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005147" GROUP_ID="SCHIZ" ID="681203120510084494" MERGED_FROM="" MODIFIED="2013-01-15 12:44:13 +0000" MODIFIED_BY="Claire Irving" REVIEW_NO="001" REVMAN_SUB_VERSION="5.2.1 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2013-01-15 12:44:13 +0000" MODIFIED_BY="Claire Irving">
<TITLE>Training to recognise the early signs of recurrence in schizophrenia</TITLE>
<CONTACT MODIFIED="2013-01-15 12:44:13 +0000" MODIFIED_BY="Claire Irving"><PERSON ID="2032890A82E26AA201A256C7F01F1170" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Indira</FIRST_NAME><LAST_NAME>Vinjamuri</LAST_NAME><POSITION>Consultant Psychiatrist</POSITION><EMAIL_1>indira.vinjamuri@merseycare.nhs.uk</EMAIL_1><EMAIL_2>vinjamuriindira@hotmail.com</EMAIL_2><ADDRESS><ORGANISATION>Mersey Care NHS Trust</ORGANISATION><ADDRESS_1>Broadoak Unit</ADDRESS_1><CITY>Liverpool</CITY><ZIP>L14 3PJ</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 250 5094</PHONE_1><PHONE_2>+44 797 046 3251</PHONE_2></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-01-15 12:44:13 +0000" MODIFIED_BY="Claire Irving"><PERSON ID="11851F0182E26AA201DC7B3ED8E7801A" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Richard</FIRST_NAME><LAST_NAME>Morriss</LAST_NAME><POSITION>Professor of Psychiatry</POSITION><EMAIL_1>richard.morriss@nottingham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Psychiatry</DEPARTMENT><ORGANISATION>University of Nottingham</ORGANISATION><ADDRESS_1>A Floor, South Block</ADDRESS_1><CITY>Nottingham</CITY><ZIP>NG7 2UH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>0115 8230427</PHONE_1><FAX_1>0115 8230433</FAX_1></ADDRESS></PERSON><PERSON ID="2032890A82E26AA201A256C7F01F1170" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Indira</FIRST_NAME><LAST_NAME>Vinjamuri</LAST_NAME><POSITION>Consultant Psychiatrist</POSITION><EMAIL_1>indira.vinjamuri@merseycare.nhs.uk</EMAIL_1><EMAIL_2>vinjamuriindira@hotmail.com</EMAIL_2><ADDRESS><ORGANISATION>Mersey Care NHS Trust</ORGANISATION><ADDRESS_1>Broadoak Unit</ADDRESS_1><CITY>Liverpool</CITY><ZIP>L14 3PJ</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 250 5094</PHONE_1><PHONE_2>+44 797 046 3251</PHONE_2></ADDRESS></PERSON><PERSON ID="1184F77482E26AA201DC7B3EFA029318" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mohammad</FIRST_NAME><MIDDLE_INITIALS>Amir</MIDDLE_INITIALS><LAST_NAME>Faizal</LAST_NAME><POSITION>Senior House Officer</POSITION><EMAIL_1>Faizal72@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Psychiatry</DEPARTMENT><ORGANISATION>Mersey Care NHS Trust</ORGANISATION><CITY>Liverpool</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="19960" ROLE="AUTHOR"><FIRST_NAME>Catherine</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Bolton</LAST_NAME><POSITION>Clinical Psychologist</POSITION><ADDRESS><ORGANISATION>Central Manchester University Hospitals NHS Foundation Trust</ORGANISATION><CITY>Manchester</CITY><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1204 390659</PHONE_1></ADDRESS></PERSON><PERSON ID="118519B282E26AA201DC7B3EDC7DFA04" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>James</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>McCarthy</LAST_NAME><POSITION>Consultant Psychiatrist</POSITION><EMAIL_1>jpmccar@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Ferndale Unit</DEPARTMENT><ORGANISATION>Merseycare NHS Trust</ORGANISATION><ADDRESS_1>Ferndale Unit, University Hospital Aintree</ADDRESS_1><ADDRESS_2>Longmoor Lane</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L9 7AL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 529 3066</PHONE_1><FAX_1>+44 151 529 3063</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-10-10 14:35:40 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="24" MONTH="9" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="3" MONTH="5" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="3" MONTH="3" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2005"/>
</DATES>
<WHATS_NEW MODIFIED="2012-09-24 13:55:38 +0100" MODIFIED_BY="[Empty name]"/>
<HISTORY/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Paula Williamson, University of Liverpool Centre for Medical Statistics</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Mersey Care NHS Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-01-07 11:19:00 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2005-01-10 03:07:23 +0000" MODIFIED_BY="[Empty name]">Training to recognise the early signs of recurrence in schizophrenia</TITLE>
<SUMMARY_BODY MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>Many people with schizophrenia experience periods of illness followed by relatively stable periods (although symptoms of illness such as hearing voices and seeing things often remain in the background). This means that many people with schizophrenia may become unwell again and need to go back into hospital. Training in early warning signs techniques encourages people to learn, detect and recognise the early warning signs of future illness. Studies indicate that noticing even small changes in signs and symptoms of schizophrenia can often predict future illness and relapse two to 10 weeks later. Early warning training may help to prevent or delay relapse, so reducing the chances of going into hospital. Recognition of early warning signs requires detailed history taking, sometimes with additional techniques such as diary keeping, completion of questionnaires and a plan of action based on anticipated early warning signs. Training can be undertaken by the individual or be group-based, involving health professionals, family members or carers. Successful training seems to require around 12 sessions and involves therapists of high competency.<BR/>
<BR/>This review includes a total of 34 studies. It found that there are positive benefits of training in early warning signs. It reduces rates of relapse and re-hospitalisation (but not on time to recurrence). It should be noted that training in early warning signs was mainly used alongside other psychological therapies, so it is not entirely clear what proportion of the positive effect is due to training in early warning signs alone. Moreover, the overall quality of the evidence from these studies was judged to be very low. This means that we do not know if interventions using early warning signs, with or without additional psychological treatments, will have the same beneficial effects outside clinical trials.<BR/>
<BR/>Further research is required to decide whether training in early warning signs is effective on its own. Effects on quality of life, satisfaction with care, money spent, and burden of care for carers are unclear, so ideally should be known before training programmes are put into wider use. At this time, there is not enough evidence to support training in early warning signs alone.</P>
<P>This plain language summary was written by consumer, Ben Gray of RETHINK.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-01-07 11:17:55 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-01-07 11:15:27 +0000" MODIFIED_BY="[Empty name]">
<P>Schizophrenia has a lifetime prevalence of less than one per cent. Studies have indicated that early symptoms that are idiosyncratic to the person with schizophrenia (early warning signs) often precede acute psychotic relapse. Early warning signs interventions propose that learning to detect and manage early warning signs of impending relapse might prevent or delay acute psychotic relapse.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-01-07 11:15:27 +0000" MODIFIED_BY="[Empty name]">
<P>To compare the effectiveness of early warning signs interventions plus treatment as usual involving and not involving a psychological therapy on time to relapse, hospitalisation, functioning, negative and positive symptomatology.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-11-27 06:43:58 +0000" MODIFIED_BY="[Empty name]">
<P>Search databases included the Cochrane Schizophrenia Group Trials Register (July 2007 and May 2012) which is based on regular searches of BIOSIS, CENTRAL, CINAHL, EMBASE, MEDLINE and PsycINFO. References of all identified studies were reviewed for inclusion. We inspected the UK National Research Registe and contacted relevant pharmaceutical companies and authors of trials for additional information.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-01-07 11:15:27 +0000" MODIFIED_BY="[Empty name]">
<P>We included all randomised clinical trials (RCTs) comparing early warning signs interventions plus treatment as usual to treatment as usual for people with schizophrenia or other non-affective psychosis</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-01-07 11:15:27 +0000" MODIFIED_BY="[Empty name]">
<P>We assessed included studies for quality and extracted data. If more than 50% of participants were lost to follow-up, the study was excluded. For binary outcomes, we calculated standard estimates of risk ratio (RR) and the corresponding 95% confidence intervals (CI), for continuous outcomes, we calculated mean differences (MD) with standard errors estimated, and for time to event outcomes we calculated Cox proportional hazards ratios (HRs) and associated 95 % CI. We assessed risk of bias for included studies and assessed overall study quality using the GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-01-07 11:17:55 +0000" MODIFIED_BY="[Empty name]">
<P>Thirty-two RCTs and two cluster-RCTs that randomised 3554 people satisfied criteria for inclusion. Only one study examined the effects of early warning signs interventions without additional psychological interventions, and many of the outcomes for this review were not reported or poorly-reported. Significantly fewer people relapsed with early warning signs interventions than with usual care (23% versus 43%; RR 0.53, 95% CI 0.36 to 0.79; 15 RCTs, 1502 participants; <I>very low quality evidence</I>). Time to relapse did not significantly differ between intervention groups (6 RCTs, 550 participants; <I>very low quality evidence</I>). Risk of re-hospitalisation was significantly lower with early warning signs interventions compared to usual care (19% versus 39%; RR 0.48, 95% CI 0.35 to 0.66; 15 RCTS, 1457 participants; <I>very low quality evidence</I>). Time to re-hospitalisation did not significantly differ between intervention groups (6 RCTs; 1149 participants; <I>very low quality evidence</I>). Participants' satisfaction with care and economic costs were inconclusive because of a lack of evidence.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-01-07 11:15:27 +0000" MODIFIED_BY="[Empty name]">
<P>This review indicates that early warning signs interventions may have a positive effect on the proportions of people re-hospitalised and on rates of relapse, but not on time to recurrence. However, the overall quality of the evidence was very low, indicating that we do not know if early warning signs interventions will have similar effects outside trials and that it is very likely that further research will alter these estimates. Moreover, the early warning signs interventions were used along side other psychological interventions, and we do not know if they would be effective on their own. They may be cost-effective due to reduced hospitalisation and relapse rates, but before mental health services consider routinely providing psychological interventions involving the early recognition and prompt management of early warning signs to adults with schizophrenia, further research is required to provide evidence of high or moderate quality regarding the efficacy of early warning signs interventions added to usual care without additional psychological interventions, or to clarify the kinds of additional psychological interventions that might aid its efficacy. Future RCTs should be adequately-powered, and designed to minimise the risk of bias and be transparently reported. They should also systematically evaluate resource costs and resource use, alongside efficacy outcomes and other outcomes that are important to people with serious mental illness and their carers.<BR/>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-01-07 11:19:00 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>The lifetime prevalence of schizophrenia is just less than one per cent with onset usually occurring during adolescence or early adulthood. Diagnosis is predictive of an increased risk of suicide, impaired occupational and social functioning, and a heightened risk of physical illness. Most people with schizophrenia experience a cyclical pattern of illness with periods of acute psychotic episodes followed by stable periods of full or partial remission, although these are often accompanied by the presence of residual symptoms (<LINK REF="REF-APA-1997" TYPE="REFERENCE">APA 1997</LINK>).</P>
<P>The use of secondary prevention strategies, in which patients are encouraged to recognise signs of impending exacerbations of illness, are common in the treatment of several chronic physical illnesses such as diabetes and heart disease and may be equally beneficial to those suffering from severe mental illness (<LINK REF="REF-Bustillo-1995" TYPE="REFERENCE">Bustillo 1995</LINK>).</P>
<P>Both retrospective (<LINK REF="REF-Bechdolf-1998" TYPE="REFERENCE">Bechdolf 1998</LINK>; <LINK REF="REF-Herz-1980" TYPE="REFERENCE">Herz 1980</LINK>) and prospective (<LINK REF="REF-Birchwood-1989" TYPE="REFERENCE">Birchwood 1989</LINK>; <LINK REF="STD-Marder-1994" TYPE="STUDY">Marder 1994</LINK>) observational studies indicate that relatively small changes in signs and symptoms of schizophrenia can reliably predict acute episodes of psychosis two to 10 weeks later. The symptoms (observed and reported by the patient) and signs (mostly behaviours observed and reported by carers or mental health professionals) are idiosyncratic to the patient, but consistently predict recurrence of psychosis in those who have a relapsing and remitting course of schizophrenia (<LINK REF="REF-Birchwood-1989" TYPE="REFERENCE">Birchwood 1989</LINK>; <LINK REF="REF-Bustillo-1995" TYPE="REFERENCE">Bustillo 1995</LINK>; <LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>; <LINK REF="STD-Marder-1994" TYPE="STUDY">Marder 1994</LINK>
<U>).</U>
</P>
<P>Early warning interventions are based on the hypothesis that learning to detect and manage early warning signs (EWS) of impending relapse might prevent the onset of acute episodes (<LINK REF="REF-Fitzgerald-2001" TYPE="REFERENCE">Fitzgerald 2001</LINK>; <LINK REF="REF-Lam-1997" TYPE="REFERENCE">Lam 1997</LINK>). The term prodrome has been used to delineate early warning signs, but this term will be avoided here because prodrome is now commonly used to delineate a period immediately before the first onset of psychotic symptoms in schizophrenia (<LINK REF="REF-Bustillo-1995" TYPE="REFERENCE">Bustillo 1995</LINK>).</P>
<P>Originally the recognition of early warning signs was combined with intermittent medication strategies. It was hoped that this would help prevent the long-term side-effects of medication such as tardive dyskinesia, by reducing overall exposure to neuroleptic medication (<LINK REF="REF-Herz-1980" TYPE="REFERENCE">Herz 1980</LINK>; <LINK REF="STD-Jolley-1990" TYPE="STUDY">Jolley 1990</LINK>). However, early randomised controlled trials suggested that over a two-year period, those randomised to early warning signs interventions and intermittent antipsychotic medication strategy experienced more acute episodes of schizophrenia than those randomised to a continuous use of maintenance antipsychotic medication only (<LINK REF="REF-Gaebel-1993" TYPE="REFERENCE">Gaebel 1993</LINK>; <LINK REF="STD-Jolley-1990" TYPE="STUDY">Jolley 1990</LINK>).</P>
<P>More recently, however, added clinical benefit has been demonstrated in patients on maintenance antipsychotics when early warning signs interventions are combined with short-term additional treatment such as diazepam (<LINK REF="REF-Carpenter-1999" TYPE="REFERENCE">Carpenter 1999</LINK>), additional oral antipsychotic (<LINK REF="STD-Marder-1994" TYPE="STUDY">Marder 1994</LINK>), cognitive therapy (<LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK>) and multifaceted psycho-educational and family interventions (<LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>). If such interventions were effective in reducing recurrences they would offer significant benefits to sufferers and their caregivers. Some practice guidelines for schizophrenia (<LINK REF="REF-APA-1997" TYPE="REFERENCE">APA 1997</LINK>) recommend working with patients and their families to address EWS of recurrence.</P>
<P>Monitoring for early warning signs in schizophrenia has often been included as a component of psychological interventions, for example, in combination with other cognitive strategies or as one aspect of family intervention. There is a need to identify which components of therapy have a positive influence on outcomes (<LINK REF="REF-Haddock-1998" TYPE="REFERENCE">Haddock 1998</LINK>). Two narrative reviews have specifically evaluated studies in schizophrenia seeking to reduce relapse through interventions based on early warning signs (<LINK REF="REF-Birchwood-2001" TYPE="REFERENCE">Birchwood 2001</LINK>; <LINK REF="REF-Herz-1995" TYPE="REFERENCE">Herz 1995</LINK>) and conclusions to date have been promising. These reviews did not systematically search for studies, however, and did not attempt meta-analysis so conclusions are open to bias. Furthermore, they did not consider the full range of possible outcomes in schizophrenia such as the individual's well being and functioning and resulting difficulties incurred by friends and relatives.</P>
<P>It is also possible that early warning signs interventions in schizophrenia might be associated with adverse outcomes, for example increased depression due to increased self-focus required by symptom monitoring. For people with a diagnosis of schizophrenia, those identified as less aware of their symptoms were less likely to report being depressed (<LINK REF="REF-Dixon-1998" TYPE="REFERENCE">Dixon 1998</LINK>). Symptom awareness has also been linked to recurrent suicidal thoughts (<LINK REF="REF-Amador-1996" TYPE="REFERENCE">Amador 1996</LINK>). Another effect might be increased medication due to the possible effect of increased symptom reporting without reducing relapse (<LINK REF="REF-Gaebel-1993" TYPE="REFERENCE">Gaebel 1993</LINK>).</P>
<P>Finally, the effectiveness of early warning signs interventions in schizophrenia might vary according to features of the intervention such as the frequency of monitoring, use of standardised checklists of early warning signs or early warning signs interventions tailored to the individual from previous relapses in that individual, participation of caregivers and health professionals in the monitoring, group- versus individually-delivered early warning signs intervention, severity of illness and the presence or absence of an acute episode of schizophrenia at the time of the intervention, or the existence of co-morbid conditions. Demographic factors such as age and gender should also be taken into account. There is evidence that patients with first episode schizophrenia can benefit from EWS interventions coupled with intermittent medication, but multi-episode cases of schizophrenia must have maintenance medication (<LINK REF="STD-Gaebel-2002" TYPE="STUDY">Gaebel 2002</LINK>).</P>
<CONDITION MODIFIED="2009-03-09 08:48:47 +0000" MODIFIED_BY="[Empty name]">
<P>Most people with schizophrenia experience a cyclical pattern of illness with periods of acute psychotic episodes followed by stable periods of full or partial remission, although these are often accompanied by the presence of residual symptoms (<LINK REF="REF-APA-1997" TYPE="REFERENCE">APA 1997</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>Recognition of early warning signs requires detailed history taking, with or without additional techniques such as diary keeping, completion of questionnaires and card sorting techniques, and a plan of action based on the early warning signs. The interventions may be individually-based or group-based and can involve family members or carers. They can be carried out in any treatment setting.</P>
</INTERVENTION>
<THEORY MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>Early warning interventions are based on the hypothesis that learning to detect and manage EWS of impending relapse might allow treatment or coping strategies to reduce symptoms or reduce the risk of harm thereby preventing or delaying relapse and/or hospitalisations (<LINK REF="REF-Fitzgerald-2001" TYPE="REFERENCE">Fitzgerald 2001</LINK>, <LINK REF="REF-Lam-1997" TYPE="REFERENCE">Lam 1997</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2011-05-23 14:50:39 +0100" MODIFIED_BY="[Empty name]">
<P>Early warning signs interventions are carried out in routine clinical care for people with schizophrenia but their availability and delivery vary considerably from one clinical service to another even in the same locality.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-12-11 14:37:00 +0000" MODIFIED_BY="[Empty name]">
<P>The primary objective was to compare the effectiveness of early warning signs intervention plus treatment as usual versus treatment as usual for those with schizophrenia. Treatment as usual could involve medication plus psychological therapy which did not incorporate early warning signs principles or only medication as part of its care plan.</P>
<P>Another objective was to compare the effectiveness of intermittent medication used on recognition of early warning signs in people not taking maintenance neuroleptic medication with treatment as usual involving maintenance neuroleptic medication.</P>
<P>Other areas of interest were early warning signs as the primary focus of the intervention or as part of another intervention; early warning signs intervention delivered to patient only or patient and carer or health professional; early warning signs intervention delivered to carer only versus carer and patient; early warning signs intervention delivered individually versus group intervention.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>All relevant randomised controlled trials were included. Where a trial was described as 'double-blind' but it implied that the study was randomised and the demographic details of each group were similar, it was included. We excluded quasi-randomised studies, such as those allocated by using alternate days of the week.<BR/>
</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>Adults over the age of 16 with a diagnosis of schizophrenia or a non-affective, non-organic serious or chronic mental illness based on standardised psychiatric criteria (including Research Diagnostic Criteria, DSM IV, ICD-10), at any stage of the disorder and in any treatment setting, or carers/health professionals of people with this diagnosis.</P>
<P>We excluded studies where</P>
<OL>
<LI>the primary diagnosis was another disorder (for example, eating disorders);</LI>
<LI>participants were selected on the basis of a non-psychiatric medical condition (for example, cancer, human immune deficiency syndrome);</LI>
<LI>samples selected for co-morbidity, i.e. addictions and mental illness;</LI>
<LI>'at risk' populations who had not yet received a definite diagnosis of schizophrenia;</LI>
<LI>early onset samples, with no established diagnosis of schizophrenia.</LI>
</OL>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Early warning signs intervention plus treatment as usual</HEADING>
<P>Interventions designed to systematically train people with a diagnosis of schizophrenia to recognise early warning signs of recurrence of episodes. The essential elements of early warning signs monitoring were defined as: i) education to increase awareness of early warning signs and identification of these early warning signs; ii) person with schizophrenia learning to self-monitor for early warning signs (e.g. paranoia), or carers and/or health professionals learning to monitor on behalf of the person with schizophrenia; iii) early action to prevent development of recurrence (e.g. seeking early help or self-coping methods).</P>
<P>Each person in the study must have received at least one hour of training specifically in recognising and managing early warning signs. Therefore, early warning signs interventions require at least one hour of face-to-face clinical contact. Any intervention that included early warning signs interventions either as a major focus or as one component of an intervention package were included. The interventions could have been individually-based or group-based, encompassed self-help approaches, involved family members or carers, and carried out in community, primary care or secondary care settings.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Treatment as usual not involving a psychological therapy</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.Treatment as usual plus another psychological therapy</HEADING>
<P>Studies where both groups simultaneously received the same psychological intervention involving early warning signs interventions were excluded (for example, psychological therapy versus psychological therapy in addition to medication).<BR/>
</P>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2012-11-14 15:48:55 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>1. Relapse</B>
<BR/>1.1 Rate of relapse<BR/>1.2 Time to relapse</P>
<P>
<B>2. Service utilisation</B>
<BR/>2.1 Rate of re-hospitalisation<BR/>2.2 Time to re-hospitalisation</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>1. Mental State</B>
<BR/>1.1 No clinically important change in general mental state (as defined by individual studies)<BR/>1.2 Mean endpoint general mental state score<BR/>1.3 Mean change in general mental state scores<BR/>1.4 No clinically important change in specific symptoms<BR/>1.5 Mean endpoint specific symptom score<BR/>1.6 Mean change in specific symptom scores</P>
<P>
<B>2. Social functioning</B>
<BR/>2.1 Average endpoint general social functioning score<BR/>2.2 Average change in general social functioning scores<BR/>2.3 No clinically important change in specific social functioning<BR/>2.4 Average endpoint specific social functioning score<BR/>2.5 Average change in specific social functioning scores</P>
<P>
<B>3. Quality of life</B>
<BR/>3.1 No clinically important change in quality of life<BR/>3.2 Average endpoint quality of life score<BR/>3.3 Average change in quality of life scores<BR/>3.4 No clinically important change in specific aspects of quality of life<BR/>3.5 Average endpoint specific aspects of quality of life<BR/>3.6 Average change in specific aspects of quality of life</P>
<P>
<B>4. Satisfaction with care</B>
<BR/>4.1 Recipient of care<BR/>4.2 Informal care givers<BR/>4.3 Professional carers</P>
<P>
<B>6. Adverse events</B>
<BR/>6.1 Incidence of adverse effects, general or specific<BR/>6.2 Leaving the study early<BR/>6.3 Measured acceptance of treatment<BR/>6.4 Use of antiparkinsonian treatment<BR/>6.5 Sudden and unexpected death</P>
<P>
<B>7. Economic burden (cost of care)</B>
</P>
<P>
<B>8. Knowledge</B>
<BR/>
</P>
<P>
<B>9. Burden of care</B>
</P>
<P>
<B>10. Medication compliance</B>
</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Cochrane Schizophrenia Group Trials Register (July 2007)</HEADING>
<P>The register was searched using the phrase:</P>
<P>[((sign* OR early sign* OR signs of earl* OR intervention* OR detect*) OR  ((relaps* OR recurren*) AND (prevent* OR predict* OR reduc* OR control*))) AND (((monitor* OR help* OR evaluat* OR) and (self* OR family*)) OR symptom manag* OR manage symptom* OR aware* OR prodrom* OR re-occur* OR reoccur*) in REFERENCE title, abstract and index fields] OR [(training* OR relapse* OR consumer* OR self* OR early*) in STUDY intervention field]</P>
<P>This register is compiled by systematic searches of major databases, handsearches and conference proceedings (see <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/SCHIZ/frame.html">group module</A>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Cochrane Schizophrenia Group Trials Register (May 2012)</HEADING>
<P>We ran another search in 2012. The Trials Search Co-ordinator searched the Cochrane Schizophrenia Group&#8217;s Trials Register (3 May 2012).<BR/>
<BR/>[((sign* OR early sign* OR signs of earl* OR intervention* OR detect*) OR  ((relaps* OR recurren*) AND (prevent* OR predict* OR reduc* OR control*))) AND (((monitor* OR help* OR evaluat* OR) and (self* OR family*)) OR symptom manag* OR manage symptom* OR aware* OR prodrom* OR re-occur* OR reoccur*) in REFERENCE title, abstract and index fields] OR [(training* OR relapse* OR consumer* OR self* OR early*) in STUDY intervention field]</P>
<P>The Cochrane Schizophrenia Group&#8217;s Trials Register is compiled by systematic searches of major databases, handsearches of journals and conference proceedings (see <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/SCHIZ/frame.html">Group Module</A>). Incoming trials are assigned to relevant existing or new review titles.</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-11-13 16:31:15 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Reference lists</HEADING>
<P>We searched all references of articles selected for inclusion for further relevant trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Personal contact</HEADING>
<P>We contacted the first author of each included study for information regarding unpublished trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. NHS National Research Register (NRR):</HEADING>
<P>Using abstracts identified from searching the Cochrane Schizophrenia Group Register, the NRR was inspected for information regarding ongoing research trials, and we contacted the corresponding authors regarding unpublished data.</P>
</SUBSECTION>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>Review author IV inspected all abstracts of studies identified as above and identified potentially relevant reports. In addition, to ensure reliability, review authors MAF and RM inspected a random sample of these abstracts, comprising 30% of the total. Where disagreement occurred, it was resolved by discussion, or where there was still doubt, the full article was acquired for further inspection. The full articles of relevant reports were acquired for reassessment and carefully inspected by IV and MAF for a final decision on inclusion (see <LINK TAG="SELECTION_CRITERIA" TYPE="SECTION">Criteria for considering studies for this review</LINK>). IV and MAF were not blinded to the names of the authors, institutions or journal of publication. Where difficulties or disputes arose, we asked review author RM for help and where it was impossible to decide, these studies were added to those awaiting assessment and the authors of the papers contacted for clarification.</P>
<P>For the May 2012 search two members of the Enhance Review inspected full reports of trials selected by the original team of authors.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Extraction</HEADING>
<P>Review authors IV and MF extracted data from all included studies found in the July 2007 search. To ensure reliability, RM independently extracted data from a random sample of these studies, comprising 30% of the total. Again, any disagreement was discussed, decisions documented and, if necessary, authors of studies contacted for clarification. With remaining problems RM helped clarify issues and those final decisions documented. Data presented only in graphs and figures were extracted whenever possible, but only included if two review authors independently had the same result. Where possible, we extracted data relevant to each component centre of multi-centre studies separately.<BR/>For the May 2012 search two members of the Enhance Reviews team extracted data, using above methods, for the included studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Management</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Forms</HEADING>
<P>A form for data collection was created, piloted in three trials independently by two review authors, and revised after author discussion. We extracted data onto these forms.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Scale-derived data</HEADING>
<P>We included continuous data from rating scales only if: a) the psychometric properties of the measuring instrument have been described in a peer-reviewed journal (<LINK REF="REF-Marshall-2000" TYPE="REFERENCE">Marshall 2000</LINK>); and b) the measuring instrument was not written or modified by one of the trialists for that particular trial.<BR/>
<BR/>Ideally, the measuring instrument should either be i. a self-report or ii. completed by an independent rater or relative (not the therapist). We realise that this is not often reported clearly but in the <LINK TAG="STUDY_DESCRIPTION" TYPE="SECTION">Description of studies</LINK> section, we noted if this is the case or not.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.3 Endpoint versus change data</HEADING>
<P>There are advantages of both endpoint and change data. Change data can remove a component of between-person variability from the analysis. On the other hand, calculation of change needs two assessments (baseline and endpoint) which can be difficult in unstable and difficult to measure conditions such as schizophrenia. We decided primarily to use endpoint data and only use change data if the former were not available. Endpoint and change data were combined in the analysis as we used mean differences rather than standardised mean differences throughout (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, chapter 9.4.5.2 ). All data in the analyses are endpoint data unless marked in a footnote as change data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.4 Skewed data</HEADING>
<P>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non-parametric data, we aimed to apply the following standards to all data before inclusion:</P>
<P>a) standard deviations (SDs) and means are reported in the paper or obtainable from the authors;<BR/>b) when a scale starts from the finite number zero, the SD, when multiplied by two, is less than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution, (<LINK REF="REF-Altman-1996" TYPE="REFERENCE">Altman 1996</LINK>);<BR/>c) if a scale starts from a positive value (such as the Positive and Negative Syndrome Scale (PANSS) (<LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>) which can have values from 30 to 210), the calculation described above was modified to take the scale starting point into account. In these cases skew is present if 2 SD &gt; (S-S min), where S is the mean score and S min is the minimum score. Endpoint scores on scales often have a finite start and end point and these rules can be applied. When continuous data are presented on a scale that includes a possibility of negative values (such as change data), it is difficult to tell whether data are skewed or not. Skewed data from studies of less than 200 participants were entered in additional tables (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) rather than into an analysis. Skewed data pose less of a problem when looking at means if the sample size is large and was entered into the syntheses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.5 Common measure</HEADING>
<P>To facilitate comparison between trials, we converted variables that can be reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.6 Conversion of continuous to binary</HEADING>
<P>Where possible, efforts were made to convert outcome measures to dichotomous data. This can be done by identifying cut-off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there is a 50% reduction in a scale-derived score such as the Brief Psychiatric Rating Scale (BPRS, <LINK REF="REF-Overall-1962" TYPE="REFERENCE">Overall 1962</LINK>) or the PANSS (<LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>), this can be considered as a clinically significant response (<LINK REF="REF-Leucht-2005a" TYPE="REFERENCE">Leucht 2005a</LINK>; <LINK REF="REF-Leucht-2005" TYPE="REFERENCE">Leucht 2005</LINK>). If data based on these thresholds were not available, we used the primary cut-off presented by the original authors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.7 Direction of graphs</HEADING>
<P>Where possible, we entered data in such a way that the area to the left of the line of no effect indicates a favourable outcome for treatment with antipsychotic combinations.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.8 'Summary of findings' table</HEADING>
<P>We used the GRADE approach to interpret findings (<LINK REF="REF-Sch_x00fc_nemann-2008" TYPE="REFERENCE">Schünemann 2008</LINK>) and used GRADE profiler (<LINK REF="REF-GRADE-2004" TYPE="REFERENCE">GRADE 2004</LINK>) to import data from RevMan 5 (<LINK REF="REF-Review-Manager-2011" TYPE="REFERENCE">Review Manager 2011</LINK>) to create 'Summary of findings' tables. These tables provide outcome-specific information concerning the overall quality of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes we rate as important to patient-care and decision making. If possible, we anticipated selecting the following main outcomes for inclusion in the 'Summary of findings' table.</P>
<OL>
<LI>Relapse: time to relapse</LI>
<LI>Relapse: rate of relapse</LI>
<LI>Service use: time to re-hospitalisation</LI>
<LI>Service use: rate of re-hospitalisation</LI>
<LI>Satisfaction with care</LI>
<LI>Adverse events: lost to follow-up</LI>
<LI>Economic burden (cost of care)</LI>
</OL>
</SUBSECTION>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<P>Review authors IV and MF independently assessed the risk of bias of each trial using The Cochrane Collaboration's 'Risk of bias' tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). This set of criteria is based on evidence of associations between overestimate of effect and high risk of bias of the article such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. Due to the nature of the intervention, it was not possible to blind participants or personnel and we marked this as low risk of bias for all studies. If the raters disagreed, the final rating was made by consensus, with the involvement of another member of the review group. Where inadequate details of randomisation and other characteristics of trials were provided, we contacted authors of the studies in order to obtain further information. Non-concurrence in quality assessment was reported, but if disputes arose as to which category a trial is to be allocated, again, resolution was made by discussion with RM. The level of risk of bias was noted in both the text of the review and in the <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>. Two members of the Enhance Review team performed the risk of bias for the included studies from the May 2012 search.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Binary data</HEADING>
<P>For binary outcomes we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI). It has been shown that RR is more intuitive (<LINK REF="REF-Boissel-1999" TYPE="REFERENCE">Boissel 1999</LINK>) than odds ratios and that odds ratios tend to be interpreted as RR by clinicians (<LINK REF="REF-Deeks-2000" TYPE="REFERENCE">Deeks 2000</LINK>). For binary data presented in the 'Summary of findings' table, where possible, we calculated illustrative comparative risks as the Number Needed to Treat/Harm (NNT/H) statistic with its confidence intervals is intuitively attractive to clinicians but is problematic both in its accurate calculation in meta-analyses and interpretation (<LINK REF="REF-Hutton-2009" TYPE="REFERENCE">Hutton 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Continuous data</HEADING>
<P>For continuous outcomes we estimated mean difference (MD) between groups. We preferred not to calculate effect size measures (standardised mean difference (SMD)). However, if scales of very considerable similarity were used, we presumed there was a small difference in measurement, and we calculated effect size and transformed the effect back to the units of one or more of the specific instruments.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Time to event data</HEADING>
<P>The outcomes &#8220;time to relapse&#8221; and "time to re-hospitalisation" were analysed using the Cox proportional hazard ratio (HR) and associated 95 % CI which takes into account the number and timing of events, and the time until last follow-up for each patient who has not experienced the event (<LINK REF="REF-Borenstein-2009" TYPE="REFERENCE">Borenstein 2009</LINK>; <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK>).</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-01-07 11:15:28 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Cluster trials</HEADING>
<P>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. Firstly, authors often fail to account for intra-class correlation in clustered studies, leading to a 'unit of analysis' error (<LINK REF="REF-Divine-1992" TYPE="REFERENCE">Divine 1992</LINK>) whereby P values are spuriously low, confidence intervals unduly narrow and statistical significance overestimated. This causes type I errors (<LINK REF="REF-Bland-1997" TYPE="REFERENCE">Bland 1997</LINK>; <LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>). If clustering had not been accounted for in primary studies, we planned to present data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review we will seek to contact first authors of studies to obtain intra-class correlation coefficients (ICCs) for their clustered data and to adjust for this by using accepted methods (<LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>). Where clustering has been incorporated into the analysis of primary studies, we presented these data as if from a non-cluster randomised study, but adjusted for the clustering effect. We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and ICC [Design effect = 1+(m-1)*ICC] (<LINK REF="REF-Donner-2002" TYPE="REFERENCE">Donner 2002</LINK>). If the ICC was not reported it was assumed to be 0.1 (<LINK REF="REF-Ukoumunne-1999" TYPE="REFERENCE">Ukoumunne 1999</LINK>). If cluster studies had appropriately analysed taking into account ICCs and relevant data documented in the report, synthesis with other studies was possible using the generic inverse variance technique.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Cross-over trials</HEADING>
<P>A major concern of cross-over trials is the carry-over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase the participants can differ systematically from their initial state despite a wash-out phase. For the same reason cross-over trials are not appropriate if the condition of interest is unstable (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). As both effects are very likely in severe mental illness, we only used data of the first phase of cross-over studies.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Studies with multiple treatment groups</HEADING>
<P>Where a study involved more than two treatment arms, if relevant, the additional treatment arms were presented in comparisons. If data were binary we planned to simply add and combine within the two-by-two table. If data were continuous we planned to combine data following the formula in section 7.7.3.8 (Combining groups) of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I>. For studies where each pair-wise comparison was relevant, we planned to include separately, with the shared intervention groups divided out approximately evenly among the comparisons: only the total number of participants were divided up and the means and standard deviations left unchanged, according to section 16.5.4 (How to include multiple groups from one study) of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I>. This differs from the original protocol (see <LINK TAG="PRO_REV_DIFF" TYPE="SECTION">Differences between protocol and review</LINK>). Where the additional treatment arms were not relevant, these data were not reproduced.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Overall loss of credibility</HEADING>
<P>If loss of data at follow-up becomes too great, then the study itself runs the risk of losing credibility (<LINK REF="REF-Xia-2009" TYPE="REFERENCE">Xia 2009</LINK>). We chose that, for any particular outcome, had more than 50% of data be unaccounted for, we did not reproduce these data or use them within analyses. Where, however, more than 50% of those in one arm of a study were lost, but the total loss was less than 50%, we marked such data with (*) to indicate that such a result may well be prone to bias.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Binary</HEADING>
<P>In the case where attrition for a binary outcome was between 0% and 50% and where these data were not clearly described, data were presented on a 'once-randomised-always-analyse' basis (an intention-to-treat analysis). Those leaving the study early were all assumed to have the same rates of negative outcome as those who completed, with the exception of the outcome of death and adverse effects. For these outcomes the rate of those who stayed in the study - in that particular arm of the trial - were used for those who did not. A sensitivity analysis was undertaken to test how prone the primary outcomes were to change when 'completer' data only were compared to the intention-to-treat analysis using the above assumptions.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Continuous</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Attrition</HEADING>
<P>In the case where attrition for a continuous outcome was between 0% and 50% and completer-only data were reported, we reproduced these.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.2 Standard deviations</HEADING>
<P>If standard deviations (SDs) were not reported, we first tried to obtain the missing values from the authors. If not available, where there were missing measures of variance for continuous data, but an exact standard error (SE) and confidence intervals (CIs) were available for group means, and either 'P' value or 't' values were available for differences in mean, we calculated them according to the rules described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>): When only the SE is reported, SDs are calculated by the formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) present detailed formula for estimating SDs from P values, t or F values, CIs, ranges or other statistics. Where these formulae do not apply, we calculated the SDs according to a validated imputation method which is based on the SDs of the other included studies (<LINK REF="REF-Furukawa-2006" TYPE="REFERENCE">Furukawa 2006</LINK>). Although some of these imputation strategies can introduce error, the alternative would have been to exclude a given study&#8217;s outcome and thus to lose information. We nevertheless examined the validity of the imputations in a sensitivity analysis excluding imputed values.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.3 Last observation carried forward</HEADING>
<P>We anticipated that in some studies the method of last observation carried forward (LOCF) will be employed within the study report. As with all methods of imputation to deal with missing data, LOCF introduces uncertainty about the reliability of the results (<LINK REF="REF-Leucht-2007" TYPE="REFERENCE">Leucht 2007</LINK>). Therefore, where LOCF data have been used in the trial, if less than 50% of the data have been assumed, we reproduced these data and indicated that they are the product of LOCF assumptions.</P>
</SUBSECTION>
</SUBSECTION>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Clinical heterogeneity</HEADING>
<P>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying people or situations which we had not predicted would arise. When such situations or participant groups arose, these were fully discussed.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Methodological heterogeneity</HEADING>
<P>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods which we had not predicted would arise. When such methodological outliers arose these were fully discussed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Statistical heterogeneity</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Visual inspection</HEADING>
<P>We visually inspected graphs to investigate the possibility of statistical heterogeneity.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.2 Employing the I<SUP>2</SUP> statistic</HEADING>
<P>Heterogeneity between studies was investigated by considering the I<SUP>2</SUP> method alongside the Chi<SUP>2</SUP> 'P' value. The I<SUP>2</SUP> provides an estimate of the percentage of inconsistency thought to be due to chance (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The importance of the observed value of I<SUP>2</SUP> depends on i. the magnitude and direction of effects and ii. the strength of evidence for heterogeneity (e.g. 'P' value from Chi<SUP>2</SUP> test, or a confidence interval for I<SUP>2</SUP>). An I<SUP>2</SUP> estimate greater than or equal to around 50% accompanied by a statistically significant Chi<SUP>2</SUP> statistic was interpreted as evidence of substantial levels of heterogeneity (Section 9.5.2 - <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). When substantial levels of heterogeneity were found in the primary outcome, we explored reasons for heterogeneity (<LINK TAG="SUBGROUP_ANALYSIS" TYPE="SECTION">Subgroup analysis and investigation of heterogeneity</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<P>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). These are described in Section 10 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small-study effects. We did not use funnel plots for outcomes where there were 10 or fewer studies, or where all studies were of similar sizes. In other cases, where funnel plots were possible, we sought statistical advice in their interpretation.<BR/>
</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<P>We understand that there is no closed argument for preference for use of fixed-effect or random-effects models. The random-effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random-effects model takes into account differences between studies even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random-effects model. It puts added weight onto small studies which often are the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. A fixed-effect model was used, unless we demonstrated statistically significant heterogeneity (P &lt; 0.10) for a specific outcome, in which case the random-effects models was preferred. The reader is, however, able to choose to inspect the data using the random-effects model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Subgroup analyses</HEADING>
<P>We conducted subgroup analyses for the primary outcomes comparing:</P>
<UL>
<LI>early warning signs training as the main focus of the intervention versus early warning signs training not the main focus of the intervention</LI>
<LI>patients only versus patients and carers/health workers</LI>
<LI>carers/health workers only versus patients and carers/health workers</LI>
<LI>group training versus individual training.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Investigation of heterogeneity</HEADING>
<P>If inconsistency was high (I<SUP>2</SUP> &gt; 75%), this was reported. First, we investigated whether data had been entered correctly. Second, if data were correct, the graph was visually inspected and outlying studies were successively removed to see if heterogeneity was restored.</P>
<P>When unanticipated clinical or methodological heterogeneity were obvious, we simply stated hypotheses regarding these for future reviews or versions of this review. We did not anticipate undertaking analyses relating to these.<BR/>
</P>
</SUBSECTION>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Implication of randomisation</HEADING>
<P>We aimed to include trials in a sensitivity analysis if they were described in a way that implied randomisation. For the primary outcomes, we included these studies and if there was no substantive difference when the implied randomised studies were added to those with better description of randomisation, then all data were employed from these studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Assumptions for lost data</HEADING>
<P>Where assumptions had to be made regarding missing SDs data (see <LINK TAG="MISSING_DATA" TYPE="SECTION">Dealing with missing data</LINK>), we compared the findings on primary outcomes when we used our assumption compared with complete data only. We undertook a sensitivity analysis to test how prone results were to change when 'completer' data only were compared to the imputed data using the above assumption. If there was a substantial difference, we reported results and discussed them but continued to employ our assumption.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Imputed data</HEADING>
<P>Where time to event data had to be imputed, we compared the imputed data with data that did not have to be imputed and reported any differences in results.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-01-07 11:19:00 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-01-07 11:19:00 +0000" MODIFIED_BY="[Empty name]">
<P>Please see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>, and <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>.</P>
<P>In Additional Tables (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> and <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>) we categorised all studies by:</P>
<SUBSECTION>
<HEADING LEVEL="6">1. Target of intervention</HEADING>
<P>1.1 Intervention targeted at patient's own recognition of early warning symptoms;<BR/>1.2 Interventions targeted at recognition of early warning symptoms by carers or health professionals;<BR/>1.3 Interventions that are targeted at both patient and carers.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2. Individual or group treatment</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">3. Focus of intervention: early warning signs is primary focus of intervention or one component of a multifaceted intervention.</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">4. Intervention as an addition or replacement for treatment as usual</HEADING>
<P>4.1 Intervention targeting early warning symptoms plus treatment as usual (TAU) versus treatment as usual not including psychological treatment;<BR/>4.2 Early warning signs intervention plus treatment as usual versus another psychological treatment not involving early warning signs intervention plus treatment as usual;<BR/>4.3 Early warning signs intervention with intermittent medication use in presence of early warning signs without continued medication versus treatment as usual using continued medication;<BR/>4.4 Early warning signs intervention involves only help seeking from others or early warning signs intervention involves other self-directed coping.</P>
</SUBSECTION>
<SEARCH_RESULTS MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<P>The search of electronic databases retrieved a total of 1784 citations. Agreement about which reports may have been randomised was 100% and 205 of the original reports were selected and ordered. Thirty-four trials met all the criteria for study selection for this review (see '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>').</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<P>The current review includes 41 reports describing 34 studies (<LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>; <LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK>; <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>; <LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>; <LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK>; <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>; <LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>; <LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK>; <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>; <LINK REF="STD-Granholm-2005" TYPE="STUDY">Granholm 2005</LINK>; <LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK>; <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>; <LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>; <LINK REF="STD-Hogarty-1997a" TYPE="STUDY">Hogarty 1997a</LINK>; <LINK REF="STD-Horan-2009" TYPE="STUDY">Horan 2009</LINK>; <LINK REF="STD-Kopelowicz-1998a" TYPE="STUDY">Kopelowicz 1998a</LINK>; <LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK>; <LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK>; <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>; <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>; <LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK>; <LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>; <LINK REF="STD-Norman-2002" TYPE="STUDY">Norman 2002</LINK>; <LINK REF="STD-Shin-2002" TYPE="STUDY">Shin 2002</LINK>; <LINK REF="STD-Shon-2002" TYPE="STUDY">Shon 2002</LINK>; <LINK REF="STD-Tait-2002" TYPE="STUDY">Tait 2002</LINK>; <LINK REF="STD-Turkington-2006" TYPE="STUDY">Turkington 2006</LINK>; <LINK REF="STD-Van-Meijel-2006" TYPE="STUDY">Van Meijel 2006</LINK>; <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>; <LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK>; <LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK>; <LINK REF="STD-Xiong-1994" TYPE="STUDY">Xiong 1994</LINK>; <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>; <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>). This review includes data on 3554 randomised people from within these 34 separate trials.</P>
<P>Details of contact with authors can be found in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Methods</HEADING>
<P>All studies were stated to be randomised. Thirty-two studies were randomised controlled trials (RCTs) and two were cluster-RCTS (<LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>; <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>). Due to the nature of the intervention, none of the studies were double-blind, 16 studies were single-blind, stating that the assessors were blinded to the participant's treatment allocation (<LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK>; <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>; <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>; <LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>; <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>; <LINK REF="STD-Granholm-2005" TYPE="STUDY">Granholm 2005</LINK>; <LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>; <LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK>; <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>; <LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>; <LINK REF="STD-Norman-2002" TYPE="STUDY">Norman 2002</LINK>; <LINK REF="STD-Turkington-2006" TYPE="STUDY">Turkington 2006</LINK>; <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>; <LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK>; <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>; <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>), four studies were not blinded or had inadequate blinding (<LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>; <LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK>; <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>; <LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK>) and blinding was unclear in the remaining 14 trials. For further details please see sections below on <LINK TAG="ALLOCATION" TYPE="SECTION">Allocation (selection bias)</LINK> and <LINK TAG="BLINDING" TYPE="SECTION">Blinding (performance bias and detection bias)</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Duration</HEADING>
<P>Most trials were undertaken between nine months and two years (<LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK>; <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>; <LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>; <LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK>; <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>; <LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>; <LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK>; <LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK>; <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>; <LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>; <LINK REF="STD-Kopelowicz-1998a" TYPE="STUDY">Kopelowicz 1998a</LINK>; <LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK>; <LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK>; <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>; <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>; <LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>; <LINK REF="STD-Norman-2002" TYPE="STUDY">Norman 2002</LINK>; <LINK REF="STD-Tait-2002" TYPE="STUDY">Tait 2002</LINK>; <LINK REF="STD-Turkington-2006" TYPE="STUDY">Turkington 2006</LINK>; <LINK REF="STD-Van-Meijel-2006" TYPE="STUDY">Van Meijel 2006</LINK>; <LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK>; <LINK REF="STD-Xiong-1994" TYPE="STUDY">Xiong 1994</LINK>; <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>; <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>), six studies were less than six months (<LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>; <LINK REF="STD-Granholm-2005" TYPE="STUDY">Granholm 2005</LINK>; <LINK REF="STD-Horan-2009" TYPE="STUDY">Horan 2009</LINK>; <LINK REF="STD-Shin-2002" TYPE="STUDY">Shin 2002</LINK>; <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>; <LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK>) and two studies had three years follow-up (<LINK REF="STD-Hogarty-1997a" TYPE="STUDY">Hogarty 1997a</LINK>; <LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Participants</HEADING>
<P>All participants were people with a chronic mental illness, mostly with schizophrenia and schizophrenia-like disorders. All studies except five included both sexes; <LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>, <LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK> and <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK> did not report the sex of the participants, <LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK> and <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK> included only male participants. The mean age for studies that reported this ranged from 28 years to 54 years.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Setting</HEADING>
<P>All studies were in a secondary care setting. Eleven studies took place in North America, 11 in Europe, 11 in East Asia and one in Australia.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Interventions</HEADING>
<P>For full details of the interventions please see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> and <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>.</P>
<P>Thirty-two studies include early warning signs recognition as part of other psychological interventions. Six studies had recognition of early warning signs as a primary focus (<LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>; <LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>; <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>; <LINK REF="STD-Shon-2002" TYPE="STUDY">Shon 2002</LINK>; <LINK REF="STD-Tait-2002" TYPE="STUDY">Tait 2002</LINK>; <LINK REF="STD-Van-Meijel-2006" TYPE="STUDY">Van Meijel 2006</LINK>). In all studies early warning signs interventions provided education to the patient about the nature of schizophrenia as well as early warning sign recognition and management in addition to treatment as usual. Twenty-three studies had the control group with only treatment as usual, three studies had a control group including treatment as usual and another psychological therapy, in four studies the control groups included treatment as usual and occupational therapy (<LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>; <LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK>; <LINK REF="STD-Kopelowicz-1998a" TYPE="STUDY">Kopelowicz 1998a</LINK>; <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>), three also included social and recreational activities (<LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK>; <LINK REF="STD-Norman-2002" TYPE="STUDY">Norman 2002</LINK>; <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>), and in one study, the control group received social skills training (<LINK REF="STD-Horan-2009" TYPE="STUDY">Horan 2009</LINK>). Six studies delivered the intervention to individuals, 16 delivered it in groups, five to both groups and individually, and in the remaining studies it was either unclear or not reported.</P>
<P>In 20 studies the early warning signs training was delivered to the patients only. In 11 studies the families or carers of the participants were included in the early warning signs programme, and in one study family involvement was optional (<LINK REF="STD-Shin-2002" TYPE="STUDY">Shin 2002</LINK>). In two of these studies, treatment as usual also included family support services (<LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>; <LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>).  <LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK> and <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK> used cognitive behavioural therapy (CBT) as part of the early warning signs intervention and in <LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>, one of the early warning signs interventions was cognitive psychotherapy.</P>
<P>In three studies the intervention was delivered to the carer/health professional only. In <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>, a cluster-RCT, although the study included interventions for both the patients and their families, only families received early warning signs training. In <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>, there were two treatment pathways: one for patients who had a carer and one for patients without carers. In the no-carer pathway patients were randomised to CBT with early warning signs training or treatment as usual. In the carer pathway, patients were randomised to CBT with early warning signs training, treatment as usual or family intervention in which only the family members received early warning signs training. <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK> was a cluster-RCT in which community health professionals were trained in an experimental medication management training programme that included early warning signs work and relapse prevention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Outcomes scales</HEADING>
<P>Scales that provided useable data are described below.</P>
<SUBSECTION>
<HEADING LEVEL="5">6.1 Mental state</HEADING>
<P>i) Positive and Negative Syndromes Scale - PANSS (<LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>) in <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>, <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>, <LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK>, <LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK> and <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>.<BR/>This scale is used for measuring symptom reduction of patients with schizophrenia and was conceived as an operationalised, drug-sensitive instrument that provides balanced representation of positive and negative symptoms and gauges their relationship to one another and to global psychopathology. It consists of four scales measuring positive and negative syndromes, their differential and general severity of illness. The name refers to the two types of symptoms in schizophrenia as defined by the American Psychiatric Association: positive symptoms, which refer to an excess or distortion of normal functions, and negative symptoms, which represent a diminution or loss of normal functions. High scores suggest greater psychopathology.<BR/>PANSS positive syndrome range from seven to 48<BR/>PANSS negative syndrome range from seven to 48<BR/>PANSS general psychopathology range from 16-96</P>
<P>ii) Brief Psychopathology Rating Scale &#8211; BPRS (<LINK REF="REF-Overall-1962" TYPE="REFERENCE">Overall 1962</LINK>) in <LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK>, <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>, <LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>, <LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>, <LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK>, <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>, <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>; <LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>, <LINK REF="STD-Shin-2002" TYPE="STUDY">Shin 2002</LINK>, <LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK>, <LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK> and <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>.<BR/>A brief rating scale used to assess the severity of a range of psychiatric symptoms, including psychotic symptoms. The scale has 16 items, and each item can be defined on a seven-point scale varying from 'not present' (0) to 'extremely severe' (6). High scores suggest greater psychopathology.</P>
<P>iii) Scale for the Assessment of Negative Symptoms - SANS (<LINK REF="REF-Andreasen-1983" TYPE="REFERENCE">Andreasen 1983</LINK>) in <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>, <LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK> and <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>.<BR/>This scale allows a global rating of the following negative symptoms: alogia (impoverished thinking), affective blunting, avolition-apathy, anhedonia-asociality, and attention impairment. Assessments are made on a six-point scale from zero (not at all) to five (severe). Higher scores indicate more symptoms.</P>
<P>iv) Scale for the Assessment of Positive Symptoms - SAPS (<LINK REF="REF-Andreasen-1983" TYPE="REFERENCE">Andreasen 1983</LINK>) in <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>.<BR/>This scale is designed to assess positive symptoms that occur in schizophrenia. On a zero to five-point system, the scale measures four domains including hallucinations, delusions, bizarre behaviour and positive formal thought disorder. Higher scores indicate more symptoms.</P>
<P>v) Psychiatric Assessment Scale &#8211; PAS (<LINK REF="REF-Krawiecka-1977" TYPE="REFERENCE">Krawiecka 1977</LINK>) in <LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK>.<BR/>This is a simple, five-point scale that measures the symptomatology of chronic psychotic patients. It consists of eight categories of symptoms: depression, anxiety, hallucinations, delusions, flattened incongruous affect, psychomotor retardation, incoherence and irrelevance of speech, and poverty of speech. High scores indicate greater psychopathology.</P>
<P>vi) Krawiecka-Goldberg-Vaughan scale - KGV (<LINK REF="REF-Krawiecka-1977" TYPE="REFERENCE">Krawiecka 1977</LINK>) in <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>.<BR/>This scale measures symptoms of psychotic illnesses such as schizophrenia and bipolar affective disorder. The measure comprises 14 symptoms and each symptom is rated on a scale from zero to three. Higher scores indicate more symptoms.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.2 Social Functioning</HEADING>
<P>i) Rehabilitation Evaluation Hall and Baker - REHAB (<LINK REF="REF-Baker-1988" TYPE="REFERENCE">Baker 1988</LINK>) in <LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>.<BR/>This is a 23-item behaviour rating scale for use with people with chronic psychiatric disability. It measures personal, social and life skills that are important in reintegrating into the community. Scores range from five to 115. Higher scores indicate worse functioning.</P>
<P>ii) Health of the Nation Outcome Scale &#8211; HoNOS (<LINK REF="REF-Wing-1998" TYPE="REFERENCE">Wing 1998</LINK>) in <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>.<BR/>This scale combines 12 outcomes scales, each measured on a five-point scale, which covers physical, personal and social problems associated with mental illness. High score indicate worse functioning.</P>
<P>iii) Global Assessment of Functioning - GAF (<LINK REF="REF-APA-1987" TYPE="REFERENCE">APA 1987</LINK>) in <LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK> and <LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>.<BR/>This scale measures the level of psychological, social, and occupational functioning of psychiatric patients. Possible scores range from one to 90. High scores indicate better functioning.</P>
<P>iv) Global Assessment of Functioning GAF-DIS (<LINK REF="REF-Goldman-1992" TYPE="REFERENCE">Goldman 1992</LINK>) in <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>.<BR/>This version of the GAF focuses on functioning, and does not combine this with symptoms. Scores also range from one to 90. High scores indicate better functioning.</P>
<P>v) GAS Global Assessment Scale - GAS (<LINK REF="REF-Endicott-1976" TYPE="REFERENCE">Endicott 1976</LINK>) in <LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>, <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK> and <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>.<BR/>This is an observer-rated scale for evaluating the overall functioning of an individual during a specified time period on a continuum from psychological or psychiatric sickness to health. Score ranges from zero to 100, where a higher score indicates better functioning.</P>
<P>vi) Independent Living Skills Survey &#8211; ILSS (<LINK REF="REF-Wallace-2000" TYPE="REFERENCE">Wallace 2000</LINK>) in <LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK>.<BR/>This survey measures the functional living skills of individuals with severe and persistent mental illness. It includes 103 items covering basic community living skills and is completed by a key relative on an 11-point Likert scale. A high score indicates better functioning.</P>
<P>vii) Specific Level of Functioning assessment scale - SLOF (<LINK REF="REF-Schneider-1983" TYPE="REFERENCE">Schneider 1983</LINK>) in <LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>.<BR/>This scale includes 43 behavioural items measured on a five-point Likert scale. There are six domains that are measured: physical functioning, personal care skills, interpersonal relationships, social acceptability, activities of community living, and work skills. A high score indicates better functioning.</P>
<P>viii) Time budget interview (<LINK REF="REF-Jolley-2006" TYPE="REFERENCE">Jolley 2006</LINK>) in <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>.<BR/>The time budget interview is a measure of social functioning that records activity. It is an interview with participants, in which a week-long diary is retrospectively completed in four time periods for each day. It covers domestic activities, social contacts, work and leisure. The activities are then scored, higher scores represent more complex activities, and better functioning.<BR/>
</P>
<P>ix) Social and Occupational Functioning Assessment Scale - SOFAS (<LINK REF="REF-APA-1994" TYPE="REFERENCE">APA 1994</LINK>) in <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>.<BR/>This scale measures social and occupational functioning. It is rated from zero to100, high scores indicate better functioning.<BR/>
</P>
<P>x) SDSS (WHO 1998) in <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK> and <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>.<BR/>This scale measures 10 aspects of social activities and roles. It is a Chinese simplified version of the WHO's Disability Assessment Schedule. Higher scores indicate worse functioning.<BR/>
</P>
<P>xi) Social Functioning Scale - SFS (<LINK REF="REF-Birchwood-1990" TYPE="REFERENCE">Birchwood 1990</LINK>) in <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>.<BR/>This is a clinician rated scale that measures the level of social functioning seven areas. Higher scores indicate higher functioning.<BR/>
</P>
<P>xii) Nurses' Observation Scale for Inpatient Evaluation - NOSIE (<LINK REF="REF-Honigfeld-1965" TYPE="REFERENCE">Honigfeld 1965</LINK>) in <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>, <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK> and <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>.<BR/>This is a 30-item scale designed to assess the behaviour of patients on an inpatient unit. It is simple to administer, and may be used to assess patients that may be too ill to participate in more interactive rating scales. High scores indicate better functioning.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.3 Satisfaction with care</HEADING>
<P>i) International Association of Psychosocial Rehabilitation Services toolkit &#8211; IAPSRS (<LINK REF="REF-Arns-2001" TYPE="REFERENCE">Arns 2001</LINK>) in <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>.<BR/>This is self-reported measure of 20-items on four sub scales: empowerment, mastery, life satisfaction and programme satisfaction. A high score indicates more satisfaction.</P>
<P>ii) Versona Service Satisfaction Scale &#8211; VSSS (<LINK REF="REF-Ruggeri-1993" TYPE="REFERENCE">Ruggeri 1993</LINK>) in <LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>.<BR/>This scale is a method for measuring service satisfaction of patients with mental health services. It consists of 82 items, measured on a five-point Likert scale. High scores indicate more satisfaction.</P>
<P>iii) California Psychotherapy Alliance Scale - CALPAS (<LINK REF="REF-Gaston-1993" TYPE="REFERENCE">Gaston 1993</LINK>) in <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>.<BR/>This is a 24-item scale that measures participants' perception of involvement in treatment. Higher scores indicate higher perception of involvement.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4 Knowledge</HEADING>
<P>i) Knowledge about Schizophrenia Questionnaire &#8211; KASQ (<LINK REF="REF-Ascher_x002d_Svanum-1999" TYPE="REFERENCE">Ascher-Svanum 1999</LINK>) in <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>.<BR/>This scale assess schizophrenic patients&#8217; knowledge about their illness and its management, including the diagnosis of schizophrenia and its prevalence, aetiology, course and prognosis, knowledge about medication and its side-effects, psychological treatments, stress factors and legal issues. It is a 25-item multiple-choice test. High scores indicate greater knowledge.</P>
<P>ii) Insight scale &#8211; IS (<LINK REF="REF-Birchwood-1994" TYPE="REFERENCE">Birchwood 1994</LINK>) in <LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>.<BR/>This is an eight-item questionnaire, which measures on a three-point scale insight in psychosis across three factors: awareness of illness, need for treatment, and attribution of symptoms. Higher scores indicate better insight.</P>
<P>ii) Scale of Unawareness of Mental Disorder - SUMD (<LINK REF="REF-Amador-1993" TYPE="REFERENCE">Amador 1993</LINK>) in <LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK>.<BR/>This is a 20-item scale measuring the past and present awareness of having a mental disorder, the effect of medications, the consequences of mental illness, and the awareness and attribution of the symptom items. It is measured on a five-point scale. Higher scores indicate worse insight.</P>
<P>iii) Insight and Treatment Attitude Questionnaire - ITAQ (<LINK REF="REF-McEvoy-1989" TYPE="REFERENCE">McEvoy 1989</LINK>) in <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK> and <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>.<BR/>The ITAQ is a semi-structured interview of 11 items that measures awareness of illness (first five items) and attitude to medication/hospitalisation and follow-up evaluation (six items). Scores range from zero (no insight) to 22 (full insight).</P>
<P>iv) Drug Attitude Inventory - DAI (<LINK REF="REF-Hogan-1983" TYPE="REFERENCE">Hogan 1983</LINK>) in <LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>.<BR/>This is a self-rating scale that measures attitude to treatment. It consists of 30 statements about attitudes to psychotropic medication. Total scores can range from +30 to -30, with positive scores predicting adherence to medication.</P>
<P>v) Knowledge About Schizophrenia Interview - KASI (<LINK REF="REF-Tarrier-1990" TYPE="REFERENCE">Tarrier 1990</LINK>) in <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>.<BR/>This interview measures families and carers' knowledge about schizophrenia, including six areas: diagnosis, symptomology, aetiology, medication, prognosis and management. Higher scores indicate more knowledge.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.5 Quality of Life</HEADING>
<P>i) Quality of Life Scale - QLS (<LINK REF="REF-Heinrich-1984" TYPE="REFERENCE">Heinrich 1984</LINK>) in <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>.<BR/>This six-point quality of life scale has been designed as an outcome instrument for schizophrenic deficit syndrome as well as to measure impaired functioning in studies of chronic schizophrenia, to assess the deficit syndrome's impact on the patient's life. There are seven severity steps (zero to six, six being adequately functioning and zero being deficient). The time frame is one month. Four item categories have been identified by factor analysis 1) interpersonal relationships (seven items), 2) instrumental role (four items), 3) intrapsychic function (seven items) and 4) commonplace objects and activities. Higher scores indicate greater quality of life.</P>
<P>ii) Lancashire Quality of Life Profile - LQLP (<LINK REF="REF-Priebe-1998" TYPE="REFERENCE">Priebe 1998</LINK>) in <LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK>.<BR/>This scale includes both objective and subjective measures of quality of life. The 27-item subjective measures cover nine domains: work and education, leisure and participation, religion, finance, living situation, legal and safety, family relations, social relations and health. it is scored on a seven-point scale. High scores indicate greater quality of life.</P>
<P>iii) EuroQoL (<LINK REF="REF-Brazier-1993" TYPE="REFERENCE">Brazier 1993</LINK>) in <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>.<BR/>The EuroQol is a self-reported questionnaire, measuring health-related quality of life. Higher scores indicate greater quality of life.</P>
<P>iv) Lehman Quality of Life Scale - LQoLS (<LINK REF="REF-Lehman-1988" TYPE="REFERENCE">Lehman 1988</LINK>) in <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>.<BR/>This is a structured, 45-minute qualify of life Interview for the chronically mentally ill. Higher scores indicate greater quality of life.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.6 Burden of care</HEADING>
<P>i) Family Burden Interview Schedule &#8211; FBIS (<LINK REF="REF-Pai-1981" TYPE="REFERENCE">Pai 1981</LINK>) in <LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK> and <LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>.<BR/>This scale consists of six measures of burden, with each item rated on a three-point scale. It includes financial burden, effects on family routine, effects on family leisure, effects on family interaction, effects on physical health of family members and effects on mental health of other family members. High scores indicate greater caregiver burden.</P>
<P>ii) Family Attitude Scale - FAS (<LINK REF="REF-Kavanagh-1997" TYPE="REFERENCE">Kavanagh 1997</LINK>) in <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>.<BR/>This is a 30-item self-report questionnaire with brief measures of anger, burden or &#8216;stress&#8217; of relatives towards a patient. Respondents identify how often each statement is true, on a five-point scale from &#8220;never&#8221; to &#8220;everyday&#8221;, and responses are summed to give a zero to 120 score.<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-01-07 11:19:00 +0000" MODIFIED_BY="[Empty name]">
<P>We excluded 86 studies that did not meet the criteria for the review, mainly because they either did not include education to increase awareness of early signs of recurrence or the early warning signs intervention was used for both control and experimental groups (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Studies awaiting assessment</HEADING>
<P>No studies are awaiting assessment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>We found seven ongoing studies (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>We prepared a 'Risk of bias' assessment for each trial. Our judgments regarding the overall risk of bias in individual studies is illustrated in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>. Overall, we felt the risk of bias in the included studies to be moderate.</P>
<ALLOCATION MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<P>All studies were reported as randomly assigned. However, 19 studies did not clearly describe how generation of randomisation sequence was undertaken and had an unclear risk of bias. Only six of the studies had a low risk of bias for allocation concealment, the risk of bias was unclear in the remaining studies.</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-01-07 11:15:29 +0000" MODIFIED_BY="[Empty name]">
<P>None of the studies were double-blind due to the nature of the intervention, therefore, all studies were rated as low risk of bias. Fourteen studies used assessors that were blinded and were rated as low risk of bias; in 17 studies the risk of bias was unclear and two studies used assessors that were not blind to allocation of treatment condition and these were rated as high risk of bias.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-07-24 15:06:26 +0100" MODIFIED_BY="[Empty name]">
<P>Fourteen of the studies had a low risk of bias for incomplete outcomes data, 17 trials had an unclear risk of bias and risk of bias was high in two studies.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>Twenty studies were rated as low risk of bias for selective outcome reporting, 11 studies had a high risk of bias for selective outcome reporting, and it was unclear in two studies.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-09-20 12:01:23 +0100" MODIFIED_BY="[Empty name]">
<P>Seven studies were of low risk of bias for other potential sources of bias, five studies were subject to other biases as they were either partly or fully funded by the pharmaceutical industry, and the remainder had an unclear risk of bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1: Early warning signs training + treatment as usual (TAU) versus TAU</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<P>For the primary outcomes, we have presented the data in subgroups according to who received the training, but the outcomes were measured in the patients. See subgroup analyses for details.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Relapse</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.1 Relapse: 1. Relapse</HEADING>
<P>Fifteen trials with a follow-up duration of two to 36 months provided data on the rate of relapse of participants (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Early warning signs intervention was found to be superior to treatment as usual in preventing relapses (15 RCTs, n = 1502, risk ratio (RR) 0.53 95% confidence interval (CI) 0.36 to 0.79). This data however showed a very high heterogeneity (I<SUP>2 </SUP>n = 81%), mostly due to the heterogeneity observed in studies where the intervention was delivered only to the patients (I<SUP>2 </SUP>n = 89%). See subgroup analyses below for more details.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Relapse: 2. Time to first relapse</HEADING>
<P>In six trials with a follow-up duration of 12 to 18 months, time taken to relapse after treatment was no longer when early warning signs intervention was delivered, compared to treatment as usual (6 RCTs, n = 550, hazard ratio (HR) 0.53, 95% CI 0.27 to 1.06; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). The pooled results showed high heterogeneity (I<SUP>2</SUP> = 72%).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Service use</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Service use: 1 Re-hospitalisation</HEADING>
<P>Fifteen trials with a follow-up duration of two months to three years provided data regarding the outcome rate of re-hospitalisation. Early warning signs intervention was found to be superior to treatment as usual in preventing re-hospitalisation of participants (15 RCTs, n = 1457, RR 0.48, 95% CI 0.35 to 0.66; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). The pooled data showed moderately high heterogeneity (I<SUP>2</SUP> = 62%).</P>
<P>In addition, <LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK> and <LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK> report a rate of re-hospitalisation for available participants at a follow-up of five years and seven years respectively (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). No significant difference was found in favour of early warning signs intervention over treatment as usual (2 RCTs, n = 156, RR 0.82 95% CI 0.49 to 1.36).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Service use: 2 Time to re-hospitalisation</HEADING>
<P>In six trials with a follow-up duration of one to two years, time to re-hospitalisation was no longer when early warning signs intervention was delivered, compared to treatment as usual (6 RCTs, n = 1149, HR 0.58, 95% CI 0.33 to 1.04; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). This data however showed a very high heterogeneity (I<SUP>2</SUP> = 83%), mostly due to the heterogeneity observed in studies where the intervention was delivered only to the patients (I<SUP>2</SUP> = 89%). See subgroup analyses below for more details.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<P>For the outcomes mental state, social functioning, burden of care, medication compliance and economic outcomes, some studies reported skewed data, which were not entered into the analysis. These are reported in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Mental state</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.1 Mental state: general 1a. Average score (BPRS, high = bad)</HEADING>
<P>Ten trials with a follow-up duration of 10 weeks to two years provided data regarding the outcome mental state on the BPRS. Early warning signs intervention was found to be superior to treatment as usual in improving the mental state of participants (9 RCTs, n = 685, 1 cluster RCT, n = 8 clusters, mean difference (MD) -4.55, 95% CI -8.21 to -0.90; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). The pooled results show very high heterogeneity (I<SUP>2</SUP> = 93%).</P>
<P>When the outlying studies <LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK> and <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK> are removed from the analysis, there is still a significant difference in favour of early warning signs training, although the magnitude of the effect is less (8 RCTS, n = 339, 1 cluster RCT, n = 8 clusters, MD -2.64 95% CI -4.62 to -0.67) much of the heterogeneity is reduced (I<SUP>2</SUP> = 38%).</P>
<P>
<LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK> also reported data for mean change in mental state on the BPRS but we could not pool this data because they measured the mean change from discharge to follow-up, rather than pre-intervention to follow-up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Mental state: general 1b. Avergae score (PANSS, high = bad)</HEADING>
<P>Three trials with a follow-up duration of nine months to two years provided data regarding the outcome mental state on the PANSS. Early warning signs intervention was not found to be superior to treatment as usual in improving the mental state of participants (3 RCTs, n = 385, MD -5.89, 95% CI -15.86 to 4.09; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). The pooled results show very high heterogeneity (I<SUP>2</SUP> = 91%).</P>
<P>When the outlier <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK> is removed, there is no heterogeneity (I<SUP>2</SUP> = 0%), and the early warning signs training is not found to be superior to treatment as usual in improving mental state on the PANSS (2 RCTS, n = 322, MD -1.45 95% CI -4.70 to 1.79).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.3 Mental state: general 1c. Average score (KGV, high = bad)</HEADING>
<P>One cluster randomised trial with a follow-up duration of nine months measured mental state on the KGV scale in patients whose community mental health professional had received early warning signs training. A significant difference was found in mental state in favour of early warning signs training (1 cluster RCT, n = 50 clusters, MD -2.60 95% CI -4.07 to -1.13; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.4 Mental state: specific 2. Average score in positive symptoms (various scales)</HEADING>
<P>(<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>)</P>
<SUBSECTION>
<HEADING LEVEL="6">1.4.1 BPRS (high = bad)</HEADING>
<P>One trial with a follow-up duration of 18 months provided data on mean endpoint score on positive symptoms on the BPRS scale. Early warning signs intervention was not superior to treatment as usual in improving positive symptoms (1 RCT, n = 64, MD -0.90, 95% CI -3.52 to 1.72)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">1.4.2 PANSS positive (high = bad)</HEADING>
<P>Four trials with a follow-up duration of 24 weeks to two years provided data on mean endpoint score on positive symptoms on the PANSS positive scale. Early warning signs intervention was not found to be superior to treatment as usual in improving the mental state of participants (4 RCTs, n = 508, MD -0.41, 95% CI -2.70 to 1.87). The pooled results show high heterogeneity (I<SUP>2</SUP> = 86%).</P>
<P>When <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>, which is an outlier, is removed from the analysis, early warning signs intervention remains not superior to treatment as usual (3 RCTS, n = 445, MD 0.42 95% CI -1.09 to 1.92), but the level of heterogeneity is moderate (I<SUP>2</SUP> = 50%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">1.4.3 SAPS (high = bad)</HEADING>
<P>One trial with a follow-up duration of one year provided data on positive symptoms on the PAS positive scale. Early warning signs intervention was found to be superior to treatment as usual in improving positive symptoms (1 RCT, n = 104, MD -2.04, 95% CI -3.22 to -0.86).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.5 Mental state: specific 3. Average score in negative symptoms (various scales)</HEADING>
<P>(<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>)</P>
<SUBSECTION>
<HEADING LEVEL="6">1.5.1 PANSS negative (high = bad)</HEADING>
<P>Four trials with a follow-up duration of 24 weeks to two years provided data on negative symptoms on the PANSS negative scale. Early warning signs intervention was not found to be superior to treatment as usual in improving the mental state of participants (4 RCTs, n = 508, MD -0.74, 95% CI -3.13 to 1.64). The pooled results show high heterogeneity (I<SUP>2</SUP> = 86%).</P>
<P>When <LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>, which is an outlier, is removed from the analysis, early warning signs intervention remains not superior to treatment as usual (3 RCTS, n = 445, MD 0.10 95% CI -1.48 to 1.69), the level of heterogeneity is moderate (I<SUP>2</SUP> = 54%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">1.5.2 SANS (high = bad)</HEADING>
<P>Three trials with a follow-up duration of one year to three years provided data on negative symptoms on the SANS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving the mental state of participants (3 RCTs, n = 194, MD -3.95, 95% CI -15.25 to 7.35). The pooled results show extremely high heterogeneity (I<SUP>2</SUP> = 99%).</P>
<P>When the study <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>, which is an outlier, is removed from the analysis, early warning signs intervention remains not superior to treatment as usual (2 RCTs, n = 90, MD -0.95, 95% CI -5.41 to 7.30), the level of heterogeneity is moderate (I<SUP>2</SUP> = 58%).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Social functioning</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Social functioning: 1. Not employed</HEADING>
<P>Two trials with a follow-up duration of two months to one year provided data on the number of participants not in employment at the end of the study (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). Early warning signs intervention was found to be superior to treatment as usual (2 RCTs, n = 185, RR 0.68, 95% CI 0.57 to 0.82). The pooled results showed no heterogeneity (I<SUP>2</SUP> = 0%).<LINK REF="STD-Xiong-1994" TYPE="STUDY">Xiong 1994</LINK> also reported on the mean number of months of employment of participants at 18 months follow-up. They found a significant difference in favour of early warning signs intervention (1 RCT, n = 58, MD -4.86, 95% CI -8.78 to -0.94).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Social functioning: 2. Average scores (various scales)</HEADING>
<P>(<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>)</P>
<P>Social functioning was measured on 11 different scales, with one to three studies providing data for each scale. On nine of these scales early warning signs training was not found to be superior to treatment as usual in improving social functioning, and on two of the scales used a significant difference was found in favour of the intervention.</P>
<SUBSECTION>
<HEADING LEVEL="6">2.2.1 GAF (high = good)</HEADING>
<P>Two trials with a follow-up duration of one to two years provided data on social functioning on the GAF scale. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (2 RCTs , n = 88, MD 2.51 95% CI -3.84 to 8.85). Pooled data showed no heterogeneity (I<SUP>2</SUP> = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.2 GAF-DIS (high = good)</HEADING>
<P>One trial with a follow-up duration of 24 weeks provided data on social functioning on the GAF-DIS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (1 RCT, n = 61, MD -6.10, 95% CI -12.34 to 0.14).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.3 ILSS (high = good)</HEADING>
<P>One trial with a follow-up duration of nine months provided data social functioning on the ILSS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (1 RCT, n = 84, MD 0.35, 95% CI -0.70 to 1.40).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.4 Time budget interview (high = good)</HEADING>
<P>One trial with a follow-up duration of two years provided data on social functioning using the time budget interview. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (1 RCT, n = 224, MD 1.61 95% CI -4.04 to 7.25).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.5 SOFAS (high = good)</HEADING>
<P>One trial with a follow-up duration of two years provided data on social functioning on the SOFAS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (1 RCT, n = 236, MD 1.21 95% CI -2.71 to 5.13).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.6 SLOF (high = good)</HEADING>
<P>One trial with a follow-up duration of 18 months provided data on social functioning on the SLOF scale. In contrast to the results on the other scales, early warning signs intervention was found to be superior to treatment as usual in improving social functioning (1 RCT, n = 64, MD 27.50, 95% CI 17.03 to 37.97).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.7 SAS (high = good)</HEADING>
<P>One trial with a follow-up duration of two years provided data on social functioning on the SOFAS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (1 RCT, n = 80, MD -0.43 95% CI -2.20 to 1.34).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.8 SFS (high = good)</HEADING>
<P>One trial with a follow-up duration of nine months provided data on social functioning on the SFS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (1cluster RCT, n = 56 clusters, MD 4.40, 95% CI -3.16 to 11.96).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.9 GAS (high = good)</HEADING>
<P>Three trials with a follow-up duration of nine months to two years provided data on social functioning on the GAS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving social functioning (2 RCTs, n = 178, and 1 cluster RCT, n = 8 clusters, MD 1.92 95% CI -0.54 to 4.38). The pooled results showed no heterogeneity (I<SUP>2</SUP> = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.2.10 NOSIE (high = good)</HEADING>
<P>Three trials with a follow-up duration of nine months to one year provided data on social functioning on the NOSIE scale. Early warning signs intervention was found to be superior to treatment as usual in improving social functioning (2 RCTs, n = 208, 1 cluster RCT, n = 8 clusters, MD 25.12, 95% CI 5.75 to 44.48). The pooled results showed very high heterogeneity (I<SUP>2</SUP> = 96%).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Quality of life</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Quality of life: Average scores (various scales)</HEADING>
<P>(<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>)</P>
<SUBSECTION>
<HEADING LEVEL="6">3.1.2 QLS (high = good)</HEADING>
<P>One trial with a follow-up duration of one year provided data on mean endpoint score in quality of life on the QLS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving quality of life (1 RCT, n = 46, MD -5.05, 95% CI -16.12 to 6.02).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">3.1.2 LQLP (high = good)</HEADING>
<P>One trial with a follow-up duration of two years provided data on mean endpoint score in quality of life on the LQLP scale. Early warning signs intervention was not found to be superior to treatment as usual in improving quality of life (1 RCT, n = 48, MD -0.40, 95% CI -1.30 to 0.50).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">3.1.3 EuroQoL (high = good)</HEADING>
<P>One trial with a follow-up duration of two years provided data on mean endpoint score in quality of life on the EuroQoL scale. Early warning signs intervention was not found to be superior to treatment as usual in improving quality of life (1 RCT, n = 206, MD -4.80, 95% CI -10.79 to 1.19).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">3.1.4 LQoLS (high = good)</HEADING>
<P>One trial with a follow-up duration of two years provided data on mean endpoint score in quality of life on the EuroQoL scale. Early warning signs intervention was not found to be superior to treatment as usual in improving quality of life (1 RCT, n = 80, MD 0.09 95% CI -0.24 to 0.42).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Satisfaction with care</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">4.1 Satisfaction with care: Average scores (various scales)</HEADING>
<P>(<LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>; <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>)</P>
<SUBSECTION>
<HEADING LEVEL="6">4.1.1 CALPAS (high = good)</HEADING>
<P>One trial with a follow-up duration of nine months provided data on mean change in satisfaction with care on the CALPAS scale. Early warning signs intervention was found to be superior to treatment as usual in improving satisfaction with care (1 cluster RCT, n = 56 clusters, MD 0.30, 95% CI 0.12 to 0.48).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">4.1.2 IAPSRS (high = good)</HEADING>
<P>One trial with a follow-up duration of 24 weeks provided data on mean endpoint score in satisfaction with care on the IAPSRS scale. Early warning signs intervention was not found to be superior to treatment as usual in satisfaction with care (1 RCT, n = 60, MD 0.10, 95% CI -0.11 to 0.31).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">4.1.3 VSSS (high = good)</HEADING>
<P>One trial with a follow-up duration of one year provided data on mean change in satisfaction with care on the VSSS scale. Early warning signs intervention was not found to be superior to treatment as usual in improving satisfaction with care, although the data may be skewed (1 RCT, n = 32, MD 2.15, 95% CI -9.66 to 13.96).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Adverse events</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.1 Adverse events: 1. Lost to follow-up</HEADING>
<P>Seventeen trials with follow-up duration of 10 weeks to two years provided data on the outcome lost to follow-up (<LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>). No significant difference was found between early warning signs intervention and treatment as usual in the number of participants lost to follow-up (17 RCTs, n = 1495, RR 0.96 95% CI 0.72 to 1.28). The pooled data showed no heterogeneity (I<SUP>2</SUP> = 0%).</P>
<P>
<LINK REF="STD-Shon-2002" TYPE="STUDY">Shon 2002</LINK> also reported data on losses to follow-up but the length of follow-up is not stated in the report and so we have not pooled these data. Two participants in the early warning signs intervention group were lost to follow-up and none in the treatment as usual group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.2 Adverse events: 2. Death</HEADING>
<P>Four trials with a follow-up duration of one to two years provided data on the number of deaths (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>). No significant difference was found between early warning signs intervention and treatment as usual in the number of deaths during the trials (4 RCTs, n = 462, RR 0.91, 95% CI 0.29 to 2.89). The pooled data showed low heterogeneity (I<SUP>2</SUP> = 4%).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Knowledge</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">6.1 Knowledge: 1. Average scores (various scales)</HEADING>
<P>(<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>; <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>)</P>
<SUBSECTION>
<HEADING LEVEL="6">6.1.1 KASQ (patients, high = good)</HEADING>
<P>One trial with a follow-up duration of 24 weeks provided data for this outcome. Early warning signs intervention was not found to be superior to treatment as usual in increasing participants' knowledge about their illness (1 RCT, n = 61, MD 1.60, 95% CI -0.84 to 4.04).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.1.2 IS (patients, high = good)</HEADING>
<P>One trial with a follow-up duration of 24 weeks provided data for this outcome. Early warning signs intervention was not found to be superior to treatment as usual in increasing participants' knowledge about their illness (1 RCT, n = 40, MD 0.96, 95% CI -0.48 to 2.40).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.1.3 ITAQ (patients, high = good)</HEADING>
<P>Two trials with a follow-up duration of one year provided data for this outcome. Early warning signs intervention was found to be superior to treatment as usual in increasing participants' knowledge about their illness (2 RCTs, n = 166, MD 7.21, 95% CI 0.94 to 13.48). The pooled data showed very high heterogeneity (I<SUP>2</SUP> = 93%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.1.4 SUMD (patients, high = bad)</HEADING>
<P>One trial with a follow-up duration of one year provided data for this outcome. Early warning signs intervention was not found to be superior to treatment as usual in increasing participants' knowledge about their illness (1 RCT, n = 81, MD -1.18, 95% CI -2.46 to 0.10).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.1.5 DAI (patients, high = good)</HEADING>
<P>One trial with a follow-up duration of one year provided data for this outcome. Early warning signs intervention was not found to be superior to treatment as usual in increasing participants' knowledge about their illness (1 cluster RCT, n = 56 clusters, MD 1.40, 95% CI -0.97 to 3.77).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">6.1.6 KASI (relatives, high = good)</HEADING>
<P>One trial with a follow-up duration of one year provided data for this outcome. Early warning signs intervention was found to be superior to treatment as usual in increasing families' knowledge about the illness of their family member (1 cluster RCT, n = 8 clusters, MD 2.83, 95% CI 0.93 to 4.73).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7. Burden of care</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">7.1 Burden of care: 1. Average scores (FBIS, high = bad)</HEADING>
<P>Two trials with a follow-up duration of one year and 18 months provided data for the outcome burden of care (<LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>). Early warning signs intervention was not found to be superior to treatment as usual in reducing the burden of care (2 RCTs, n = 110, MD 3.29, 95% CI -8.43 to 15.00). The pooled data showed high heterogeneity (I<SUP>2</SUP> = 87%).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8. Medication compliance</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">8.1 Medication compliance: Not compliant to medication</HEADING>
<P>Three trials with a follow-up duration of nine months to one year provided data for the outcome medication compliance, although <LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK> only reports data post-intervention and not at nine months (<LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>). Early warning signs training was found to be superior to treatment as usual in improving medication compliance (4 RCTs, n = 374, MD 0.57 95% CI 0.42 to 0.77). The pooled data showed no heterogeneity (I<SUP>2</SUP> = 0%). <LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK> also reported data on mean number of missed doses, but the data were skewed (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9. Economic burden (cost of care)</HEADING>
<P>Two studies presented data on cost of care. <LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK> showed no significant difference between the mean cost of care for the early warning signs training group and standard care group. <LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK> found that the mean costs of care were less in the early warning signs group than the standard psychiatric group, but the data could not be analysed as no standard deviations were reported. See <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> for details.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">10. Subgroup analysis</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">10.1 Relaspe: Time to first relapse</HEADING>
<P>Time taken to relapse after treatment was longer when early warning signs intervention compared to treatment as usual was delivered to patients only (3 RCTs, n = 372, HR 0.26, 95% CI 0.13 to 0.53). In contrast, there was no difference in the time taken to relapse when early warning signs intervention was delivered to both the patients and their carer/health professional (3 RCTs, n = 178, HR 1.00 95% CI 0.59 to 1.68). The pooled results showed low heterogeneity (I<SUP>2</SUP> = 35% and 15%, respectively).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.2 Relapse: Rate of relapse</HEADING>
<P>Early warning signs intervention was found to be superior to treatment as usual in preventing relapses when the intervention was delivered only to the patients (8 RCTs, n = 933, RR 0.43, 95% CI 0.20 to 0.92), but showed high heterogeneity (I<SUP>2</SUP> = 89%). In contrast, there was no significant difference where the training was delivered to both the patients and their carer/health professional (6 RCTs, n = 491, RR 0.68 95% CI 0.46 to 1.02), or to only the family or the health professionals caring for the patients (2 RCTs, n = 78, RR 0.58 95% CI 0.24 to 1.37). These results showed moderate or no heterogeneity (I<SUP>2</SUP> = 0% and 63%, respectively).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.3 Service use: Time to re-hospitalisation</HEADING>
<P>Time to re-hospitalisation after treatment was longer when early warning signs intervention was delivered to both the patients and their carer/health professional compared to treatment as usual (3 RCTs, n = 740, HR 0.62, 95% CI 0.46 to 0.83), but showed high heterogeneity (I<SUP>2</SUP> = 89%). In contract, there was no difference in the time taken to relapse when early warning signs intervention was delivered to patients only (3 RCTs, n = 409, HR 0.37 95% CI 0.07 to 1.95). These results showed no heterogeneity (I<SUP>2</SUP> = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.4 Service use: Rate of re-hospitalisation</HEADING>
<P>Early warning signs intervention was found to be superior to treatment as usual in preventing re-hospitalisation when the intervention was delivered only to the patients (7 RCTs, n = 791, RR 0.30, 95% CI 0.14 to 0.66), but showed high heterogeneity (I<SUP>2</SUP> = 80%); or when early warning signs training was delivered to both the patients and their carer/health professional (7 RCTs, n = 625, RR 0.64 95% CI 0.51 to 0.79), these results showed no heterogeneity (I<SUP>2</SUP> = 0%). In contrast, there was no significant difference where the training was delivered to only the family or the health professionals caring for the patients (1 RCT, n = 41, RR 0.53 95% CI 0.15 to 1.82).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">11. Sensitivity analysis</HEADING>
<P>All studies were described as randomised and we did not have to make assumptions regarding missing SDs data so sensitivity analyses were not undertaken for these reasons.</P>
<SUBSECTION>
<HEADING LEVEL="5">11.1 Imputed data</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">11.1.1 Relapse: Time to relapse</HEADING>
<P>When the data that was imputed were removed from the analysis there remains no significant difference in the length of time taken to relapse between early warning signs training and treatment as usual (2 RCTs, n = 226, HR 0.60 95% CI 0.14 to 2.59).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">11.1.2 Service use: Time to re-hospitalisation</HEADING>
<P>When the data that was imputed were removed from the analysis there remains no significant difference in the length of time taken to re-hospitalisation between early warning signs training and treatment as usual (3 RCTs, n = 258, HR 0.87 95% CI 0.41 to 1.83).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>The summary below reflects the outcomes chosen for the <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>, and considered the main findings of this review that can support evidence-based decision making. Nine studies reported an improvement in general mental state suggesting that early warning signs intervention is not associated with an increase in depressive symptoms (<LINK REF="REF-Dixon-1998" TYPE="REFERENCE">Dixon 1998</LINK>) as we had postulated before undertaking the review. For all outcomes included in the 'Summary of findings' tables, the quality of evidence was found to be very low. Overall, 32 randomised controlled trials and two cluster randomised trials were identified that met our criteria for an early warning signs intervention in schizophrenia. The studies were conducted over varying time periods with differing periods of follow-up and the actual interventions themselves were of varying lengths, from two weeks to three years. This made comparing the data difficult.</P>
<P>
<B>Rate of relapse and rate of re-hospitalisation: </B>We found significant differences in favour of early warning signs interventions in the number of participants relapsing and the number of participants being re-hospitalised. The results are highly heterogeneous, which is not explained by differences in the populations, although the heterogeneity is higher for studies where the intervention was delivered only to patients. <LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK> had a much shorter duration of follow-up than the other included trials of two months, but removing this study does not explain the heterogeneity. The heterogeneity may be related to the differences in the nature of the interventions and the length of time over which they were delivered.</P>
<P>
<B>Time to relapse and time to re-hospitalisation: </B>Much of the data for these outcomes needed to be imputed as it was not reported in the studies in a way that could be added to the meta-analysis. No significant differences were found in the length of time taken to for participants to relapse or to be re-hospitalised. There was high heterogeneity in the results. For time to relapse, this is probably due to differences in the populations, as subgroup analyses show that when the early warning sign interventions are delivered to patients only, the intervention does significantly increase the length of time before relapsing.  </P>
<P>Only three studies reported on satisfaction with care. Two randomised controlled trials (RCTs) found no significant difference in satisfaction with care between early warning signs training and treatment as usual (although one may have skewed data), and one cluster RCT did find a significant difference in favour of early warning signs training. We found no evidence of a difference in losses to follow-up between the treatment groups. Two studies report on costs of care, but not in a form that could be added to the meta-analysis. One showed no significant difference between the mean cost of care for the early warning signs training group and standard care group, although the data were skewed. In contrast, another found that the mean costs of care were less in the early warning signs group ($1641) than the standard psychiatric group ($5199).</P>
<P>Nine studies reported an improvement in general mental state suggesting that early warning signs intervention is not associated with an increase in depressive symptoms (<LINK REF="REF-Dixon-1998" TYPE="REFERENCE">Dixon 1998</LINK>) as we had postulated before undertaking the review.<BR/>
</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Completeness</HEADING>
<P>Most studies reported at least one primary outcome. Many of the trials did not present usable data, such as means or SDs, or the data was from un-validated scales. The results for time to relapse and time to re-hospitalisation have to be treated with some caution as we had to impute data from 58% of the studies because of incomplete reporting of these outcomes. The studies often used different assessment scales and there is no agreement currently on how comparisons can be made between these scales for people suffering from schizophrenia. Therefore, we were unable to pool some of the data, which reduces the possibility of detecting a treatment effect. Very few studies reported data for satisfaction with care, quality of life, medication compliance and economic burden.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Applicability</HEADING>
<P>Included studies of early warning signs interventions have international applicability because they have been conducted in many European countries (including United Kingdom), Asia (China, Japan, Korea), Australia and North America. All studies have been carried out in both genders and in the age range 16 to 65 years so the results cannot be generalised to children, adolescents or the elderly. It is unclear to what extent the results can be generalised to people with schizophrenia with comorbid personality disorder, axis 1 disorder, substance use disorders or medical comorbidity because most studies did not report if people with these conditions were included or not.</P>
<P>One limitation of the applicability of the results of the review is that only one study examined the effectiveness of early warning signs interventions alone without any other psychological intervention being applied at the same time. This study (<LINK REF="STD-Van-Meijel-2006" TYPE="STUDY">Van Meijel 2006</LINK>) found a positive benefit of early warning signs intervention on rate of relapse of the similar effect size as the overall review but did not report outcomes such as hospitalisation, social functioning and mental state. Therefore, the only conclusions that can be drawn from the review are on the overall effectiveness of psychological interventions incorporating early warning signs interventions and it is currently unclear how many of the benefits of these interventions can be attributed to training to recognise and manage early warning signs as opposed to other psychological intervention techniques. We also had no data to draw any conclusions concerning the effectiveness of early warning signs interventions coupled with intermittent medication alongside lower dose maintenance antipsychotic medication.</P>
<P>Six studies (<LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>; <LINK REF="STD-Shon-2002" TYPE="STUDY">Shon 2002</LINK>; <LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK>; <LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK>; <LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>; <LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>) examined the medication management and symptom management skills training modules, based on Liberman&#8217;s Social Skills training for schizophrenic patients (<LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>), which includes early warning signs training. These showed positive results for time to relapse, rate of relapse, time to hospitalisation, and rate of re-hospitalisation, some of which were outliers in the data. These studies were conducted mostly in China. <LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>, which was conducted in the USA, did not report these outcomes.</P>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>The quality of the current evidence is very low based on GRADE. Most studies did not address incomplete data adequately. Only 14 of the 34 included studies described an adequate sequence generation, and only six described the methods used to conceal allocation. Although it is not possible with this type of intervention to blind participants, only 15 studies used assessors that were blind to treatment allocation.</P>
<P>A matter of concern in relation to the robustness of our findings is that much of the provided primary outcome data for time to relapse and time to hospitalisation could not be directly used in the meta-analysis and needed to be imputed. One could argue that this may be due to selective reporting of outcome measures and thereby introducing bias. Furthermore, the results are limited to the extent of follow-up from the trials (<LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK>), which was no more than two years for these outcomes, and therefore there is only limited information about the long-term effects of early warning signs interventions. Rates of relapse and re-hospitalisation are also reported at varying time lengths depending on duration of the study, hence compromising comparability.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>A thorough search strategy was used in this review. There may still be gaps in the search strategy such as unpublished data (grey literature), which are difficult to get hold of. We included studies where we were confident that an early warning signs intervention had been attempted. Some trials did not give precise descriptions of the nature of the psychological intervention tested and we did not get a response when we wrote to some authors for clarification.</P>
<P>For most outcomes we are not able to tell if there was publication bias, as no more than 11 trials reported data for these, and a funnel plot could not be performed. For rate of relapse, there does not appear to be publication bias, although for rate of re-hospitalisation and losses to follow-up there appears to be publication bias as the funnel plot indicates that there may be the equivalent number of 'negative' trials that have not been included in this analysis.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2011-05-21 15:21:22 +0100" MODIFIED_BY="[Empty name]">
<P>We do not know of any other systematic reviews on this topic.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. For people with schizophrenia</HEADING>
<P>Early warning signs intervention may reduce the likelihood of relapse and readmission, as well as reduce the length of hospital stay when they are part of a more complete package of care. It may well have other outcomes, that are, at this point, under-researched. However, we do not know if early warning signs will be effective in reducing the likelihood of relapse and readmission, or reduce the length of hospital stay, when they are part of a complete package of care, or if they are delivered on their own</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. For clinicians</HEADING>
<P>We do not know if the reduction in relapse and length of hospital stay with training to recognise early warning sings of relapse will be useful for clinicians to use as a part of their treatment programme. There were some indications from trials that early warning signs delivered to patients/carers/health providers had differential effects on different outcomes, but no consistent patterns of benefits emerged that could reliably inform clinical decisions</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. For managers and policy makers</HEADING>
<P>This review found no evidence of moderate or high quality to suggest that mental health services might wish to consider routinely providing psychological interventions involving the recognition and management of early warning signs to adults with schizophrenia. They may have suggested a cost-effective intervention, had the evidence of benefit in reduced hospitalisation and relapse rates in the pooled estimates been judged of moderate or high quality. There is also insufficient evidence to support the use of early warning signs interventions alone or with intermittent medication use alongside low-dose antipsychotic maintenance medication.<BR/>
</P>
</SUBSECTION>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>1. For two of the primary outcomes we had to impute time to event data; if we had the main data reported by authors, this data would be more accurate. Following CONSORT for good reporting of clinical trials more closely would have helped to considerably increase the amount of data available in this review.</P>
<P>2. Further research is required to establish whether early warning signs interventions on their own are effective or whether they are effective with additional intermittent medication use alongside low-dose antipsychotic maintenance medication. Such an approach might be low cost, should widely applicable interventions for people with schizophrenia or schizoaffective disorder prove effective.</P>
<P>3. Trials should make use of validated scales and report fully the means and SDs of results, which would allow more data to be pooled in analyses and improve the interpretation of early warning signs interventions.</P>
<P>4. The method of sequence generation, allocation concealment and blinding should be more clearly described to enable researchers to be more confident that risks of bias are low in trials.</P>
<P>5. Future early warning signs interventions trials should report data on relapse and re-hospitalisation, as well as quality of life and economic burdens.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>The review authors would like to thank the Cochrane Schizophrenia Group for supporting this review. The Cochrane Schizophrenia Group maintains and provides a template for the methods section of their reviews. We have used and adapted this.</P>
<P>We would like to acknowledge and thank Ashely Jones and Paula Williamson who provided statistical expertise for the original version of this review.</P>
<P>Enhance Reviews provided support for this review in the data extraction, analysis and write-up of results.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known. </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-11-27 07:06:20 +0000" MODIFIED_BY="[Empty name]">
<P>IV rated all studies for inclusion after both sets of searches, contacted authors, extracted secondary data with MF, conducted analysis and wrote the review.</P>
<P>MF rated random studies for inclusion, extracted primary data with AJ and secondary data with IV and conducted analysis.</P>
<P>RM had the original idea for the review, devised methodology, checked random studies for inclusion and helped with the final version of the review.</P>
<P>CB and JMC were involved in the protocol development.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>The protocol aimed to compare effectiveness of intermittent medication used on recognition of early warning signs in people not taking maintenance neuroleptic medication with treatment as usual (TAU) involving maintenance neuroleptic medication. We have not been able to do this because the studies that were identified used early warning signs intervention in both control and treatment groups and had to be excluded.</P>
<P>Cochrane methodology has been updated since initial publicationo of our protocol, we have updated our methods section of the protocol to reflect these advances.</P>
<P>For the study <LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>, which had multiple treatment arms, data were entered into the analysis for each pair-wise comparison separately, with shared intervention groups divided among the comparisons, according to the methods in section 16.5.4 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>); the total number of participants was divided and the means and standard deviations remained the same. This differs from the protocol which stated that for continuous data we would combine data from multiple treatment groups.<BR/>
</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-01-08 12:39:42 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-01-08 12:39:42 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-01-08 12:37:25 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Anzai-2002" MODIFIED="2013-01-08 12:37:25 +0000" MODIFIED_BY="[Empty name]" NAME="Anzai 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-08 12:37:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Anzai N, Yoneda S, Kumagai N, Nakamura Y, Ikebuchi E, Liberman R</AU>
<TI>Training persons with schizophrenia in illness self-management: A randomised controlled trial in Japan</TI>
<SO>Psychiatric services</SO>
<YR>2002</YR>
<VL>53</VL>
<PG>545-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bauml-2007" MODIFIED="2012-12-11 11:08:45 +0000" MODIFIED_BY="[Empty name]" NAME="Bauml 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 11:08:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bauml J, Pitschel-Walz G, Volz A, Engel R, Kissling W</AU>
<TI>Psychoeducation in schizophrenia: 7 year follow up concerning rehospitalization and days in hospital in the Munich psychosis information project study</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2007</YR>
<VL>68</VL>
<NO>6</NO>
<PG>854-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:08:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pitschel-Walz G, Bauml J, Bender W, Engel R, Wagner M, Kissling W</AU>
<TI>Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project study</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2006</YR>
<VL>67</VL>
<NO>3</NO>
<PG>443-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bradley-2006" MODIFIED="2013-01-08 12:37:16 +0000" MODIFIED_BY="[Empty name]" NAME="Bradley 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-01-08 12:37:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bradley GM, Couchman GM, Perlesz A, Nguyen AT, Singh B, Reiss C</AU>
<TI>Multiple-family group treatment for English and Vietnamese-speaking families living with schizophrenia</TI>
<SO>Psychiatric Services</SO>
<YR>2006</YR>
<VL>57</VL>
<NO>4</NO>
<PG>521-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buchkremer-1997" MODIFIED="2013-01-07 11:23:47 +0000" MODIFIED_BY="[Empty name]" NAME="Buchkremer 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-10-15 21:08:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Buchkremer G, Klingberg S, Holle R, Schulze Monking H, Hornung WP</AU>
<TI>Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1997</YR>
<VL>96</VL>
<PG>483-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:23:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hornung P, Feldman R, Klingberg S, Buchkremer G, Reker T</AU>
<TI>Long-term effects of a psychoeducational psychotherapeutic intervention for schizophrenic outpatients and their key-persons - results of a five-year follow-up</TI>
<SO>European Archives of Psychiatry and Clinical Neuroscience</SO>
<YR>1999</YR>
<VL>249</VL>
<PG>162-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:23:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hornung WP, Feldmann R, Schonauer K, Schafer A, Schulze Monking H, Klingberg S, et al</AU>
<TI>Psychoeducational psychotherapeutic treatment of schizophrenic patients and their caregivers. II. Supplementary findings at a 2 year follow up</TI>
<SO>Nervenarzt</SO>
<YR>1999</YR>
<VL>70</VL>
<NO>5</NO>
<PG>444-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:10:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hornung WP, Holle R, Schulze Monking H, Klingberg S, Buchkremer G</AU>
<TI>Psychoeducational-psychotherapeutic treatment of schizophrenic patients and their caregivers. Results of a 1-year catamnestic study</TI>
<SO>Nervenarzt</SO>
<YR>1995</YR>
<VL>66</VL>
<NO>11</NO>
<PG>828-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:10:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hornung WP, Kieserg A, Feldmann R, Buchkremer G</AU>
<TI>Psychoeducational training for schizophrenic patients: background, procedure and empirical findings</TI>
<SO>Patient Education and Counseling</SO>
<YR>1996</YR>
<VL>29</VL>
<PG>257-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:23:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hornung WP, Klingberg S. Feldmann R, Schonauer K, Schulze Monking H</AU>
<TI>Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1998</YR>
<VL>97</VL>
<PG>213-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:11:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klingberg S, Buchkremer G, Holle R, Monking HS, Hornung WP</AU>
<TI>Differential therapy effects of psychoeducational psychotherapy for schizophrenic patients- results of a 2-year follow-up</TI>
<SO>European Archives of Psychiatry and Clinical Neuroscience</SO>
<YR>1999</YR>
<VL>249</VL>
<PG>66-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2007" MODIFIED="2013-01-08 12:37:09 +0000" MODIFIED_BY="[Empty name]" NAME="Chan 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-01-08 12:37:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chan SHW, Lee SWK, Chan IWM</AU>
<TI>TRIP: a psycho-educational programme in Hong Kong for people with schizophrenia</TI>
<SO>Occupational Therapy International</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>2</NO>
<PG>86-98</PG>
<IDENTIFIERS MODIFIED="2012-12-11 13:44:41 +0000" MODIFIED_BY="Heather Maxwell"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2003" MODIFIED="2013-01-08 12:37:03 +0000" MODIFIED_BY="[Empty name]" NAME="Chen 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-08 12:37:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chen H, Chang Y, Xiang Y</AU>
<TI>Efficacy of the rehabilitation strategy for inpatients with schizophrenia</TI>
<SO>Chinese Mental Health Journal</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>12</NO>
<PG>839-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chien-2004" MODIFIED="2011-10-15 21:13:44 +0100" MODIFIED_BY="[Empty name]" NAME="Chien 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-10-15 21:12:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chien W-T, Chan SW, Thompson DR</AU>
<TI>Effects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow up</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>189</VL>
<PG>41-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:13:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chien W-T, Chan SWC</AU>
<TI>One-year follow-up of a multiple-family-group intervention for Chinese families of patients with schizophrenia</TI>
<SO>Psychiatric Services</SO>
<YR>2004</YR>
<VL>55</VL>
<NO>11</NO>
<PG>1276-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-01-08 10:04:59 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Drury-1996" MODIFIED="2013-01-08 12:36:53 +0000" MODIFIED_BY="[Empty name]" NAME="Drury 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-01-08 12:36:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Drury V, Birchwood M, Cochrane R, Macmillan F</AU>
<TI>Cognitive therapy and recovery from acute psychosis: A controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1996</YR>
<VL>169</VL>
<PG>593-601</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garety-2008" MODIFIED="2013-01-08 12:36:21 +0000" MODIFIED_BY="[Empty name]" NAME="Garety 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-01-08 12:36:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, Kuipers E</AU>
<TI>Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2008</YR>
<VL>192</VL>
<NO>6</NO>
<PG>412-23</PG>
<IDENTIFIERS MODIFIED="2012-09-24 09:29:10 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Granholm-2005" MODIFIED="2013-01-07 11:24:10 +0000" MODIFIED_BY="[Empty name]" NAME="Granholm 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-01-07 11:24:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Granholm E, McQuaid JR, McClure FS, Auslander LA, Perivoliotis D, Pedrelli P, et al</AU>
<TI>A randomised, controlled trial of cognitive behavioural social skills training for middle-aged and older outpatients with chronic schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2005</YR>
<VL>162</VL>
<PG>520-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:24:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McQuaid JR, Granholm E, McClure FS, Roepke S, Pedrelli P, Patterson TL, et al</AU>
<TI>Development of an integrated cognitive behavioral and social skills training intervention for older patients with schizophrenia</TI>
<SO>Journal of Psychotherapy Practice and Research</SO>
<YR>2000</YR>
<VL>9</VL>
<PG>149-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gumley-2003" MODIFIED="2012-12-11 11:23:36 +0000" MODIFIED_BY="[Empty name]" NAME="Gumley 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-10-15 21:18:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gumley A, Karatzias A, Power K, Reilly J, McNay L, O'Grady M</AU>
<TI>Early intervention for relapse in schizophrenia: Impact of cognitive behavioural therapy on negative beliefs about psychosis and self-esteem</TI>
<SO>British Journal of Clinical Psychology</SO>
<YR>2006</YR>
<VL>45</VL>
<PG>247-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 11:23:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gumley A, O'Grady M, McNay L, Reilly J, Power K, Norrie J</AU>
<TI>Early intervention for relapse in schizophrenia: results of a 12 month randomized controlled trial of cognitive behavioural therapy</TI>
<SO>Psychological Medicine</SO>
<YR>2003</YR>
<VL>33</VL>
<PG>419-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-2009" MODIFIED="2013-01-08 12:36:11 +0000" MODIFIED_BY="[Empty name]" NAME="Harris 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-01-08 12:36:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Harris N, Lovell K, Day J, Roberts C</AU>
<TI>An evaluation of a medication management training programme for community mental health professionals; service user level outcomes: a cluster randomised controlled trial</TI>
<SO>International Journal of Nursing Studies</SO>
<YR>2009</YR>
<VL>46</VL>
<NO>5</NO>
<PG>645-52</PG>
<IDENTIFIERS MODIFIED="2012-09-24 09:30:33 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herz-2000" MODIFIED="2012-12-11 11:24:40 +0000" MODIFIED_BY="[Empty name]" NAME="Herz 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-12-11 11:24:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Herz MI, Lamberti JS, Mintz J, Scott R, O'Dell SP, McCartan L, Nix G</AU>
<TI>A program for relapse prevention in schizophrenia: a controlled study</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2000</YR>
<VL>57</VL>
<PG>277-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:19:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herz MI, Lamberti S</AU>
<TI>Prodromal symptoms and early intervention in Schizophrenia</TI>
<SO>Neurology, Psychiatry and Brain Research</SO>
<YR>1998</YR>
<VL>6</VL>
<PG>37-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hogarty-1997a" MODIFIED="2013-01-07 11:24:24 +0000" MODIFIED_BY="[Empty name]" NAME="Hogarty 1997a" YEAR="1997">
<REFERENCE MODIFIED="2013-01-07 11:23:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hogarty GE, Greenwald D, Ulrich RF, Kornblith SJ, DiBarry AL, Cooley S, et al</AU>
<TI>Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>154</VL>
<PG>1514-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:24:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hogarty GE, Kornblith SJ, Greenwald D, DiBarry AL, Cooley S, Ulrich RF, et al</AU>
<TI>Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>154</VL>
<NO>11</NO>
<PG>1504-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Horan-2009" MODIFIED="2013-01-08 12:36:00 +0000" MODIFIED_BY="[Empty name]" NAME="Horan 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-01-08 12:36:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Horan WP, Kern RS, Shokat-Fadai K, Sergi MJ, Wynn JK, Green MF</AU>
<TI>Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients</TI>
<SO>Schizophrenia Research</SO>
<YR>2009</YR>
<VL>107</VL>
<NO>1</NO>
<PG>47-54</PG>
<IDENTIFIERS MODIFIED="2012-09-24 09:31:10 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kopelowicz-1998a" MODIFIED="2013-01-08 12:35:54 +0000" MODIFIED_BY="[Empty name]" NAME="Kopelowicz 1998a" YEAR="1998">
<REFERENCE MODIFIED="2013-01-08 12:35:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kopelowicz A, Wallace CJ, Zarate R</AU>
<TI>Teaching psychiatric inpatients to re-enter the community: A brief method of improving the continuity of care</TI>
<SO>Psychiatric Services</SO>
<YR>1998</YR>
<VL>49</VL>
<NO>10</NO>
<PG>1313-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kopelowicz-2003" MODIFIED="2013-01-08 12:35:45 +0000" MODIFIED_BY="[Empty name]" NAME="Kopelowicz 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-08 12:35:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kopelowicz A, Zarate R, Smith VG, Mintz J, Liberman RP</AU>
<TI>Disease management in Latinos with schizophrenia: A family-assisted, skills training approach</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>2</NO>
<PG>211-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuipers-1997" MODIFIED="2013-01-07 11:25:12 +0000" MODIFIED_BY="[Empty name]" NAME="Kuipers 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-01-07 11:25:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garety P, Fowler D, Kuipers E, Freeman G, Dunn P, Bebbington C, et al</AU>
<TI>London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis II: Predictors of outcome</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>171</VL>
<PG>420-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:25:12 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, et al</AU>
<TI>London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis I: Effects of the treatment phase</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>171</VL>
<PG>319-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2003" MODIFIED="2013-01-08 12:35:38 +0000" MODIFIED_BY="[Empty name]" NAME="Li 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-08 12:35:38 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="BOOK">
<AU>Li Z</AU>
<SO>The effect of a nurse-initiated patient/family education strategy on people with schizophrenia in Beijing [PhD thesis]</SO>
<YR>2003</YR>
<PB>Hong Kong Polytechnic University</PB>
<IDENTIFIERS MODIFIED="2012-09-24 09:32:19 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liberman-1998" MODIFIED="2013-01-08 12:35:25 +0000" MODIFIED_BY="[Empty name]" NAME="Liberman 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-01-08 12:35:25 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-08 12:35:25 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Liberman RP, Wallace CJ, Blackwell G, Kopelowicz A, Vaccaro JV, Mintz J</AU>
<TI>Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1998</YR>
<VL>155</VL>
<NO>8</NO>
<PG>1087-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McDonell-2006" MODIFIED="2013-01-07 11:25:27 +0000" MODIFIED_BY="[Empty name]" NAME="McDonell 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-10-15 21:26:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dyck DG, Hendryx MS, Short RA, Voss WD, McFarlane WR</AU>
<TI>Service use among patients with schizophrenia in psycho-educational multiple-family group treatment</TI>
<SO>Psychiatric Services</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>6</NO>
<PG>749-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:25:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dyck DG, Short RA, Hendryx MS, Norell D, Myers M, Patterson T, et al</AU>
<TI>Management of negative symptoms among patients with schizophrenia attending multiple-family groups</TI>
<SO>Psychiatric Services</SO>
<YR>2000</YR>
<VL>51</VL>
<NO>4</NO>
<PG>513-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hazel NA, McDonell MG, Short RA, Rodgers ML, Berry CM, Dyck DG</AU>
<TI>Impact of multiple-family groups for outpatients with schizophrenia on caregivers' distress and resources</TI>
<SO>Psychiatric Services</SO>
<YR>2004</YR>
<VL>55</VL>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 11:53:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McDonell MG, Short RA, Hazel NA, Berry CM, Dyck DG</AU>
<TI>Multiple-family group treatment of outpatients with schizophrenia: Impact on service utilization</TI>
<SO>Family Process</SO>
<YR>2006</YR>
<VL>45</VL>
<NO>3</NO>
<PG>359-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Merinder-1999" MODIFIED="2013-01-08 12:35:18 +0000" MODIFIED_BY="[Empty name]" NAME="Merinder 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-01-08 12:35:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Merinder L-B, Viuff AG, Laugesen HD, Clemmensen K, Misfelt S, Espensen B</AU>
<TI>Patient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>1994</YR>
<VL>34</VL>
<PG>287-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:25:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Merinder LB</AU>
<SO>Impact of Patient and Relative Education on Knowledge, Satisfaction with Services and Clinical Outcome in Schizophrenia</SO>
<YR>2000</YR>
<PB>Univ. of Aarhus</PB>
<CY>Aarhus, Denmark</CY>
<IDENTIFIERS MODIFIED="2012-09-24 09:37:54 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Norman-2002" MODIFIED="2013-01-08 12:34:58 +0000" MODIFIED_BY="[Empty name]" NAME="Norman 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-08 12:34:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Norman RMG, Malla AK, McLean TS, McIntosh EM, Neufeld RWJ, Voruganti LP, et al</AU>
<TI>An evaluation of a stress management program for individuals with schizophrenia</TI>
<SO>Schizophrenia Research</SO>
<YR>2002</YR>
<VL>58</VL>
<PG>293-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shin-2002" MODIFIED="2013-01-08 12:34:44 +0000" MODIFIED_BY="[Empty name]" NAME="Shin 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-08 12:34:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Shin S-K, Lukens EP</AU>
<TI>Effects of psychoeducation for Korean Americans with chronic mental illness</TI>
<SO>Psychiatric Services</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>9</NO>
<PG>1125-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shon-2002" MODIFIED="2013-01-08 12:34:41 +0000" MODIFIED_BY="[Empty name]" NAME="Shon 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-08 12:34:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Shon K-H, Park S-S</AU>
<TI>Medication and symptom management education program for the rehabilitation of psychiatric patients in Korea: The effects of promoting schedule on self-efficacy theory</TI>
<SO>Yonsei Medical Journal</SO>
<YR>2002</YR>
<VL>43</VL>
<NO>5</NO>
<PG>579-89</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tait-2002" MODIFIED="2013-01-08 12:34:33 +0000" MODIFIED_BY="[Empty name]" NAME="Tait 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-08 12:34:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tait A, McNay L, Gumley A, O'Grady M</AU>
<TI>The development and implementation of an individualised early signs monitoring system in the prediction of relapse in schizophrenia</TI>
<SO>Journal of Mental Health</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>2</NO>
<PG>141-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turkington-2006" MODIFIED="2013-01-07 11:26:22 +0000" MODIFIED_BY="[Empty name]" NAME="Turkington 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-12-11 11:57:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Kingdon DG, Turkington D</AU>
<SO>Cognitive-Behavioural Therapy of Schizophrenia</SO>
<YR>1994</YR>
<PB>Guilford Publications</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 11:58:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Turkington D, Kingdon D, Rathod S, Hammond K, Pelton J, Mehta R</AU>
<TI>Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>189</VL>
<PG>36-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:26:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Turkington D, Kingdon D, Turner T</AU>
<TI>Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2002</YR>
<VL>180</VL>
<PG>523-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:29:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Turkington D, Kingdon DG, Turner T</AU>
<TI>Improving insight in schizophrenia: the effects of cognitive-behaviour therapy and psychoeducation</TI>
<SO>Proceedings of the 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, PA, USA</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Meijel-2006" MODIFIED="2013-01-07 11:26:30 +0000" MODIFIED_BY="[Empty name]" NAME="Van Meijel 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-01-07 11:26:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Van Meijel B, Kruitwagen C, Van Der Gaag M, Khan R, Grypdonck M</AU>
<TI>An intervention study to prevent relapse in patients with schizophrenia</TI>
<SO>Journal of Nursing Scholarship</SO>
<YR>2006</YR>
<VL>38</VL>
<NO>1</NO>
<PG>42-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:30:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Meijel B, Van Der Gaag M, Kahn R, Grypdonck M</AU>
<TI>Relapse prevention in patients with schizophrenia: The application of an intervention protocol in nursing practice</TI>
<SO>Archives of Psychiatric Nursing</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>4</NO>
<PG>165-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-01-08 10:05:36 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vreeland-2006" MODIFIED="2013-01-08 12:33:28 +0000" MODIFIED_BY="[Empty name]" NAME="Vreeland 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-01-08 12:33:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vreeland B, Minsky S, Yanos PT, Menza M, Gara M, Kim E, et al</AU>
<TI>Efficacy of the team solutions program for educating patients about illness management and treatment</TI>
<SO>Psychiatric Services</SO>
<YR>2006</YR>
<VL>57</VL>
<NO>6</NO>
<PG>822-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weng-2005" MODIFIED="2013-01-08 12:33:41 +0000" MODIFIED_BY="[Empty name]" NAME="Weng 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-01-08 12:33:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weng Y, Xiang Y, Liberman R</AU>
<TI>Psychiatric rehabilitation in a Chinese psychiatric hospital</TI>
<SO>Psychiatric Services</SO>
<YR>2005</YR>
<VL>56</VL>
<NO>4</NO>
<PG>401-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xiang-2001" MODIFIED="2013-01-08 12:33:51 +0000" MODIFIED_BY="[Empty name]" NAME="Xiang 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-01-08 12:33:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Xiang Y, Weng Y, Hou Y</AU>
<TI>A preliminary study of medication management and symptom management skills training for preventing schizophrenics' relapse</TI>
<SO>Chinese Journal of Psychiatry</SO>
<YR>2001</YR>
<VL>34</VL>
<NO>3</NO>
<PG>153-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xiong-1994" MODIFIED="2013-01-08 12:33:58 +0000" MODIFIED_BY="[Empty name]" NAME="Xiong 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-01-08 12:33:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Xiong W, Phillips MR, Hu X, Wang R, Dai Q, Kleinman J, et al</AU>
<TI>Family-based intervention for schizophrenic patients in China. A randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1994</YR>
<VL>165</VL>
<PG>239-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhan-2003" MODIFIED="2013-01-08 12:34:10 +0000" MODIFIED_BY="[Empty name]" NAME="Zhan 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-08 12:34:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zhan L, Zhang L, Sun X</AU>
<TI>Study on skill-training for preventing relapse of schizophrenics</TI>
<SO>Journal of Nursing Science</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>4</NO>
<PG>243-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2004" MODIFIED="2013-01-08 12:34:18 +0000" MODIFIED_BY="[Empty name]" NAME="Zhang 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-01-08 12:34:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Y, Li S, Feng J</AU>
<TI>A study of preventing recurrence through social and independent living skill in patients with schizophrenia</TI>
<SO>Chinese Journal of Nursing</SO>
<YR>2004</YR>
<VL>39</VL>
<NO>8</NO>
<PG>573-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-01-08 12:39:42 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Armstrong-1991" MODIFIED="2011-10-15 21:35:30 +0100" MODIFIED_BY="[Empty name]" NAME="Armstrong 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-10-15 21:35:30 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study intervention does not include education to increase awareness of early signs of recurrence&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:35:30 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Armstrong H, Cox G, Short B, Allmon D</AU>
<TI>A comparative evaluation of two day treatment programs</TI>
<SO>Psychosocial Rehabilitation Journal</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>4</NO>
<PG>53-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beebe-2004" MODIFIED="2011-10-15 21:36:23 +0100" MODIFIED_BY="[Empty name]" NAME="Beebe 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-10-15 21:36:23 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include early warning signs recognition&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:36:23 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beebe LH, Tian L</AU>
<TI>TIPS: telephone intervention-problem solving for persons with schizophrenia</TI>
<SO>Issues in Mental Health Nursing</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>3</NO>
<PG>317-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Birchwood-2003" MODIFIED="2012-12-11 12:06:42 +0000" MODIFIED_BY="[Empty name]" NAME="Birchwood 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-12-11 12:06:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Birchwood M</AU>
<TI>Early signs project</TI>
<SO>National Research Register</SO>
<YR>2003</YR>
<IDENTIFIERS MODIFIED="2012-09-24 10:49:50 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buchkremer-1991" MODIFIED="2013-01-07 11:27:29 +0000" MODIFIED_BY="[Empty name]" NAME="Buchkremer 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-01-07 11:27:29 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study intervention is similar for both groups&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:27:29 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buchkremer G, Stricker K, Holle R, Kuhs H</AU>
<TI>The predictability of relapses in schizophrenic patients</TI>
<SO>European Archives of Psychiatry and Clinical Neuroscience</SO>
<YR>1991</YR>
<VL>240</VL>
<PG>292-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carra-2007" MODIFIED="2012-12-11 12:12:57 +0000" MODIFIED_BY="[Empty name]" NAME="Carra 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 12:12:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carra G, Montomoli C, Clerici M, Cazzullo CL</AU>
<TI>Family interventions for schizophrenia in Italy: randomized controlled trial</TI>
<SO>European Archives of Psychiatry and Clinical Neuroscience</SO>
<YR>2007</YR>
<VL>257</VL>
<NO>1</NO>
<PG>23-30</PG>
<IDENTIFIERS MODIFIED="2012-09-24 10:50:09 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cerniglia-1978" MODIFIED="2011-10-15 21:36:43 +0100" MODIFIED_BY="[Empty name]" NAME="Cerniglia 1978" YEAR="1978">
<REFERENCE MODIFIED="2011-10-15 21:36:43 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:36:43 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cerniglia R, Horenstein D, Christensen E</AU>
<TI>Group decision-making and self-management in the treatment of psychiatric patients</TI>
<SO>Journal of Clinical Psychology</SO>
<YR>1978</YR>
<VL>34</VL>
<NO>2</NO>
<PG>489-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Collins-2007" MODIFIED="2012-12-11 12:13:17 +0000" MODIFIED_BY="[Empty name]" NAME="Collins 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 12:13:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Collins LM, Granholm E, McQuaid JR</AU>
<TI>Clinical insight moderates treatment outcome in cognitive behavioral social skills training for chronic schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>2</NO>
<PG>426</PG>
<IDENTIFIERS MODIFIED="2012-09-24 10:50:24 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Craig-Thomas-2000" NAME="Craig Thomas 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;Population includes early psychosis and is an exclusion criterion&lt;/p&gt;" PRIMARY="NO" TYPE="OTHER">
<AU>Craig Thomas KJ</AU>
<TI>Brixton early psychosis project</TI>
<SO>National Research Register</SO>
<YR>2000</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deng-2007" MODIFIED="2012-12-11 12:13:31 +0000" MODIFIED_BY="[Empty name]" NAME="Deng 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 12:13:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deng HY, Shao YF, Xu XP</AU>
<TI>The effect of comprehensive social skills training on chronic inpatients of schizophrenia</TI>
<TO>&#31038;&#20132;&#32508;&#21512;&#25216;&#33021;&#35757;&#32451;&#23545;&#20303;&#38498;&#24930;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#30340;&#30103;&#25928;</TO>
<SO>Chinese Journal of Behavioral Medical Science [&#20013;&#22269;&#34892;&#20026;&#21307;&#23398;&#31185;&#23398;]</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>3</NO>
<PG>227-9</PG>
<IDENTIFIERS MODIFIED="2012-09-24 10:55:50 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dong-2008" MODIFIED="2012-12-11 12:13:47 +0000" MODIFIED_BY="[Empty name]" NAME="Dong 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-12-11 12:13:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dong R, Lin Q, Wang S</AU>
<TI>Effect of social function training on rehabilitation outcome of male hospitalized schizophrenics</TI>
<TO>&#31038;&#20250;&#21151;&#33021;&#35757;&#32451;&#23545;&#20303;&#38498;&#30007;&#24615;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#24247;&#22797;&#25928;&#26524;&#30340;&#24433;&#21709;</TO>
<SO>Journal of Clinical Psychosomatic Diseases [&#20020;&#24202;&#24515;&#36523;&#30142;&#30149;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>4</VL>
<NO>5</NO>
<PG>407-9</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:01:10 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Druss-2010" MODIFIED="2012-12-11 12:14:05 +0000" MODIFIED_BY="[Empty name]" NAME="Druss 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-12-11 12:14:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Druss BG, Zhao L, Von ESA, Bona JR, Fricks L, Jenkins-Tucker S, et al</AU>
<TI>The health and recovery peer (harp) program: A peer-led intervention to improve medical self-management for persons with serious mental illness</TI>
<SO>Schizophrenia Research</SO>
<YR>2010</YR>
<VL>118</VL>
<NO>1-3</NO>
<PG>264-70</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:01:59 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Falloon-1996" NAME="Falloon 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Study intervention is similar for both groups&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Falloon I, McGill C, Matthews S, Keith S, Schooler N</AU>
<TI>Family treatment for schizophrenia- The design and research application of therapist training models</TI>
<SO>Journal of Psychotherapy practice and Research</SO>
<YR>1996</YR>
<VL>5</VL>
<PG>45-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Foster-2008" MODIFIED="2012-12-11 12:14:21 +0000" MODIFIED_BY="[Empty name]" NAME="Foster 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-12-11 12:14:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Foster JH, Jumnoodoo R</AU>
<TI>Relapse prevention in serious and enduring mental illness: a pilot study</TI>
<SO>Journal of Psychiatric and Mental Health Nursing</SO>
<YR>2008</YR>
<VL>15</VL>
<NO>7</NO>
<PG>552-61</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:02:22 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gaebel-2002" MODIFIED="2013-01-07 11:27:44 +0000" MODIFIED_BY="[Empty name]" NAME="Gaebel 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-07 11:27:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gaebel W, Janner M, Frommann N, Pietzcker A, Kopcke W, Linden M, et al</AU>
<TI>First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies</TI>
<SO>Schizophrenia Research</SO>
<YR>2002</YR>
<VL>53</VL>
<PG>145-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gleeson-2009" MODIFIED="2012-12-11 12:12:08 +0000" MODIFIED_BY="[Empty name]" NAME="Gleeson 2009" YEAR="2010">
<REFERENCE MODIFIED="2012-12-11 12:09:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alvarez-Jimenez M, Gleeson JF, Cotton S, Wade D, Gee D, Pearce T, et al</AU>
<TI>Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis</TI>
<SO>Canadian Journal of Psychiatry [Revue Canadienne de Psychiatrie]</SO>
<YR>2009</YR>
<VL>54</VL>
<NO>10</NO>
<PG>710-8</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:02:46 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:10:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gleeson J, Cotton S, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, et al</AU>
<TI>An RCT of relapse prevention therapy for first-episode psychosis patients</TI>
<SO>Early Intervention in Psychiatry</SO>
<YR>2008</YR>
<VL>2</VL>
<NO>Suppl 1</NO>
<PG>A20</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:02:55 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:10:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gleeson J, Wade D, Castle D, Gee D, Crisp K, Pearce T, et al</AU>
<TI>The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics</TI>
<SO>Journal of Mental Health</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>1</NO>
<PG>19-32</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:03:02 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:11:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Gleeson JF, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, et al</AU>
<TI>A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: Outcome at 30-month follow-up</TI>
<SO>http://schizophreniabulletin.oxfordjournals.org/content/early/2011/11/29/schbul.sbr165.full.pdf+html</SO>
<YR>(accessed 05 December 2011)</YR>
<IDENTIFIERS MODIFIED="2012-09-24 11:04:03 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:11:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gleeson JFM, Cotton SM, Alvarez-Jimenez M, Wade D, Crisp K, Newman B, et al</AU>
<TI>Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2010</YR>
<VL>71</VL>
<NO>4</NO>
<PG>475-83</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:11:41 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:11:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gleeson JFM, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, et al</AU>
<TI>A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2009</YR>
<VL>70</VL>
<NO>4</NO>
<PG>477-86</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:11:50 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:12:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Newman B</AU>
<TI>EPISODE II: Prevention of relapse following early psychosis</TI>
<SO>Australian New Zealand Clinical Trials Registry</SO>
<YR>2003</YR>
<IDENTIFIERS MODIFIED="2012-09-24 11:11:58 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glick-1989" MODIFIED="2013-01-07 11:27:59 +0000" MODIFIED_BY="[Empty name]" NAME="Glick 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-01-07 11:27:59 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:27:59 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glick I, Jacobs M, Lieberman J, Simpson G, Schooler N</AU>
<TI>Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms and extrapyramidal signs</TI>
<SO>Psychoparmacology Bulletin</SO>
<YR>1989</YR>
<VL>25</VL>
<NO>3</NO>
<PG>344-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glick-1990" MODIFIED="2013-01-07 11:28:38 +0000" MODIFIED_BY="[Empty name]" NAME="Glick 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-01-07 11:28:30 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study intervention does not include training to recognise early waring signs of recurrence&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:28:30 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glick I, Clarkin J, Spencer J, Haas G, Lewis A, Peyser J, et al</AU>
<TI>A controlled evaluation of inpatient family intervention- I. Preliminary results of the six-month follow-up</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1985</YR>
<VL>42</VL>
<PG>882-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:28:38 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:28:38 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Glick I, Spencer J, Clarkin J, Haas G, Lewis A, Peyser J, et al</AU>
<TI>A randomised clinical trial of inpatient family intervention. IV- Followup results for subjects with schizophrenia</TI>
<SO>Schizophrenia Research</SO>
<YR>1990</YR>
<VL>3</VL>
<PG>187-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glynn-2002" MODIFIED="2013-01-07 11:28:46 +0000" MODIFIED_BY="[Empty name]" NAME="Glynn 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-07 11:28:46 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study intervention appplicable to both groups&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:28:46 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glynn S, Marder S, Liberman R, Blair K, Wirshing W, Wirshing D, et al</AU>
<TI>Supplementing clinic-based skills training with manual-based community support sessions: Effects on social adjustment of patients with schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2002</YR>
<VL>159</VL>
<NO>5</NO>
<PG>829-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldberg-1977" MODIFIED="2011-10-15 21:44:40 +0100" MODIFIED_BY="[Empty name]" NAME="Goldberg 1977" YEAR="1977">
<REFERENCE MODIFIED="2011-10-15 21:44:40 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include training to recognise early warning signs of relapse&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:44:40 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldberg S, Schooler N, Hogarty G, Roper M</AU>
<TI>Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1977</YR>
<VL>34</VL>
<PG>171-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gong-2007" MODIFIED="2012-12-11 12:17:19 +0000" MODIFIED_BY="[Empty name]" NAME="Gong 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 12:17:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gong CP, Zhang JJ, Zheng G</AU>
<TI>Three-year follow-up study of family synthetically intervention for community family bed patients with schizophrenia</TI>
<TO>&#23478;&#24237;&#32508;&#21512;&#24178;&#39044;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#20020;&#24202;&#24247;&#22797;&#30340;&#20316;&#29992;</TO>
<SO>Chinese Journal of Behavioral Medical Science [&#20013;&#22269;&#34892;&#20026;&#21307;&#23398;&#31185;&#23398;]</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>10</NO>
<PG>903-5</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:13:48 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grawe-1998" MODIFIED="2012-09-24 11:17:20 +0100" MODIFIED_BY="[Empty name]" NAME="Grawe 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-09-24 11:17:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Population includes early onset schizophrenia, which is an exclusion criterion&lt;/p&gt;" NOTES_MODIFIED="2012-09-24 11:17:20 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grawe RW, Widen JH</AU>
<TI>Results of two years optimal out-patient treatment of first episode schizophrenia: a controlled study</TI>
<SO>Nordisk Psykiatrisk Tidsskrift</SO>
<YR>1998</YR>
<VL>52</VL>
<NO>41</NO>
<PG>76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gray-2004" MODIFIED="2012-12-11 12:18:13 +0000" MODIFIED_BY="[Empty name]" NAME="Gray 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-12-11 12:17:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gray R, Leese M, Bindman J, Becker T, Burti L, David A, et al</AU>
<TI>Adherence therapy for people with schizophrenia: European multi-centre randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>189</VL>
<PG>508-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:18:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gray R, Robson D</AU>
<TI>Effect of a adherence counselling training package for case managers on relapse for patients with schizophrenia: cluster randomised controlled</TI>
<SO>European Psychiatry</SO>
<YR>2005</YR>
<VL>20</VL>
<PG>S63</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:17:29 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 21:46:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;No early warning signs intervention&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:46:27 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gray R, Wykes T, Edmonds M, Leese M, Gournay K</AU>
<TI>Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2004</YR>
<VL>185</VL>
<PG>157-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guohui-2003" MODIFIED="2012-12-11 12:18:41 +0000" MODIFIED_BY="[Empty name]" NAME="Guohui 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-12-11 12:18:41 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;There is no intervention to recognise early warning signs&lt;/p&gt;" NOTES_MODIFIED="2012-12-11 12:18:41 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guohui L, Liping C, Xilin W</AU>
<TI>Rapid control of excitation and agitation with olanzapine</TI>
<SO>Shanghai Archives of Psychiatry</SO>
<YR>2003</YR>
<VL>15</VL>
<NO>6</NO>
<PG>344-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hahlweg-1999" MODIFIED="2011-10-15 21:49:18 +0100" MODIFIED_BY="[Empty name]" NAME="Hahlweg 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-10-15 21:49:18 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Early warning signs intervention applies to both groups&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:49:18 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hahlweg K, Wiedemann G</AU>
<TI>Principles and results of family therapy in schizophrenia</TI>
<SO>European Archives of Psychiatry and Clinical Neuroscience</SO>
<YR>1999</YR>
<VL>249</VL>
<NO>Suppl.4</NO>
<PG>108-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haut-2007" MODIFIED="2012-12-11 12:19:25 +0000" MODIFIED_BY="[Empty name]" NAME="Haut 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 12:19:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haut KM, Johnson MK, Hegeman BM, Goghari VM, MacDonald AW</AU>
<TI>Cognitive remediation and changes in prefrontal cortical function in schizophrenia: behavioral vs functional sensitivity to change</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>2</NO>
<PG>370</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:17:56 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayward-1995" MODIFIED="2013-01-07 11:29:21 +0000" MODIFIED_BY="[Empty name]" NAME="Hayward 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-01-07 11:29:21 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;No early warning signs intervention&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:29:21 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayward P, Chan N, Kemp R, Youle S, David A</AU>
<TI>Medication self management: a preliminary report on an intervention to improve medication compliance</TI>
<SO>Journal of Mental Health</SO>
<YR>1995</YR>
<VL>4</VL>
<NO>5</NO>
<PG>511-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herz-1989" MODIFIED="2013-01-07 11:29:39 +0000" MODIFIED_BY="[Empty name]" NAME="Herz 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-01-07 11:29:39 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Early warning signs recognition is used as intervention in both control and experimental groups&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:29:39 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herz MI, Glazer W, Mirza M, Mostert M, Hafez H</AU>
<TI>Treating prodromal episodes to prevent relapse in schizophrenia</TI>
<SO>British Journal of Psychiatry Supplementum</SO>
<YR>1989</YR>
<VL>155</VL>
<NO>Suppl 5</NO>
<PG>123-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herz-1991" MODIFIED="2011-10-15 21:51:19 +0100" MODIFIED_BY="[Empty name]" NAME="Herz 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-10-15 21:51:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herz MI, Glazer WM, Mostert MA, Sheard MA, Szymanski HV, Hafez H, Mirza M, Vana J</AU>
<TI>Intermittent vs maintenance medication in schizophrenia.Two-year results</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1991</YR>
<VL>48</VL>
<PG>333-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hogarty-1988" MODIFIED="2013-01-07 11:29:32 +0000" MODIFIED_BY="[Empty name]" NAME="Hogarty 1988" YEAR="1988">
<REFERENCE MODIFIED="2013-01-07 11:29:32 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:29:32 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hogarty G, McEvoy J, Munetz M, Dibarry AL, Bartone P, Cather R, et al</AU>
<TI>Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1988</YR>
<VL>45</VL>
<PG>797-805</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Horan-2011" MODIFIED="2012-12-11 12:20:29 +0000" MODIFIED_BY="[Empty name]" NAME="Horan 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-12-11 12:20:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M, et al</AU>
<TI>Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders</TI>
<SO>Journal of Psychiatric Research</SO>
<YR>2011</YR>
<VL>45</VL>
<NO>8</NO>
<PG>1113-22</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:18:51 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hou-2007" MODIFIED="2012-12-11 12:20:50 +0000" MODIFIED_BY="[Empty name]" NAME="Hou 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 12:20:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hou DQ, Zeng ZX, Wang HY</AU>
<TI>Effect of insight education and self-confidence training on the quality of life and well-being rating in first episode schizophrenia</TI>
<SO>Chinese Journal of Rehabilitation Theory and Practice [&#20013;&#22269;&#24247;&#22797;&#29702;&#35770;&#19982;&#23454;&#36341;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>5</NO>
<PG>479-81</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:19:10 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jolley-1990" MODIFIED="2012-12-11 12:21:42 +0000" MODIFIED_BY="[Empty name]" NAME="Jolley 1990" YEAR="1990">
<REFERENCE MODIFIED="2011-10-15 21:53:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jolley AG, Hirsch SR, McRink A, Manchanda R</AU>
<TI>Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: Clinical outcome at one year</TI>
<SO>BMJ</SO>
<YR>1989</YR>
<VL>298</VL>
<PG>985-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 12:21:42 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;Early warning signs intervention applies to both experimental and control groups&lt;/p&gt;" NOTES_MODIFIED="2012-12-11 12:21:42 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jolley AG, Hirsch SR, Morrison E, McRink A, Wilson L</AU>
<TI>Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenia outpatients: clinical and social outcome at two years</TI>
<SO>BMJ</SO>
<YR>1990</YR>
<VL>301</VL>
<PG>837-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jumnoodoo-2008" MODIFIED="2011-10-15 21:54:29 +0100" MODIFIED_BY="[Empty name]" NAME="Jumnoodoo 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-10-15 21:54:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jumnoodoo R</AU>
<TI>Relapse prevention among schizophrenia: a multi stage randomised controlled group study</TI>
<SO>National Research Register</SO>
<YR>2003</YR>
<VL>4</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-10-15 21:53:44 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kallert-2004a" MODIFIED="2011-10-15 21:55:31 +0100" MODIFIED_BY="[Empty name]" NAME="Kallert 2004a" YEAR="2004">
<REFERENCE MODIFIED="2011-10-15 21:55:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kallert TW, Schellong J, Kulke C, Kernweiss N, Ripke B</AU>
<TI>German results on implementation and effectiveness of the psychoedutraining study</TI>
<SO>Proceedings of the Thematic Conference of the World Psychiatric Association on "Treatments in Psychiatry: An Update"; 2004 Nov 10-13; Florence, Italy</SO>
<YR>2004</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klosterk_x00f6_tter-2007" MODIFIED="2012-09-24 11:19:55 +0100" MODIFIED_BY="[Empty name]" NAME="Klosterkötter 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-24 11:19:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Klosterkötter J</AU>
<TI>Secondary prevention of schizophrenia: a randomised controlled trial</TI>
<SO>http://www.controlled-trials.com</SO>
<YR>2007</YR>
<MD>Other</MD>
<IDENTIFIERS MODIFIED="2012-09-24 11:19:55 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kopelowicz-1998b" NAME="Kopelowicz 1998b" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Study intervention does not include recognition of early warning signs&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kopelowicz A</AU>
<TI>Adapting social skills training for Latinos with schizophrenia</TI>
<SO>International Review of Psychiatry</SO>
<YR>1998</YR>
<VL>10</VL>
<PG>47-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leavey-2004" MODIFIED="2011-10-15 21:55:50 +0100" MODIFIED_BY="[Empty name]" NAME="Leavey 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-10-15 21:55:50 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study includes early onset psychosis samples which is an exclusion&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:55:50 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leavey G, Gulamhussein S, Papadopoulos C, Johnson-Sabine E, Blizard B, King M</AU>
<TI>A randomised controlled trial of a brief intervention for families of patients with a first episode of psychosis</TI>
<SO>Psychological Medicine</SO>
<YR>2004</YR>
<VL>34</VL>
<PG>423-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leclerc-2000" MODIFIED="2013-01-07 11:29:56 +0000" MODIFIED_BY="[Empty name]" NAME="Leclerc 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-01-07 11:29:56 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Early warning signs recognition not included in the intervention&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:29:56 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leclerc C, Lesage AD, Ricard N, Lecomte T, Cyr M</AU>
<TI>Assessment of a new rehabilitative coping skills module for persons with schizophrenia</TI>
<SO>American Journal of Orthopsychiatry</SO>
<YR>2000</YR>
<VL>70</VL>
<NO>3</NO>
<PG>380-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leff-1984" MODIFIED="2013-01-07 11:30:06 +0000" MODIFIED_BY="[Empty name]" NAME="Leff 1984" YEAR="1984">
<REFERENCE MODIFIED="2013-01-07 11:30:06 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:30:06 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leff J, Kuipers L, Berkowitz R, Eberlein-Fries R, Sturgeon D</AU>
<TI>Psychosocial relevance and benefit of neuroleptic maintenance: Experience in the United Kingdom</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>1984</YR>
<VL>45</VL>
<NO>5</NO>
<PG>43-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leff-2001" MODIFIED="2011-10-15 21:56:34 +0100" MODIFIED_BY="[Empty name]" NAME="Leff 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-10-15 21:56:34 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:56:34 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leff J, Sharpley M, Chisholm D, Bell R, Gamble C</AU>
<TI>Training community psychiatric nurses in schizophrenia family work: A study of clinical and economic outcomes for patients and relatives</TI>
<SO>Journal of Mental Health</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>2</NO>
<PG>189-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lenior-2001" MODIFIED="2011-10-15 21:57:03 +0100" MODIFIED_BY="[Empty name]" NAME="Lenior 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-10-15 21:57:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lenior M, Dingemans P, Linszen D, De-Hann L, Schene A</AU>
<TI>Social functioning and the course of early-onset schizophrenia</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2001</YR>
<VL>179</VL>
<PG>53-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liang-2002" MODIFIED="2013-01-07 11:30:19 +0000" MODIFIED_BY="[Empty name]" NAME="Liang 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-07 11:30:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liang Q, Liang B</AU>
<TI>Effect of health education on the effectiveness of patients with schizophrenia</TI>
<SO>Journal of Nursing Science</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>12</NO>
<PG>931-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liberman-1986" MODIFIED="2013-01-07 11:30:27 +0000" MODIFIED_BY="[Empty name]" NAME="Liberman 1986" YEAR="1986">
<REFERENCE MODIFIED="2013-01-07 11:30:27 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:30:27 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liberman RP, Mueser KT, Wallace CJ</AU>
<TI>Social skills training for schizophrenic individuals at risk of relapse</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1986</YR>
<VL>143</VL>
<NO>4</NO>
<PG>523-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liberman-1988" MODIFIED="2011-10-15 21:57:43 +0100" MODIFIED_BY="[Empty name]" NAME="Liberman 1988" YEAR="1988">
<REFERENCE MODIFIED="2011-10-15 21:57:43 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Early warning signs work conducted with both groups&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 21:57:43 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Liberman PR, Eclam AT, Marder RS, Wirshing W, Johnston-Cronk K</AU>
<TI>Symptom management training for schizophrenics</TI>
<SO>Proceedings of the 141st Annual Meeting of the American Psychiatric Association;1988 May 7-12; Quebec, Canada</SO>
<YR>1988</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linden-2001" MODIFIED="2013-01-07 11:31:00 +0000" MODIFIED_BY="[Empty name]" NAME="Linden 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-01-07 11:31:00 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:31:00 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linden M, Godemann F, Gaebel W, Kopke W, Muller P, Muller-Spahn F, et al</AU>
<TI>A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>4</NO>
<PG>585-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linszen-1994" MODIFIED="2013-01-07 11:31:09 +0000" MODIFIED_BY="[Empty name]" NAME="Linszen 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Population age 15-26, no early warning signs intervention&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linszen D, Dingemans P, Lenior M</AU>
<TI>Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications</TI>
<SO>Schizophrenia Research</SO>
<YR>2001</YR>
<VL>51</VL>
<NO>1</NO>
<PG>55-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:31:09 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;population age 15-26. Both groups have early warning signs intervention.&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:31:09 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Linszen D, Dingemans P, Van Der Does JW, Nugter A, Scholte P, Lenior R, et al</AU>
<TI>Treatment, expressed emotion and relapse in recent onset schizophrenic disorders</TI>
<SO>Psychological Medicine</SO>
<YR>1996</YR>
<VL>26</VL>
<NO>2</NO>
<PG>333-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:00:11 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Population age 15-26. Early warning signs work applied to both groups&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:00:11 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linszen D, Lenior M, de-Haan L, Dingemans P, Gersons B</AU>
<TI>Early intervention, untreated psychosis and the course of early schizophrenia</TI>
<SO>British Journal of Psychiatry Supplementum</SO>
<YR>1998</YR>
<VL>172</VL>
<NO>33</NO>
<PG>84-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:00:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Age group 15-26 and no early warning signs intervention.&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:00:27 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linszen DH, Dingemans PM, Lenior ME, Nugter A, Scholte WF, Willem Van Der Does AJ</AU>
<TI>Relapse criteria in schizophrenic disorders: Different perspectives</TI>
<SO>Psychiatry Research</SO>
<YR>1994</YR>
<VL>54</VL>
<PG>273-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:00:33 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Age group 15-26, intervention similar for both groups&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:00:33 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nugter A, Dingemans P, Van Der Does JW, Linszen D, Gersons B</AU>
<TI>Family treatment, expressed emotion and relapse in recent onset schizophrenia</TI>
<SO>Psychiatry Research</SO>
<YR>1997</YR>
<VL>72</VL>
<PG>23-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linszen-1998" MODIFIED="2012-12-11 13:14:19 +0000" MODIFIED_BY="[Empty name]" NAME="Linszen 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-12-11 13:14:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linszen D, Dingemans P, Scholte W, Lenior M, Goldstein M</AU>
<TI>Early recognition, intensive intervention and other protective and risk factors for psychotic relapse in patients with first psychotic episodes in schizophrenia</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>Suppl 1</NO>
<PG>S7-S12</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:21:52 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linszen-1998a" MODIFIED="2012-09-24 11:22:00 +0100" MODIFIED_BY="[Empty name]" NAME="Linszen 1998a" YEAR="1998">
<REFERENCE MODIFIED="2012-09-24 11:22:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Linszen D, Dingemans PM, Lenior ME, Scholte WF, Goldstein M</AU>
<TI>Early family and individual interventions and relapse in recent-onset schizophrenia and related disorders</TI>
<SO>Italian Journal of Psychiatry and Behavioural Sciences</SO>
<YR>1998</YR>
<VL>8</VL>
<PG>77-84</PG>
<MD>Journal article</MD>
<IDENTIFIERS MODIFIED="2012-09-24 11:22:00 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lopez_x002d_Luengo-2003" MODIFIED="2011-10-15 22:00:49 +0100" MODIFIED_BY="[Empty name]" NAME="Lopez-Luengo 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-10-15 22:00:49 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include early warning signs recognition&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:00:49 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lopez-Luengo B, Vazquez C</AU>
<TI>Effects of attention process training on cognitive functioning of schizophrenic patients</TI>
<SO>Psychiatry Research</SO>
<YR>2003</YR>
<VL>119</VL>
<PG>41-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malm-2003" MODIFIED="2011-10-15 22:01:21 +0100" MODIFIED_BY="[Empty name]" NAME="Malm 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-10-15 22:01:21 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Both groups received early warning signs intervention&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:01:21 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malm U, Ivarsson B, Allebeck P, Falloon IRH</AU>
<TI>Integrated care in schizophrenia: a 2-year randomized controlled study of two community-based treatment programs</TI>
<SO>Acta Psychiatrica Scandinavia</SO>
<YR>2003</YR>
<VL>107</VL>
<PG>415-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marder-1994" MODIFIED="2013-01-07 11:31:42 +0000" MODIFIED_BY="[Empty name]" NAME="Marder 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-12-11 13:15:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eckman TA, Wirshing WC, Marder SR, Liberman RP, Johnston-Cronk K, Zimmermann K, et al</AU>
<TI>Technique for training schizophrenic patients in Illness self-management: A controlled trial</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1992</YR>
<VL>149</VL>
<NO>11</NO>
<PG>1549-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:31:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marder S, Wirshing W, Mintz J, McKenzie J, Johnston K, Eckman T, et al</AU>
<TI>Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1996</YR>
<VL>153</VL>
<NO>12</NO>
<PG>1585-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-07 09:17:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marder SR, Mintz J, Van Putten T, Lebell M, Wirshing WC, Johnston-Cronk K</AU>
<TI>Early prediction of relapse in schizophrenia: an application of receiver operating characteristic (ROC) methods</TI>
<SO>Psychopharmacology Bulletin</SO>
<YR>1991</YR>
<VL>27</VL>
<PG>79-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:31:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Marder SR, Wirshing WC, Van Putten T, Mintz J, McKenzie J, Johnston-Cronk K, et al</AU>
<TI>Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1994</YR>
<VL>51</VL>
<PG>280-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:07:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wirshing W, Eckman T, Liberman R, Marder S</AU>
<TI>Management of risk of relapse through skills training of chronic schizophrenics</TI>
<SO>Advances in Neuropsychiatry and Psychoparmacology</SO>
<YR>1991</YR>
<VL>Schizophrenia Research</VL>
<NO>1</NO>
<PG>255-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:31:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wirshing WC, Marder SR, Eckman T, Liberman RP, Mintz J</AU>
<TI>Acquisition and retention of skills training methods in chronic schizophrenic outpatients</TI>
<SO>Psychopharmacology Bulletin</SO>
<YR>1992</YR>
<VL>28</VL>
<NO>3</NO>
<PG>241-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marder-2003" MODIFIED="2013-01-07 11:31:50 +0000" MODIFIED_BY="[Empty name]" NAME="Marder 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-07 11:31:50 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author acknowledges that there was no formal assessment of prodromal symptoms and early warning signs recognition was not included in the intervention.&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:31:50 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marder S, Glynn SM, Wirshing W, Wirshing D, Ross D, Widmark C, et al</AU>
<TI>Maintenance treatment of schizophrenia with risperidone and haloperidol: 2-year outcomes</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2003</YR>
<VL>160</VL>
<NO>8</NO>
<PG>1405-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mausbach-2008" MODIFIED="2012-12-11 13:18:20 +0000" MODIFIED_BY="[Empty name]" NAME="Mausbach 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-12-11 13:18:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mausbach BT, Cardenas V, McKibbin CL, Jeste DV, Patterson TL</AU>
<TI>Reducing emergency medical service use in patients with chronic psychotic disorders: results from the FAST intervention study</TI>
<SO>Behaviour Research and Therapy</SO>
<YR>2008</YR>
<VL>46</VL>
<NO>1</NO>
<PG>145-53</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:23:41 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McFarlane-1995" MODIFIED="2013-01-07 11:32:03 +0000" MODIFIED_BY="[Empty name]" NAME="McFarlane 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-10-15 22:09:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McFarlane WR, Link B, Dushay R, Marchal J, Crilly J</AU>
<TI>Psychoeducational multiple family groups: four-year relapse outcome in schizophrenia</TI>
<SO>Family Process</SO>
<YR>1995</YR>
<VL>34</VL>
<NO>2</NO>
<PG>127-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:32:03 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Psychoeducation available to all groups&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:32:03 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McFarlane WR, Lukens E, Link B, Dushay R, Deakins SA, Newmark M, et al</AU>
<TI>Multiple-family groups and psychoeducation in the treatment of schizophrenia</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1995</YR>
<VL>52</VL>
<NO>8</NO>
<PG>679-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McGill-1983" MODIFIED="2013-01-07 11:32:13 +0000" MODIFIED_BY="[Empty name]" NAME="McGill 1983" YEAR="1983">
<REFERENCE MODIFIED="2013-01-07 11:32:13 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;No early warning signs intervention&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:32:13 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McGill CW, Falloon I, Boyd J, Wood-Siverio C</AU>
<TI>Family educational intervention in the treatment of schizophrenia</TI>
<SO>Hospital and Community Psychiatry</SO>
<YR>1983</YR>
<VL>34</VL>
<NO>10</NO>
<PG>934-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Merson-1992" MODIFIED="2013-01-07 11:32:29 +0000" MODIFIED_BY="[Empty name]" NAME="Merson 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-10-15 22:12:35 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;No early warning signs intervention&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:12:35 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Merson S, Tyrer P, Carlen D, Johnson T</AU>
<TI>The cost of treatment of psychiatric emergencies: a comparison of hospital and community services</TI>
<SO>Psychological Medicine</SO>
<YR>1996</YR>
<VL>26</VL>
<NO>4</NO>
<PG>727-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:32:29 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Population not schizophrenia, intervention not recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:32:29 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Merson S, Tyrer P, Onyett S, Lack S, Birkett P, Lynch S, et al</AU>
<TI>Early intervention in psychiatric emergencies: a controlled clinical trial</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>339</VL>
<PG>1311-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monking-1994" MODIFIED="2011-10-15 22:14:38 +0100" MODIFIED_BY="[Empty name]" NAME="Monking 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-10-15 22:14:38 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;No early warning signs intervention&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:14:38 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schulze Monking H</AU>
<TI>Self-help groups for families of schizophrenic patients: formation, development and therapeutic impact</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>1994</YR>
<VL>29</VL>
<PG>149-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montero-2001" MODIFIED="2013-01-07 11:32:42 +0000" MODIFIED_BY="[Empty name]" NAME="Montero 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-01-07 11:32:42 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;No early warning signs intervention&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:32:42 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montero I, Asencio A, Hernandez I, Masanet MJ, Lacruz M, Bellver F, et al</AU>
<TI>Two strategies for family intervention in schizophrenia: a randomized trial in a Mediterranean environment</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>4</NO>
<PG>661-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moxon-2008" MODIFIED="2012-12-11 13:21:20 +0000" MODIFIED_BY="[Empty name]" NAME="Moxon 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-12-11 13:21:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moxon AM, Ronan KR</AU>
<TI>Providing information to relatives and patients about expressed emotion and schizophrenia in a community-support setting: a randomized, controlled trial</TI>
<SO>Clinical Schizophrenia and Related Psychoses</SO>
<YR>2008</YR>
<VL>2</VL>
<NO>1</NO>
<PG>47-58</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:24:41 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Munroe_x002d_Blum-1993" MODIFIED="2012-12-11 13:21:36 +0000" MODIFIED_BY="[Empty name]" NAME="Munroe-Blum 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-12-11 13:21:36 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;All groups have skills training and psychoeducation&lt;/p&gt;" NOTES_MODIFIED="2012-12-11 13:21:36 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Munroe-Blum H, McCleary L, Foster G</AU>
<TI>Social treatments study: design and preliminary outcome</TI>
<SO>Schizophrenia Research</SO>
<YR>1993</YR>
<VL>9</VL>
<NO>1, 2</NO>
<PG>269</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newton-2005" MODIFIED="2012-12-11 13:23:47 +0000" MODIFIED_BY="[Empty name]" NAME="Newton 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-12-11 13:23:47 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention is not recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2012-12-11 13:23:47 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newton E, Landau S, Smith P, Monks P, Shergill S, Wykes T</AU>
<TI>Early psychological intervention for auditory hallucinations: An exploratory study of young people's voices groups</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>2005</YR>
<VL>193</VL>
<NO>1</NO>
<PG>58-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nordentoft-1998" MODIFIED="2013-01-07 11:33:01 +0000" MODIFIED_BY="[Empty name]" NAME="Nordentoft 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-01-07 11:32:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jorgensen P, Nordentoft M, Abel MB, Gouliaev G, Jeppesen P, Kassow P</AU>
<TI>Early detection and assertive community treatment of young psychotics: The opus study</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>2000</YR>
<VL>35</VL>
<PG>283-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-11 13:24:55 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;First episode psychosis form the population&lt;/p&gt;" NOTES_MODIFIED="2012-12-11 13:24:55 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nordentoft M, Jeppesen P, Abel MB, Hemmingsen R, Reisby N</AU>
<TI>Can duration of untreated psychosis be shortened and does optimal treatment program improve outcome? A randomised controlled study</TI>
<SO>Nordisk Psykiatrisk Tidsskrift</SO>
<YR>1998</YR>
<VL>52</VL>
<NO>41</NO>
<PG>76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:33:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Nordentoft M, Jeppesen P, Kassow P, Abel M, Petersen L, Thorup A, et al</AU>
<TI>OPUS-project: A randomised controlled trial of integrated psychiatric treatment in first-episode psychosis - Clinical outcome improved</TI>
<SO>Proceedings of the 3rd International Conference on Early Psychosis; 2002 Sep 25-28; Copenhagen, Denmark</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:21:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Nordentoft M, Reisby N, Jeppesen P, Abel M, Kassow P, Jirgensen P</AU>
<TI>Opus-project: differences in treatment outcome of a randomised controlled trial of integrated psychiatric treatment of first-episode psychosis</TI>
<SO>Proceedings of the 11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:22:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ohlenschlaeger J, Thorup A, Petersen L, Jeppesen P, Abel M, Nordentoft M</AU>
<TI>Coercion in first episode psychosis</TI>
<SO>Proceedings of the 3rd International Conference on Early Psychosis; 2002 Sep 25-28; Copenhagen, Denmark</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:22:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petersen L, Jeppesen P, Thorup A, Abel M, Ohlenschlaeger J, Christensen TO</AU>
<TI>A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness</TI>
<SO>BMJ</SO>
<YR>2005</YR>
<VL>331</VL>
<NO>7517</NO>
<PG>602</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Owens-2001" MODIFIED="2013-01-08 12:39:42 +0000" MODIFIED_BY="[Empty name]" NAME="Owens 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-01-08 12:39:42 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study intervention did not focus on early relapse symptom recognition but compliance.&lt;/p&gt;" NOTES_MODIFIED="2013-01-08 12:39:42 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cunningham Owens D, Carroll A, Fattah S, Clyde Z, Coffey I, Johnstone E</AU>
<TI>A randomized, controlled trial of a brief interventional package for schizophrenic out-patients</TI>
<SO>Acta Psychiatrica Scandinavia</SO>
<YR>2001</YR>
<VL>103</VL>
<PG>362-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-15 22:22:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrison G, Owens D, Holton A, Neilson D and Boot D</AU>
<TI>A prospective study of severe mental disorder in Afro-Caribbean patients</TI>
<SO>Psychological Medicine</SO>
<YR>1988</YR>
<VL>18</VL>
<PG>643-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Papageorgiou-2002" MODIFIED="2013-01-07 11:33:43 +0000" MODIFIED_BY="[Empty name]" NAME="Papageorgiou 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-01-07 11:33:43 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Sample not specifically schizophrenia, intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:33:43 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Papageorgiou A, King M, Janmohamed A, Davidson O, Dawson J</AU>
<TI>Advance directives for patients compulsorily admitted to hospital with serious mental illness. Randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2002</YR>
<VL>181</VL>
<PG>513-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pietzcker-1993" MODIFIED="2013-01-07 11:34:30 +0000" MODIFIED_BY="[Empty name]" NAME="Pietzcker 1993" YEAR="1993">
<REFERENCE MODIFIED="2013-01-07 11:33:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bandelow B, Muller P, Frick U, Gaebel W, Linden M, Muller-Spahn F, et al</AU>
<TI>Depressive syndromes in schizophrenic patients under neuroleptic therapy</TI>
<SO>European Archives of Psychiatry and Clinical Neuroscience</SO>
<YR>1992</YR>
<VL>241</VL>
<PG>291-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:34:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gaebel W, Frick U, Kopcke W, Linden M, Muller P, Muller-Spahn F, et al</AU>
<TI>Early neuroleptic intervention in schizophrenia: Are prodromal symptoms valid predictors of relapse?</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1993</YR>
<VL>163</VL>
<NO>Suppl 21</NO>
<PG>8-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:34:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pietzcker A, Gaebel W, Kopcke W, Linden M, Muller P, Muller-Spahn F, et al</AU>
<TI>A German multicenter study on the neuroleptic long-term treatment of schizophrenic patients, preliminary report</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1986</YR>
<VL>19</VL>
<PG>161-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:34:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pietzcker A, Gaebel W, Kopcke W, Linden M, Muller P, Muller-Spahn F, et al</AU>
<TI>Intermittent vs maintenance neuroleptic long-term treatment in schizophrenia-two-year results of a German multicentre study</TI>
<SO>Journal of Psychiatric Research</SO>
<YR>1993</YR>
<VL>27</VL>
<NO>4</NO>
<PG>321-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:34:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pietzcker A</AU>
<TI>A German multicentre study on the long-term treatment of schizophrenic outpatients</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1985</YR>
<VL>18</VL>
<PG>333-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Power-2003" MODIFIED="2013-01-07 11:34:37 +0000" MODIFIED_BY="[Empty name]" NAME="Power 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-07 11:34:37 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;EPPIC study: first episode psychosis population is an exclusion criterion&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:34:37 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Power P, Bell R, Mills R, Herrman-Doig T, Davern M, Henry L, et al</AU>
<TI>Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis</TI>
<SO>Australian and New Zealand Journal of Psychiatry</SO>
<YR>2003</YR>
<VL>37</VL>
<NO>4</NO>
<PG>414-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rogers-2003" MODIFIED="2013-01-07 11:34:49 +0000" MODIFIED_BY="[Empty name]" NAME="Rogers 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-07 11:34:49 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include early warning signs recognition&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:34:49 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rogers A, Day J, Randall F, Bentall RP</AU>
<TI>Patient's understanding and participation in a trial designed to improve the management of anti-psychotic medication. A qualitative study</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>2003</YR>
<VL>38</VL>
<PG>720-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rossotto-2003" MODIFIED="2011-10-15 22:29:46 +0100" MODIFIED_BY="[Empty name]" NAME="Rossotto 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-10-15 22:29:46 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Both groups receive intervention including illness education&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:29:46 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rossotto E, Wirshing D, Wirshing W, Boyd J, Liberman R, Marder S</AU>
<TI>Reducing rehospitalization rates for patients with schizophrenia: the community re-entry supplemental intervention</TI>
<SO>Schizophrenia Research</SO>
<YR>2003</YR>
<VL>60</VL>
<NO>1</NO>
<PG>328</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rotondi-2005" MODIFIED="2013-01-07 11:35:06 +0000" MODIFIED_BY="[Empty name]" NAME="Rotondi 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-12-11 13:37:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rotondi AJ, Haas G, Anderson C, Ganguli R, Keshavan M, Newhill C, et al</AU>
<TI>A randomized trial of a telehealth intervention to provide in-home psychoeducation to persons with schizophrenia and their families: intervention design and preliminary findings</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>2</NO>
<PG>533</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:27:46 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:35:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rotondi AJ, Haas GL, Anderson CM, Newhill CE, Spring MB, Ganguli R, et al</AU>
<TI>A clinical trial to test the feasibility of a telehealth psychoeducational intervention for persons with schizophrenia and their families: intervention and 3 month findings</TI>
<SO>Rehabilitation Psychology</SO>
<YR>2005</YR>
<VL>50</VL>
<NO>4</NO>
<PG>325-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salzer-2004" MODIFIED="2011-10-15 22:33:40 +0100" MODIFIED_BY="[Empty name]" NAME="Salzer 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-10-15 22:33:40 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:33:40 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salzer MS, Tunner T, Charney NJ</AU>
<TI>A low-cost, telephone intervention to enhance schizophrenia treatment: a demonstration study</TI>
<SO>Schizophrenia Research</SO>
<YR>2004</YR>
<VL>66</VL>
<PG>75-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saren-2003" MODIFIED="2013-01-07 11:35:14 +0000" MODIFIED_BY="[Empty name]" NAME="Saren 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-01-07 11:35:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:35:14 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saren T, Xiang Y, Weng Y, Feng Y</AU>
<TI>Social skill training for rehabilitating social skill disability of schizophrenics in the community</TI>
<SO>Chinese Journal of Clinical Rehabilitation</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>5</NO>
<PG>734-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schonell-1995" MODIFIED="2009-03-09 08:50:48 +0000" MODIFIED_BY="[Empty name]" NAME="Schonell 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-03-09 08:50:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schonell H, Kumpf S, Gralle J, Gebhardt R</AU>
<TI>Efficacy of psychoeducational training for schizophrenic and schizoaffective disorders</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1995</YR>
<VL>28</VL>
<PG>213</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schooler-1997" MODIFIED="2013-01-07 11:35:33 +0000" MODIFIED_BY="[Empty name]" NAME="Schooler 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-01-07 11:35:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keith SJ, Bellack A, Frances A, Mance R, Matthews S: The Treatment Strategies in Schizophrenia Collabortive Study Group</AU>
<TI>The influence of diagnosis and family treatment on acute treatment response and short term outcome in schizophrenia</TI>
<SO>Psychopharmacology Bulletin</SO>
<YR>1989</YR>
<VL>25</VL>
<NO>3</NO>
<PG>336-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;TSS study&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mueser K, Sengupta A, Schooler N, Bellack A, Xie H, Glick I</AU>
<TI>Family treatment and medication dosage reduction in Schizophrenia: Effects on patient social functioning, family attitudes, and burden</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>2001</YR>
<VL>69</VL>
<NO>1</NO>
<PG>3-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-07 11:35:33 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;TSS study: early warning signs intervention applied to both groups&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:35:33 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schooler N, Keith S, Severe J, Matthews S, Bellack A, Glick I, et al</AU>
<TI>Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1997</YR>
<VL>54</VL>
<PG>453-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-1999" MODIFIED="2013-01-07 11:35:40 +0000" MODIFIED_BY="[Empty name]" NAME="Smith 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-01-07 11:35:40 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:35:40 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith TE, Hull JW, Romanelli S, Fertuck E, Weiss KA</AU>
<TI>Symptoms and neurocognition as rate limiters in skills training for psychotic patients</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1999</YR>
<VL>156</VL>
<NO>11</NO>
<PG>1817-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-So-2006" MODIFIED="2012-12-11 13:40:09 +0000" MODIFIED_BY="[Empty name]" NAME="So 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-12-11 13:40:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>So HW, Chen EYH, Wong CW, Hung SF, Chung DWS, Ng SM, et al</AU>
<TI>Efficacy of brief intervention for carers of people with first-episode psychosis: a waiting list controlled study</TI>
<SO>Hong Kong Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>3</NO>
<PG>92-100</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:29:01 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tamaras-2000" MODIFIED="2011-10-15 22:37:34 +0100" MODIFIED_BY="[Empty name]" NAME="Tamaras 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-10-15 22:37:34 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Study mainly focusses on high expressed emotions&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:37:34 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tamaras V, Mavreas V, Economou M, Ioannovich E, Karydi V, Stefanis C</AU>
<TI>The effect of family intervention on chronic schizophrenics under individual psychosocial treatment: a 3-year study</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>2000</YR>
<VL>35</VL>
<NO>11</NO>
<PG>487-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsang-2001" MODIFIED="2013-01-07 11:35:53 +0000" MODIFIED_BY="[Empty name]" NAME="Tsang 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-01-07 11:35:53 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention purely rehabilitation, no recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2013-01-07 11:35:53 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsang HWH</AU>
<TI>Rehab Rounds: Social skills training to help mentally ill persons find and keep a job</TI>
<SO>Psychiatric Services</SO>
<YR>2001</YR>
<VL>52</VL>
<PG>891-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Der-Krieke-2010" MODIFIED="2012-12-11 13:40:52 +0000" MODIFIED_BY="[Empty name]" NAME="Van Der Krieke 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-12-11 13:40:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Der Krieke AJ, Emerencia AC, Sytema S, Wunderink L, Aiello M, Petkov N, et al</AU>
<TI>Wegweis: An online self-management tool for people with psychosis</TI>
<SO>Early Intervention in Psychiatry</SO>
<YR>2010</YR>
<VL>4</VL>
<NO>Suppl 1</NO>
<PG>179</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:29:22 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Velligan-2002" MODIFIED="2011-10-15 22:37:55 +0100" MODIFIED_BY="[Empty name]" NAME="Velligan 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-10-15 22:37:55 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Intervention does not include recognition of early warning signs&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:37:55 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Velligan DI, Prihoda TJ, Ritch JL, Maples N, Bow-Thomas C, Dassori A</AU>
<TI>A randomised single-blind pilot study of compensatory strategies in schizophrenia outpatients</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>2</NO>
<PG>283-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wallace-1985" MODIFIED="2011-10-15 22:38:22 +0100" MODIFIED_BY="[Empty name]" NAME="Wallace 1985" YEAR="1985">
<REFERENCE MODIFIED="2011-10-15 22:38:22 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The intervention does not clearly indicate training to recognise early waring signs of relapse&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:38:22 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wallace CJ, Liberman RP</AU>
<TI>Social skills training for patients with schizophrenia: A controlled clinical trial</TI>
<SO>Psychiatry Research</SO>
<YR>1985</YR>
<VL>15</VL>
<PG>239-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-2007" MODIFIED="2012-12-11 13:41:27 +0000" MODIFIED_BY="[Empty name]" NAME="Wei 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-12-11 13:41:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wei CX, Chu PH, Wei GM</AU>
<TI>Evaluation on the healing effects of self - control education on schizophrenia inpatients</TI>
<SO>Heilongjiang Nursing Journal [Modern Nursing][&#29616;&#20195;&#25252;&#29702;]</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>25</NO>
<PG>2367-9</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:31:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woods-2002" MODIFIED="2011-10-15 22:49:00 +0100" MODIFIED_BY="[Empty name]" NAME="Woods 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-10-15 22:49:00 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Population is at risk of schizophrenia, which is an exclusion criterion&lt;/p&gt;" NOTES_MODIFIED="2011-10-15 22:49:00 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Woods SW, Wexler BE, Miller TJ, Hawkins KA, Saab WA, Davidson L</AU>
<TI>Novel early interventions for prodromal states</TI>
<SO>Proceedings of the 155th Annual meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, PA, USA</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x675c__x82b3_-2010" MODIFIED="2012-09-24 11:33:48 +0100" MODIFIED_BY="[Empty name]" NAME="&#26460;&#33459; 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-24 11:33:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>&#26460;&#33459;, &#39759;&#26149;&#39321;, &#26970;&#24179;&#21326;</AU>
<TI>Self-management education as the central group of patients with schizophrenia take care of themselves, of happiness and self-esteem [Google translate]</TI>
<TO>&#20197;&#33258;&#25105;&#31649;&#29702;&#20026;&#20013;&#24515;&#22242;&#20307;&#25945;&#32946;&#23545;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#33258;&#29702;&#12289;&#24184;&#31119;&#24230;&#21450;&#33258;&#23562;&#30340;&#24433;&#21709;</TO>
<SO>&#20013;&#22269;&#25252;&#29702;&#31649;&#29702;</SO>
<YR>2010</YR>
<VL>1</VL>
<PG>18-21</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:31:53 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x738b__x8389_-2010" MODIFIED="2012-12-11 13:41:59 +0000" MODIFIED_BY="[Empty name]" NAME="&#29579;&#33673; 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-12-11 13:41:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#29579;&#33673;</AU>
<TI>Self-care education on self-care ability of patients with schizophrenia rehabilitation and quality of life [Google Translate]</TI>
<TO>&#33258;&#25105;&#25252;&#29702;&#25945;&#32946;&#23545;&#24247;&#22797;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#33258;&#29702;&#33021;&#21147;&#21644;&#29983;&#27963;&#36136;&#37327;&#30340;&#24433;&#21709;</TO>
<SO>Chinese Journal of Coal Industry Medicine</SO>
<YR>2010</YR>
<VL>2</VL>
<PG>282-4</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:33:55 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x8bb8__x7389__x82b3_-2008" MODIFIED="2012-12-11 13:42:16 +0000" MODIFIED_BY="[Empty name]" NAME="&#35768;&#29577;&#33459; 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-12-11 13:42:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#35768;&#29577;&#33459;, &#33931;&#33738;&#33459;, &#21556;&#26195;&#26757;, &#24352;&#32043;&#23071;, &#21776;&#32418;, &#26041;&#26149;&#38686;, et al</AU>
<TI>Title only available in Chinese characters</TI>
<SO>Medical Journal of Chinese People's Health China and China Medicine</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>5</NO>
<PG>471-3</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:35:38 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x8bb8__x7389__x82b3_-2008a" MODIFIED="2012-12-11 13:42:31 +0000" MODIFIED_BY="[Empty name]" NAME="&#35768;&#29577;&#33459; 2008a" YEAR="2008">
<REFERENCE MODIFIED="2012-12-11 13:42:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>&#35768;&#29577;&#33459;, &#33931;&#33738;&#33459;, &#21556;&#26195;&#26757;, &#24352;&#32043;&#23071;, &#21776;&#32418;, &#26041;&#26149;&#38686;, et al</AU>
<TI>Application program training in the community care of patients with schizophrenia</TI>
<TO>&#31243;&#24335;&#35757;&#32451;&#22312;&#31934;&#31070;&#20998;&#35010;&#30151;&#24739;&#32773;&#31038;&#21306;&#25252;&#29702;&#20013;&#30340;&#24212;&#29992;</TO>
<SO>Chinese Journal of Nursing [Chung Hua Hu Li Tsa Chih][&#20013;&#21326;&#25252;&#29702;&#26434;&#24535;]</SO>
<YR>2008</YR>
<VL>43</VL>
<NO>4</NO>
<PG>334-6</PG>
<IDENTIFIERS MODIFIED="2012-09-24 11:36:14 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-07-15 14:28:02 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2012-09-24 11:45:08 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Farhall-2001" MODIFIED="2012-09-24 11:40:56 +0100" MODIFIED_BY="[Empty name]" NAME="Farhall 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-09-24 11:40:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Farhall J</AU>
<TI>Trialling CBT for psychosis in ordinary mental health services</TI>
<SO>Australian New Zealand Clinical Trials Registry</SO>
<YR>2001</YR>
<IDENTIFIERS MODIFIED="2012-09-24 11:40:51 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-2012" MODIFIED="2012-09-24 11:41:09 +0100" MODIFIED_BY="[Empty name]" NAME="Jones 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-09-24 11:41:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jones P</AU>
<TI>Cts: Cognitive training for schizophrenia</TI>
<SO>http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=11571</SO>
<YR>2012</YR>
<IDENTIFIERS MODIFIED="2012-09-24 11:41:09 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00046085" MODIFIED="2012-09-24 11:41:50 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00046085" YEAR="2002">
<REFERENCE MODIFIED="2012-09-24 11:41:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00046085</AU>
<TI>Online family support and education for schizophrenia</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2002</YR>
<MD>Other</MD>
<IDENTIFIERS MODIFIED="2012-09-24 11:41:37 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00069433" MODIFIED="2012-09-24 11:42:37 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00069433" YEAR="2003">
<REFERENCE MODIFIED="2012-09-24 11:42:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00069433</AU>
<TI>Skills training for schizophrenia: enhancing outcomes</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2003</YR>
<MD>Other</MD>
<IDENTIFIERS MODIFIED="2012-09-24 11:42:15 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00169052" MODIFIED="2012-09-24 11:43:39 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00169052" YEAR="2005">
<REFERENCE MODIFIED="2012-09-24 11:43:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00169052</AU>
<TI>Rehabilitation and health care for elderly with SMI</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2012-09-24 11:43:28 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00435721" MODIFIED="2012-09-24 11:44:21 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00435721" YEAR="2007">
<REFERENCE MODIFIED="2012-09-24 11:44:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00435721</AU>
<TI>The families coping with mental illness program</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2012-09-24 11:44:09 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00515671" MODIFIED="2012-09-24 11:45:08 +0100" MODIFIED_BY="[Empty name]" NAME="NCT00515671" YEAR="2007">
<REFERENCE MODIFIED="2012-09-24 11:44:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00515671</AU>
<TI>IMR for veterans with SMI</TI>
<SO>http://www.clinicaltrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2012-09-24 11:44:45 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-01-07 11:38:21 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-01-07 11:38:21 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Altman-1996" MODIFIED="2005-01-10 01:15:26 +0000" MODIFIED_BY="[Empty name]" NAME="Altman 1996" TYPE="JOURNAL_ARTICLE">
<AU>Altman DG, Bland JM</AU>
<TI>Detecting skewness from summary information</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>313</VL>
<PG>1200</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Amador-1993" MODIFIED="2012-06-25 09:02:09 +0100" MODIFIED_BY="[Empty name]" NAME="Amador 1993" TYPE="JOURNAL_ARTICLE">
<AU>Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM</AU>
<TI>Assessment of insight in psychosis</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1993</YR>
<VL>150</VL>
<PG>873-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Amador-1996" MODIFIED="2011-10-15 22:49:50 +0100" MODIFIED_BY="[Empty name]" NAME="Amador 1996" TYPE="JOURNAL_ARTICLE">
<AU>Amador XF, Flaum M, Friedman JH, Gorman JM, Kasapis C, Yale SA</AU>
<TI>Suicidal behaviour in schizophrenia and its relationship to awareness of illness</TI>
<SO>Americal Journal of Psychiatry</SO>
<YR>1996</YR>
<VL>153</VL>
<NO>9</NO>
<PG>1185-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Andreasen-1983" MODIFIED="2011-10-15 22:50:35 +0100" MODIFIED_BY="[Empty name]" NAME="Andreasen 1983" TYPE="BOOK">
<AU>Andreasen NC</AU>
<SO>The Scale for the Assessment of Negative Symptoms (SANS)</SO>
<YR>1983</YR>
<PB>University of Iowa</PB>
<CY>Iowa City, Iowa</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APA-1987" MODIFIED="2011-10-15 22:51:16 +0100" MODIFIED_BY="[Empty name]" NAME="APA 1987" TYPE="BOOK_SECTION">
<AU>American Psychiatric Association</AU>
<TI>Global assessment of functioning</TI>
<SO>American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders</SO>
<YR>1987</YR>
<EN>3rd</EN>
<PB>American Psychiatric Association</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APA-1994" MODIFIED="2012-07-30 15:06:32 +0100" MODIFIED_BY="[Empty name]" NAME="APA 1994" TYPE="BOOK">
<AU>American Psychiatric Association</AU>
<SO>Diagnostic and Statistical Manual of Mental Disorders</SO>
<YR>1994</YR>
<PB>(DSM&#8211;IV) APA</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APA-1997" MODIFIED="2011-10-15 22:51:26 +0100" MODIFIED_BY="[Empty name]" NAME="APA 1997" TYPE="OTHER">
<AU>American Psychiatric Association</AU>
<TI>Practice guideline for the treatment of patients with schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>154</VL>
<NO>4</NO>
<PG>1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arns-2001" MODIFIED="2011-10-15 22:51:53 +0100" MODIFIED_BY="[Empty name]" NAME="Arns 2001" TYPE="JOURNAL_ARTICLE">
<AU>Arns P, Rogers ES, Cook J, Mowbray C</AU>
<TI>The IAPSRS toolkit: development, utility, and relation to other performance measurement systems. Members of the IAPSRS research committee. International association of psychological rehabilitation services</TI>
<SO>Psychiatric Rehabilitation Journal</SO>
<YR>2001</YR>
<VL>25</VL>
<NO>1</NO>
<PG>43-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ascher_x002d_Svanum-1999" MODIFIED="2011-10-15 22:52:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ascher-Svanum 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ascher-Svanum H</AU>
<TI>Development and validation of a measure of patients&#8217; knowledge about schizophrenia</TI>
<SO>Psychiatric Services</SO>
<YR>1999</YR>
<VL>50</VL>
<PG>561-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Baker-1988" MODIFIED="2011-05-19 10:55:43 +0100" MODIFIED_BY="[Empty name]" NAME="Baker 1988" TYPE="JOURNAL_ARTICLE">
<AU>Baker R, Hall JN</AU>
<TI>REHAB: a new assessment instrument for chronic psychiatric patients</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1988</YR>
<VL>14</VL>
<PG>97-111</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bechdolf-1998" MODIFIED="2011-10-15 22:54:10 +0100" MODIFIED_BY="[Empty name]" NAME="Bechdolf 1998" TYPE="JOURNAL_ARTICLE">
<AU>Bechdolf A, Halve S, Schulze-Lutter F, Klosterkotter J</AU>
<TI>Self-experienced vulnerability, prodromic symptoms and coping strategies before schizophrenic and affective episodes</TI>
<SO>Fortschritte Der Neurologie-Psychiatrie</SO>
<YR>1998</YR>
<VL>66</VL>
<PG>378-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Birchwood-1989" MODIFIED="2013-01-07 11:36:22 +0000" MODIFIED_BY="[Empty name]" NAME="Birchwood 1989" TYPE="JOURNAL_ARTICLE">
<AU>Birchwood M, Smith J, MacMillan F, Hogg B, Prasad R, Harvey C, et al</AU>
<TI>Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation</TI>
<SO>Psychological Medicine</SO>
<YR>1989</YR>
<VL>19</VL>
<PG>649-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Birchwood-1990" MODIFIED="2012-07-30 15:08:58 +0100" MODIFIED_BY="[Empty name]" NAME="Birchwood 1990" TYPE="JOURNAL_ARTICLE">
<AU>Birchwood, M, Smith, J, Cochrane, R, Wetton, S, Copestake, S</AU>
<TI>The social functioning scale the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1990</YR>
<VL>157</VL>
<PG>853-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Birchwood-1994" MODIFIED="2011-10-15 22:54:57 +0100" MODIFIED_BY="[Empty name]" NAME="Birchwood 1994" TYPE="JOURNAL_ARTICLE">
<AU>Birchwood M, Smith J, Drury V, Healy J, Macmillan F, Slade M</AU>
<TI>A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1994</YR>
<VL>89</VL>
<NO>1</NO>
<PG>62-7</PG>
<IDENTIFIERS MODIFIED="2011-05-20 08:03:21 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-20 08:03:21 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7908156"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Birchwood-2001" MODIFIED="2009-03-14 13:24:28 +0000" MODIFIED_BY="[Empty name]" NAME="Birchwood 2001" TYPE="JOURNAL_ARTICLE">
<AU>Birchwood M, McGovern D, Spencer E</AU>
<TI>Management of first episode psychosis</TI>
<SO>Advances in Psychiatric Treatment</SO>
<YR>2001</YR>
<VL>7</VL>
<PG>133-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bland-1997" MODIFIED="2005-01-10 01:15:26 +0000" MODIFIED_BY="[Empty name]" NAME="Bland 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bland JM</AU>
<TI>Statistics notes. Trials randomised in clusters</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boissel-1999" MODIFIED="2013-01-07 11:36:35 +0000" MODIFIED_BY="[Empty name]" NAME="Boissel 1999" TYPE="JOURNAL_ARTICLE">
<AU>Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al</AU>
<TI>The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use</TI>
<TO>Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'etude des Indices d'efficacite</TO>
<SO>Therapie</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>4</NO>
<PG>405-11</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10667106"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Borenstein-2009" MODIFIED="2012-08-28 09:41:09 +0100" MODIFIED_BY="[Empty name]" NAME="Borenstein 2009" TYPE="BOOK">
<AU>Borenstein M, Hedges LV, Higgins J, Rothstein H</AU>
<SO>Introduction to Meta-Analysis</SO>
<YR>2009</YR>
<PB>John Wiley &amp; Sons Inc</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brazier-1993" MODIFIED="2013-01-07 11:36:48 +0000" MODIFIED_BY="[Empty name]" NAME="Brazier 1993" TYPE="JOURNAL_ARTICLE">
<AU>Brazier J, Jones N, Kind P</AU>
<TI>Testing the validity of the EuroQol and comparing it with the SF&#8211;36 health survey questionnaire</TI>
<SO>Quality of Life Research</SO>
<YR>1993</YR>
<VL>2</VL>
<PG>169-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bustillo-1995" MODIFIED="2013-01-07 11:36:56 +0000" MODIFIED_BY="[Empty name]" NAME="Bustillo 1995" TYPE="JOURNAL_ARTICLE">
<AU>Bustillo J, Buchanan RW, Carpenter WT</AU>
<TI>Prodromal symptoms versus early warning signs and clinical action in schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1995</YR>
<VL>21</VL>
<PG>553-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carpenter-1999" MODIFIED="2009-03-14 13:24:28 +0000" MODIFIED_BY="[Empty name]" NAME="Carpenter 1999" TYPE="JOURNAL_ARTICLE">
<AU>Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Breier AF</AU>
<TI>Diazepam treatment of early signs of exacerbation in schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1999</YR>
<VL>156</VL>
<PG>299-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2000" MODIFIED="2011-05-21 15:32:01 +0100" MODIFIED_BY="[Empty name]" NAME="Deeks 2000" TYPE="CONFERENCE_PROC">
<AU>Deeks J</AU>
<TI>Issues in the selection for meta-analyses of binary data</TI>
<SO>Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape town</SO>
<YR>2000</YR>
<PB>Cochrane Collaboration</PB>
<CY>Cape Town</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Divine-1992" MODIFIED="2005-01-10 01:15:26 +0000" MODIFIED_BY="[Empty name]" NAME="Divine 1992" TYPE="JOURNAL_ARTICLE">
<AU>Divine GW, Brown JT, Frazier LM</AU>
<TI>The unit of analysis error in studies about physicians' patient care behaviour</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1992</YR>
<VL>7</VL>
<NO>6</NO>
<PG>623-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dixon-1998" MODIFIED="2009-03-14 13:24:28 +0000" MODIFIED_BY="[Empty name]" NAME="Dixon 1998" TYPE="JOURNAL_ARTICLE">
<AU>Dixon M, King S, Steiger H</AU>
<TI>The contribution of depression and denial towards understanding the unawareness of symptoms in schizophrenic outpatients</TI>
<SO>British Journal of Medical Psychology</SO>
<YR>1998</YR>
<VL>71</VL>
<NO>1</NO>
<PG>85-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donner-2002" MODIFIED="2005-01-10 01:15:26 +0000" MODIFIED_BY="[Empty name]" NAME="Donner 2002" TYPE="JOURNAL_ARTICLE">
<AU>Donner A, Klar N</AU>
<TI>Issues in the meta-analysis of cluster randomized trials</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>2971-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2011-05-21 15:32:58 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey-Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2011-05-21 15:32:29 +0100" MODIFIED_BY="[Empty name]" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Endicott-1976" MODIFIED="2011-10-15 22:58:14 +0100" MODIFIED_BY="[Empty name]" NAME="Endicott 1976" TYPE="JOURNAL_ARTICLE">
<AU>Endicott J, Spitzer RL, Fleiss JL, Cohen J</AU>
<TI>The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1976</YR>
<VL>33</VL>
<PG>766-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fitzgerald-2001" MODIFIED="2011-10-15 22:58:34 +0100" MODIFIED_BY="[Empty name]" NAME="Fitzgerald 2001" TYPE="JOURNAL_ARTICLE">
<AU>Fitzgerald PB</AU>
<TI>The role of early warning symptoms in the detection and prevention of relapse in schizophrenia</TI>
<SO>Australian and New Zealand Journal of Psychiatry</SO>
<YR>2001</YR>
<VL>35</VL>
<PG>758-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furukawa-2006" MODIFIED="2011-10-15 22:58:41 +0100" MODIFIED_BY="[Empty name]" NAME="Furukawa 2006" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Barbui C, Cipriani A, Brambilla, P, Watanabe N</AU>
<TI>Imputing missing standard deviations in meta-analyses can provide accurate results</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2006</YR>
<VL>59</VL>
<NO>1</NO>
<PG>7-10</PG>
<IDENTIFIERS MODIFIED="2011-09-16 09:11:13 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Gaebel-1993" MODIFIED="2013-01-07 11:37:20 +0000" MODIFIED_BY="[Empty name]" NAME="Gaebel 1993" TYPE="JOURNAL_ARTICLE">
<AU>Gaebel W, Frick U, Kopcke W, Linden M, Muller P, Muller-Spahn F, et al</AU>
<TI>Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1993</YR>
<VL>Suppl 21</VL>
<PG>8-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gaston-1993" MODIFIED="2012-09-12 13:29:14 +0100" MODIFIED_BY="[Empty name]" NAME="Gaston 1993" TYPE="BOOK">
<AU>Gaston L, Marmar C</AU>
<SO>Manual of California Psychotherapy Alliance Scale</SO>
<YR>1993</YR>
<PB>Department of Psychiatry McGill University</PB>
<CY>Montreal, Canada</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goldman-1992" MODIFIED="2011-05-19 11:49:10 +0100" MODIFIED_BY="[Empty name]" NAME="Goldman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Goldman HH, Skodol AD, Lave TR</AU>
<TI>Revising axis V for DSM-IV: a review of measures of social functioning</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1992</YR>
<VL>149</VL>
<PG>1148-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADE-2004" MODIFIED="2011-05-21 15:31:43 +0100" MODIFIED_BY="[Empty name]" NAME="GRADE 2004" TYPE="COMPUTER_PROGRAM">
<TI>GRADE Profiler</TI>
<YR>2004</YR>
<EN>3.2</EN>
<PB>GRADE Working Group</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gulliford-1999" MODIFIED="2005-01-10 01:15:26 +0000" MODIFIED_BY="[Empty name]" NAME="Gulliford 1999" TYPE="JOURNAL_ARTICLE">
<AU>Gulliford MC</AU>
<TI>Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1999</YR>
<VL>149</VL>
<PG>876-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haddock-1998" MODIFIED="2009-03-14 13:24:28 +0000" MODIFIED_BY="[Empty name]" NAME="Haddock 1998" TYPE="JOURNAL_ARTICLE">
<AU>Haddock G, Tarrier N, Spaulding W</AU>
<TI>Individual cognitive behavioural therapy in the treatment of hallucinations and delusions</TI>
<SO>Clinical Psychology Review</SO>
<YR>1998</YR>
<VL>18</VL>
<PG>821-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heinrich-1984" MODIFIED="2011-05-21 15:40:21 +0100" MODIFIED_BY="[Empty name]" NAME="Heinrich 1984" TYPE="JOURNAL_ARTICLE">
<AU>Heinrich DW, Hanlon TE, Carpenter WT</AU>
<TI>The quality of life scale: an instrument for rating the schizophrenic deficit syndrome</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<PG>388-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Herz-1980" MODIFIED="2009-03-14 13:24:28 +0000" MODIFIED_BY="[Empty name]" NAME="Herz 1980" TYPE="JOURNAL_ARTICLE">
<AU>Herz MI, Melville C</AU>
<TI>Relapse in schizophrenia</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1980</YR>
<VL>137</VL>
<PG>801-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Herz-1995" MODIFIED="2009-03-14 13:24:28 +0000" MODIFIED_BY="[Empty name]" NAME="Herz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Herz MI, Lamberti JS</AU>
<TI>Prodromal symptoms and relapse prevention in schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1995</YR>
<VL>21</VL>
<PG>541-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2011-10-15 23:00:41 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hogan-1983" MODIFIED="2012-07-30 15:12:51 +0100" MODIFIED_BY="[Empty name]" NAME="Hogan 1983" TYPE="JOURNAL_ARTICLE">
<AU>Hogan, TP, Awad, AG</AU>
<TI>A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity</TI>
<SO>Psychological Medicine</SO>
<YR>1983</YR>
<VL>13</VL>
<PG>177-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Honigfeld-1965" MODIFIED="2012-08-28 08:46:57 +0100" MODIFIED_BY="[Empty name]" NAME="Honigfeld 1965" TYPE="JOURNAL_ARTICLE">
<AU>Honigfeld G, Gillis RD, Klett CJ</AU>
<TI>Nurses' observation scale for inpatient evaluation: a new scale for measuring improvement in chronic schizophrenia</TI>
<SO>Journal of Clinical Psychology</SO>
<YR>1965</YR>
<VL>21</VL>
<PG>65-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hutton-2009" MODIFIED="2012-12-11 13:50:09 +0000" MODIFIED_BY="[Empty name]" NAME="Hutton 2009" TYPE="JOURNAL_ARTICLE">
<AU>Hutton Jane L</AU>
<TI>Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials</TI>
<SO>British journal of Haematology</SO>
<YR>2009</YR>
<VL>146</VL>
<NO>1</NO>
<PG>27-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jolley-2006" MODIFIED="2013-01-07 11:37:36 +0000" MODIFIED_BY="[Empty name]" NAME="Jolley 2006" TYPE="JOURNAL_ARTICLE">
<AU>Jolley S, Garety PA, Ellett L, Kuipers E, Freeman D, Bebbington PE, et al</AU>
<TI>A validation of a new measure of activity in psychosis</TI>
<SO>Schizophrenia Research</SO>
<YR>2006</YR>
<VL>85</VL>
<PG>288&#8211;95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kavanagh-1997" MODIFIED="2013-01-07 11:37:43 +0000" MODIFIED_BY="[Empty name]" NAME="Kavanagh 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kavanagh J, O'Halloran P, Manicavasagar V, Clark D, Piatkowska O, Tennant C, et al</AU>
<TI>The family attitude scale: reliability and validity of a new scale for measuring the emotional climate of families</TI>
<SO>Psychiatry Research</SO>
<YR>1997</YR>
<VL>70</VL>
<PG>185-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kay-1986" MODIFIED="2011-05-21 15:28:18 +0100" MODIFIED_BY="[Empty name]" NAME="Kay 1986" TYPE="BOOK">
<AU>Kay SR, Opler LA, Fiszbein A</AU>
<SO>Positive and Negative Syndrome Scale (PANSS) Manual</SO>
<YR>1986</YR>
<PB>North Tonawanda, NY: Multi-Health Systems</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Krawiecka-1977" MODIFIED="2011-05-19 10:56:19 +0100" MODIFIED_BY="[Empty name]" NAME="Krawiecka 1977" TYPE="JOURNAL_ARTICLE">
<AU>Krawiecka M, Goldberg D, Vaughan M</AU>
<TI>A standardized psychiatric assessment scale for rating chronic psychotic patients</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1977</YR>
<VL>55</VL>
<NO>4</NO>
<PG>299-308</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lam-1997" MODIFIED="2012-09-24 11:50:17 +0100" MODIFIED_BY="[Empty name]" NAME="Lam 1997" TYPE="JOURNAL_ARTICLE">
<AU>Lam D, Wong G</AU>
<TI>Prodromes, coping strategies, insight and social functioning in bipolar affective disorders</TI>
<SO>Psychological Medicine</SO>
<YR>1997</YR>
<VL>27</VL>
<PG>1091-1100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lehman-1988" MODIFIED="2012-09-20 10:41:33 +0100" MODIFIED_BY="[Empty name]" NAME="Lehman 1988" TYPE="JOURNAL_ARTICLE">
<AU>Lehman AF</AU>
<TI>A quality of life interview for the chronically mentally ill</TI>
<SO>Evaluation and Program Planning</SO>
<YR>1988</YR>
<VL>11</VL>
<NO>1</NO>
<PG>51-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2005" MODIFIED="2011-05-21 15:30:31 +0100" MODIFIED_BY="[Empty name]" NAME="Leucht 2005" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR</AU>
<TI>What does the PANSS mean?</TI>
<SO>Schizophrenia Research</SO>
<YR>2005</YR>
<VL>79</VL>
<NO>2-3</NO>
<PG>231-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="15982856"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2005a" MODIFIED="2011-05-21 15:30:36 +0100" MODIFIED_BY="[Empty name]" NAME="Leucht 2005a" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R</AU>
<TI>Clinical implications of brief psychiatric rating scale scores</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2005</YR>
<VL>187</VL>
<PG>366-71</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="16199797"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2007" MODIFIED="2011-05-21 15:32:51 +0100" MODIFIED_BY="[Empty name]" NAME="Leucht 2007" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Engel RR, Bauml J, Davis JM</AU>
<TI>Is the superior efficacy of new generation antipsychotics an artifact of LOCF?</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>1</NO>
<PG>183-91</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="16905632"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Marshall-2000" MODIFIED="2005-01-10 01:15:26 +0000" MODIFIED_BY="[Empty name]" NAME="Marshall 2000" TYPE="JOURNAL_ARTICLE">
<AU>Marshall M, Lockwood A, Adams C, Bradley C, Joy C, Fenton M</AU>
<TI>Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2000</YR>
<VL>176</VL>
<PG>249-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McEvoy-1989" MODIFIED="2013-01-07 11:37:56 +0000" MODIFIED_BY="[Empty name]" NAME="McEvoy 1989" TYPE="JOURNAL_ARTICLE">
<AU>McEvoy JP, Apperson LG, Applebaum PS, Ortlip P, Brecosky J, Hammill K, et al</AU>
<TI>Insight in schizophrenia: Its relation to acute psychopathology</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1989</YR>
<VL>177</VL>
<PG>43-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Overall-1962" MODIFIED="2011-05-21 15:28:35 +0100" MODIFIED_BY="[Empty name]" NAME="Overall 1962" TYPE="JOURNAL_ARTICLE">
<AU>Overall JE, Gorham DR</AU>
<TI>The brief psychiatric rating scale</TI>
<SO>Psychological Reports</SO>
<YR>1962</YR>
<VL>10</VL>
<PG>799-812</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pai-1981" MODIFIED="2011-10-15 23:01:30 +0100" MODIFIED_BY="[Empty name]" NAME="Pai 1981" TYPE="JOURNAL_ARTICLE">
<AU>Pai S, Kapur RL</AU>
<TI>The burden on the family of a psychiatric patient: development of an interview schedule</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1981</YR>
<VL>138</VL>
<PG>332-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Priebe-1998" MODIFIED="2011-10-15 23:02:13 +0100" MODIFIED_BY="[Empty name]" NAME="Priebe 1998" TYPE="BOOK_SECTION">
<AU>Preibe S</AU>
<TI>Lancashire quality of life profile</TI>
<TO>Berliner Lebensqualitatsprofil (BeLP)</TO>
<SO>Compendium of Quality of Life Instruments</SO>
<YR>1998</YR>
<VL>3</VL>
<PG>14d-14e</PG>
<ED>Salek M</ED>
<PB>Wiley &amp; Sons</PB>
<CY>Chichester, England</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Review-Manager-2011" MODIFIED="2011-10-15 23:02:42 +0100" MODIFIED_BY="[Empty name]" NAME="Review Manager 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ruggeri-1993" MODIFIED="2011-10-15 23:02:56 +0100" MODIFIED_BY="[Empty name]" NAME="Ruggeri 1993" TYPE="JOURNAL_ARTICLE">
<AU>Ruggeri M, Dall'Agnola R</AU>
<TI>The development and use of the Verona Expectations for Care Scale (VECS) and the Verona Service Satisfaction Scale (VSSS) for measuring expectations and satisfaction with community-based psychiatric services in patients, relatives and professionals</TI>
<SO>Psychological Medicine</SO>
<YR>1993</YR>
<VL>23</VL>
<PG>511-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schneider-1983" MODIFIED="2011-10-15 23:03:27 +0100" MODIFIED_BY="[Empty name]" NAME="Schneider 1983" TYPE="JOURNAL_ARTICLE">
<AU>Schneider LC, Struening EL</AU>
<TI>SLOF: A behavioral rating scale for assessing the mentally ill</TI>
<SO>Social Work Research and Abstracts</SO>
<YR>1983</YR>
<VL>19</VL>
<PG>9-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2008" MODIFIED="2013-01-07 11:38:08 +0000" MODIFIED_BY="[Empty name]" NAME="Schünemann 2008" TYPE="BOOK_SECTION">
<AU>Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al</AU>
<TI>Chapter 12: Interpreting results and drawing conclusions</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PG>359-83</PG>
<PB>John Wiley &amp; Son</PB>
<CY>Chichester</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tarrier-1990" MODIFIED="2012-08-28 09:18:05 +0100" MODIFIED_BY="[Empty name]" NAME="Tarrier 1990" TYPE="JOURNAL_ARTICLE">
<AU>Tarrier N, Barrowclough C</AU>
<TI>Family interventions for schizophrenia</TI>
<SO>Behavior Modification</SO>
<YR>1990</YR>
<VL>14</VL>
<NO>4</NO>
<PG>408-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tierney-2007" MODIFIED="2012-08-27 12:28:01 +0100" MODIFIED_BY="[Empty name]" NAME="Tierney 2007" TYPE="JOURNAL_ARTICLE">
<AU>Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M</AU>
<TI>Practical methods for incorporating summary time-to-event data into meta-analysis</TI>
<SO>Trials</SO>
<YR>2007</YR>
<VL>8</VL>
<PG>16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ukoumunne-1999" MODIFIED="2011-10-15 23:03:45 +0100" MODIFIED_BY="[Empty name]" NAME="Ukoumunne 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ</AU>
<TI>Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review</TI>
<SO>Health Technology Assessment</SO>
<YR>1999</YR>
<VL>3</VL>
<NO>5</NO>
<PG>1-75</PG>
<IDENTIFIERS MODIFIED="2011-10-15 23:03:45 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wallace-2000" MODIFIED="2011-10-15 23:04:10 +0100" MODIFIED_BY="[Empty name]" NAME="Wallace 2000" TYPE="JOURNAL_ARTICLE">
<AU>Wallace CJ, Liberman RP, Tauber R, Wallace J</AU>
<TI>The independent living skills survey: A comprehensive measure of the community functioning of severely and persistently mentally ill individuals</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>2000</YR>
<VL>26</VL>
<NO>3</NO>
<PG>631-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wing-1998" MODIFIED="2011-10-15 23:04:23 +0100" MODIFIED_BY="[Empty name]" NAME="Wing 1998" TYPE="JOURNAL_ARTICLE">
<AU>Wing JK, Beevor AS, Curtis RH, Park SB, Hadden S, Burns A</AU>
<TI>Health of the Nation Outcome Scales (HoNOS). Research and development</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1998</YR>
<VL>172</VL>
<PG>11-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Xia-2009" MODIFIED="2013-01-07 11:38:21 +0000" MODIFIED_BY="[Empty name]" NAME="Xia 2009" TYPE="JOURNAL_ARTICLE">
<AU>Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al</AU>
<TI>Loss to outcomes stakeholder survey: the LOSS study</TI>
<SO>Psychiatric Bulletin</SO>
<YR>2009</YR>
<VL>33</VL>
<NO>7</NO>
<PG>254-7</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2012-06-24 14:33:54 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Anzai-2002">
<CHAR_METHODS MODIFIED="2011-04-10 12:58:59 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 9 weeks.</P>
<P>Design: parallel.</P>
<P>Setting: secondary care.<BR/>Country: Tokyo.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-12 14:19:22 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (ICD-10 and DSM-IV).</P>
<P>N = 32.<BR/>Age: average ~47 years (SD 11).<BR/>Sex: not reported.<BR/>History: persistent and refractory symptoms of psychosis and poor insight into their illness. Mean duration of the current hospitalisation 4 ± 4.3 years, mean duration of illness 20.5 ± 11.6 years.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-12 14:19:44 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: CREP (Community Re-entry Program) includes identifying and keeping track of warning signs of relapse with a relapse prevention plan, group therapy, 18 one-hour sessions, twice a week (N = 16).</P>
<P>2. TAU + other: occupational rehabilitation activities (N = 16).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>Social functioning: REHAB scale.</P>
<P>Unable to use:</P>
<P>Service use: re-hospitalisation (number not reported).<BR/>Mental state: PANSS (no mean and SD).<BR/>
</P>
<P>Knowledge: related to self management of illness, HOW (mean and SD not reported for the TAU group).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-20 22:17:34 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bauml-2007">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 2 years*.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Germany.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:24:27 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: Schizophrenia (DSM-III-R and ICD-9).</P>
<P>N = 101.<BR/>Age: average ~34 years (SD 11).<BR/>Sex: M 51, F 50.<BR/>History: indication for an antipsychotic relapse prevention for a period of at least 12 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: Patients had 4 weekly sessions of 60 minutes, then 4 more monthly sessions. Relatives were separately invited to 8 bi-weekly sessions of 90 to 120 minutes. Sessions were conducted by psychiatrists. Comprehensive information given about symptoms, aetiology, treatment, relapse prevention, etc. and individual crisis plans drawn up (N = 51).</P>
<P>2. TAU: maintenance therapy with antipsychotic medication, outpatient appointments (N = 50).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>Service use: re-hospitalisation rate, (2-year follow-up reported in review, 7-year follow-up data available for a subgroup but not reported in review), time to re-hospitalisation**.<BR/>Mental state: BPRS.<BR/>Social functioning: GAF.</P>
<P>Quality of life: Lancashire quality of life profile (German).<BR/>Adverse events: death***.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:30 +0000" MODIFIED_BY="[Empty name]">
<P>Results based only on Technical University of Munich study centre.</P>
<P>*48 participants also followed up at 7 years.</P>
<P>**Time to relapse was imputed using method 7 from <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK> (report presents P value and events on each arm and randomisation ratio is 1:1).</P>
<P>***1 suicide at 12-month follow-up in the intervention group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bradley-2006">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 12 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Australia.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:24:36 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: Schizophrenia (DSM-IV).</P>
<P>N = 59*.<BR/>Age: Average ~34 years (SD 8).<BR/>Sex: M 15, F 35.<BR/>History: number of previous episodes: treatment group mean 0.6 (SD 1.5), control group 0.29 (SD 0.86).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:24:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 26 sessions of multiple family group intervention for patients and families which involved recognising early warning signs, 26 sessions over 12 months (N = 25).</P>
<P>2. TAU: Regular appointments with case manager/doctor and individual psychosocial rehabilitation. Family contact (direct or on telephone) focused on psychoeducation, monitoring mental state and general support (N = 25).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-27 12:12:13 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Relapse**: rate of relapse, time to relapse.</P>
<P>Mental state: BPRS, SANS.</P>
<P>Social functioning: HONOS.</P>
<P>Quality of life: Quality of life scale.<BR/>Adverse events: death***.</P>
<P>Burden of care: FBIS (Family Burden Interview Schedule).</P>
<P>Unable to use -</P>
<P>Relapse**: time to relapse (hazard ratio not reported), duration (no mean and SD).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-27 13:40:04 +0100" MODIFIED_BY="[Empty name]">
<P>*59 consumer-caregiver pairs. 34 pairs were English speaking and 25 were Vietnamese speaking.</P>
<P>**Relapse is defined as the reemergence of frank psychotic symptoms after a period of remission of such symptoms, persisting continuously for a minimum of 7 days and requiring intensive community treatment or hospital admission. Time to relapse was imputed using method 4 from <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK> (report presents HR and events on each arm and randomisation ratio is 1:1).</P>
<P>***1 participant in the treatment group died from a heroin overdose.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buchkremer-1997">
<CHAR_METHODS MODIFIED="2011-05-18 10:30:25 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 2 years*.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Germany.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:24:46 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-III-R).</P>
<P>N = 191.<BR/>Age: average ~ 31 years (SD 7).<BR/>Sex: M 111, F 80.<BR/>History: mean number of hospitalisations 4.7 (SD 3.6); at least two acute psychotic episodes within the past 5 years; at least 4 weeks of psychopathological stabilization.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducational medication management (PMT) + TAU: all patients given detailed individualised information about schizophrenia and treatment; trained to recognize early symptoms, individual crisis schedules drawn up and medication management skills promoted. 10 sessions, first 5 at weekly intervals and 5 at fortnightly intervals (N = 32).</P>
<P>2. PMT + TAU + Key counselling (KC): Key-person counselling: relatives and carers were given information about schizophrenia and recognition of impending relapses, with coping strategies. 20 sessions (N = 35).</P>
<P>3. PMT + TAU + cognitive psychotherapy (CP): Cognitive psychotherapy: mediation of problem solving skills and improve coping strategies. 15 sessions, 7 sessions at weekly and 8 sessions at fortnightly intervals (N = 34).</P>
<P>4. PMT + TAU + CP + KP: (N = 33).</P>
<P>5. TAU: regular leisure time group activities. (N = 57).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>Mental state: BPRS.</P>
<P>Service use: re-hospitalisation rate, time to re-hospitalisation**.<BR/>Social functioning: Global Assessment Scale (GAS).<BR/>
</P>
<P>Unable to use -</P>
<P>Mental state: SANS (no mean and SD).</P>
<P>Knowledge: Illness related attitudes - KK-Skala scale (no mean and SD).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>Multi-centre study: 7 centres in Germany.</P>
<P>* 126 participants also followed up at 5 years.</P>
<P>**re-hospitalisation is reported as 36 hour full hospitalisation or 5-day partial hospitalisation.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chan-2007">
<CHAR_METHODS MODIFIED="2012-06-25 08:33:15 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. <BR/>Blinding: no details. <BR/>Duration: 12 months. <BR/>Design: parallel. <BR/>Setting: inpatient secondary care. <BR/>Country: Hong Kong.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:25:10 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia or schizo-affective disorder (DSM-IV).</P>
<P>N = 81.</P>
<P>Age: 18-63 years, mean: 35.82 years.</P>
<P>Sex: M 81.</P>
<P>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: Transforming Relapse and Installing Prosperity (TRIP) programme to improve illness insight and health, ten 50-minute sessions over two weeks, includes relapse prevention plan development and symptom management (N = 44).<BR/>2. TAU + other: traditional ward occupational therapy of equivalent frequency and length, including a routine of work, rest and leisure activities (n = 37).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-12-12 14:28:06 +0000" MODIFIED_BY="[Empty name]">
<P>Service utilisation: Number of re-hospitalisations*.<BR/>Knowledge: Scale of Unawareness of Mental Disorder (SUMD)**.</P>
<P>Unable to use -</P>
<P>Short Form Health Survey (SF-36) questionnaire** (overall score not reported).</P>
<P>Time to relapse (unable to read data from curve).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-14 19:04:45 +0000" MODIFIED_BY="[Empty name]">
<P>*Number of re-hospitalisations was classified as relapse in the study, but as service utilisation in our review.<BR/>**Translated to Chinese.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2003">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Blinding: double-blind.<BR/>Duration: 10 weeks, follow-up 1 year.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:25:26 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (ICD-10 and CCMD-3).</P>
<P>N = 64.<BR/>Age: 15-55 years, average ~31 years (SD 9).<BR/>Sex: M 35, F 28.<BR/>History: average length of illness: 7.12 ± 5.45 years (N = 32, intervention group)vs. 8. 03 ± 5.95 years (N = 32, control group).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:25:32 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: teamwork education, medication management skills training module, symptom management skills training module. (N = 32).</P>
<P>2. TAU: antipsychotic therapy (N = 32).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse: relapse rate.</P>
<P>Service use: re-hospitalisation rate (hospital stay &#8805; 4 weeks).<BR/>Mental state: PANSS;<BR/>Social functioning: SDSS (Social dysfunction screening scale), NOSIE, not employed (no work after discharge &#8805; half a year).</P>
<P>Adverse events: lost to follow-up.</P>
<P>Knowledge: ITAQ (Insight and treatment attitude questionnaire)</P>
<P>Not used in the review:</P>
<P>MRSS (Morningside Rehabilitation Status Scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-12-12 14:29:29 +0000" MODIFIED_BY="[Empty name]">
<P>Assessment of curative effect: based on PANSS scale score.<BR/>Relapse: score of items P2, P3 , P6 , G5 or G9 &#8805; 5, or two of which &#8805; 4.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chien-2004">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 18 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Hong Kong.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-12 14:29:54 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 96*.<BR/>Age: average ~42 years (SD 7).</P>
<P>Sex: M 128, F 72.</P>
<P>History: the relative with schizophrenia had no other mental illness, and the duration of the schizophrenia was 3 years or less at the time of recruitment.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 12 bi-weekly 2-hour sessions over 6 months by trained psychiatric nurses to educate, improve illness management including recognising early warning signs and improve coping skills, multiple family group intervention (N = 33).</P>
<P>2. TAU: routine psychiatric outpatient and family support services (N = 31).<BR/>3. TAU + mutual support: peer-led group for information, support and coping skills for caregiving, 12 bi-weekly 2-hour sessions over 6 months, and did not include the patients (N = 32).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-14 19:05:18 +0000" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.<BR/>Mental state: BPRS (Positive symptoms).<BR/>Social functioning: SLOF (Specific level of functioning scale).</P>
<P>Burden of care: FBIS (Family Burden Interview Schedule).</P>
<P>Not used-</P>
<P>Service use: mean number of re-hospitalisations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-15 13:28:35 +0100" MODIFIED_BY="[Empty name]">
<P>*96 families of out-patients with schizophrenia.</P>
<P>Data used only from interventions 1. and 2.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-12-11 22:25:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Drury-1996">
<CHAR_METHODS MODIFIED="2011-05-18 09:44:39 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 9 months*.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:25:48 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (ICD-9).</P>
<P>N = 62**.<BR/>Age: average ~30 years (SD 9)<BR/>Sex: M 25, F 15.</P>
<P>History: mean number of previous episodes: treatment group 3.5 (SD 3.5), control group 3.0 (SD 2.7).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:25:54 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: four individual and group cognitive therapy, and family engagement. Cognitive therapy involved individual and group procedures including early warning signs recognition and strategies for coping (N = 30).</P>
<P>2. TAU: care of psychiatrist + recreation and informal support (N = 32).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 09:45:43 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up*.</P>
<P>Mental state: PAS (Psychiatric assessment scale)*.</P>
<P>Unable to use:</P>
<P>Mental state: self report measure of delusional conviction (no mean and SD).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 09:45:34 +0100" MODIFIED_BY="[Empty name]">
<P>*Usable data reported after 12 weeks of treatment.</P>
<P>**Demographic data given only for participants completing the study.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garety-2008">
<CHAR_METHODS MODIFIED="2012-06-25 13:07:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. </P>
<P>Blinding: single blind.<BR/>Duration: 24 months.<BR/>Design: parallel. </P>
<P>Setting: secondary care. </P>
<P>Country: UK</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:26:02 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: non-affective psychoses (ICD-10 or DSM-IV).</P>
<P>N = 301.</P>
<P>Age: 18-65 years.</P>
<P>Sex: M 211 F 90.</P>
<P>History: Patients with recent relapse, whether or not they had been admitted.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:26:21 +0000" MODIFIED_BY="[Empty name]">
<P>There were two randomisation pathways:</P>
<P>Patients without carers:</P>
<P>1. CBT + TAU: Cognitive behavioural therapy focused on relapse prevention including pragmatic relapse prevention plan and identification of early signs, 12-20 sessions over nine weeks,  (N = 106)<BR/>2. TAU (N = 112)</P>
<P>Patients with carers:</P>
<P>1. CBT + TAU: Cognitive behavioural therapy focused on relapse prevention including pragmatic relapse prevention plan and identification of early signs, 12-20 sessions over nine weeks,  (N = 27)<BR/>2. TAU (N = 28)</P>
<P>3. Family Intervention + TAU: Family intervention focused on relapse prevention including how family members might understand warning signs, 12-20 sessions over nine weeks, (N = 28)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-22 15:05:55 +0100" MODIFIED_BY="[Empty name]">
<P>Rate of relapse*.<BR/>Mental state: PANSS.<BR/>Social functioning: Time-budget interview, SOFAS (Social and Occupational Assessment Scale)<BR/>Quality of Life: EuroQol<BR/>Adverse events: death, suicide attempts, violent incidence, lost to follow-up.<BR/>
</P>
<P>Not used-</P>
<P>Mental health: BDI (Beck Depression Inventory), BAI (Beck Anxiety Inventory).</P>
<P>Days on hospital and number of admissions.<BR/>Unable to use -<BR/>
</P>
<P>PSYRATS (Psychotic Symptom Rating Scale) (reported on two subscales).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>*Measured in a subgroup of participants that relapsed after partial or full remission.</P>
<P>Protocol: ISRCTN83557988.</P>
<P>For the patients with carers pathway, data for the TAU group were split in two in the analyses: total number of participants were divided and the means and standard deviations remained the same.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-12-11 22:26:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Granholm-2005">
<CHAR_METHODS MODIFIED="2011-04-04 12:45:56 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single blind.</P>
<P>Duration: 6 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:26:24 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 76.<BR/>Age: average ~54 years (SD 7).<BR/>Sex: M 56, F 20.</P>
<P>History: not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:26:30 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 24 weekly 2 hour group cognitive behavioural therapy sessions, including early detection and management of symptoms (N = 37).</P>
<P>2. TAU: ongoing care as usual (N = 39).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-17 11:52:24 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Unable to use -</P>
<P>Mental state:PANSS (Positive and negative syndrome scale); HDRS (Hamilton Depression Rating Scale); Beck Cognitive insight scale (mean and SD not reported).</P>
<P>Social functioning: Independent Living Skills Survey; UCSD performance based skills assessment; coping skills (mean and SD not reported).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-01 20:07:25 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gumley-2003">
<CHAR_METHODS MODIFIED="2011-04-04 13:16:01 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 12 months. </P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:26:33 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 144.<BR/>Age: average ~36 years (SD 10).<BR/>Sex: M 66. F 134.</P>
<P>History: receiving antipsychotic medication, prone to relapse.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: clinical psychologist provided CBT, 5-session engagement phase and intensive targeted phase of 2-3 sessions per week at the appearance of relapse. Individualised case formulation of the cognitive behavioural factors associated with relapse, an idiosyncratic early signs questionnaire incorporating these factors was developed (N = 72).</P>
<P>2.TAU: Treatment overseen by consultant psychiatrist for ongoing medication, regular reviews, follow-up from a community mental health nurse (N = 72).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Relapse*: relapse number, time to relapse.</P>
<P>Service use: Re-hospitalisation rate.<BR/>Mental state: PANSS positive, PANSS negative.</P>
<P>Unable to use -</P>
<P>Service use: time to re-hospitalisation.</P>
<P>Mental state: Personal beliefs about Illness questionnaire (overall score not reported); Brief symptom inventory (only baseline data reported).</P>
<P>Social functioning: Social Functioning Scale (overall score not reported).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 13:25:25 +0100" MODIFIED_BY="[Empty name]">
<P>*Increase in participant's self-reported early signs, failure to return questionnaire more than once, treating team reported symptom changes or circumstances/stressors suggestive of relapse. Time to relapse data was log transformed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 10:07:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harris-2009">
<CHAR_METHODS MODIFIED="2012-07-17 14:30:35 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Cluster randomised, community health professional unit of randomisation. </P>
<P>Blinding: Not blinded.</P>
<P>Duration: 9 months.</P>
<P>Design: Parallel.<BR/>Setting: Mental health trusts.<BR/>Country: England.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-07 10:07:23 +0000" MODIFIED_BY="[Empty name]">
<P>Community mental health professionals (CMHPs) with caseloads of service users (SU) with a diagnosis of schizophrenia (DSM-IV).</P>
<P>CMHP <BR/>N = 28 pairs; service users N = 169.<BR/>Age: CMHP &#8211; Experimental : 39, Control: 40; SU -  Experimental : 44, Control: 41.4  </P>
<P>Sex: CMHP : 20 male, 36 female; SU:  96 male, 73 female.</P>
<P>History: SU length of illness &#8211; Experimental : 17.25 years, Control: 12 years  </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:26:59 +0000" MODIFIED_BY="[Empty name]">
<P>1. Experimental medication management training programme, including early warning signs work and relapse prevention, (N = 28 CMHP; N = 88 SU).</P>
<P>2. Waiting list (N = 28 CMHP; N = 81 SU).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-18 09:12:17 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: KGV (M) Version 6.</P>
<P>Social functioning scale: SFS.</P>
<P>Knowledge: Drug attitude inventory (DAI).</P>
<P>Satsifaction with care: The Californian Psychopharmacology Alliance Scale (CALPAS).</P>
<P>Unable to use-</P>
<P>Leaving the study early (number lost from each group not reported).</P>
<P>Not used-</P>
<P>Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-22 14:34:19 +0100" MODIFIED_BY="[Empty name]">
<P>Results adjusted for clustering: "Based on experience of similar studies with process outcomes a value of 0.05 was assumed for the ICC." </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Herz-2000">
<CHAR_METHODS MODIFIED="2011-04-04 15:15:55 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 18 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:27:02 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-III-R).</P>
<P>N = 82.<BR/>Age: average ~29 years (SD 9)<BR/>Sex: M 53, F 29.</P>
<P>History: increased risk for relapse (at least 1 hospitalisation in past 3 years or 2 or more lifetime hospital admissions).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:27:09 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 5 components of PRP (Program for relapse prevention): education for patients and family about relapse and recognizing prodromal symptoms and behaviours, active monitoring of prodromal symptoms by team, immediate clinical intervention within 24 to 48 hours, supportive group/individual therapy improving coping skills, multifamily psychoeducation (N = 41).</P>
<P>2. TAU: individual supportive therapy and medication management biweekly for 15-30 min (N = 41).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse*: relapse rate, time to relapse.</P>
<P>Service use: re-hospitalisation rate.<BR/>
</P>
<P>Unable to use -</P>
<P>Mental state: PANSS; Early Signs Questionnaire (no mean and SD).</P>
<P>Social functioning: GAS (no mean and SD).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 13:25:16 +0100" MODIFIED_BY="[Empty name]">
<P>*defined as increase in any PANSS to moderately severe or higher and a GAS score of 30 or less. Time to relapse data was log transformed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hogarty-1997a">
<CHAR_METHODS MODIFIED="2011-04-06 12:53:04 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 3 years. </P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:27:12 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.</P>
<P>N = 97.<BR/>Age: average ~28 years (SD 7).<BR/>Sex: M 56, F 41.</P>
<P>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:27:22 +0000" MODIFIED_BY="[Empty name]">
<P>1. Personal therapy + TAU: taught awareness of one's own individual prodromes of psychosis (N = 23).</P>
<P>2. Family psychoeducation/management (family therapy) + TAU: included the three broad phases of joining, survival skills training and reintegration within the home, and reintegration into the community (N = 26).<BR/>3. Personal therapy + family therapy + TAU: (N = 26).<BR/>4. TAU: supportive therapy, active listening, correct empathy, reassurance (N = 24).</P>
<P>Treatment sessions were 30-45 min weekly for about 3 years. Personal and family therapy patients also received 1.9 additional monthly medication management sessions in years 1 and 2, and an additional 1.3 sessions each month in year 3.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse*: rate of relapse.</P>
<P>Unable to use -</P>
<P>Time to relapse: defined as also including early treatment termination.</P>
<P>Service use: re-hospitalisation rate (only reported for patients who had relapse episodes).<BR/>Mental state: BPRS; Raskin negative symptom scale; Covi anxiety scale; Wing negative symptom scale (no mean and SD).<BR/>Social functioning: GAS (no data for TAU group).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-17 13:48:59 +0100" MODIFIED_BY="[Empty name]">
<P>*Defined as mild or less to greater than mild on two or more of the four psychotic symptoms on the BPRS or a 2 point increase on one or more severe symptoms + decrease of 10 points or more on GAS.</P>
<P>Data for intervention groups 1, 2 and 3 were combined.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Horan-2009">
<CHAR_METHODS MODIFIED="2012-06-25 14:50:10 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Blinding: no details.</P>
<P>Duration: 6 weeks.</P>
<P>Design: parallel.</P>
<P>Setting: outpatient secondary care.</P>
<P>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia or schizoaffective disorder (DSM-IV).</P>
<P>N = 34.</P>
<P>Age: mean age social cognition: 50.7; mean age control (relapse prevention): 45.9 years.<BR/>Sex: social cognition: 87% M; control (relapse prevention): 100% M.</P>
<P>History: Clinically stable outpatients with no psychiatric hospitalisations in the past 6 months and the same antipsychotic medication for previous 3 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:27:34 +0000" MODIFIED_BY="[Empty name]">
<P>1. Social cognition: social skills training (N = 17)<BR/>2. Control*: illness self-management and relapse prevention skills including identifying and managing warning signs of relapse (n = 7).<BR/>Both programmes consisted of 12 one-hour groups that met twice weekly.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-22 14:21:46 +0100" MODIFIED_BY="[Empty name]">
<P>Loss to follow-up<BR/>Unable to use -<BR/>Mental state: BPRS (total scores not reported) </P>
<P>Satisfaction with treatment (not validated scale)</P>
<P>Not used -</P>
<P>Facial Emotion Identification Test, Half-profile of Nonverbal Sensitivity, Ambiguous Intentions Hostility Questionnaire, The  Awareness of Social Inference Test , MATRICS Consensus Cognitive Battery (MCCB): cognitive performance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-25 14:49:51 +0100" MODIFIED_BY="[Empty name]">
<P>*EWS training was the control group, social skills the intervention.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-12-11 22:27:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kopelowicz-1998a">
<CHAR_METHODS MODIFIED="2011-05-18 12:02:24 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 1 month. </P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:27:37 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 70*.<BR/>Age: average ~35 years (SD 11).<BR/>Sex: M 42, F 17.<BR/>History: mean duration of illness 12 years (SD 9).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:27:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: (CREP) community re-entry programme: eight sessions each 45 minutes, in groups, twice a day, four days a week schedule, over 2 weeks.; including teaching patients early warning signs of relapse (N = 28).</P>
<P>2. TAU+ other: occupational therapy sessions conducted by certified therapists (N = 31).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-17 12:02:18 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Unable to use -</P>
<P>Knowledge and performance of skills (no mean and SD).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-04-06 13:01:16 +0100" MODIFIED_BY="[Empty name]">
<P>*Data were reported on 59 subjects that completed participation, defined as attending at least four sessions.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kopelowicz-2003">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 9 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:27:45 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 92.<BR/>Age: average ~38 years (SD 11).<BR/>Sex: M 62, F 30.</P>
<P>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: skills training groups met for 90-minute sessions four times per week for 3 months. Skills training for patients and relatives included medication management and symptom management (identification and intervention of early warning signs) (N = 45).</P>
<P>2. TAU: monthly psychiatric visits for medication management and case management by social workers (N = 47).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Service use: re-hospitalisation rate.<BR/>Mental state: PANSS.<BR/>Social functioning: ILSS (Independent Living Skills Survey).</P>
<P>Medication compliance.</P>
<P>Unable to use -</P>
<P>Quality of life: Quality of life interview (no data).</P>
<P>Knowledge: Skill acquisition and generalisation (no overall scores).</P>
<P>Burden of care: FBIS (no SD).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-01 20:07:24 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuipers-1997">
<CHAR_METHODS MODIFIED="2011-04-06 13:34:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: not blind.<BR/>Duration: 9 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:27:53 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 60.<BR/>Age: average ~40 years.<BR/>Sex: M 38, F 22.<BR/>History: at least one current positive psychotic symptom that was distressing, unremitting, and medication resistant.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 9 months of individual CBT weekly or fortnightly, individual CBT included discussion of relapse signatures, trigger identification and seeking help (N = 28).</P>
<P>2. TAU: case management and medication, including involvement of a key worker (N = 32).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-29 10:01:51 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Mental state: BPRS.</P>
<P>Economic burden (cost of care).<BR/>
</P>
<P>Unable to use -</P>
<P>Mental state: Insight; BDI; BAI; Beck Hopelessness Scale; NART; Quick test (no data).</P>
<P>Social functioning: SFS (Social Functioning Scale) (no data).</P>
<P>Satisfaction of care: Satisfaction with therapy questionnaire (results not reported for TAU group).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-01 20:07:24 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2003">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: cluster-randomised (ward unit of randomisation).<BR/>Blinding: not reported.<BR/>Duration: 9 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Hong Kong.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:28:02 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-II-R).</P>
<P>N = 101.<BR/>Age: experimental group 16-61 years, mean age 32.9 (SD 9.7); control group 15-49 years, mean 32.2 (SD 8.9)<BR/>Sex: M 43, F 58 .<BR/>History: number of hospitalisations ranged from first to sixth time, duration of illness ranged from 0 to 21 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-12 14:42:23 +0000" MODIFIED_BY="[Empty name]">
<P>1. Comprehensive patient/family education guide (CP/FEG): Nurse initiated patient/family education strategy. 8 hours with patients, 36 hours with families in hospital, then 2 hours per month for 3 months. Included early warning signs of relapse and responding to early warning signs training for families (N = 46, 4 wards).</P>
<P>2. TAU (N = 55, 4 wards).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse rate.</P>
<P>Re-hospitalisation rate.</P>
<P>Pychotic symptoms of patient: Chinese version of the BPRS (Zhang 1998).</P>
<P>Social functioning: Chinese version of the NOSIE (measured at discharge) and GAS (Zhang 1998).</P>
<P>Knowledge (of relative): Chinese version of Knowledge about Schizophrenia Interview (KASI) (Tsang, Chan &amp; Tam 1999).</P>
<P>Burden of care: FAS.</P>
<P>Medication compliance.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Results not adjusted for randomisation. ICC of 0.1 used to impute data.</P>
<P>Relapse defined as re-hospitalisation, recurrence of schizophrenic symptoms or a marked increase in the number or intensity of symptoms measured by a BPRS score of 5 or above on the relapse scale indicating exacerbation of the illness.</P>
<P>EWS part of training only delivered to family.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liberman-1998">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 2 years.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:28:11 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia.</P>
<P>N = 84.<BR/>Age: 37.1 years (SD 8.8).<BR/>Sex: M 84.<BR/>History: outpatients with persistent and unremitting forms of schizophrenia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:28:18 +0000" MODIFIED_BY="[Empty name]">
<P>1. Social skills training: UCLA Social and Independent Living Skills Program consisting of basic conversation, recreation for leisure, medication management, and symptom management, including Identifying warning signs of relapse and developing a relapse prevention plan, over 6 months, 3 hours per day, 4 days a week (N = 42)*.</P>
<P>2. Psychosocial occupational therapy: expressive, artistic, and recreational activities that mediated supportive therapy in groups and individually, over 6 months, 3 hours per day, 4 days a week (N = 42)*.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-20 10:45:10 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: BPRS**</P>
<P>Social functioning: Independent Living Skills Survey (ILSS)**</P>
<P>Social functioning: Global Assessment Scale (GAS)**</P>
<P>Adverse events: Lost to follow-up*</P>
<P>Quality of life: Lehman Quality of Life Scale (LQoLS)**</P>
<P>Not used in the review-</P>
<P>Profile of Adaptation to Life subscales</P>
<P>Rosenberg Self-Esteem Scale</P>
<P>Brief Symptom Inventory (BSI)</P>
<P>Social Activities Scale (SAS) (not a validated scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-20 10:44:26 +0100" MODIFIED_BY="[Empty name]">
<P>*Total included participants for each group was not clearly reported "assigned half to psychosocial occupational therapy and half to skills training", assumed this to be 42 in each treatment group. </P>
<P>**Data reported for 80 participants at 2 years follow-up, number in each group not reported, assumed to be 40 in each group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McDonell-2006">
<CHAR_METHODS MODIFIED="2011-05-16 10:40:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 3 years.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:28:33 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia, schizoaffective disorder, other psychotic disorders (DSM-IV).</P>
<P>N = 97*.<BR/>Age: average ~32 years (SD 9).</P>
<P>Sex: M 74, F 21.</P>
<P>History: mean illness duration ~10 years (SD 8.5).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:28:38 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: multiple-family group treatment delivered by two clinicians to groups of 5-8 families over 2 years, including early warning signs work and relapse prevention, 24 sessions in year 1 and 12 sessions in year 2 (N = 53).</P>
<P>2. TAU: outpatient services, medication management and case management (N = 44).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Service use: re-hospitalisation rate*.<BR/>
</P>
<P>Unable to use -</P>
<P>Mental state: BPRS; MSANS (Modified scale for the assessment of negative symptoms) (only baseline data reported).</P>
<P>Burden of care: care givers' social support (no mean and SD).</P>
<P>Economic outcomes: Inpatient and outpatient service utilisation (no SD).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-16 10:33:46 +0100" MODIFIED_BY="[Empty name]">
<P>*Demographic data not reported for 2 participants.</P>
<P>**Community hospitalisation when imminent danger to oneself or others, grave disability, or medically necessary. State hospitalisation when need for long-term care not possible at a community hospital or direct referral from the justice system.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Merinder-1999">
<CHAR_METHODS MODIFIED="2011-05-18 10:40:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single blind.<BR/>Duration: 1 year.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Denmark.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-06-25 11:26:28 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (ICD-10, OPCRIT).</P>
<P>N=46.<BR/>Age: average ~36 years (SD 35).<BR/>Sex: M 24, F 22.</P>
<P>History: 8.2 years with a median of five earlier admissions.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:28:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 8 session psychoeducation programme for patients and relatives including sessions called "Stress and early signs of relapse, emergency plan" and "What can you and your family do about it?", 8 weekly sessions separately for patients and relatives (N = 23).</P>
<P>2. TAU+ other: pharmacological intervention, psychosocial rehabilitation, supportive psychotherapy (N = 23).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Rate of relapse, time to relapse*.</P>
<P>Rate of re-hospitalisations**</P>
<P>Mental state: BPRS.<BR/>Social functioning: GAF (Global Assessment of Function).</P>
<P>Satisfaction with care: VSSS (Verona Service Satisfaction scale).<BR/>
</P>
<P>Knowledge: Insight scale***.</P>
<P>Unable to use -</P>
<P>Relapse*: time to (no hazard ratio).</P>
<P>Knowledge of schizophrenia scale (not validated scale).</P>
<P>GCSI (Global Clinical Assessment of Severity of Side Effects; results not reported for separately for treatment groups).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>*3 levels rated: Type 1- aggravation of symptoms without change of treatment; Type 2- aggravation of symptoms with change in medication, Type 3- aggravation of symptoms with admission to hospital. Time to relapse was imputed using method 7 from <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK> (report presents P value and events on each arm and randomisation ratio is 1:1).</P>
<P>**Re-hospitalisation rate was added to the analysis as the number of participants with Type 3 relapse.<BR/>***Translated to Danish.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Norman-2002">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 1 year.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Canada.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:28:45 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-III-R).</P>
<P>N = 130*.<BR/>Age: Average ~34 years (SD 9).<BR/>Sex: M 81, F 40.</P>
<P>History: clinically stable.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:28:50 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 12 weeks of group sessions+ 12 individual sessions emphasizing on three aspects of stress management. Stress management program included 12 aspects, one of which included recognition and reporting any increase in symptoms and learning to recognise and avoid situations that trigger symptoms. (N = 64).</P>
<P>2. TAU: social activities programme, including mutual support and recreational activities (N = 66).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Service use: Re-hospitalisation rate.<BR/>
</P>
<P>Unable to use -</P>
<P>Mental state: SAPS; SANS (no SD).</P>
<P>Social functioning: Life Skills Profile (no SD).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-04-06 14:51:51 +0100" MODIFIED_BY="[Empty name]">
<P>* Demogaphic data reported for participants completing the study.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-12-12 14:49:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shin-2002">
<CHAR_METHODS MODIFIED="2011-05-18 09:58:05 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 10 weeks.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:28:53 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 48.<BR/>Age: Average ~38 years (SD 8).<BR/>Sex: M 20, F 28.<BR/>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-12 14:49:01 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: 90 minutes long, 10 weekly group therapy. Culturally sensitive psychoeducational group program (including early warning signs recognition and relapse prevention) and individual supportive therapy and family work. (N = 24).</P>
<P>2. TAU: individual supportive therapy (N = 24).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-19 12:24:22 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Mental state: BPRS.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-04-06 14:58:03 +0100" MODIFIED_BY="[Empty name]">
<P>All sessions and outcome measures were conducted in Korean.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-12-11 22:29:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shon-2002">
<CHAR_METHODS MODIFIED="2011-05-18 09:59:50 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: unclear, 12 sessions.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Korea.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:29:01 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia, delusional disorders, mood disorders (DSM-IV).</P>
<P>N = 40*.<BR/>Age: average ~32 years (SD 8).<BR/>Sex: M 22, F 16.<BR/>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:29:06 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: medication compliance and symptom management program consisting of 12 sessions, each lasting 70 minutes and included developing skills to recognize symptoms and effective methods of preventing relapse (N = 18).</P>
<P>2. TAU: standard psychiatric treatment post discharge (N = 20).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 08:33:43 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up.</P>
<P>Unable to use -</P>
<P>Mental state: Relapse symptom measurement (not validated scale).</P>
<P>Medication compliance: Medication use scale; Scale for family support in medication compliance (not validated scales).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-04-06 15:06:03 +0100" MODIFIED_BY="[Empty name]">
<P>*Two participants were excluded from the experimental group during the randomisation process.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-12-11 22:29:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tait-2002">
<CHAR_METHODS MODIFIED="2011-04-06 15:39:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 10 months*.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:29:08 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 20.<BR/>Age: average ~39 years.<BR/>Sex: M 14, F 6.<BR/>History:</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:29:14 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: initial engagement and formulation for 5 one-hour sessions, early signs monitoring fortnightly for 10 months, targeted cognitive therapy intensively for a brief period, about 2-3 sessions per week (N = 9).</P>
<P>2.TAU: routine appointments with psychiatrist and key worker (CPN, social worker or OT) (N = 11).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-16 12:55:23 +0100" MODIFIED_BY="[Empty name]">
<P>Relapse**: relapse rate.</P>
<P>Unable to use - </P>
<P>Mental state: Early signs monitoring; PANSS (no data).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-04-07 08:27:08 +0100" MODIFIED_BY="[Empty name]">
<P>*Average follow-up 10 months (range from 5-13 months).</P>
<P>**Relapse defined as i) significant increase in early signs; ii) presence of relevant psychosocial factors associated with previous relapses; iii) non return of early sings monitoring questionnaires.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turkington-2006">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 1 year.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:29:16 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (ICD-10).</P>
<P>N = 422.<BR/>Age: Average ~40 years.<BR/>Sex: M 325, F 97.<BR/>History: ongoing positive and/or negative symptoms or at risk of relapse.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: community psychiatric nurse delivered 6 hour-long sessions over 2-3 months, carers offered 3 sessions. CBT including symptom management and relapse prevention (N = 257).</P>
<P>2. TAU: care of community mental health teams (N = 165).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-27 14:18:00 +0100" MODIFIED_BY="[Empty name]">
<P>Time to first relapse*.</P>
<P>Unable to use -</P>
<P>Mental state: Comprehensive psychopathological rating scale; Schizophrenia change scale, Montgomery and Asberg rating scale (no SD).<BR/>Insight: Insight rating scale (no SD).<BR/>
</P>
<P>Burden of care: Burden of care questionnaire (no SD).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-27 14:17:57 +0100" MODIFIED_BY="[Empty name]">
<P>*Time to relapse was imputed using method 3 from <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK> (report presents HR and CIs).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Meijel-2006">
<CHAR_METHODS MODIFIED="2011-04-07 11:42:56 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 1 year.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: Netherlands.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:29:24 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 95.<BR/>Age: average ~35 years.<BR/>Sex: M 65, F 30**.<BR/>History: mean number of previous episodes: treatment group 4.4, control group 3.8.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:29:29 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: Relapse prevention plan with patient and carers, early signs are systematically inventoried and recognition assisted, followed by an action plan (pure early warning signs work). 4 phases: preparatory phase, listing of early warning signs, monitoring of the early signs, preparation of an action plan (N = 51).</P>
<P>2. TAU: care as usual (N = 44).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-27 13:42:43 +0100" MODIFIED_BY="[Empty name]">
<P>Relapse*: relapse rate, time to relapse.</P>
<P>Unable to use -<BR/>Mental state: PANSS (no SD); CGI (no data).<BR/>Knowledge: Insight scale (no mean and SD).<BR/>
</P>
<P>Satisfaction with care: Working Alliance Inventory (no mean and SD).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>*Relapse defined as a significant increase in i) delusions, ii) hallucinations, iii) disorganisation of thinking, iv) chaotic or aggressive behaviour; 6 or higher on CGI; symptoms had to be present for at least 7 days. Time to relapse was imputed using method 7 from <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK> (report presents P value and events on each arm and randomisation ratio is 1:1).</P>
<P>**Demographic data only reported for participants completing the study.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vreeland-2006">
<CHAR_METHODS MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: single-blind.<BR/>Duration: 24 weeks.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:29:53 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-IV).</P>
<P>N = 74.<BR/>Age: average not reported, range 35 to 64 years.<BR/>Sex: M 33, F 41.<BR/>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:29:59 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: (Team Solutions Program): groups met twice a day, two days per week, for 24 weeks including education and management of illness, one session covering preventing relapse and crisis resolution (N = 40).</P>
<P>2. TAU + other: Day treatment: prevocational work areas, recreational groups, social skills training, psychoeducational groups (N = 34).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-20 07:50:00 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS positive and PANSS negative.<BR/>Social functioning: GAF-DIS (Global Assessment of Functioning-Disability Scale).</P>
<P>Satisfaction with care: IAPSRS (International association of psychosocial rehabilitation services).<BR/>
</P>
<P>Knowledge: KASQ.</P>
<P>Unable to use -</P>
<P>Mental state: CGI (no overall scores).</P>
<P>Quality of life: PGWB (Psychological general well-being scale) (no overall scores).</P>
<P>Knowledge: TSCKAS (not validated scale).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-01 20:07:23 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weng-2005">
<CHAR_METHODS MODIFIED="2011-05-18 10:01:46 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 2 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:05 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM-III-R).</P>
<P>N = 124.<BR/>Age: not reported.<BR/>Sex: not reported.<BR/>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:30:10 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: Multimodal rehabilitation program including medication management and symptom management delivered in groups of 8-10 patients over 2 months (N = 62).</P>
<P>2. TAU: standard inpatient services (N = 62).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse: number.</P>
<P>Service use: re-hospitalisation number.</P>
<P>Social functioning: employment.<BR/>Unable to use -</P>
<P>Mental state: BPRS (mean change from discharge to follow-up).<BR/>Social functioning: SDSS (Social disability screening scale); NOSIE-30 (Nurses' observation scale for inpatient evaluation) (mean change from discharge to follow-up).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-10-01 20:07:25 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xiang-2001">
<CHAR_METHODS MODIFIED="2012-07-17 09:53:05 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Duration: 20 weeks, follow-up 1 year.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:13 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-2-R/ ICD-10).</P>
<P>N = 133.<BR/>Age: average ~38 years (SD 21).</P>
<P>Sex: male and female.<BR/>History: patients in remission, average length of illness: median~10.5 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: With reference to "Social and independent living skills" by Liberman: 1) medication self-management, including information on antipsychotic medication, how to self-manage medication, assess the effect of medication, recognise adverse effect of medication, communicate the effect and adverse effect of medication to medical staff. 2) early warning sign training, including training on how to recognise and monitor signs of relapse, deal with symptoms of relapse, resist intake of alcohol and narcotics. Training was provided by a psychiatrist and a psychologist. Frequency 90~120 minutes per session, 3 sessions a week for 20 weeks. (N = 66).</P>
<P>2. TAU: standard psychological intervention (N = 67).<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse: Relapse rate, time to relapse*.</P>
<P>Service use: re-hospitalisation rate, time to re-hospitalisation*.<BR/>Mental state: BPRS.</P>
<P>Adverse events: leaving the study early.</P>
<P>Unable to use-</P>
<P>Number of missed doses (skewed data).</P>
<P>Score of patient compliance with medication (not a validated scale).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>In Chinese.</P>
<P>*Time to relapse and time to re-hospitalisation were imputed using method 7 from <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK> (report presents P value and events on each arm and randomisation ratio is 1:1).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xiong-1994">
<CHAR_METHODS MODIFIED="2011-05-18 10:02:38 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Blinding: unclear.<BR/>Duration: 18 months.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:20 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM III R).</P>
<P>N = 63*.<BR/>Age: average ~ 31 years (SD 10).<BR/>Sex: M 43, F 20.<BR/>History: mean duration of illness 7.5 years (SD 6.8); mean number of hospitalisations 4 (SD 5.1).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: Family-based intervention, included discussion about detecting relapse. Introduction: two to three 45-minute sessions- family +/- patient; then monthly 45-minute counselling with patient (average 8.1 contacts per year) and family, and 90-minute family group; finally maintenance: families seen once in 2-3 months and monthly group meetings up to 18 months (N = 34).</P>
<P>2. TAU: prescription for antipsychotic medication given at discharge, sporadic renewals (N = 29).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse**: relapse rate.</P>
<P>Service use: re-hospitalisation rate.<BR/>Adverse events: deaths***.</P>
<P>Employment: mean number of months of employment.</P>
<P>Unable to use -</P>
<P>Mental state: SAPS; SANS; BPRS (no mean and SD).</P>
<P>Social functioning: SDSS; GAF (no mean and SD).</P>
<P>Burden of care: overall burden on a 4 point scale (not validated scale).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 09:02:05 +0100" MODIFIED_BY="[Empty name]">
<P>*The number of patients in the groups at different time periods varies because the length of follow-up after hospitalisation differed.</P>
<P>**Relapse: hospitalisation or serious suicide attempt or deterioration on SAPS as marked or severe, symptoms on SANS marked or severe, BPRS items 4,7,11,12,and 15 rated severe; overall GAF score 40 or less; greater than 80% disability on SDSS.</P>
<P>***Suicides treated as relapses in the data, not entered as relapse on our analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhan-2003">
<CHAR_METHODS MODIFIED="2012-07-10 16:41:56 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Duration: 1 year.</P>
<P>Design: parallel.<BR/>Setting: secondary care.<BR/>Country: China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:28 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: first episode or relapsing schizophrenia (CCMD-2-R).</P>
<P>N = 146.</P>
<P>Age: 37. 87 ± 10.12 years for intervention group and 36. 59 ± 11.12 years for control group.<BR/>History: average length of illness: 3. 45 ± 1.58 years for intervention group and 3. 57 ±1. 78 years for control group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: pharmacotherapy, with reference to "social and independent living skills" by Liberman, intervention group received the following: 1) medication self-management, including information on antipsychotic medication, how to self-manage medication, assess the effect of medication, recognise adverse effect of medication, communicate the effect and adverse effect of medication to medical staff. 2) symptom self-monitoring, including training on how to recognise and monitor signs of relapse, learn to communicate with medical staff and prevent relapse, deal with persisting symptoms and develop good living habits. Training was provided by psychiatrists and psychologists. Frequency: 60~90 minutes per session, 1 session a week for 12 weeks. (N = 74).</P>
<P>2. TAU: pharmacotherapy + standard psychological intervention (N = 72).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-17 10:51:38 +0100" MODIFIED_BY="[Empty name]">
<P>Relapse: relapse rate (occurrence of overt psychiatric symptoms, BPRS score &#8805;28).<BR/>Mental state: BPRS.</P>
<P>Social functioning: NOSIE.</P>
<P>Medication compliance.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-17 12:42:14 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2004">
<CHAR_METHODS MODIFIED="2012-07-10 16:43:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomisation.<BR/>Duration: 1 year.<BR/>Setting: secondary care.<BR/>Country: China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:38 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (CCMD-III) and their families.</P>
<P>N = 120.<BR/>Age: 26 ± 8 years for intervention group and 28 ± 7 years for control group.<BR/>Sex: male and female.<BR/>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-11 22:30:43 +0000" MODIFIED_BY="[Empty name]">
<P>1. Psychoeducation + TAU: With reference to "social and independent living skills" by Liberman, intervention group received the following: 1) independent community living skill , 2) medication self-management, 3) symptom self-monitoring skills, including recognise early warning signs of relapse, symptom coping strategy, apply these strategy in a community setting. 16 sessions of group work by health professional, social and independent living skills training with elements of early warning signs training. Class learning (90~120 minutes per session, 2 sessions a week for 8 weeks) Plus community follow-up and home-based intervention. (N = 60).</P>
<P>2. TAU: Conventional rehabilitation service (outpatient follow-up every 3 months, or telephone counselling as needed)<BR/>(N = 60).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>Relapse: relapse rate.</P>
<P>Service use: re-hospitalisation rate.<BR/>Mental state: SAPS; SANS; BPRS.<BR/>Social functioning: SDSS (Social dysfunction screening scale).</P>
<P>Knowledge: ITAQ (Insight and treatment attitude questionnaire).</P>
<P>Compliance with medication.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-17 12:42:10 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BAI: Beck Anxiety Inventory<BR/>BDI: Beck Depression Inventory<BR/>BPRS: Brief Psychopathology Rating Scale<BR/>BSI: Brief Symptom Inventory<BR/>CBT: cognitive behavioural therapy<BR/>CG-I: Clinical Global Impression<BR/>DSM: Diagnostic and Statistical Manual<BR/>EWS: early warning signs<BR/>FBIS: Family Burden Interview Schedule<BR/>GAF: Global Assessment of Functioning<BR/>GAF-DIS: Global Assessment of Functioning<BR/>GAS: S Global Assessment Scale<BR/>Hamilton Depression Rating Scale<BR/>HoNOS: Health of the Nation Outcome Scale<BR/>ICD: International Classification of Diseases<BR/>ILSS: Independent Living Skills Survey<BR/>ITAQ: Insight and Treatment Attitude Questionnaire<BR/>LQoLS: Lehman Quality of Life Scale<BR/>NOSIE: Nurses' Observation Scale for Inpatient Evaluation<BR/>PANSS: Positive and Negative Syndromes Scale <BR/>PAS: Psychiatric Assessment Scale<BR/>PSYRATS: Psychotic Symptom Rating Scale<BR/>REHAB: Rehabilitation Evaluation Hall and Baker<BR/>SANS: Scale for the Assessment of Negative Symptoms<BR/>SAS: Social Activities Scale<BR/>SLOF: Specific Level of Functioning assessment scale<BR/>SOFAS: Social and Occupational Functioning Assessment Scale<BR/>SUMD: Scale of Unawareness of Mental Disorder<BR/>TAU: treatment as usual</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:53:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Armstrong-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:53:35 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: 50% schizophrenia.<BR/>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:53:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beebe-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:53:39 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-06-24 14:42:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Birchwood-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-24 14:42:08 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-06-24 14:42:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buchkremer-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-24 14:42:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups; mainly evaluated therapeutic relatives' group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:42:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carra-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:42:13 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: relatives of people with schizophrenia.</P>
<P>Interventions: multiple group family treatment, does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-06-24 14:46:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cerniglia-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-24 14:46:54 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Collins-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: cognitive behavioural social skills training.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 11:29:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Craig-Thomas-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 11:29:08 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: population includes early psychosis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 12:53:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deng-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 12:53:10 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: chronic schizophrenia (CCMD-3)</P>
<P>Intervention: social skills training vs routine care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 11:29:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dong-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 11:29:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised. </P>
<P>Participants: schizophrenia (CCMD-3), in remission.</P>
<P>Intervention: rehabilitation therapy (mainly social skills training and psycho-education) vs routine care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:42:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Druss-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:42:51 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: &lt;5 0% schizophrenic, mostly bipolar disorder.</P>
<P>Interventions: Health and Recovery Program (HARP), no early warning signs training.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 11:29:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Falloon-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 11:29:27 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:43:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Foster-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:43:10 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: quasi-randomised.</P>
<P>Participants: serious and enduring mental illness, mostly depressive illness, &lt; 50% schizophrenia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:43:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gaebel-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:43:15 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 11:29:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gleeson-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 11:29:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: first episode of a DSM-IV psychotic disorder.</P>
<P>Interventions: early warning signs training versus TAU, which includes some early warning signs training.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:43:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Glick-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:43:34 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 14:14:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Glick-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 14:14:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 14:13:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Glynn-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 14:13:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:56:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldberg-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:56:37 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-11 22:30:50 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gong-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-11 22:30:50 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: Quasi-randomisation (randomised using hospital admission number: odds = intervention group, even = control group).</P>
<P>Participants: schizophrenia (CCMD-3).<BR/>Intervention: Family intervention vs routine care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:58:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grawe-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:58:39 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: population includes early psychosis and this is an exclusion criterion.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 11:40:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gray-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 11:40:41 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 11:40:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guohui-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 11:40:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:56:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hahlweg-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:56:56 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:59:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haut-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:59:05 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: cognitive remediation versus control group skills training (includes relapse prevention skills).</P>
<P>Outcomes: working memory tasks, fMRI.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hayward-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:00 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: do not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Herz-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Herz-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:08 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hogarty-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 14:36:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Horan-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 14:36:04 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised</P>
<P>Participants: schizophrenia, schizoaffective, delusional, disorder or psychosis</P>
<P>Interventions: Social Cognitive Skills Training, does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:59:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hou-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:59:23 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: Patients were randomly assigned according to hospital admission number.</P>
<P>Participants: first onset schizophrenia (CCMD-3) </P>
<P>Intervention: insight and confidence training vs routine care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jolley-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jumnoodoo-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:24 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: ICD-10 criteria were not used for diagnoses and less than 50% of patients had a diagnosis of schizophrenia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:59:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kallert-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:59:40 +0000" MODIFIED_BY="[Empty name]">
<P>Clarification from authors not available, no published papers relevant to the abstract from a conference.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 13:59:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Klosterk_x00f6_tter-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 13:59:48 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: exclusion criteria was schizophrenia.</P>
<P>Interventions: clinical management and aripiprazole combined versus clinical management and placebo; CBT versus clinical management and placebo.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kopelowicz-1998b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:34 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: do not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 12:18:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leavey-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 12:18:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: population includes early psychosis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leclerc-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:44 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-22 16:27:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leff-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-22 16:27:57 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions:do not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leff-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:50 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lenior-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:53 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: Early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 14:00:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liang-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 14:00:28 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Patients: schizophrenia (CCMD-2-R).</P>
<P>Intervention: Psychoeducation vs routine care. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:57:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liberman-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:57:57 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liberman-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:01 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 14:42:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Linden-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 14:42:59 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 14:41:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Linszen-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 14:41:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 14:43:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Linszen-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 14:43:11 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia, recent onset.</P>
<P>Interventions: Early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-14 12:34:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Linszen-1998a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-14 12:34:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia, recent onset.</P>
<P>Interventions: Early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 12:19:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lopez_x002d_Luengo-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 12:19:05 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 12:19:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malm-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 12:19:13 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marder-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marder-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 15:06:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mausbach-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 15:06:01 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 14:46:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McFarlane-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 14:46:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 15:05:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McGill-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 15:05:55 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-22 16:35:20 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Merson-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-22 16:35:20 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: not schizophrenia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Monking-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:27 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Montero-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:29 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-12 10:02:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moxon-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-12 10:02:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomised</P>
<P>Participants: Schizophrenia &amp; family members</P>
<P>Interventions: Psychoeductaion, does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Munroe_x002d_Blum-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:37 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Newton-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:42 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 12:21:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nordentoft-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 12:21:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: population includes early psychosis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Owens-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:47 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 12:26:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Papageorgiou-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 12:26:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: sample not specifically schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:58:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pietzcker-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:58:54 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 12:26:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Power-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 12:26:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: population includes early psychosis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rogers-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:06 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rossotto-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:02 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 14:01:38 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rotondi-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 14:01:38 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: Schizophrenia and family members.</P>
<P>Interventions: web-based tele-health psycho education, includes early warning signs training, but no face-to-face contact.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salzer-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Saren-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schonell-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:23 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: Clarification from authors not available regarding whether early warning signs of recurrence was the focus of intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schooler-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:28 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: schizophrenia.<BR/>Interventions: Early warning signs intervention is used for both control and experimental groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:31 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 14:22:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-So-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 14:22:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: carers of people with first episode psychoses (schizophrenia, schizoaffective or schizophreniform disorder).</P>
<P>Interventions: family psycho-education, relapse prevention only included as one third of a 1.5 hour session.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tamaras-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 14:02:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsang-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 14:02:05 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-12 10:09:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Der-Krieke-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-12 10:09:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Velligan-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:45 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 08:59:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wallace-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 08:59:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Participants: schizophrenia.</P>
<P>Interventions: does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 16:52:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wei-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 16:52:29 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Quasi-randomisation. Randomised according to hospital admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-15 12:45:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Woods-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-15 12:45:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: population includes early psychosis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 16:37:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-_x675c__x82b3_-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 16:37:04 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: quasi-randomisation. Randomised according to hospital admission order.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-_x738b__x8389_-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Patients: schizophrenia (CCMD-3), male patients only.</P>
<P>Intervention: self-management education vs routine care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 16:50:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-_x8bb8__x7389__x82b3_-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 16:50:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Patients: schizophrenia (CCMD-3)</P>
<P>Intervention: comprehensive skills training vs routine care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 16:37:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-_x8bb8__x7389__x82b3_-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 16:37:09 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Patients: Schizophrenia.</P>
<P>Intervention: comprehensive skills training vs routine care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CBT: cognitive behavioural therapy<BR/>CCMD-3: Chinese Classification of Mental Disorders Version 3<BR/>DSM-IV: Diagnostic and Statistical Manual of Mental Disorders Version 4<BR/>HARP: Health and Recovery Program<BR/>fMRI: Functional magnetic resonance imaging <BR/>ICD: International Classification of Diseases<BR/>TAU: treatment as usual<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-07-15 14:28:02 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2012-12-11 22:30:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Farhall-2001">
<CHAR_STUDY_NAME MODIFIED="2012-07-15 13:26:34 +0100" MODIFIED_BY="[Empty name]">
<P>Applicability of Cognitive Behavior Therapy to Unselected Mental Health Service Clients With Psychotic Disorders</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-11-07 21:11:00 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomised.</P>
<P>Duration: 12 to 24 sessions over a maximum of 12 month period.</P>
<P>Setting: Community mental health services - unspecified.</P>
<P>Country: Australia</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:53 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: A preliminary DSM-IV diagnosis of schizophrenia, schizoaffective disorder, mood disorder with psychotic features, or delusional disorder.</P>
<P>N = target 94.</P>
<P>Age: not stated.</P>
<P>History: A recovery "need" in one of the areas addressed by the therapy elements (below)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-15 13:33:31 +0100" MODIFIED_BY="[Empty name]">
<P>1. Recovery therapy: A variant of CBT. Implementation, as needed by the client, of one or more of the following elements: i) introduction or enhancement of techniques for better coping with persisting positive symptoms ii) adoption of a more adaptive explanatory model of their disorder by clients iii) strengthening of positive beliefs of self within a reality framework iv) implementation of practical strategies for relapse prevention, v) progress in resolution of personal/emotional issues impeding adaptation.</P>
<P>2. Standard case management.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-15 13:33:56 +0100" MODIFIED_BY="[Empty name]">
<P>Mental state: PANSS </P>
<P>Readmissions, </P>
<P>Insight, </P>
<P>Depression. </P>
<P>Uptake and effectiveness of Recovery therapy- dropout rates,</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-07-15 13:35:18 +0100" MODIFIED_BY="[Empty name]">
<P>1/06/2001<BR/>
</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-15 13:26:35 +0100" MODIFIED_BY="[Empty name]">
<P>Mr John Farhall<BR/>Address: Academic Unit Whittlesea Community Mental Health<BR/>Service c/o The Northern Hospital 185 Cooper Street<BR/>Epping VIC 3076<BR/>Country: Australia<BR/>Tel: +61 3 94098779<BR/>Fax: +61 3 94089508<BR/>Email: john.farhall@mh.org.au</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-07-15 13:35:25 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2012-12-11 22:30:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jones-2012">
<CHAR_STUDY_NAME MODIFIED="2012-07-15 13:35:32 +0100" MODIFIED_BY="[Empty name]">
<P>Investigation into the efficacy of cognitive training on cognition in adults with schizophrenia.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-07-15 13:36:01 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: not reported.</P>
<P>Duration: not reported.</P>
<P>Setting: Multi-centre.</P>
<P>Country: England</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:56 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: Schizophrenia DSM-IV</P>
<P>N = 75</P>
<P>Age: not reported.</P>
<P>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-15 13:36:16 +0100" MODIFIED_BY="[Empty name]">
<P>Cognitive training</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-15 13:37:03 +0100" MODIFIED_BY="[Empty name]">
<P>Cognition</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-07-15 13:37:08 +0100" MODIFIED_BY="[Empty name]">
<P>Not reported.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-15 13:37:10 +0100" MODIFIED_BY="[Empty name]">
<P>Ms Jennifer Cook<BR/>University of Cambridge<BR/>Psychiatry<BR/>Herchel Smith Building<BR/>Robinson Way<BR/>Cambridge<BR/>Cambridgeshire</P>
<P>CB2 0SZ<BR/>UNITED KINGDOM<BR/>Tel: 07793386431<BR/>jc746@cam.ac.uk</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-07-15 13:37:13 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00046085">
<CHAR_STUDY_NAME MODIFIED="2012-07-15 13:37:35 +0100" MODIFIED_BY="[Empty name]">
<P>Online Family Support and Education for Schizophrenia.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-07-15 13:38:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomised.</P>
<P>Duration: 18 months</P>
<P>Setting: not reported.</P>
<P>Country: United States, California</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:30:58 +0000" MODIFIED_BY="[Empty name]">
<P>Relatives of patients with schizophrenia.</P>
<P>Diagnosis: DSM-IV diagnosis of schizophrenia or schizoaffective disorder.<BR/>
</P>
<P>N = 72.</P>
<P>Age: 18-60.</P>
<P>History: Stable antipsychotic medication regimen for at least 1 month.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-30 14:34:37 +0100" MODIFIED_BY="[Empty name]">
<P>Family Psychoeducational Program: Relatives of patients with schizophrenia receive 18 months of customary care with access to the educational website for the first year. Families are provided with private, secure access to the website, which features family-to-family chat capabilities, video lectures on the management of schizophrenia, written materials on important issues in schizophrenia management, professionally facilitated online discussions of the material, and additional resource links.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<P>Relatives:</P>
<P>Perception of the patient's symptoms</P>
<P>Knowledge of the illness</P>
<P>Illness's impact on the family member</P>
<P>Perception of the website intervention</P>
<P>Patients with schizophrenia or schizoaffective disorder:<BR/>Symptoms</P>
<P>Medication compliance<BR/>Side effects</P>
<P>Hospitalisations</P>
<P>Social functioning</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-07-15 13:27:06 +0100" MODIFIED_BY="[Empty name]">
<P>March 2001</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-15 13:27:06 +0100" MODIFIED_BY="[Empty name]">
<P>National Institute of Mental Health (NIMH)<BR/>ClinicalTrials.gov Identifier: NCT00046085<BR/>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-07-15 13:41:12 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2012-12-11 22:31:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00069433">
<CHAR_STUDY_NAME MODIFIED="2012-07-15 13:27:15 +0100" MODIFIED_BY="[Empty name]">
<P>Enhancing the Outcome of Skills Training for People With Schizophrenia</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-07-30 14:33:43 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomised.</P>
<P>Duration: 12 months.</P>
<P>Setting: not reported.</P>
<P>Country: United States.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:31:03 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia or schizoaffective disorder for &gt; 5 years.</P>
<P>N = 60.</P>
<P>Age: 18 = 55.</P>
<P>History: Use of stable dose risperidone, olanzapine, or quetiapine for at least 1 month with no planned medication changes; social Behavior Scale (SBS) score &gt; 45</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-15 13:27:15 +0100" MODIFIED_BY="[Empty name]">
<P>Social skills and symptom management training</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-15 13:42:14 +0100" MODIFIED_BY="[Empty name]">
<P>Not reported.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-07-15 13:42:17 +0100" MODIFIED_BY="[Empty name]">
<P>Not reported.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-15 13:27:15 +0100" MODIFIED_BY="[Empty name]">
<P>
<A HREF="http://clinicaltrials.gov/ct2/show/NCT00069433">NCT00069433</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-07-15 13:42:20 +0100" MODIFIED_BY="[Empty name]">
<P>Trial suspended. http://clinicaltrials.gov/ct2/show/NCT00069433</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00169052">
<CHAR_STUDY_NAME MODIFIED="2012-07-30 14:28:01 +0100" MODIFIED_BY="[Empty name]">
<P>Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-07-30 14:33:53 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Duration: not reported.</P>
<P>Setting: community.</P>
<P>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:31:05 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia,schizoaffective disorder,bipolar disorder, major depression with functional impairment.</P>
<P>N = 180.</P>
<P>Age: over 50 years.</P>
<P>History: older persons with serious mental illness.</P>
<P>Sex: female.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-30 14:34:53 +0100" MODIFIED_BY="[Empty name]">
<P>Health management (HM) and supported rehabilitation (SR) intervention (by nurses who monitor and facilitate routine preventive and acute health care) versus usual care.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]">
<P>Independent living skills.</P>
<P>Social skills.</P>
<P>Health behaviour skills.<BR/>Preventive health care.<BR/>
</P>
<P>Acute emergency, hospitalisation and long-term institution-based care.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-07-30 14:28:01 +0100" MODIFIED_BY="[Empty name]">
<P>September 2001</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-30 14:36:19 +0100" MODIFIED_BY="[Empty name]">
<P>Principal Investigator: Stephen J Bartels, MD Dartmouth. </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-07-30 14:36:17 +0100" MODIFIED_BY="[Empty name]">
<P>ClinicalTrials.gov identifier: NCT00169052</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00435721">
<CHAR_STUDY_NAME MODIFIED="2012-07-30 14:40:25 +0100" MODIFIED_BY="[Empty name]">
<P>The Families Coping With Mental Illness Program.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-07-30 14:40:11 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.</P>
<P>Duration: not reported.</P>
<P>Setting: not reported.</P>
<P>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:31:08 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: Self identified family members of individuals with schizophrenia or schizoaffective disorder or psychosis NOS</P>
<P>N = 50.</P>
<P>Age: 18 years and over.</P>
<P>History: not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-30 14:40:47 +0100" MODIFIED_BY="[Empty name]">
<P>Practical, short-term support and education program for relatives of individuals with schizophrenia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-30 14:41:23 +0100" MODIFIED_BY="[Empty name]">
<P>Family knowledge.</P>
<P>Family Burden.</P>
<P>Expressed emotion.</P>
<P>Social Support.<BR/>Coping Strategies.<BR/>Confidence in knowledge.<BR/>Use of community resources.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-07-30 14:41:29 +0100" MODIFIED_BY="[Empty name]">
<P>June 2002</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-30 14:42:12 +0100" MODIFIED_BY="[Empty name]">
<P>Principal Investigator: Michelle S. Friedman-Yakoobian, Ph.D, Massachusetts General Hospital, Beth Israel Deaconess Medical Center.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]">
<P>Protocol<BR/>Allocation: randomised.</P>
<P>Participants: relatives of individuals with schizophrenia or schizoaffective disorder.</P>
<P>Interventions: behavioural psycho-education, does not include education to increase awareness of early signs of recurrence.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2012-12-11 22:31:11 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00515671">
<CHAR_STUDY_NAME MODIFIED="2012-07-15 13:42:27 +0100" MODIFIED_BY="[Empty name]">
<P>Illness Management and Recovery for Veterans With Severe Mental Illness</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-07-15 13:43:00 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomised.</P>
<P>Duration:18 months (nine months course, follow-up at 18 months).</P>
<P>Setting: Day Treatment Program of Roudebush Veterans affairs.</P>
<P>Country: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-12-11 22:31:11 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: SCID-confirmed diagnosis of schizophrenia or schizoaffective disorder.<BR/>
</P>
<P>N = 200.</P>
<P>Age: 18 and older.</P>
<P>History: Currently receiving (or newly admitted to) mental health services from the Day Treatment Program of Roudebush Veterans affairs.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-15 13:43:36 +0100" MODIFIED_BY="[Empty name]">
<P>Illness Management and Recovery Training</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-15 13:44:18 +0100" MODIFIED_BY="[Empty name]">
<P>Illness Management Ratings</P>
<P>Patient Activation</P>
<P>Functioning Level,<BR/>Perceived Recovery<BR/>Psychiatric symptoms</P>
<P>Substance abuse</P>
<P>Hope</P>
<P>Employment<BR/>Independent living</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-07-15 13:27:31 +0100" MODIFIED_BY="[Empty name]">
<P>May 2008</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-15 13:27:31 +0100" MODIFIED_BY="[Empty name]">
<P>ClinicalTrials.gov identifier: NCT00515671<BR/>
<BR/>Contact: Michelle P Salyers, MS PhD<BR/>(317) 988-4419<BR/>mpsalyer@iupui.edu<BR/>Contact: Gretchen Ricketts<BR/>(317) 988-2802<BR/>grickett@iupui.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-07-15 13:44:20 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 12:42:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Anzai-2002">
<DESCRIPTION>
<P>"Randomised" no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 13:27:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bauml-2007">
<DESCRIPTION>
<P>Block randomisation of 8 to 12 patients, "the randomisation list for each study centre was generated by a computerised random sampling in the study evaluation centre".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 13:40:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-2006">
<DESCRIPTION>
<P>"randomised" - participants divided into English speaking and Vietnamese speaking, randomly allocated within their group by drawing names form a canister.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:33:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buchkremer-1997">
<DESCRIPTION>
<P>"randomised" - initial homogeneity of the groups was ensured by applying a randomisation technique in which the prognostic factors of sex, Strauss-Carpenter prognosis score and medication compliance were balanced by preliminary matching; then randomly assigned to one of five groups with an allocation ratio of 1:1:1:1:2.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 08:34:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>"Randomly assigned", no further details reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 08:19:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2003">
<DESCRIPTION>
<P>Randomised using draw lots.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chien-2004">
<DESCRIPTION>
<P>"Randomised" - computer-generated random numbers table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 10:25:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drury-1996">
<DESCRIPTION>
<P>"randomised" - no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 13:12:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garety-2008">
<DESCRIPTION>
<P>"Randomisation schedules were independently generated by a trial randomisation service in a separate location from all trial centres using randomised permuted blocks"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 12:39:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Granholm-2005">
<DESCRIPTION>
<P>"randomised" - sequential list of random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 12:57:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gumley-2003">
<DESCRIPTION>
<P>"Patient randomised according to predetermined envelopes containing the treatment group, devised by researcher, which was unbeknown to the assessors, therapist or participants".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-18 07:51:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Harris-2009">
<DESCRIPTION>
<P>"Service users were randomly selected from each CMHP&#8217;s sample frame to form their &#8216;study caseload&#8217; before CMHPs were randomised to either the training programme or training waiting list." Does not report method of randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 14:38:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Herz-2000">
<DESCRIPTION>
<P>"randomised" - computer-generated cards.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 12:30:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hogarty-1997a">
<DESCRIPTION>
<P>"randomised" - no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-12 09:29:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Horan-2009">
<DESCRIPTION>
<P>"randomly assigned", no further information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:21:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-1998a">
<DESCRIPTION>
<P>"Randomised" -no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-23 17:05:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-2003">
<DESCRIPTION>
<P>"randomised" -no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 13:31:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kuipers-1997">
<DESCRIPTION>
<P>Randomised permuted blocking, block size of six.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-11 17:34:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>"Random assignment", no further details reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-13 13:55:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liberman-1998">
<DESCRIPTION>
<P>Randomised "Cohorts of 10&#8211;12 outpatients with persistent and unremitting forms of schizophrenia were entered into the study through a randomization procedure".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:09:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McDonell-2006">
<DESCRIPTION>
<P>Randomisation of participants conducted by (1) separating participants on the basis of 'atypical v conventional medication at status; (2) assigning a number and (3) pulling a piece of paper with the number from a hat giving a 50% chance of being in either group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 12:46:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Merinder-1999">
<DESCRIPTION>
<P>Patients were block randomised, stratified for gender and for illness duration.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Norman-2002">
<DESCRIPTION>
<P>Participants were randomly assigned within matching by gender and number of previous hospitalisations, no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:53:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shin-2002">
<DESCRIPTION>
<P>"randomised" - no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:23:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shon-2002">
<DESCRIPTION>
<P>"Randomised" - no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:19:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tait-2002">
<DESCRIPTION>
<P>"Randomised" - no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:34:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turkington-2006">
<DESCRIPTION>
<P>Randomisation conducted by computer-generated blocks of 6 random numbers and stratified by site.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:41:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Meijel-2006">
<DESCRIPTION>
<P>Randomisation of nurses (therapists) and patients, nurses were divided at random per department between experimental and treatment conditions. A researcher determined at random the order in which the patients would be approached for participation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 09:22:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vreeland-2006">
<DESCRIPTION>
<P>Randomisation of participants based on a table of random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 09:35:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weng-2005">
<DESCRIPTION>
<P>"Randomly assigned" - no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 09:47:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiang-2001">
<DESCRIPTION>
<P>Randomised using random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 10:04:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiong-1994">
<DESCRIPTION>
<P>"Randomly assigned" - no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:17:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhan-2003">
<DESCRIPTION>
<P>Randomised by a tossing a coin.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 11:02:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2004">
<DESCRIPTION>
<P>Randomised using random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 12:43:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Anzai-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 13:27:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bauml-2007">
<DESCRIPTION>
<P>"The study centres could learn to which treatment condition the group was assigned via telephone".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:18:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-2006">
<DESCRIPTION>
<P>"A staff member drew names from a canister and without looking at the names, assigned them to experimental and control groups".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:33:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buchkremer-1997">
<DESCRIPTION>
<P>"Randomisation was carried out by an independent institution".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 08:34:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 08:19:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2003">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 10:17:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chien-2004">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 10:28:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drury-1996">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 13:12:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garety-2008">
<DESCRIPTION>
<P>Central randomisation "Randomisation schedules were independently generated by a trial randomisation service"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:20:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Granholm-2005">
<DESCRIPTION>
<P>"The project coordinator assigned participants to treatments in the order that they consented, and the coordinator was the only staff person other than therapists with knowledge of group membership".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-16 09:14:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gumley-2003">
<DESCRIPTION>
<P>"A member of the research team opened an envelope that informed as to which group individual participants were to be allocated. Another member of the team witnessed this procedure, and the envelope was placed in the participant's case file".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-18 07:53:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Harris-2009">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 15:12:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Herz-2000">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 12:35:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hogarty-1997a">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-12 09:29:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Horan-2009">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 12:51:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-1998a">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 13:20:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-2003">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-13 14:50:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kuipers-1997">
<DESCRIPTION>
<P>Carried out by the trial statistician.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-11 17:54:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>No details reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-13 13:52:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liberman-1998">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:09:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McDonell-2006">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:30:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Merinder-1999">
<DESCRIPTION>
<P>Randomisation by an independent institution, no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:46:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Norman-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:54:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shin-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 15:04:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shon-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 15:17:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tait-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:34:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turkington-2006">
<DESCRIPTION>
<P>Results of the randomisation placed in sealed envelopes and only opened at the time of treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:41:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Meijel-2006">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vreeland-2006">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 09:35:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weng-2005">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 09:47:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiang-2001">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 10:05:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiong-1994">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 10:28:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhan-2003">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 11:02:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2004">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:04:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Anzai-2002">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:04:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bauml-2007">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:04:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-2006">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:04:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buchkremer-1997">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:04:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:04:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2003">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chien-2004">
<DESCRIPTION>
<P>Clinic staff were blinded, blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:05:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Drury-1996">
<DESCRIPTION>
<P>"Prescribing clinicians were blind to group allocation", blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:06:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garety-2008">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:07:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Granholm-2005">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:07:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gumley-2003">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:07:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Harris-2009">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:07:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Herz-2000">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:07:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hogarty-1997a">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:07:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Horan-2009">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:07:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kopelowicz-1998a">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:08:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kopelowicz-2003">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:08:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kuipers-1997">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:08:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-09-13 13:12:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liberman-1998">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:09:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McDonell-2006">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:09:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Merinder-1999">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Norman-2002">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shin-2002">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shon-2002">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tait-2002">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turkington-2006">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Meijel-2006">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vreeland-2006">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:10:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weng-2005">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:11:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiang-2001">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:11:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiong-1994">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:11:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhan-2003">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-23 13:11:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2004">
<DESCRIPTION>
<P>Blinding of participants and personnel was not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-03 12:43:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Anzai-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-03 13:22:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bauml-2007">
<DESCRIPTION>
<P>"The treating study psychiatrists were blind to the randomisation".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-03 13:53:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-2006">
<DESCRIPTION>
<P>"Independent researchers, who were blind to study condition, conducted assessments".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buchkremer-1997">
<DESCRIPTION>
<P>For the outcome re-hospitalisation there was blinding: "Where necessary, rehospitalisation data were obtained directly from the pertaining psychiatric institutions with the consent of the patient. As the project staff had no influence on the re-hospitalisation decision, this is an independent outcome criterion. Referral to hospital was accordingly 'blind' with respect to allocation to one treatment condition".</P>
<P>Other outcome measurements were not blind: "data were recorded by trained project staff who were not blind with respect to the group to which the patients were assigned".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-06-25 08:36:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-23 13:05:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2003">
<DESCRIPTION>
<P>"Double blind." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-10 13:05:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chien-2004">
<DESCRIPTION>
<P>"An independent trained assessor (research assistant) undertook measurements at baseline (Time 1), 6 months (Time 2) and 18 months (Time 3), using a set of questionnaires. Both assessor and clinic staff were masked to treatment allocation".<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-04 10:26:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drury-1996">
<DESCRIPTION>
<P>"All patients were rated by the first author and a random subset of patients were blindly rated by MB and JFM".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-23 13:06:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garety-2008">
<DESCRIPTION>
<P>"Trial research assessors were independent of treatment delivery and every effort was made to ensure they were kept masked to allocation" "Patients were reminded by the assessors not to talk about treatment allocation". "The primary outcome variable, relapse, was assessed by masked panel evaluation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Granholm-2005">
<DESCRIPTION>
<P>The assessors were blinded to treatment group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-04 13:12:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gumley-2003">
<DESCRIPTION>
<P>"Two research nurses, who were not blind to the treatment allocation of participants, conducted follow-up assessments". </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-18 07:47:03 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Harris-2009">
<DESCRIPTION>
<P>&#8220;There was no &#8216;blind&#8217; assessment of service user level outcomes.&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-04 15:15:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Herz-2000">
<DESCRIPTION>
<P>"Assessments were done by research interviewers who were master's-level mental health professionals, blinded as to patient group assignment, not associated with clinical care and instructed not to inquire about a patient's treatment during interviews".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-06 12:39:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hogarty-1997a">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-12 09:29:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Horan-2009">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-06 13:02:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-1998a">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-23 13:08:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kopelowicz-2003">
<DESCRIPTION>
<P>"All of the raters were blind to the treatment condition of the patients and relatives", "to ensure blindness the raters were instructed to remind patients and relative subjects at each visit to not disclose what kinds if treatment they were receiving".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-23 13:18:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuipers-1997">
<DESCRIPTION>
<P>"In a trial of psychological treatment it is extremely difficult to make assessments that are totally blind to the treatment condition and this was not attempted. However, all assessments were carried out by independent research workers who were not involved in the treatments".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-11 17:54:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>No details reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-09-16 08:44:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liberman-1998">
<DESCRIPTION>
<P>Blinding of outcome assessors "psychiatrists were blind to the psychosocial treatment assignment", "Blindness of the assessors was promoted by geographically distancing the treatment program from the locales for pharmacotherapy and ratings of outcome and by repeatedly instructing the subjects to refrain from mentioning their psychosocial treatment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-06 14:09:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McDonell-2006">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-06 14:30:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Merinder-1999">
<DESCRIPTION>
<P>"The ratings of psychopathology and psychosocial function were performed by researchers not involved in the intervention and not informed of the treatment allocation".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-06 14:48:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Norman-2002">
<DESCRIPTION>
<P>Data was collected by psychiatrists who "were not responsible for the clinical care of the relevant clients and were kept blind as to the assignment of clients to the stress management or social activities conditions".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-07 08:23:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shin-2002">
<DESCRIPTION>
<P>"The BPRS was completed before and after the intervention in Korean by a bilingual Korean psychiatrist, who was blinded to participants' treatment modality [...] the other scales were verbally presented to the study participants by the first author in Korean and self-report answers were written down by the participants".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-06 15:04:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shon-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-06 15:18:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tait-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-07 08:37:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turkington-2006">
<DESCRIPTION>
<P>Raters were independent. Patients were "asked not to reveal or even hint at their treatment allocation to the raters. Raters were informed that some study material would be left with TAU patients to help preserve the blindness of the ratings".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-07 11:41:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Meijel-2006">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-10 09:24:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vreeland-2006">
<DESCRIPTION>
<P>"Trained raters who were blind to the study group assignment conducted interviews with participants to complete outcome measures at baseline, eight weeks and 24 weeks".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-10 13:14:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weng-2005">
<DESCRIPTION>
<P>"Double-blind assessments", no further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-17 09:47:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiang-2001">
<DESCRIPTION>
<P>Assessor blind.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-10 13:14:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiong-1994">
<DESCRIPTION>
<P>"As in all family intervention studies, there was some difficulty in maintaining blinding [...] this problem by instructing families not to state who had provided treatment and by ensuring that the evaluators were unaware of the purpose of the study".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-17 10:29:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhan-2003">
<DESCRIPTION>
<P>Assessor blind.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-17 11:02:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2004">
<DESCRIPTION>
<P>Assessor blind.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-06-25 08:36:00 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:49:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Anzai-2002">
<DESCRIPTION>
<P>"Before training started, two participants in the training group and one in the control group were discharged from the hospital. These patients were not included in calculations of the discharge rates". No further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:55:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bauml-2007">
<DESCRIPTION>
<P>Nineteen patients excluded prior to index discharge and 34 patients dropped out during the 7-year follow-up. Missing patients were not included in the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:55:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-2006">
<DESCRIPTION>
<P>"Nine pairs did not complete the data collection procedure after treatment or at 18 months (four in the control group and five in the treatment group". Missing patients were not included in the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-07 11:15:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buchkremer-1997">
<DESCRIPTION>
<P>"In a modified intention-to-treat approach all patients who had attended at least one group session were included in the main analysis"; "44 patients who were re-hospitalised or dropped out for other reasons during the period between randomization and the start of group treatment (2 to 6 months) had to be excluded. However, these patients were followed up as completely as possible."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-25 08:54:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Number of patients randomised not reported. Data reported on treatment completers only.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-23 13:16:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2003">
<DESCRIPTION>
<P>One person dropped out of the control group due to myocardial infarction. The reason for this is unlikely to be related to the true outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-04 10:09:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chien-2004">
<DESCRIPTION>
<P>Analysis of data was on an intention-to-treat basis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-04 10:39:46 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Drury-1996">
<DESCRIPTION>
<P>22 patients were excluded after randomisation and not included in the final analyses.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-12-12 14:33:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garety-2008">
<DESCRIPTION>
<P>96% followed up for primary outcome data, secondary outcome data were available for 82% of the total sample at 12 months and for 80% at 24 months. No reasons for losses reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-04 12:43:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Granholm-2005">
<DESCRIPTION>
<P>"Intent-to-treat analyses were used to examine all outcome variables".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-04 13:13:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gumley-2003">
<DESCRIPTION>
<P>All data analysed on an intention-to-treat basis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-12-12 14:37:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Harris-2009">
<DESCRIPTION>
<P>6 CMHPs withdrew from the study, 3 that had been randomised to the intervention and 3 randomised to the control group. "34 [service users] withdrew from the study and 12 were lost to follow-up"; 16 from the intervention group and 30 from the control group.</P>
<P>Intention-to-treat analysis used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-04 15:26:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Herz-2000">
<DESCRIPTION>
<P>The study did not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:49:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hogarty-1997a">
<DESCRIPTION>
<P>Not intention-to-treat: "Since missing data were relatively few and not different among treatment conditions, only the data collected were analysed."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:50:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Horan-2009">
<DESCRIPTION>
<P>Three participants out of 34 dropped out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:50:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-1998a">
<DESCRIPTION>
<P>Data reported on treatment completers only.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:50:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-2003">
<DESCRIPTION>
<P>"Baseline comparisons were conducted with all 92 subjects who were randomised, but all subsequent analyses included only those subjects who were assessed at all three time points".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:53:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuipers-1997">
<DESCRIPTION>
<P>'Decision to treat' analysis using the standard 'carry forward' method to impute missing values reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>There were 10 dropouts in the experimental group and 22 dropouts in the control group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-07 11:15:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liberman-1998">
<DESCRIPTION>
<P>Total included participants for each group was not clearly reported. "Attrition was minimal; only 14 of 84 subjects dropped out during the 2-year period (four in the control group and 10 in the social skills training group; x<SUP>2</SUP> = 2.44, df = 1, P = 0.12). Almost all of the dropouts were accounted for by individuals moving to new geographical areas of the state or country and becoming unavailable for assessments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-06 14:11:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McDonell-2006">
<DESCRIPTION>
<P>Data analysed on an intention-to-treat basis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-06 14:39:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Merinder-1999">
<DESCRIPTION>
<P>Data analyses on an intention-to-treat basis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:53:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Norman-2002">
<DESCRIPTION>
<P>"Nine clients were lost to follow-up (five did not complete the intervention and four were unavailable for 1 year post-test assessments), leaving a net sample of 121 clients, 60 of whom were assigned to the stress management condition and 61 to the social activities. Because of sporadic instances of missing data, analyses are based on sample sizes varying between 112 and 121".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shin-2002">
<DESCRIPTION>
<P>All patients accounted for.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-07 08:26:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shon-2002">
<DESCRIPTION>
<P>The study does not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-07 08:19:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tait-2002">
<DESCRIPTION>
<P>"The mean postal response rate of ESM questionnaires [...] is 83%". No further details provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-07 08:39:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Turkington-2006">
<DESCRIPTION>
<P>Data analysed on an intention-to-treat basis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-12-11 22:29:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Meijel-2006">
<DESCRIPTION>
<P>"11 patients dropped out from the experimental group and 2 from the control group. The reasons for dropping out of the experimental group were: premature discharge (n = 1); stress caused by preparing the relapse prevention plan (n = 2); psychotic relapse (n = 1); lack of motivation to prepare the relapse prevention plan (n = 5); and lack of time of the nurses (n = 2). The reason for dropping out of the control group was completion of the treatment (n = 2).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-10 13:13:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vreeland-2006">
<DESCRIPTION>
<P>Three participants were not included in the final analysis "because of missing data for the primary outcomes at time 1".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:54:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weng-2005">
<DESCRIPTION>
<P>"61 patients in each group were successfully followed up one year after discharge", no further details about participants lost to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-17 10:00:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiang-2001">
<DESCRIPTION>
<P>2 people in the intervention group left the study early and 3 in the control group. Incomplete outcome data was excluded from the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-04-10 13:14:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiong-1994">
<DESCRIPTION>
<P>One patient from the experimental group and one patient in the control group committed suicide. One patient form the experimental group died from complications of inadequately treated diabetes. "These deaths were treated as relapses in the analysis". "Non-compliance does not confound the results because all subjects are included in the analysis". </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-17 10:29:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhan-2003">
<DESCRIPTION>
<P>No incomplete outcome data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-24 14:55:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2004">
<DESCRIPTION>
<P>16 people left the study early, 6 from the intervention group and 10 from the control group. Incomplete outcome data were excluded from the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-09-20 08:02:58 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:58:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Anzai-2002">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:58:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bauml-2007">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:58:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-2006">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:58:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buchkremer-1997">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 08:36:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 08:21:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2003">
<DESCRIPTION>
<P>All measured outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 10:17:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chien-2004">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 10:31:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Drury-1996">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 13:38:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garety-2008">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 12:41:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Granholm-2005">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 13:16:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gumley-2003">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-18 07:53:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Harris-2009">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 15:28:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Herz-2000">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:16:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hogarty-1997a">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-12 09:39:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Horan-2009">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 13:03:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kopelowicz-1998a">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 13:23:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kopelowicz-2003">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 13:41:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kuipers-1997">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:09:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>Number of participants for the outcome burden of care (FAS) not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-20 08:02:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liberman-1998">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:11:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McDonell-2006">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:39:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Merinder-1999">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:49:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Norman-2002">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 15:01:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shin-2002">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 15:11:29 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shon-2002">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:19:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tait-2002">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Turkington-2006">
<DESCRIPTION>
<P>Not all expected outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:45:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Meijel-2006">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 09:26:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vreeland-2006">
<DESCRIPTION>
<P>Not all expected outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 09:39:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weng-2005">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:17:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiang-2001">
<DESCRIPTION>
<P>Insufficient information to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 12:23:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiong-1994">
<DESCRIPTION>
<P>All stated outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 10:29:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhan-2003">
<DESCRIPTION>
<P>All measured outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 11:02:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2004">
<DESCRIPTION>
<P>All measured outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 12:43:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Anzai-2002">
<DESCRIPTION>
<P>Small sample size. Protocol not available. Source of funding not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 13:26:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bauml-2007">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-03 14:04:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-2006">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 09:44:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buchkremer-1997">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 08:36:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2007">
<DESCRIPTION>
<P>Protocol not available. Source of funding not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 08:21:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2003">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 10:17:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chien-2004">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 10:33:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drury-1996">
<DESCRIPTION>
<P>Small sample size. Protocol not available. Source of funding not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 14:33:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garety-2008">
<DESCRIPTION>
<P>Protocol pre-published (ISRCTN83557988). Source of funding: Wellcome Trust.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 12:46:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Granholm-2005">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 13:16:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gumley-2003">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-18 07:53:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Harris-2009">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-04 15:36:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Herz-2000">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 12:39:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hogarty-1997a">
<DESCRIPTION>
<P>Protocol not available. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-12 09:29:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Horan-2009">
<DESCRIPTION>
<P>Protocol not available. Source of funding:  US Mental Illness Research, Eduation and Clinical Center.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:22:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-1998a">
<DESCRIPTION>
<P>Protocol not available. Source of funding not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 13:27:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kopelowicz-2003">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 13:44:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kuipers-1997">
<DESCRIPTION>
<P>Protocol not available. Charitable donation from Janssen Pharmaceutica.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-22 15:23:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-13 13:02:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liberman-1998">
<DESCRIPTION>
<P>Funded by Department of Veterans Affairs and NIMH.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:12:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McDonell-2006">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:41:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Merinder-1999">
<DESCRIPTION>
<P>Protocol not available. Part funded by Lunbeck A/S, Denmark.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 14:49:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Norman-2002">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 15:02:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shin-2002">
<DESCRIPTION>
<P>Protocol not available. Source of funding not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 15:11:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shon-2002">
<DESCRIPTION>
<P>Protocol not available. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-06 15:39:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tait-2002">
<DESCRIPTION>
<P>Small sample size. Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 08:44:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Turkington-2006">
<DESCRIPTION>
<P>Protocol not available. Trial funded by a research grant from Pfizer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:46:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Van-Meijel-2006">
<DESCRIPTION>
<P>Protocol not available. Financial support in part from Eli Lilly The Netherlands.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 09:33:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vreeland-2006">
<DESCRIPTION>
<P>Protocol not available. Funded in part by Eli Lily and Company.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-07 11:15:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weng-2005">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 09:48:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Xiang-2001">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-10 12:32:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Xiong-1994">
<DESCRIPTION>
<P>Protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 10:29:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhan-2003">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-17 11:03:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2004">
<DESCRIPTION>
<P>None obvious.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2012-08-30 11:26:23 +0100" MODIFIED_BY="Grade Profiler">Early warning signs training and treatment as usual compared to treatment as usual for schizophrenia</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Early warning signs training and treatment as usual compared to treatment as usual for schizophrenia</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with schizophrenia<BR/>
<B>Settings:</B> secondary care<BR/>
<B>Intervention:</B> Early warning signs training and treatment as usual<BR/>
<B>Comparison: </B>treatment as usual</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Treatment as usual</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Early warning signs training and treatment as usual</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Relapse: Rate of relapse</B>
<BR/>Follow-up: 3 to 36 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>432 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>229 per 1000</B>
<BR/>(155 to 341)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.53 </B>
<BR/>(0.36 to 0.79)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1502<BR/>(15 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1, 2,3 </SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Relapse: Time to relapse</B>
<BR/>Follow-up: 12 to 18 months</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>
<B>HR 0.53 </B>
<BR/>(0.27 to 1.06)</P>
</TD>
<TD>
<P>550<BR/>(6 studies)</P>
</TD>
<TD>
<P>&#8853;&#8861;&#8861;&#8861;</P>
<P>
<B>very low</B>
<SUP>2, 3, 4</SUP>
</P>
</TD>
<TD>
<P>The data were added to the meta-analysis as generic inverse variance.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Service use: Rate of re-hospitalisation</B>
<BR/>Follow-up: 2 to 36 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>385 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>185 per 1000</B>
<BR/>(135 to 254)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.48 </B>
<BR/>(0.35 to 0.66)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1457<BR/>(15 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2, 6, 7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Service use: Time to re-hospitalisation</B>
<BR/>Follow-up: 12 to 24 months</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>
<B>HR 0.58 </B>
<BR/>(0.33 to 1.04)</P>
</TD>
<TD>
<P>1149<BR/>(6 studies)</P>
</TD>
<TD>
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2, 3, 5</SUP>
</P>
</TD>
<TD>
<P>The data were added to the meta-analysis as generic inverse variance.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Satisfaction with care</B>
<BR/>Follow-up: 24 weeks to 12 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>8, 9</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2 RCTs (92 participants) and 1 cluster RCT (56 clusters) report on satisfaction with care.<SUP>10</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Adverse events: Lost to follow-up</B>
<BR/>Follow-up: 10 weeks to 24 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>105 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>101 per 1000</B>
<BR/>(76 to 134)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.96 </B>
<BR/>(0.72 to 1.28)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1495<BR/>(17 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>3, 7, 11 ,16</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Economic burden (cost of care)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>129<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>12, 13, 14</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Two studies report on costs of care, but data could not be pooled.<SUP>15</SUP>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; <B>HR:</B> Hazard ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Eight studies had an unclear risk of bias for sequence generation and 13 for allocation concealment. One study did not use assessors that were blinded and in seven it was unclear. Eight studies had an unclear risk of bias for attrition and two studies had received funding from industry.</P>
<P>
<SUP>2</SUP>There was high heterogeneity in the pooled results.</P>
<P>
<SUP>3</SUP>The 95% confidence intervals are wide and include both significant benefit and harm of the intervention.</P>
<P>
<SUP>4</SUP>The data were not provided for most studies and had to be imputed. Three studies had an unclear risk of bias for random sequence generation and all studies had an unclear risk for allocation concealment. In one study the assessors were not blinded and in another the risk of bias for blinding was unclear. In three studies there was an unclear risk of bias for attrition.</P>
<P>
<SUP>5</SUP>The data were not provided for most studies and had to be imputed. Two studies had an unclear risk of bias for random sequence generation and two were unclear for allocation concealment. One study did not have assessors that were blinded and in another it was unclear. Three studies had an unclear risk of attrition bias. One study was funded by industry.</P>
<P>
<SUP>6</SUP>Nine studies had an unclear risk of bias for sequence generation and 12 for allocation concealment. One study did not use assessors that were blinded and in seven it was unclear. One study had a high risk of attrition bias and eight studies had an unclear risk of bias for attrition. One study had received funding from industry.</P>
<P>
<SUP>7</SUP>The funnel plot indicates that there may be the equivalent number of &#8217;negative&#8217; trials that have not been included in this analysis.</P>
<P>
<SUP>8</SUP>Two studies had an unclear risk of bias for sequence generation and three for allocation concealment. One study did not use blind assessors and one study had an unclear risk of bias for attrition. Two studies were part funded by industry.</P>
<P>
<SUP>9</SUP>Only three studies reported this outcome.</P>
<P>
<SUP>10</SUP>The two RCTs found no significant difference in satisfaction with care between early warning signs training and treatment as usual, although the data may be skewed for one trial. The cluster RCT did find a significant difference in favour of early warning signs training.</P>
<P>
<SUP>11</SUP>Ten studies had an unclear risk of bias for sequence generation and fifteen for allocation concealment. One study did not use assessors that were blinded and in seven it was unclear. One study had a high risk of attrition bias and eight studies had an unclear risk of bias for attrition. Two studies had received funding from industry.</P>
<P>
<SUP>12</SUP>One study had skewed data and the other did not report SDs.</P>
<P>
<SUP>13</SUP>The two studies found very different results.</P>
<P>
<SUP>14</SUP>This outcome included relatively few participants.</P>
<P>
<SUP>15</SUP>
<LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK> showed no significant difference between the mean cost of care for the early warning signs training group and standard care group, but the data was skewed. <LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK> found that the mean costs of care were less in the early warning signs group ($1641) than the standard psychiatric group ($5199), no SDs were reported.</P>
<P>
<SUP>16</SUP> Some indication of publication bias from funnel plot.<BR/>
</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2013-01-07 11:22:42 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-10-10 13:39:30 +0100" MODIFIED_BY="[Empty name]">Skewed and incomplete data</TITLE>
<TABLE COLS="3" ROWS="13">
<TR>
<TD VALIGN="TOP">
<P>Outcome</P>
</TD>
<TD VALIGN="TOP">
<P>Study</P>
</TD>
<TD VALIGN="TOP">
<P>Results</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Mental state: average score in positive symptoms (PAS positive, high = bad)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 20) had a mean of 2.06 (SD 2.57) and the control group (N = 20) had a mean of 4.59 (SD 2.72).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Mental state: average score in positive symptoms (PAS negative, high = bad)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 20) had a mean of 1.33 (SD 1.8) and the control group (N = 20) had a mean of 1.71 (SD 2.2).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Social functioning: average score (REHAB scale, high = bad)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 14) had a mean of 18.2 (SD 13) and the control group (N = 15) had a mean of 32.5 (SD 22.7).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Social functioning: average score (HoNOS scale, high = bad)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 25) had a mean of 9.26 (SD 4.63) and the control group (N = 24) had a mean of 7.66 (SD 4.85).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Social functioning: average score (SDSS, high = bad)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 31) had a mean of 4.04 (SD 3.89) and the control group (N = 31) had a mean of 7.63 (SD 4.27).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Social functioning: average score (SDSS, high = bad)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 54) had a mean of 4.8 (SD 3) and the control group (N = 50) had a mean of 9.8 (SD 3.9).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Social functioning: average months of employment</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Xiong-1994" TYPE="STUDY">Xiong 1994</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 30) had a mean of 7.83 (SD 3) and the control group (N = 28) had a mean of 4.64 (SD 7.39).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Burden of care: average score (FBIS, high = bad)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N= 24) had a mean of 18.95 (SD 15.39) and the control group (N = 22) had a mean of 9.38 (SD 8.1).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Burden of care: average score (FAS, high = good)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group (N = 46) had a mean of 21 (SD 14.54) and the control group (N = 55) had a mean of 25.15 (SD 20).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Mean number of missed doses</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs group had a mean of 0.2 missed doses (SD 0.6) and the control group had a mean of 4.7 missed doses (SD 2.2).</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Economic burden (cost of care)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The early warning signs training group had a mean care package cost of £1220 (SD 736) and the standard treatment group had a mean care package cost of £1403 (SD 887) after 18 months follow-up. There was no significant difference between the costs.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Economic burden (cost of care)</P>
</TD>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>The mean cost of inpatient service utilisation was $5199 for the standard psychiatric care group and $1641 for the early warning signs training group at 3 years post-randomisation.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>FAS: Family Attitude Scale<BR/>FIBS: Family Burden Interview Schedule<BR/>HoNOS: Health of the Nation Outcome Scale<BR/>PAS: Psychiatric Assessment Scale<BR/>REHAB: Rehabilitation Evaluation Hall and Baker<BR/>SD: standard deviation<BR/>SDSS: Social disability screening scale</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-12-11 22:39:48 +0000" MODIFIED_BY="[Empty name]">Comparison of nature of intervention of studies that reported primary outcome as relapse/ re-hospitalisation</TITLE>
<TABLE COLS="9" ROWS="35">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH ALIGN="CENTER">
<P>EWS as primary focus</P>
</TH>
<TH ALIGN="CENTER">
<P>EWS delivered to patient only</P>
</TH>
<TH ALIGN="CENTER">
<P>EWS delivered to patient and carer/ health worker</P>
</TH>
<TH ALIGN="CENTER">
<P>EWS delivered to carer/ health worker only</P>
</TH>
<TH ALIGN="CENTER">
<P>
<B>EWS delivered individually</B>
</P>
</TH>
<TH ALIGN="CENTER">
<P>
<B>EWS delivered in groups</B>
</P>
</TH>
<TH ALIGN="CENTER">
<P>
<B>EWS promoting only help seeking from others</B>
</P>
</TH>
<TH ALIGN="CENTER">
<P>
<B>EWS promoting additional self-directed coping</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>not reported </P>
</TD>
<TD ALIGN="CENTER">
<P>not reported </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>not reported</P>
</TD>
<TD ALIGN="CENTER">
<P>not reported</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
<P>&#10007; </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>not reported </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003; (CBT)</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003; (family intervention)</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003; (CBT)</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003; (family intervention)</P>
</TD>
<TD ALIGN="CENTER">
<P>no (CBT)</P>
<P>yes (family intervention)</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003; (CBT)</P>
<P>no (family intervention) </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Granholm-2005" TYPE="STUDY">Granholm 2005</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hogarty-1997a" TYPE="STUDY">Hogarty 1997a</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Horan-2009" TYPE="STUDY">Horan 2009</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kopelowicz-1998b" TYPE="STUDY">Kopelowicz 1998b</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>optional</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Norman-2002" TYPE="STUDY">Norman 2002</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shin-2002" TYPE="STUDY">Shin 2002</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007; </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>optional </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shon-2002" TYPE="STUDY">Shon 2002</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>unclear</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Tait-2002" TYPE="STUDY">Tait 2002</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003; includes cognitive therapy</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Turkington-2006" TYPE="STUDY">Turkington 2006</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Van-Meijel-2006" TYPE="STUDY">Van Meijel 2006</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK>  </P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Xiong-1994" TYPE="STUDY">Xiong 1994</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>not reported</P>
</TD>
<TD ALIGN="CENTER">
<P>not reported</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10007;</P>
</TD>
<TD ALIGN="CENTER">
<P>&#10003;</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CBT: cognitive behavioural therapy<BR/>EWS: early warning signs</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2013-01-07 11:22:42 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-11-26 06:50:06 +0000" MODIFIED_BY="[Empty name]">Comparison of description of intervention of studies that reported primary outcome as relapse/ re-hospitalisation</TITLE>
<TABLE COLS="6" ROWS="34">
<TR>
<TH>
<P>
<B>Study ID</B>
</P>
</TH>
<TH>
<P>
<B>Focus of intervention</B>
</P>
</TH>
<TH>
<P>
<B>At least one hour/ session focus on EWS</B>
</P>
</TH>
<TH>
<P>
<B>EWS intervention delivered by</B>
</P>
</TH>
<TH>
<P>
<B>No. of sessions</B>
</P>
</TH>
<TH>
<P>
<B>Control group</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Anzai-2002" TYPE="STUDY">Anzai 2002</LINK>
</P>
</TD>
<TD>
<P>Community re-entry program</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Ward Nurses</P>
</TD>
<TD>
<P>18 one-hour sessions</P>
</TD>
<TD>
<P>Occupational rehabilitation</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bauml-2007" TYPE="STUDY">Bauml 2007</LINK>
</P>
</TD>
<TD>
<P>Psychoeducation of patients and relatives (reduce re-hospitalisation and improve compliance)</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Psychiatrist or clinical psychologist</P>
</TD>
<TD>
<P>8 one-hour groups, 4 sessions weekly and 4 monthly</P>
<P>8 bi-weekly 90-minute sessions for relatives</P>
</TD>
<TD>
<P>Outpatient treatment, antipsychotic medication</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bradley-2006" TYPE="STUDY">Bradley 2006</LINK>  </P>
</TD>
<TD>
<P>Multiple family group treatment</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P/>
<P>Psychoeducation:Psychiatrist, psychologists, social workers, occupational therapists</P>
<P>Family groups: Therapists</P>
</TD>
<TD>
<P>3 single family joining sessions.</P>
<P>2 half-day psychoeducation sessions.</P>
<P>Multiple family group fortnightly for 12 months</P>
</TD>
<TD>
<P>Appointments with case manager and doctor for medication and individual psychosocial rehabilitation. Family contact as required</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Buchkremer-1997" TYPE="STUDY">Buchkremer 1997</LINK>  </P>
</TD>
<TD>
<P>Psychoeducational medication training and key person counselling</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Project staff</P>
</TD>
<TD>
<P>10 sessions, first 5 at weekly intervals and 5 at fortnightly intervals</P>
</TD>
<TD>
<P>1.Cognitive psychotherapy: 7 sessions weekly and 8 sessions fortnightly</P>
<P>2. Leisure time group activities led by students of psychology or educational sociology</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chan-2007" TYPE="STUDY">Chan 2007</LINK>
</P>
</TD>
<TD>
<P>Psychoeducation &amp; relapse prevention</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>Occupational therapist</P>
</TD>
<TD>
<P>Ten 50-minute sessions over two weeks for patients</P>
</TD>
<TD>
<P>Traditional ward occupational therapy including work, rest, leisure activities</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chen-2003" TYPE="STUDY">Chen 2003</LINK>
</P>
</TD>
<TD>
<P>Medication &amp; symptom management training programme</P>
</TD>
<TD>
<P>not reported</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
<TD>
<P>Antipsychotic therapy</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chien-2004" TYPE="STUDY">Chien 2004</LINK>
</P>
</TD>
<TD>
<P>Psychoeducation</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Trained psychiatric nurses</P>
</TD>
<TD>
<P>12 bi-weekly 2-hour sessions over 6 months for patients and families together</P>
</TD>
<TD>
<P>1. Mutual support group for families only</P>
<P>2. Standard outpatient care</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Drury-1996" TYPE="STUDY">Drury 1996</LINK>
</P>
</TD>
<TD>
<P> Cognitive Therapy</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
<TD>
<P>8 hours a week &#8211; four individual and four group sessions, 2 sessions with family engagement</P>
</TD>
<TD>
<P>Recreation therapy,  leisure and social activities outside the ward</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Garety-2008" TYPE="STUDY">Garety 2008</LINK>
</P>
</TD>
<TD>
<P>CBT or family intervention</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Each session with 2 therapists - mix of doctoral clinical psychologists and nurses all trained in CBT</P>
</TD>
<TD>
<P>9 months (intended minimum 12 months, max 20 months) &#8211; 1-hour sessions with a mean number of 14.3 session</P>
</TD>
<TD>
<P>TAU- standard of care delivered according to national and local service protocols including antipsychotic medication.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Granholm-2005" TYPE="STUDY">Granholm 2005</LINK>
</P>
</TD>
<TD>
<P>Cognitive behavioural skills training</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Each session led by 2 therapists - mix of doctoral or senior graduate level psychologists</P>
</TD>
<TD>
<P>24 two-hour weekly group sessions</P>
</TD>
<TD>
<P>TAU &#8211; continuation of prior treatment</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gumley-2003" TYPE="STUDY">Gumley 2003</LINK>  </P>
</TD>
<TD>
<P>Targeted CBT for relapse</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Clinical psychologist</P>
</TD>
<TD>
<P>5 session engagement phase between 0-12 weeks; intensive targeted phase (2-3 sessions per week) after for 12 months</P>
</TD>
<TD>
<P>Ongoing medication, regular psychiatric review, follow-up from a key worker, access to multidisciplinary community mental health team</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Harris-2009" TYPE="STUDY">Harris 2009</LINK>
</P>
</TD>
<TD>
<P>Medication management training programme</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
<TD>
<P>Community mental health professionals (CMHPs; nurses, occupational therapists, social workers) received a 10-day programme: 3 days assessment training, followed by seven fortnightly study days. These were followed by 1-hour individual supervision sessions, at the CMHP&#8217;s workplace, every month for 6 months, giving a total educational input of 9 months.</P>
</TD>
<TD>
<P>Waiting list</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Herz-2000" TYPE="STUDY">Herz 2000</LINK>
</P>
</TD>
<TD>
<P>Relapse prevention</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Master's level nurse clinician or certified social worker</P>
</TD>
<TD>
<P>One-hour weekly supportive group therapy OR 30-45-minute individual supportive therapy</P>
<P>90-minute multifamily psychoeducation groups bi-weekly for 6 months and monthly after</P>
</TD>
<TD>
<P>Individual supportive therapy and medication management biweekly for 15-30 minutes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hogarty-1997a" TYPE="STUDY">Hogarty 1997a</LINK>
</P>
</TD>
<TD>
<P>Personal therapy (relapse prevention) and/or family therapy (psychoeducation/ management)</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Personal and family therapy: master's level psychiatric nurse clinical specialists and doctoral- level clinical psychologists</P>
<P/>
</TD>
<TD>
<P>30-45-minute weekly for about 3 years</P>
<P>1.9 additional monthly medication management sessions</P>
</TD>
<TD>
<P>Supportive therapy</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Horan-2009" TYPE="STUDY">Horan 2009</LINK>
</P>
</TD>
<TD>
<P>Symptom management</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
<TD>
<P>12 one-hour groups that met twice weekly</P>
</TD>
<TD>
<P>Social cognitive intervention</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kopelowicz-1998b" TYPE="STUDY">Kopelowicz 1998b</LINK>
</P>
</TD>
<TD>
<P>Community re-entry program</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>2 trainers per session &#8211; from a multi-disciplinary staff of 10</P>
</TD>
<TD>
<P>Eight 45-minute group sessions, twice a day for 4 days in a week.</P>
</TD>
<TD>
<P>Occupational therapy</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kopelowicz-2003" TYPE="STUDY">Kopelowicz 2003</LINK>  </P>
</TD>
<TD>
<P>Family assisted skills training program</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Nurses, psychologists and social workers</P>
</TD>
<TD>
<P>90-minute sessions four times per week for 3 months.</P>
<P>Weekly group sessions with families included</P>
</TD>
<TD>
<P>Case management by social workers and monthly 20-minute psychiatric visits to see a psychiatrist</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kuipers-1997" TYPE="STUDY">Kuipers 1997</LINK>
</P>
</TD>
<TD>
<P>CBT</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Therapist</P>
</TD>
<TD>
<P>Weekly sessions that become fortnightly- up to one hour and up to nine months</P>
</TD>
<TD>
<P>Standard care- case management and medication</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>
</P>
</TD>
<TD>
<P>Comprehensive patient/ family education guide (CP/FEG)</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Ward Nurses</P>
</TD>
<TD>
<P>In hospital- Patient 8 hours; family member 36 hours. Post-discharge- patient and family member 2 hours per month for 3 months.</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Liberman-1998" TYPE="STUDY">Liberman 1998</LINK>
</P>
</TD>
<TD>
<P>Social and Independent Living Skills Program consisting of basic conversation, recreation for leisure, medication management, and symptom management</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Occupational therapist and paraprofessionals</P>
</TD>
<TD>
<P>6 months of intensive, clinic-based treatment 3 hours a day, 4 days per week.</P>
</TD>
<TD>
<P>Psychosocial occupational therapy</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-McDonell-2006" TYPE="STUDY">McDonell 2006</LINK>  </P>
</TD>
<TD>
<P>Multiple family group treatment</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>clinicians</P>
</TD>
<TD>
<P>24 sessions in year 1 and 12 sessions in year 2</P>
</TD>
<TD>
<P>Outpatient services: medication management, case management, phone consultation, crisis services, group psychotherapy, occupational therapy, individual psychotherapy</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Merinder-1999" TYPE="STUDY">Merinder 1999</LINK>  </P>
</TD>
<TD>
<P>Patient and relative psychoeducation</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>not stated</P>
</TD>
<TD>
<P>8 weekly sessions separately for patients and relatives</P>
</TD>
<TD>
<P>Psychopharmacological treatment, psychosocial rehabilitation efforts, some supportive psychotherapy</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Norman-2002" TYPE="STUDY">Norman 2002</LINK>  </P>
</TD>
<TD>
<P>Stress management program</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Nurse case managers</P>
</TD>
<TD>
<P>12 weeks of group sessions, and 12 individual sessions</P>
</TD>
<TD>
<P>Social activities program similar in frequency and length to treatment group</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shin-2002" TYPE="STUDY">Shin 2002</LINK>
</P>
</TD>
<TD>
<P>Psychoeducational group  program with individual supportive therapy</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Group sessions &#8211; psychiatric social worker</P>
<P>Individual sessions &#8211; Master&#8217;s degree student</P>
</TD>
<TD>
<P>10 weekly group sessions (90 minutes each) &amp; individual sessions (45 minutes each)</P>
</TD>
<TD>
<P>Individual supportive therapy</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shon-2002" TYPE="STUDY">Shon 2002</LINK>
</P>
</TD>
<TD>
<P>Self management educational group</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>2 psychiatric nurses &amp; 2 social workers</P>
</TD>
<TD>
<P>12 group sessions (70 minutes each)</P>
</TD>
<TD>
<P>Non-equivalent control group - undefined</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Tait-2002" TYPE="STUDY">Tait 2002</LINK>  </P>
</TD>
<TD>
<P>EWS recognition and targeted cognitive therapy</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Therapist</P>
</TD>
<TD>
<P>5 one-hour sessions on initial engagement and formulation</P>
<P>Early signs monitoring questionnaire dispatched fortnightly for an average of 10 months</P>
<P>Targeted cognitive therapy, intensive for a brief period, about 2-3 sessions per week</P>
</TD>
<TD>
<P>Routine appointments with psychiatrist and key worker (community psychiatric worker, social worker or occupational therapist)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Turkington-2006" TYPE="STUDY">Turkington 2006</LINK>  </P>
</TD>
<TD>
<P>Modify patient's condition and family approach</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Trained Community Psychiatric Nurse</P>
</TD>
<TD>
<P>up to 6 hour-long sessions of CBT and/or 3 sessions with carer</P>
</TD>
<TD>
<P>Care of community mental health teams</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Van-Meijel-2006" TYPE="STUDY">Van Meijel 2006</LINK>  </P>
</TD>
<TD>
<P>Relapse prevention plan using EWS monitoring</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Trained nurses</P>
</TD>
<TD>
<P>Therapy for a total of mean (SD) 155 (94) days</P>
</TD>
<TD>
<P>Care as usual</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Weng-2005" TYPE="STUDY">Weng 2005</LINK>  </P>
</TD>
<TD>
<P>Psychiatric rehabilitation</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Interdisciplinary teams</P>
</TD>
<TD>
<P>2 months, possibly weekly sessions</P>
</TD>
<TD>
<P>Standard inpatient services and activities</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Xiang-2001" TYPE="STUDY">Xiang 2001</LINK>
</P>
</TD>
<TD>
<P>Medication &amp; symptom management training programme</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Psychiatrist and a psychologist</P>
</TD>
<TD>
<P>90 to 120-minute sessions, 3 sessions per week for 20 weeks</P>
</TD>
<TD>
<P>Antipsychotic medication and standard psychological intervention</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Xiong-1994" TYPE="STUDY">Xiong 1994</LINK>
</P>
</TD>
<TD>
<P>Family based intervention</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Clinicians</P>
</TD>
<TD>
<P>1. Introduction- two to three 45-minute sessions- family +/- patient</P>
<P>2. Monthly 45-minute counselling with patient (average 8.1 contacts per year) and family and 90 minute family group</P>
<P>3. Maintenance- families seen once in 2-3 months and monthly group meetings up to 18 months</P>
</TD>
<TD>
<P>2-3 months of medication post discharge +/- out patient follow-up</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zhan-2003" TYPE="STUDY">Zhan 2003</LINK>
</P>
</TD>
<TD>
<P>Medication &amp; symptom management training programme</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Psychiatrist and a psychologist</P>
</TD>
<TD>
<P>60 to 90 minutes per session, 1 session per week for 12 weeks</P>
</TD>
<TD>
<P>Pharmacotherapy and standard psychological intervention</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zhang-2004" TYPE="STUDY">Zhang 2004</LINK>
</P>
</TD>
<TD>
<P>Life skills, medication &amp; symptom management training programme</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Psychiatrist and psychiatric nurse</P>
</TD>
<TD>
<P>Group training for 90 to 120 minutes, 2 times a week. Then community follow-up by nurses, number of sessions not reported</P>
</TD>
<TD>
<P>Conventional rehabilitation service (outpatient follow-up every 3 months, or telephone counselling as needed)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-01-07 11:41:06 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-01-07 11:41:06 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>EARLY WARNING SIGNS TRAINING + TAU versus TREATMENT AS USUAL (TAU)</NAME>
<DICH_OUTCOME CHI2="85.97703262109948" CI_END="0.7901504370472432" CI_START="0.35550754082851" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5300041874921724" ESTIMABLE="YES" EVENTS_1="196" EVENTS_2="307" I2="81.39037890443143" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.10229021534295607" LOG_CI_START="-0.449151182823167" LOG_EFFECT_SIZE="-0.27572069908306157" METHOD="MH" MODIFIED="2012-11-20 13:58:26 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.3687606603696167E-11" P_Q="0.5625854402868551" P_Z="0.0018334646000588393" Q="1.15042515996893" RANDOM="YES" SCALE="60.8" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.5113721179967455" TOTALS="YES" TOTAL_1="791" TOTAL_2="711" WEIGHT="100.0" Z="3.1159610948489753">
<NAME>Relapse: 1. Relapse</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="72.97443647912796" CI_END="0.9186058265137411" CI_START="0.19846602356013127" DF="8" EFFECT_SIZE="0.4269801466196643" ESTIMABLE="YES" EVENTS_1="104" EVENTS_2="201" I2="89.03725689983486" ID="CMP-001.01.01" LOG_CI_END="-0.036870804275441815" LOG_CI_START="-0.70231383168846" LOG_EFFECT_SIZE="-0.3695923179819508" MODIFIED="2012-10-03 22:44:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.2537748617091893E-12" P_Z="0.029468707520537846" STUDIES="8" TAU2="1.1130330866005091" TOTAL_1="474" TOTAL_2="459" WEIGHT="50.10739890811306" Z="2.1771589824103637">
<NAME>training delivered to patient only</NAME>
<DICH_DATA CI_END="0.5258477357671826" CI_START="0.05557866226890505" EFFECT_SIZE="0.17095588235294118" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.27913999175711024" LOG_CI_START="-1.2550919105313794" LOG_EFFECT_SIZE="-0.7671159511442448" MODIFIED="2012-09-06 08:46:27 +0100" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="0.5732789881279176" STUDY_ID="STD-Chen-2003" TOTAL_1="32" TOTAL_2="31" VAR="0.328648798228969" WEIGHT="4.941922907794429"/>
<DICH_DATA CI_END="2.7719612043502577" CI_START="0.3464694954939371" EFFECT_SIZE="0.98" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.44278714770942657" LOG_CI_START="-0.46033499632443686" LOG_EFFECT_SIZE="-0.00877392430750515" MODIFIED="2012-07-16 10:44:16 +0100" MODIFIED_BY="[Empty name]" ORDER="84" O_E="0.0" SE="0.5304984179322041" STUDY_ID="STD-Garety-2008" TOTAL_1="25" TOTAL_2="14" VAR="0.2814285714285715" WEIGHT="5.23627018025365">
<FOOTNOTE>Carer pathway, patient intervention</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="2.0414591348968116" CI_START="1.0707433860700037" EFFECT_SIZE="1.4784718010915707" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="34" LOG_CI_END="0.3099406908147608" LOG_CI_START="0.029685400460927887" LOG_EFFECT_SIZE="0.16981304563784436" MODIFIED="2012-09-06 08:46:23 +0100" MODIFIED_BY="[Empty name]" ORDER="85" O_E="0.0" SE="0.16462334483990257" STUDY_ID="STD-Garety-2008" TOTAL_1="97" TOTAL_2="92" VAR="0.027100845666277476" WEIGHT="7.709428121855015">
<FOOTNOTE>No carer pathway</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.9335732006516049" CI_START="0.28963984807112" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="25" LOG_CI_END="-0.029851623732371393" LOG_CI_START="-0.5381416889980303" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2012-07-16 10:27:31 +0100" MODIFIED_BY="[Empty name]" ORDER="354" O_E="0.0" SE="0.2985721004134498" STUDY_ID="STD-Gumley-2003" TOTAL_1="72" TOTAL_2="72" VAR="0.08914529914529915" WEIGHT="6.912902924080189"/>
<DICH_DATA CI_END="29.487412841980653" CI_START="0.45593842079301883" EFFECT_SIZE="3.6666666666666665" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4696366702208143" LOG_CI_START="-0.3410938093436892" LOG_EFFECT_SIZE="0.5642714304385625" MODIFIED="2012-09-06 08:46:35 +0100" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="1.063632046956621" STUDY_ID="STD-Tait-2002" TOTAL_1="9" TOTAL_2="11" VAR="1.1313131313131313" WEIGHT="2.527154006323713"/>
<DICH_DATA CI_END="1.2519544939482823" CI_START="0.18194691364537485" EFFECT_SIZE="0.4772727272727273" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.09758854342207605" LOG_CI_START="-0.7400553069266124" LOG_EFFECT_SIZE="-0.3212333817522681" MODIFIED="2012-07-16 10:28:14 +0100" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.4920361440987512" STUDY_ID="STD-Van-Meijel-2006" TOTAL_1="40" TOTAL_2="42" VAR="0.24209956709956706" WEIGHT="5.509588072167145"/>
<DICH_DATA CI_END="0.3111107746908992" CI_START="0.06559773857264324" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="42" LOG_CI_END="-0.5070849477219934" LOG_CI_START="-1.1831111323065204" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2012-09-06 08:46:27 +0100" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.3971011272085347" STUDY_ID="STD-Weng-2005" TOTAL_1="61" TOTAL_2="61" VAR="0.15768930523028885" WEIGHT="6.20468983086721"/>
<DICH_DATA CI_END="0.2420116078928754" CI_START="0.015177348781597941" EFFECT_SIZE="0.06060606060606061" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="33" LOG_CI_END="-0.6161638029331192" LOG_CI_START="-1.8188040854946934" LOG_EFFECT_SIZE="-1.2174839442139063" MODIFIED="2012-09-06 08:46:26 +0100" MODIFIED_BY="[Empty name]" ORDER="115" O_E="0.0" SE="0.7064368551420787" STUDY_ID="STD-Xiang-2001" TOTAL_1="64" TOTAL_2="64" VAR="0.4990530303030303" WEIGHT="4.108487022425829"/>
<DICH_DATA CI_END="0.6087915722154328" CI_START="0.193703549844597" EFFECT_SIZE="0.34340222575516693" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="34" LOG_CI_END="-0.21553136833614753" LOG_CI_START="-0.7128624202525284" LOG_EFFECT_SIZE="-0.464196894294338" MODIFIED="2012-09-06 08:46:28 +0100" MODIFIED_BY="[Empty name]" ORDER="258" O_E="0.0" SE="0.292134721724093" STUDY_ID="STD-Zhan-2003" TOTAL_1="74" TOTAL_2="72" VAR="0.08534269563681326" WEIGHT="6.956955842345885"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8919864550576144" CI_END="1.369999592520906" CI_START="0.2448912239335573" DF="1" EFFECT_SIZE="0.579224375351141" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.13672043798418174" LOG_CI_START="-0.6110267782298053" LOG_EFFECT_SIZE="-0.23715317012281176" MODIFIED="2012-10-03 22:44:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3449396774083393" P_Z="0.213782339696738" STUDIES="2" TAU2="0.0" TOTAL_1="44" TOTAL_2="34" WEIGHT="9.242720147351825" Z="1.2432321035273335">
<NAME>training delivered to carer/health professional only</NAME>
<DICH_DATA CI_END="3.1897722085471165" CI_START="0.2555065574480642" EFFECT_SIZE="0.9027777777777778" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.5037596698586467" LOG_CI_START="-0.5925979494354726" LOG_EFFECT_SIZE="-0.04441913978841288" MODIFIED="2012-07-16 10:44:30 +0100" MODIFIED_BY="[Empty name]" ORDER="86" O_E="0.0" SE="0.6440058926311076" STUDY_ID="STD-Garety-2008" TOTAL_1="24" TOTAL_2="13" VAR="0.4147435897435897" WEIGHT="4.482505343799084">
<FOOTNOTE>Carer pathway, family intervention</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.2777559419661997" CI_START="0.12133699199350009" EFFECT_SIZE="0.39375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.10644790923763021" LOG_CI_START="-0.9160067756423166" LOG_EFFECT_SIZE="-0.4047794332023431" MODIFIED="2012-07-26 13:04:01 +0100" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.6005949431307973" STUDY_ID="STD-Li-2003" TOTAL_1="20" TOTAL_2="21" VAR="0.3607142857142857" WEIGHT="4.760214803552741">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.607136474745491" CI_END="1.0211572473368085" CI_START="0.4568858084283705" DF="5" EFFECT_SIZE="0.6830463047861157" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="95" I2="63.254575940500956" ID="CMP-001.01.03" LOG_CI_END="0.00909262395988445" LOG_CI_START="-0.34019233158528495" LOG_EFFECT_SIZE="-0.16554985381270024" MODIFIED="2012-10-03 22:44:36 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.018307289983344188" P_Z="0.06318037674070662" STUDIES="6" TAU2="0.15513402407918545" TOTAL_1="273" TOTAL_2="218" WEIGHT="40.64988094453511" Z="1.8579199932177037">
<NAME>training delivered to both patient and carer/health professional</NAME>
<DICH_DATA CI_END="0.8545331823159571" CI_START="0.18723673148229047" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.06827106855831859" LOG_CI_START="-0.7276089487857565" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2012-07-16 10:27:10 +0100" MODIFIED_BY="[Empty name]" ORDER="353" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-Bradley-2006" TOTAL_1="24" TOTAL_2="24" VAR="0.15000000000000002" WEIGHT="6.276827365351303"/>
<DICH_DATA CI_END="1.1098356102786089" CI_START="0.2252585857623013" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" LOG_CI_END="0.045258655510932236" LOG_CI_START="-0.6473186468388946" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2012-07-16 10:27:37 +0100" MODIFIED_BY="[Empty name]" ORDER="357" O_E="0.0" SE="0.40682333571322604" STUDY_ID="STD-Herz-2000" TOTAL_1="41" TOTAL_2="41" VAR="0.16550522648083624" WEIGHT="6.133044107313619"/>
<DICH_DATA CI_END="2.9413708862524723" CI_START="0.8949366785677245" EFFECT_SIZE="1.6224489795918366" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="11" LOG_CI_END="0.4685497894500458" LOG_CI_START="-0.0482076921941326" LOG_EFFECT_SIZE="0.2101710486279566" MODIFIED="2012-09-04 11:57:13 +0100" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.3035459027085793" STUDY_ID="STD-Hogarty-1997a" TOTAL_1="98" TOTAL_2="53" VAR="0.09214011505116627" WEIGHT="6.87859894397991"/>
<DICH_DATA CI_END="1.3317651076709347" CI_START="0.5496279369581132" EFFECT_SIZE="0.8555555555555555" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" LOG_CI_END="0.12442763216301023" LOG_CI_START="-0.25993120069669623" LOG_EFFECT_SIZE="-0.06775178426684303" MODIFIED="2012-07-16 10:28:02 +0100" MODIFIED_BY="[Empty name]" ORDER="102" O_E="0.0" SE="0.2257742810286991" STUDY_ID="STD-Merinder-1999" TOTAL_1="24" TOTAL_2="22" VAR="0.05097402597402599" WEIGHT="7.382141148171707"/>
<DICH_DATA CI_END="1.1000159946857866" CI_START="0.4210446633822163" EFFECT_SIZE="0.6805555555555556" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="0.04139900002483855" LOG_CI_START="-0.37567183283034816" LOG_EFFECT_SIZE="-0.16713641640275478" MODIFIED="2012-07-24 16:25:20 +0100" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.2449894717530557" STUDY_ID="STD-Xiong-1994" TOTAL_1="32" TOTAL_2="28" VAR="0.060019841269841265" WEIGHT="7.265273060983865"/>
<DICH_DATA CI_END="0.7989242689728446" CI_START="0.2217182864213173" EFFECT_SIZE="0.4208754208754209" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="22" LOG_CI_END="-0.09749438605018222" LOG_CI_START="-0.6541984865681295" LOG_EFFECT_SIZE="-0.37584643630915593" MODIFIED="2012-08-31 09:35:50 +0100" MODIFIED_BY="[Empty name]" ORDER="401" O_E="0.0" SE="0.3270107443739837" STUDY_ID="STD-Zhang-2004" TOTAL_1="54" TOTAL_2="50" VAR="0.10693602693602693" WEIGHT="6.713996318734713"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<IV_OUTCOME CHI2="17.879431347391883" CI_END="1.064970768729923" CI_START="0.2658445496397883" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="0.5320870928640776" ESTIMABLE="YES" I2="72.03490478611131" I2_Q="88.6546260436759" ID="CMP-001.02" LOG_CI_END="0.02733768744281524" LOG_CI_START="-0.5753722391889186" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.27401727587305164" MODIFIED="2012-10-03 22:47:22 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0031013815456086835" P_Q="0.002989031467119041" P_Z="0.07472247803408731" Q="8.814165172956542" RANDOM="YES" SCALE="16.82" SHOW_PARTICIPANTS="YES" SORT_BY="WEIGHT" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.5230459057520022" TOTALS="YES" TOTAL_1="278" TOTAL_2="272" WEIGHT="100.0" Z="1.7821640829921588">
<NAME>Relapse: 2. Time to first relapse</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="3.091130067013996" CI_END="0.5340144004877392" CI_START="0.12873641830933946" DF="2" EFFECT_SIZE="0.26219668427423093" ESTIMABLE="YES" I2="35.29874328672354" ID="CMP-001.02.01" LOG_CI_END="-0.272447031420814" LOG_CI_START="-0.8902985779329168" LOG_EFFECT_SIZE="-0.5813728046768654" MODIFIED="2012-10-03 22:45:05 +0100" MODIFIED_BY="Karla Soares-Weiser" NO="1" P_CHI2="0.2131914706489494" P_Z="2.2558850796693624E-4" STUDIES="3" TAU2="0.14549126688650146" TOTAL_1="189" TOTAL_2="183" WEIGHT="46.88188871055812" Z="3.6884904316910214">
<NAME>training delivered to patient only</NAME>
<IV_DATA CI_END="0.3793764514469932" CI_START="0.021692825207338673" EFFECT_SIZE="0.09071795328941251" ESTIMABLE="YES" ESTIMATE="-2.4" LOG_CI_END="-0.4209296300209595" LOG_CI_START="-1.6636838831146492" LOG_EFFECT_SIZE="-1.0423067565678044" MODIFIED="2012-08-31 09:28:13 +0100" MODIFIED_BY="Karla Soares-Weiser" ORDER="292" SE="0.73" STUDY_ID="STD-Xiang-2001" TOTAL_1="66" TOTAL_2="67" WEIGHT="11.869986420594618">
<FOOTNOTE>Data imputed using method 7 from Tierney 2007</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.2691920940822854" CI_START="0.15283741775208035" EFFECT_SIZE="0.4404316545059993" ESTIMABLE="YES" ESTIMATE="-0.82" LOG_CI_END="0.10352735817535572" LOG_CI_START="-0.8157703084966887" LOG_EFFECT_SIZE="-0.35612147516066645" MODIFIED="2012-08-30 08:50:14 +0100" MODIFIED_BY="[Empty name]" ORDER="342" SE="0.54" STUDY_ID="STD-Van-Meijel-2006" TOTAL_1="51" TOTAL_2="44" WEIGHT="15.385903830927031">
<FOOTNOTE>Data imputed using method 7 from Tierney 2007</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="0.5634863072549443" CI_START="0.14861625653364294" EFFECT_SIZE="0.28938421793905067" ESTIMABLE="YES" ESTIMATE="-1.24" LOG_CI_END="-0.24911663286698124" LOG_CI_START="-0.8279336822530833" LOG_EFFECT_SIZE="-0.5385251575600323" MODIFIED="2012-08-28 13:24:10 +0100" MODIFIED_BY="[Empty name]" ORDER="340" SE="0.34" STUDY_ID="STD-Gumley-2003" TOTAL_1="72" TOTAL_2="72" WEIGHT="19.625998459036474">
<FOOTNOTE>Data log transformed</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="2.353346347002427" CI_END="1.6791827552725602" CI_START="0.5920922887048363" DF="2" EFFECT_SIZE="0.9971114083807402" ESTIMABLE="YES" I2="15.014634265479094" ID="CMP-001.02.02" LOG_CI_END="0.22509796551692066" LOG_CI_START="-0.22761059504829198" LOG_EFFECT_SIZE="-0.0012563147656856589" MODIFIED="2012-10-03 22:47:22 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3083027552084574" P_Z="0.9913206072688695" STUDIES="3" TAU2="0.03233318773399894" TOTAL_1="89" TOTAL_2="89" WEIGHT="53.11811128944187" Z="0.010878220155216516">
<NAME>training delivered to both patient and carer/health professional</NAME>
<IV_DATA CI_END="3.7090757165650423" CI_START="0.5650829680110712" EFFECT_SIZE="1.4477346146633243" ESTIMABLE="YES" ESTIMATE="0.37" LOG_CI_END="0.569265699047334" LOG_CI_START="-0.24788778243892765" LOG_EFFECT_SIZE="0.16068895830420313" MODIFIED="2012-08-30 08:50:16 +0100" MODIFIED_BY="[Empty name]" ORDER="339" SE="0.48" STUDY_ID="STD-Bradley-2006" TOTAL_1="25" TOTAL_2="25" WEIGHT="16.635651566317428">
<FOOTNOTE>Data imputed using method 4 from Tierney 2007</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="3.072170002770028" CI_START="0.5475047436119365" EFFECT_SIZE="1.2969300866657718" ESTIMABLE="YES" ESTIMATE="0.26" LOG_CI_END="0.487445244309382" LOG_CI_START="-0.26161211371969106" LOG_EFFECT_SIZE="0.11291656529484548" MODIFIED="2012-08-28 13:24:00 +0100" MODIFIED_BY="[Empty name]" ORDER="26" SE="0.44" STUDY_ID="STD-Herz-2000" TOTAL_1="41" TOTAL_2="41" WEIGHT="17.489897676881736">
<FOOTNOTE>Data log transformed</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.3300102836611465" CI_START="0.31186443952884335" EFFECT_SIZE="0.6440364210831413" ESTIMABLE="YES" ESTIMATE="-0.44" LOG_CI_END="0.12385499895206588" LOG_CI_START="-0.5060341430269274" LOG_EFFECT_SIZE="-0.19108957203743085" MODIFIED="2012-08-30 08:50:17 +0100" MODIFIED_BY="[Empty name]" ORDER="341" SE="0.37" STUDY_ID="STD-Merinder-1999" TOTAL_1="23" TOTAL_2="23" WEIGHT="18.992562046242714">
<FOOTNOTE>Data imputed using method 7 from Tierney 2007</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<DICH_OUTCOME CHI2="36.45139002751518" CI_END="0.6645893178949838" CI_START="0.3524687203737283" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="0.48399064707129813" ESTIMABLE="YES" EVENTS_1="153" EVENTS_2="264" I2="61.59268552054625" I2_Q="40.38637571630734" ID="CMP-001.03" LOG_CI_END="-0.17744664352156717" LOG_CI_START="-0.4528794181671788" LOG_EFFECT_SIZE="-0.31516303084437297" METHOD="MH" MODIFIED="2013-01-07 11:39:49 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="8.927188560219346E-4" P_Q="0.1868465290683926" P_Z="7.278940480255374E-6" Q="3.3549377747648554" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.2025336712395098" TOTALS="YES" TOTAL_1="772" TOTAL_2="685" WEIGHT="100.00000000000003" Z="4.485364463312238">
<NAME>Service use: 1a. Re-hospitalisation</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="30.518367487175325" CI_END="0.6565188189236498" CI_START="0.1407131063362347" DF="6" EFFECT_SIZE="0.30394210366275803" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="129" I2="80.33970852955562" ID="CMP-001.03.01" LOG_CI_END="-0.1827528204693112" LOG_CI_START="-0.8516654495132773" LOG_EFFECT_SIZE="-0.5172091349912943" MODIFIED="2012-10-03 22:45:28 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="3.132061790644958E-5" P_Z="0.0024380755738933777" STUDIES="7" TAU2="0.7774962480687502" TOTAL_1="431" TOTAL_2="360" WEIGHT="41.024989756100126" Z="3.0309228232299468">
<NAME>training delivered to patient only</NAME>
<DICH_DATA CI_END="1.1508883564863877" CI_START="0.49542519813625824" EFFECT_SIZE="0.7551020408163265" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="17" LOG_CI_END="0.06103319633738553" LOG_CI_START="-0.3050219082604229" LOG_EFFECT_SIZE="-0.1219943559615187" MODIFIED="2012-08-31 09:38:41 +0100" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.21502258044274403" STUDY_ID="STD-Buchkremer-1997" TOTAL_1="98" TOTAL_2="34" VAR="0.04623471010025632" WEIGHT="10.522314007856345"/>
<DICH_DATA CI_END="1.6537516125247342" CI_START="0.24051952709988664" EFFECT_SIZE="0.6306818181818182" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.21847028066358617" LOG_CI_START="-0.6188496587185709" LOG_EFFECT_SIZE="-0.20018968902749235" MODIFIED="2012-08-31 09:38:41 +0100" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.0" SE="0.49184587719362544" STUDY_ID="STD-Chan-2007" TOTAL_1="44" TOTAL_2="37" VAR="0.2419123669123669" WEIGHT="5.889621684035968"/>
<DICH_DATA CI_END="0.5359944902276944" CI_START="0.010360397085572397" EFFECT_SIZE="0.07451923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="13" LOG_CI_END="-0.2708396746281396" LOG_CI_START="-1.9846235989568006" LOG_EFFECT_SIZE="-1.1277316367924701" MODIFIED="2012-08-31 09:38:30 +0100" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.0" SE="1.0066851605178988" STUDY_ID="STD-Chen-2003" TOTAL_1="32" TOTAL_2="31" VAR="1.0134150124069479" WEIGHT="2.152738071012423"/>
<DICH_DATA CI_END="1.1278502497309013" CI_START="0.2971848926589626" EFFECT_SIZE="0.5789473684210527" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="19" LOG_CI_END="0.052251440043689444" LOG_CI_START="-0.5269732716328973" LOG_EFFECT_SIZE="-0.23736091579460392" MODIFIED="2012-08-31 09:38:41 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.34023946284739154" STUDY_ID="STD-Gumley-2003" TOTAL_1="72" TOTAL_2="72" VAR="0.11576289207868154" WEIGHT="8.223836903530799"/>
<DICH_DATA CI_END="1.1708741007076509" CI_START="0.22069219707020996" EFFECT_SIZE="0.5083333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" LOG_CI_END="0.06851019967744082" LOG_CI_START="-0.6562130217511565" LOG_EFFECT_SIZE="-0.2938514110368578" MODIFIED="2012-08-31 09:38:40 +0100" MODIFIED_BY="[Empty name]" ORDER="301" O_E="0.0" SE="0.4257060077049616" STUDY_ID="STD-Norman-2002" TOTAL_1="60" TOTAL_2="61" VAR="0.1812256049960968" WEIGHT="6.820992183850429"/>
<DICH_DATA CI_END="0.23410277921430894" CI_START="0.014780719921693474" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="34" LOG_CI_END="-0.6305934304286479" LOG_CI_START="-1.8303044123279002" LOG_EFFECT_SIZE="-1.2304489213782739" MODIFIED="2012-08-31 09:38:30 +0100" MODIFIED_BY="[Empty name]" ORDER="300" O_E="0.0" SE="0.7047161694327587" STUDY_ID="STD-Weng-2005" TOTAL_1="61" TOTAL_2="61" VAR="0.4966248794599807" WEIGHT="3.743956247212178"/>
<DICH_DATA CI_END="0.33802320088462284" CI_START="0.0205442834286833" EFFECT_SIZE="0.08333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="24" LOG_CI_END="-0.47105349004670766" LOG_CI_START="-1.687309002048542" LOG_EFFECT_SIZE="-1.0791812460476249" MODIFIED="2012-08-31 09:38:31 +0100" MODIFIED_BY="[Empty name]" ORDER="116" O_E="0.0" SE="0.7144345083117603" STUDY_ID="STD-Xiang-2001" TOTAL_1="64" TOTAL_2="64" VAR="0.5104166666666666" WEIGHT="3.6715306586019825"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8201462057237174" CI_START="0.15143014288261936" DF="0" EFFECT_SIZE="0.525" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.2601062746821901" LOG_CI_START="-0.8197876678702763" LOG_EFFECT_SIZE="-0.2798406965940431" MODIFIED="2012-10-03 22:47:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3097250440484808" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="21" WEIGHT="4.32725366766059" Z="1.0157991727160325">
<NAME>training delivered to carer/health professional only</NAME>
<DICH_DATA CI_END="1.8201462057237174" CI_START="0.15143014288261936" EFFECT_SIZE="0.525" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2601062746821901" LOG_CI_START="-0.8197876678702763" LOG_EFFECT_SIZE="-0.2798406965940431" MODIFIED="2012-07-26 13:20:03 +0100" MODIFIED_BY="[Empty name]" ORDER="405" O_E="0.0" SE="0.6343350474165466" STUDY_ID="STD-Li-2003" TOTAL_1="20" TOTAL_2="21" VAR="0.4023809523809524" WEIGHT="4.32725366766059">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.975017786829508" CI_END="0.7925083384651079" CI_START="0.5142605639447532" DF="6" EFFECT_SIZE="0.638400959483917" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="129" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="-0.10099615960821388" LOG_CI_START="-0.2888167782607714" LOG_EFFECT_SIZE="-0.19490646893449262" MODIFIED="2012-10-03 22:47:37 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.42599454661091996" P_Z="4.7456261962113176E-5" STUDIES="7" TAU2="0.0" TOTAL_1="321" TOTAL_2="304" WEIGHT="54.6477565762393" Z="4.067813876943363">
<NAME>training delivered to both patient and carer/health professional</NAME>
<DICH_DATA CI_END="0.9810432776027886" CI_START="0.5080999045842839" EFFECT_SIZE="0.7060226595110316" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="43" LOG_CI_END="-0.00831183379282407" LOG_CI_START="-0.29405088664554546" LOG_EFFECT_SIZE="-0.15118136021918477" MODIFIED="2012-08-20 10:51:41 +0100" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="0.1678445340768118" STUDY_ID="STD-Bauml-2007" TOTAL_1="78" TOTAL_2="74" VAR="0.02817178761946204" WEIGHT="11.346151220822637">
<FOOTNOTE>
Data from 
Pitschel-Walz
 2006.
</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.1242522280876854" CI_START="0.28143706731913376" EFFECT_SIZE="0.5625" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="16" LOG_CI_END="0.0508637569428731" LOG_CI_START="-0.5506187033760729" LOG_EFFECT_SIZE="-0.2498774732165999" MODIFIED="2012-07-25 10:33:26 +0100" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.3533137745775461" STUDY_ID="STD-Herz-2000" TOTAL_1="41" TOTAL_2="41" VAR="0.12483062330623307" WEIGHT="7.996043146108617"/>
<DICH_DATA CI_END="1.1338648164226142" CI_START="0.17369520842407266" EFFECT_SIZE="0.4437869822485207" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.054561279441063405" LOG_CI_START="-0.7602121618850104" LOG_EFFECT_SIZE="-0.3528254412219735" MODIFIED="2012-07-25 10:33:33 +0100" MODIFIED_BY="[Empty name]" ORDER="303" O_E="0.0" SE="0.4786019526285168" STUDY_ID="STD-Kopelowicz-2003" TOTAL_1="39" TOTAL_2="45" VAR="0.22905982905982905" WEIGHT="6.065010297577875"/>
<DICH_DATA CI_END="1.072669653895185" CI_START="0.44619543957729896" EFFECT_SIZE="0.6918238993710691" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="24" LOG_CI_END="0.03046599449181497" LOG_CI_START="-0.35047487281626793" LOG_EFFECT_SIZE="-0.16000443916222648" MODIFIED="2012-09-04 11:57:35 +0100" MODIFIED_BY="[Empty name]" ORDER="302" O_E="0.0" SE="0.22376655114447302" STUDY_ID="STD-McDonell-2006" TOTAL_1="53" TOTAL_2="44" VAR="0.050071469411092064" WEIGHT="10.362493086804617"/>
<DICH_DATA CI_END="2.410322264637571" CI_START="0.4553356557486173" EFFECT_SIZE="1.0476190476190477" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.38207511244917736" LOG_CI_START="-0.34166834027260334" LOG_EFFECT_SIZE="0.02020338608828699" MODIFIED="2012-08-30 09:16:31 +0100" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="0.42513048671664416" STUDY_ID="STD-Merinder-1999" TOTAL_1="24" TOTAL_2="22" VAR="0.18073593073593075" WEIGHT="6.829706843933069"/>
<DICH_DATA CI_END="0.9929254369809375" CI_START="0.123372808710058" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="-0.003083363310827761" LOG_CI_START="-0.9087805479886212" LOG_EFFECT_SIZE="-0.4559319556497244" MODIFIED="2012-07-25 10:33:48 +0100" MODIFIED_BY="[Empty name]" ORDER="299" O_E="0.0" SE="0.5320110095531053" STUDY_ID="STD-Xiong-1994" TOTAL_1="32" TOTAL_2="28" VAR="0.2830357142857143" WEIGHT="5.390823848690089"/>
<DICH_DATA CI_END="0.8170901458060854" CI_START="0.14755198336898162" EFFECT_SIZE="0.3472222222222222" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.08773002710716853" LOG_CI_START="-0.8310549484112931" LOG_EFFECT_SIZE="-0.45939248775923086" MODIFIED="2012-07-25 10:33:52 +0100" MODIFIED_BY="[Empty name]" ORDER="402" O_E="0.0" SE="0.43663273829174576" STUDY_ID="STD-Zhang-2004" TOTAL_1="54" TOTAL_2="50" VAR="0.19064814814814815" WEIGHT="6.65752813230239"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.489042102487294" CI_END="1.359493534013267" CI_START="0.4940648130497558" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.819559588269588" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="45" I2="77.72353261187017" I2_Q="77.67000257056016" ID="CMP-001.04" LOG_CI_END="0.1333771463486486" LOG_CI_START="-0.3062160751583103" LOG_EFFECT_SIZE="-0.08641946440483085" METHOD="MH" MODIFIED="2013-01-07 11:40:12 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.03411283242421981" P_Q="0.034328279031009545" P_Z="0.4409338991578692" Q="4.478280855875072" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10438545539574327" TOTALS="YES" TOTAL_1="97" TOTAL_2="59" WEIGHT="100.0" Z="0.770617150173815">
<NAME>Service use: 1b. Re-hospitalisation (5-7 year follow-up)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3574101822322449" CI_START="0.7949933021065312" DF="0" EFFECT_SIZE="1.038812785388128" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="24" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.1327111026060681" LOG_CI_START="-0.09963653030004235" LOG_EFFECT_SIZE="0.016537286153012906" MODIFIED="2012-10-03 22:45:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.780244888038518" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="35" WEIGHT="54.203428682506186" Z="0.2789999179809663">
<NAME>training delivered to patient only</NAME>
<DICH_DATA CI_END="1.3574101822322449" CI_START="0.7949933021065312" EFFECT_SIZE="1.038812785388128" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="24" LOG_CI_END="0.1327111026060681" LOG_CI_START="-0.09963653030004235" LOG_EFFECT_SIZE="0.016537286153012906" MODIFIED="2012-08-28 12:43:57 +0100" MODIFIED_BY="[Empty name]" ORDER="419" O_E="0.0" SE="0.13648214970838138" STUDY_ID="STD-Buchkremer-1997" TOTAL_1="73" TOTAL_2="35" VAR="0.018627377189021025" WEIGHT="54.203428682506186"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9215470921862061" CI_START="0.41584413634186085" DF="0" EFFECT_SIZE="0.6190476190476191" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="21" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-0.03548246689738357" LOG_CI_START="-0.3810694179567814" LOG_EFFECT_SIZE="-0.20827594242708247" MODIFIED="2012-10-03 22:47:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.018155327272269255" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="24" WEIGHT="45.79657131749381" Z="2.3624349516197896">
<NAME>training delivered to both patient and carer/health professional</NAME>
<DICH_DATA CI_END="0.9215470921862061" CI_START="0.41584413634186085" EFFECT_SIZE="0.6190476190476191" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="21" LOG_CI_END="-0.03548246689738357" LOG_CI_START="-0.3810694179567814" LOG_EFFECT_SIZE="-0.20827594242708247" MODIFIED="2012-08-28 12:46:25 +0100" MODIFIED_BY="[Empty name]" ORDER="420" O_E="0.0" SE="0.20299948573528756" STUDY_ID="STD-Bauml-2007" TOTAL_1="24" TOTAL_2="24" VAR="0.04120879120879122" WEIGHT="45.79657131749381"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<IV_OUTCOME CHI2="29.56845113448292" CI_END="1.040886032720605" CI_START="0.32630989786527237" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="0.5827962036822556" ESTIMABLE="YES" I2="83.09008484327079" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.017403180932150725" LOG_CI_START="-0.4863697526813993" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.23448328587462433" MODIFIED="2013-01-07 11:41:06 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.793224320889575E-5" P_Q="0.5452285182105231" P_Z="0.06806935890928464" Q="0.36593530076788927" RANDOM="YES" SCALE="16.82" SHOW_PARTICIPANTS="YES" SORT_BY="WEIGHT" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.3793824042735471" TOTALS="YES" TOTAL_1="567" TOTAL_2="582" WEIGHT="99.99999999999999" Z="1.824547388817921">
<NAME>Service use: 2. Time to re-hospitalisation</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="18.740756539393146" CI_END="1.946579954620893" CI_START="0.06852367892122103" DF="2" EFFECT_SIZE="0.36522160369415047" ESTIMABLE="YES" I2="89.32807223766025" ID="CMP-001.05.01" LOG_CI_END="0.2892722468096474" LOG_CI_START="-1.1641593285393492" LOG_EFFECT_SIZE="-0.43744354086485093" MODIFIED="2012-10-03 22:45:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="8.521157991447925E-5" P_Z="0.23808291124901904" STUDIES="3" TAU2="1.903753785644051" TOTAL_1="236" TOTAL_2="173" WEIGHT="43.43147356313716" Z="1.179792155208836">
<NAME>training delivered to patient only</NAME>
<IV_DATA CI_END="0.3792245946329777" CI_START="0.02085058343656764" EFFECT_SIZE="0.08892161745938634" ESTIMABLE="YES" ESTIMATE="-2.42" LOG_CI_END="-0.421103504226876" LOG_CI_START="-1.6808817881848628" LOG_EFFECT_SIZE="-1.0509926462058694" MODIFIED="2012-08-31 09:37:07 +0100" MODIFIED_BY="[Empty name]" ORDER="292" SE="0.74" STUDY_ID="STD-Xiang-2001" TOTAL_1="66" TOTAL_2="67" WEIGHT="9.446553185551071">
<FOOTNOTE>Data imputed from using method 7 from Tierney 2007</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="0.9197795574467702" CI_START="0.0910470611291471" EFFECT_SIZE="0.28938421793905067" ESTIMABLE="YES" ESTIMATE="-1.24" LOG_CI_END="-0.03631624706326726" LOG_CI_START="-1.0407340680567974" LOG_EFFECT_SIZE="-0.5385251575600323" MODIFIED="2012-08-31 09:37:06 +0100" MODIFIED_BY="[Empty name]" ORDER="340" SE="0.59" STUDY_ID="STD-Gumley-2003" TOTAL_1="72" TOTAL_2="72" WEIGHT="12.037113932376775">
<FOOTNOTE>Data log transformed</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.776055613230469" CI_START="1.0259356671136302" EFFECT_SIZE="1.3498588075760032" ESTIMABLE="YES" ESTIMATE="0.3" LOG_CI_END="0.2494565606210554" LOG_CI_START="0.01112012852089565" LOG_EFFECT_SIZE="0.13028834457097557" MODIFIED="2012-08-31 09:37:07 +0100" MODIFIED_BY="[Empty name]" ORDER="350" SE="0.14" STUDY_ID="STD-Buchkremer-1997" TOTAL_1="98" TOTAL_2="34" WEIGHT="21.947806445209316">
<FOOTNOTE>
Data log transformed
</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.7055376986054092" CI_END="0.8328874020129022" CI_START="0.4573563569677779" DF="2" EFFECT_SIZE="0.6171923103449831" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="-0.07941370686423403" LOG_CI_START="-0.3397452801148716" LOG_EFFECT_SIZE="-0.20957949348955285" MODIFIED="2012-10-03 22:47:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.42623342731120417" P_Z="0.0016009622136070507" STUDIES="3" TAU2="0.0" TOTAL_1="331" TOTAL_2="409" WEIGHT="56.568526436862825" Z="3.1557313929201967">
<NAME>training delivered to both patient and carer/health professional</NAME>
<IV_DATA CI_END="2.190184077208606" CI_START="0.45658262718926435" EFFECT_SIZE="1.0" ESTIMABLE="YES" ESTIMATE="0.0" LOG_CI_END="0.34048061728594237" LOG_CI_START="-0.3404806172859424" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-08-28 13:24:46 +0100" MODIFIED_BY="[Empty name]" ORDER="26" SE="0.4" STUDY_ID="STD-Herz-2000" TOTAL_1="41" TOTAL_2="41" WEIGHT="16.234842877075153">
<FOOTNOTE>Data log transformed</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="0.9112476427589171" CI_START="0.35805831402228516" EFFECT_SIZE="0.5712090638488149" ESTIMABLE="YES" ESTIMATE="-0.56" LOG_CI_END="-0.04036358211772087" LOG_CI_START="-0.4460462376139212" LOG_EFFECT_SIZE="-0.24320490986582102" MODIFIED="2012-08-30 11:41:02 +0100" MODIFIED_BY="[Empty name]" ORDER="1" SE="0.23829999999999998" STUDY_ID="STD-Turkington-2006" TOTAL_1="165" TOTAL_2="257" WEIGHT="20.076581957986654">
<FOOTNOTE>Data imputed using method 3 from Tierney 2007</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="0.8876229042524713" CI_START="0.3603095642125703" EFFECT_SIZE="0.5655254386995371" ESTIMABLE="YES" ESTIMATE="-0.57" LOG_CI_END="-0.051771499745436614" LOG_CI_START="-0.4433242096242704" LOG_EFFECT_SIZE="-0.24754785468485355" MODIFIED="2012-08-30 11:41:01 +0100" MODIFIED_BY="[Empty name]" ORDER="351" SE="0.23" STUDY_ID="STD-Bauml-2007" TOTAL_1="125" TOTAL_2="111" WEIGHT="20.257101601801022">
<FOOTNOTE>Data imputed from using method 7 from Tierney 2007</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="138.02498060947477" CI_END="-0.8957257815465254" CI_START="-8.20574214317358" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_SIZE="-4.550733962360053" ESTIMABLE="YES" I2="93.47944121400428" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="NaN" LOG_CI_START="NaN" LOG_DATA="NO" LOG_EFFECT_SIZE="NaN" MODIFIED="2012-12-12 12:15:01 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="-1.3322676295501878E-15" P_Q="1.0" P_Z="0.014675533926528185" Q="0.0" RANDOM="YES" SCALE="27.28" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="30.460178324669293" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.440288565226608">
<NAME>Mental state: general 1a. Average score (BPRS, high = bad)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_DATA CI_END="6.150087313511322" CI_START="-6.550087313511322" EFFECT_SIZE="-0.2" ESTIMABLE="YES" ESTIMATE="-0.2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-23 11:27:50 +0100" MODIFIED_BY="[Empty name]" ORDER="280" SE="3.2399" STUDY_ID="STD-Bauml-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.490846790700699"/>
<IV_DATA CI_END="3.479913508521687" CI_START="-7.239913508521687" EFFECT_SIZE="-1.88" ESTIMABLE="YES" ESTIMATE="-1.88" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-23 11:28:19 +0100" MODIFIED_BY="[Empty name]" ORDER="281" SE="2.7347" STUDY_ID="STD-Bradley-2006" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.166369605245027"/>
<IV_DATA CI_END="1.9500409284089433" CI_START="-5.350040928408943" EFFECT_SIZE="-1.7" ESTIMABLE="YES" ESTIMATE="-1.7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-23 11:28:43 +0100" MODIFIED_BY="[Empty name]" ORDER="282" SE="1.8623" STUDY_ID="STD-Buchkremer-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.249859633805329"/>
<IV_DATA CI_END="1.8200271043578162" CI_START="-7.420027104357816" EFFECT_SIZE="-2.8" ESTIMABLE="YES" ESTIMATE="-2.8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-23 11:29:12 +0100" MODIFIED_BY="[Empty name]" ORDER="283" SE="2.3572" STUDY_ID="STD-Kuipers-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.655575671655024"/>
<IV_DATA CI_END="0.26220461964233355" CI_START="-7.942204619642333" EFFECT_SIZE="-3.84" ESTIMABLE="YES" ESTIMATE="-3.84" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-24 16:35:41 +0100" MODIFIED_BY="[Empty name]" ORDER="279" SE="2.093" STUDY_ID="STD-Li-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.981413914709272">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="5.1221753338904135" CI_START="-3.222175333890413" EFFECT_SIZE="0.95" ESTIMABLE="YES" ESTIMATE="0.95" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-09-20 09:13:44 +0100" MODIFIED_BY="[Empty name]" ORDER="740" SE="2.1287" STUDY_ID="STD-Liberman-1998" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.938422219650892">
<FOOTNOTE>Change data; number of participants in each group not reported, assumed to be 40.</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.689923785401263" CI_START="-6.169923785401263" EFFECT_SIZE="-2.24" ESTIMABLE="YES" ESTIMATE="-2.24" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-23 11:29:43 +0100" MODIFIED_BY="[Empty name]" ORDER="284" SE="2.0051" STUDY_ID="STD-Merinder-1999" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.085690937521454"/>
<IV_DATA CI_END="-4.139972259134888" CI_START="-12.44002774086511" EFFECT_SIZE="-8.29" ESTIMABLE="YES" ESTIMATE="-8.29" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-26 08:00:14 +0100" MODIFIED_BY="[Empty name]" ORDER="285" SE="2.1174" STUDY_ID="STD-Shin-2002" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.952068646232204"/>
<IV_DATA CI_END="-6.929943338018044" CI_START="-9.470056661981955" EFFECT_SIZE="-8.2" ESTIMABLE="YES" ESTIMATE="-8.2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-03 23:13:41 +0100" MODIFIED_BY="[Empty name]" ORDER="286" SE="0.648" STUDY_ID="STD-Xiang-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.261651280658022"/>
<IV_DATA CI_END="-13.300014460558423" CI_START="-16.179985539441578" EFFECT_SIZE="-14.74" ESTIMABLE="YES" ESTIMATE="-14.74" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-03 23:13:42 +0100" MODIFIED_BY="[Empty name]" ORDER="287" SE="0.7347" STUDY_ID="STD-Zhan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.218101299822074"/>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="46.18916056757256" CI_END="4.085638060958394" CI_START="-15.863088961607886" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.888725450324746" ESTIMABLE="YES" I2="91.33995952546444" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2012-12-12 12:15:13 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="2.249450292701738E-9" P_Q="1.0" P_Z="0.2472170373558812" Q="0.0" RANDOM="YES" SCALE="39.52" SORT_BY="WEIGHT" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="111.63163421348723" TOTALS="YES" TOTAL_1="200" TOTAL_2="185" UNITS="" WEIGHT="100.00000000000001" Z="1.1571354687870352">
<NAME>Mental state: general 1b. Average score (PANSS, high = bad)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_DATA CI_END="10.725058832700533" CI_START="-13.985058832700538" EFFECT_SIZE="-1.6300000000000026" ESTIMABLE="YES" MEAN_1="54.41" MEAN_2="56.04" MODIFIED="2012-07-23 12:33:17 +0100" MODIFIED_BY="[Empty name]" ORDER="87" SD_1="16.7" SD_2="18.02" SE="6.3037172775396195" STUDY_ID="STD-Garety-2008" TOTAL_1="22" TOTAL_2="12" WEIGHT="17.109555832750996">
<FOOTNOTE>Carer pathway, patient intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="11.653341155741685" CI_START="-12.733341155741684" EFFECT_SIZE="-0.5399999999999991" ESTIMABLE="YES" MEAN_1="55.5" MEAN_2="56.04" MODIFIED="2012-07-23 12:33:17 +0100" MODIFIED_BY="[Empty name]" ORDER="232" SD_1="15.26" SD_2="18.02" SE="6.22120674253262" STUDY_ID="STD-Garety-2008" TOTAL_1="20" TOTAL_2="12" WEIGHT="17.227170910273145">
<FOOTNOTE>Carer pathway, family intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="2.7975299186974967" CI_START="-9.397529918697504" EFFECT_SIZE="-3.3000000000000043" ESTIMABLE="YES" MEAN_1="54.3" MEAN_2="57.6" MODIFIED="2012-07-23 12:33:17 +0100" MODIFIED_BY="[Empty name]" ORDER="360" SD_1="12.8" SD_2="15.7" SE="3.111041818520156" STUDY_ID="STD-Kopelowicz-2003" TOTAL_1="39" TOTAL_2="45" WEIGHT="21.34896512332931"/>
<CONT_DATA CI_END="-16.460147769027348" CI_START="-25.879852230972656" EFFECT_SIZE="-21.17" ESTIMABLE="YES" MEAN_1="31.17" MEAN_2="52.34" MODIFIED="2012-09-12 13:16:33 +0100" MODIFIED_BY="[Empty name]" ORDER="106" SD_1="3.13" SD_2="13.02" SE="2.403029988368851" STUDY_ID="STD-Chen-2003" TOTAL_1="32" TOTAL_2="31" WEIGHT="22.058867736045904"/>
<CONT_DATA CI_END="3.626043014515985" CI_START="-4.906043014515986" EFFECT_SIZE="-0.6400000000000006" ESTIMABLE="YES" MEAN_1="56.68" MEAN_2="57.32" MODIFIED="2012-07-23 12:33:17 +0100" MODIFIED_BY="[Empty name]" ORDER="88" SD_1="12.98" SD_2="15.43" SE="2.1765925538254725" STUDY_ID="STD-Garety-2008" TOTAL_1="87" TOTAL_2="85" WEIGHT="22.255440397600648">
<FOOTNOTE>No carer pathway</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="-1.1300270115949593" CI_START="-4.069972988405041" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="-2.6" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="NaN" LOG_CI_START="NaN" LOG_DATA="NO" LOG_EFFECT_SIZE="NaN" MODIFIED="2012-12-12 12:15:23 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="5.269549312097496E-4" Q="0.0" RANDOM="NO" SCALE="14.86" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="72" TOTAL_2="51" WEIGHT="100.0" Z="3.466666666666667">
<NAME>Mental state: general 1c. Average score (KGV, high = bad)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_DATA CI_END="-1.1300270115949593" CI_START="-4.069972988405041" EFFECT_SIZE="-2.6" ESTIMABLE="YES" ESTIMATE="-2.6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-23 11:45:45 +0100" MODIFIED_BY="[Empty name]" ORDER="263" SE="0.75" STUDY_ID="STD-Harris-2009" TOTAL_1="72" TOTAL_2="51" WEIGHT="100.0">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="37.41206722544125" CI_END="-0.6190816624231872" CI_START="-2.5611081448285606" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.590094903625874" ESTIMABLE="YES" I2="81.28945947354707" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2012-12-12 12:15:54 +0000" MODIFIED_BY="[Empty name]" NO="9" NOTES="&lt;p&gt;need to put a footnote or explanation in text about why Garety trial in this 3 times - also n's for this trial - 2 of them in the high 20's 1 is 87 - is this correct or - should 87 be divided by 3?&lt;/p&gt;" NOTES_MODIFIED="2012-12-12 12:15:54 +0000" NOTES_MODIFIED_BY="[Empty name]" P_CHI2="3.918523554635733E-6" P_Q="0.39746125184379144" P_Z="0.001329366386160277" Q="1.8453159273530284" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="3.619833050479434" TOTALS="SUB" TOTAL_1="357" TOTAL_2="319" UNITS="" WEIGHT="300.0" Z="3.2095635886976184">
<NAME>Mental state: specific 2. Average score in positive symptoms (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.7169923415786483" CI_START="-3.516992341578649" DF="0" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" MODIFIED="2012-12-12 12:15:36 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5002834420703011" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="31" WEIGHT="100.0" Z="0.6740438472288273">
<NAME>BPRS (high = bad)</NAME>
<CONT_DATA CI_END="1.7169923415786483" CI_START="-3.516992341578649" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" MEAN_1="9.7" MEAN_2="10.6" MODIFIED="2011-05-15 12:08:02 +0100" MODIFIED_BY="[Empty name]" ORDER="350" SD_1="3.1" SD_2="6.8" SE="1.335224709342187" STUDY_ID="STD-Chien-2004" TOTAL_1="33" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="36.0693646781682" CI_END="1.8740060360503192" CI_START="-2.701540694677147" DF="5" EFFECT_SIZE="-0.41376732931341387" ESTIMABLE="YES" I2="86.13782071125205" ID="CMP-001.09.02" MODIFIED="2012-12-12 12:15:45 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="9.199473423038285E-7" P_Z="0.7229794654350054" STUDIES="4" TAU2="6.267062125310931" TOTAL_1="270" TOTAL_2="238" WEIGHT="100.00000000000001" Z="0.3544796332151894">
<NAME>PANSS positive (high = bad)</NAME>
<CONT_DATA CI_END="-3.4675821599273933" CI_START="-6.572417840072606" EFFECT_SIZE="-5.02" ESTIMABLE="YES" MEAN_1="7.34" MEAN_2="12.36" MODIFIED="2012-08-28 10:50:24 +0100" MODIFIED_BY="[Empty name]" ORDER="107" SD_1="1.08" SD_2="4.28" SE="0.7920644727749491" STUDY_ID="STD-Chen-2003" TOTAL_1="32" TOTAL_2="31" WEIGHT="19.762030285907404"/>
<CONT_DATA CI_END="2.561089164469733" CI_START="-1.1610891644697343" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="16.02" MEAN_2="15.32" MODIFIED="2012-07-25 11:00:04 +0100" MODIFIED_BY="[Empty name]" ORDER="89" SD_1="6.44" SD_2="6.01" SE="0.9495527362491185" STUDY_ID="STD-Garety-2008" TOTAL_1="87" TOTAL_2="85" WEIGHT="19.005909290664032">
<FOOTNOTE>No carer pathway</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="4.36324548218514" CI_START="-4.383245482185139" EFFECT_SIZE="-0.009999999999999787" ESTIMABLE="YES" MEAN_1="14.23" MEAN_2="14.24" MODIFIED="2012-07-25 11:00:03 +0100" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="6.41" SD_2="6.11" SE="2.231288695445805" STUDY_ID="STD-Garety-2008" TOTAL_1="22" TOTAL_2="12" WEIGHT="12.115543028896482">
<FOOTNOTE>Carer pathway, patient intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="6.723045489496189" CI_START="-2.1630454894961906" EFFECT_SIZE="2.2799999999999994" ESTIMABLE="YES" MEAN_1="16.52" MEAN_2="14.24" MODIFIED="2012-07-25 11:00:05 +0100" MODIFIED_BY="[Empty name]" ORDER="91" SD_1="6.9" SD_2="6.11" SE="2.266901598469342" STUDY_ID="STD-Garety-2008" TOTAL_1="21" TOTAL_2="13" WEIGHT="11.945382692205664">
<FOOTNOTE>Carer pathway, family intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-0.06648392901137457" CI_START="-1.9935160709886277" EFFECT_SIZE="-1.0300000000000011" ESTIMABLE="YES" MEAN_1="8.85" MEAN_2="9.88" MODIFIED="2011-05-15 14:01:12 +0100" MODIFIED_BY="[Empty name]" ORDER="364" SD_1="2.09" SD_2="3.61" SE="0.4915988653815674" STUDY_ID="STD-Gumley-2003" TOTAL_1="72" TOTAL_2="72" WEIGHT="20.933095566494003"/>
<CONT_DATA CI_END="5.256172605362998" CI_START="-0.456172605362994" EFFECT_SIZE="2.400000000000002" ESTIMABLE="YES" MEAN_1="16.6" MEAN_2="14.2" MODIFIED="2011-05-16 13:14:31 +0100" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="6.0" SD_2="5.3" SE="1.4572576985557495" STUDY_ID="STD-Vreeland-2006" TOTAL_1="36" TOTAL_2="25" WEIGHT="16.23803913583243"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.8643583599464444" CI_START="-3.215641640053554" DF="0" EFFECT_SIZE="-2.039999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.03" MODIFIED="2012-12-12 12:15:54 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="6.7146239526545E-4" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="50" WEIGHT="100.0" Z="3.400973895650354">
<NAME>SAPS (high = bad)</NAME>
<CONT_DATA CI_END="-0.8643583599464444" CI_START="-3.215641640053554" EFFECT_SIZE="-2.039999999999999" ESTIMABLE="YES" MEAN_1="9.98" MEAN_2="12.02" MODIFIED="2012-07-17 12:45:59 +0100" MODIFIED_BY="[Empty name]" ORDER="396" SD_1="2.69" SD_2="3.36" SE="0.5998281852762938" STUDY_ID="STD-Zhang-2004" TOTAL_1="54" TOTAL_2="50" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="290.7881365583207" CI_END="1.4527052479295346" CI_START="-3.214419542524415" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8808571472974404" ESTIMABLE="YES" I2="97.24885612780302" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2012-12-12 12:16:11 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.1102230246251565E-15" P_Q="0.5862032170418768" P_Z="0.45940086595408514" Q="0.2963129872482744" RANDOM="YES" SCALE="20.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="38.16206819561281" TOTALS="SUB" TOTAL_1="370" TOTAL_2="332" UNITS="" WEIGHT="200.0" Z="0.7398337785005972">
<NAME>Mental state: specific 3. Average score in negative symptoms (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="34.48719519922765" CI_END="1.6408931684333048" CI_START="-3.1290412425883343" DF="5" EFFECT_SIZE="-0.7440740370775146" ESTIMABLE="YES" I2="85.50186534127897" ID="CMP-001.10.01" MODIFIED="2012-12-12 12:16:02 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.9042003663871654E-6" P_Z="0.5408822557008591" STUDIES="4" TAU2="7.061987159566221" TOTAL_1="270" TOTAL_2="238" WEIGHT="99.99999999999999" Z="0.6114793994372322">
<NAME>PANSS negative (high = bad)</NAME>
<CONT_DATA CI_END="-3.7524374503436775" CI_START="-7.2475625496563225" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="7.76" MEAN_2="13.26" MODIFIED="2012-08-28 10:54:18 +0100" MODIFIED_BY="[Empty name]" ORDER="108" SD_1="2.13" SD_2="4.5" SE="0.8916299296522144" STUDY_ID="STD-Chen-2003" TOTAL_1="32" TOTAL_2="31" WEIGHT="18.845704649599725"/>
<CONT_DATA CI_END="1.2322719654214969" CI_START="-1.772271965421496" EFFECT_SIZE="-0.2699999999999996" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="11.91" MODIFIED="2012-07-24 17:38:51 +0100" MODIFIED_BY="[Empty name]" ORDER="92" SD_1="4.83" SD_2="5.21" SE="0.7664793727186958" STUDY_ID="STD-Garety-2008" TOTAL_1="87" TOTAL_2="85" WEIGHT="19.356946661246607">
<FOOTNOTE>No carer pathway</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="5.534496760378656" CI_START="-3.394496760378659" EFFECT_SIZE="1.0699999999999985" ESTIMABLE="YES" MEAN_1="12.95" MEAN_2="11.88" MODIFIED="2012-07-24 17:38:51 +0100" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="8.09" SD_2="5.19" SE="2.277846325541713" STUDY_ID="STD-Garety-2008" TOTAL_1="21" TOTAL_2="13" WEIGHT="12.086827056794338">
<FOOTNOTE>Carer pathway, family intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="3.7601515161467556" CI_START="-3.1601515161467577" EFFECT_SIZE="0.29999999999999893" ESTIMABLE="YES" MEAN_1="12.18" MEAN_2="11.88" MODIFIED="2012-07-24 17:38:50 +0100" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="4.38" SD_2="5.19" SE="1.765415866536319" STUDY_ID="STD-Garety-2008" TOTAL_1="22" TOTAL_2="12" WEIGHT="14.547124830498346">
<FOOTNOTE>Carer pathway, patient intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-0.11545042003081707" CI_START="-3.2245495799691826" EFFECT_SIZE="-1.67" ESTIMABLE="YES" MEAN_1="10.55" MEAN_2="12.22" MODIFIED="2011-05-15 14:01:55 +0100" MODIFIED_BY="[Empty name]" ORDER="365" SD_1="4.07" SD_2="5.36" SE="0.7931521151568455" STUDY_ID="STD-Gumley-2003" TOTAL_1="72" TOTAL_2="72" WEIGHT="19.252248432307088"/>
<CONT_DATA CI_END="6.0360888507536155" CI_START="0.16391114924638384" EFFECT_SIZE="3.0999999999999996" ESTIMABLE="YES" MEAN_1="18.0" MEAN_2="14.9" MODIFIED="2011-05-16 13:15:17 +0100" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="6.9" SD_2="4.8" SE="1.4980320423809366" STUDY_ID="STD-Vreeland-2006" TOTAL_1="36" TOTAL_2="25" WEIGHT="15.911148369553885"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="162.3642996259604" CI_END="7.348749468001347" CI_START="-15.25219575330416" DF="2" EFFECT_SIZE="-3.9517231426514074" ESTIMABLE="YES" I2="98.7682021204123" ID="CMP-001.10.02" MODIFIED="2012-12-12 12:16:11 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="-4.440892098500626E-16" P_Z="0.49309762761883913" STUDIES="3" TAU2="93.45121753591552" TOTAL_1="100" TOTAL_2="94" WEIGHT="100.0" Z="0.6853903640427307">
<NAME>SANS (high = bad)</NAME>
<CONT_DATA CI_END="14.592759555429526" CI_START="-2.912759555429526" EFFECT_SIZE="5.84" ESTIMABLE="YES" MEAN_1="32.78" MEAN_2="26.94" MODIFIED="2011-05-19 10:26:39 +0100" MODIFIED_BY="[Empty name]" ORDER="223" SD_1="15.31" SD_2="15.59" SE="4.465775710405995" STUDY_ID="STD-Bradley-2006" TOTAL_1="25" TOTAL_2="23" WEIGHT="29.316055729773176"/>
<CONT_DATA CI_END="0.37785651091308425" CI_START="-2.7778565109130846" EFFECT_SIZE="-1.2000000000000002" ESTIMABLE="YES" MEAN_1="7.2" MEAN_2="8.4" MODIFIED="2011-05-16 10:19:17 +0100" MODIFIED_BY="[Empty name]" ORDER="54" SD_1="2.0" SD_2="3.1" SE="0.8050436249640377" STUDY_ID="STD-McDonell-2006" TOTAL_1="21" TOTAL_2="21" WEIGHT="35.327310892639176"/>
<CONT_DATA CI_END="-13.340187723706292" CI_START="-16.29981227629371" EFFECT_SIZE="-14.82" ESTIMABLE="YES" MEAN_1="8.64" MEAN_2="23.46" MODIFIED="2012-08-28 10:55:03 +0100" MODIFIED_BY="[Empty name]" ORDER="397" SD_1="3.26" SD_2="4.32" SE="0.7550201370873544" STUDY_ID="STD-Zhang-2004" TOTAL_1="54" TOTAL_2="50" WEIGHT="35.356633377587656"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.009586951605660652" CI_END="0.8197224362626078" CI_START="0.5702277101077995" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6836873903722471" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="81" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-0.0863331778672714" LOG_CI_START="-0.2439516820554923" LOG_EFFECT_SIZE="-0.16514242996138187" METHOD="MH" MODIFIED="2012-10-03 22:55:15 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.9220013938079825" P_Q="1.0" P_Z="4.0075162938566006E-5" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="93" TOTAL_2="92" WEIGHT="100.0" Z="4.10704589173389">
<NAME>Social functioning: 1a. Not employed</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9266753753752872" CI_START="0.5167015175191961" EFFECT_SIZE="0.6919642857142857" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="28" LOG_CI_END="-0.03307237737029864" LOG_CI_START="-0.286760262957444" LOG_EFFECT_SIZE="-0.15991632016387133" MODIFIED="2012-07-17 09:46:04 +0100" MODIFIED_BY="[Empty name]" ORDER="113" O_E="0.0" SE="0.14901751976917574" STUDY_ID="STD-Chen-2003" TOTAL_1="32" TOTAL_2="31" VAR="0.022206221198156684" WEIGHT="34.924965893587995"/>
<DICH_DATA CI_END="0.8555256532381434" CI_START="0.5392873407794285" EFFECT_SIZE="0.6792452830188679" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="53" LOG_CI_END="-0.06776696345457854" LOG_CI_START="-0.2681797742124251" LOG_EFFECT_SIZE="-0.1679733688335018" MODIFIED="2011-05-16 14:31:39 +0100" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.11772347709857205" STUDY_ID="STD-Weng-2005" TOTAL_1="61" TOTAL_2="61" VAR="0.013858817060178018" WEIGHT="65.075034106412"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="33.415068453147555" CI_END="1.1901064264021537" CI_START="-0.5139628729936099" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="0.33807177670427196" ESTIMABLE="YES" I2="67.08071983924413" I2_Q="80.96467321102003" ID="CMP-001.12" MODIFIED="2013-01-07 11:05:31 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="4.505427165722997E-4" P_Q="2.0161188359235638E-5" P_Z="0.4367589378962934" Q="31.520341449948468" RANDOM="NO" SCALE="59.93" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="442" TOTAL_2="395" UNITS="" WEIGHT="700.0" Z="0.7776778875891855">
<NAME>Social functioning: 2a. Average scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours EWS + TAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.9511502894125337" CI_END="8.851761433730738" CI_START="-3.8366319816656005" DF="1" EFFECT_SIZE="2.507564726032569" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" MODIFIED="2012-12-12 12:16:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.329426851726659" P_Z="0.43852745124637005" STUDIES="2" TAU2="0.0" TOTAL_1="46" TOTAL_2="42" WEIGHT="100.0" Z="0.7746822455809493">
<NAME>GAF (high = good)</NAME>
<CONT_DATA CI_END="8.533859336517851" CI_START="-10.73385933651784" EFFECT_SIZE="-1.0999999999999943" ESTIMABLE="YES" MEAN_1="61.7" MEAN_2="62.8" MODIFIED="2012-10-10 09:54:03 +0100" MODIFIED_BY="[Empty name]" ORDER="342" SD_1="19.3" SD_2="14.4" SE="4.915324675610623" STUDY_ID="STD-Bauml-2007" TOTAL_1="24" TOTAL_2="24" WEIGHT="43.366330831513864"/>
<CONT_DATA CI_END="13.700227416890193" CI_START="-3.1602274168901943" EFFECT_SIZE="5.27" ESTIMABLE="YES" MEAN_1="9.77" MEAN_2="4.5" MODIFIED="2012-10-10 09:54:11 +0100" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="14.75" SD_2="12.45" SE="4.301215473032541" STUDY_ID="STD-Merinder-1999" TOTAL_1="22" TOTAL_2="18" WEIGHT="56.63366916848613">
<FOOTNOTE>Change data</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13810691264837782" CI_START="-12.338106912648382" DF="0" EFFECT_SIZE="-6.100000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.02" MODIFIED="2012-12-12 12:16:33 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.05529234303286483" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="25" WEIGHT="100.0" Z="1.9165718820004198">
<NAME>GAF-DIS (high = good)</NAME>
<CONT_DATA CI_END="0.13810691264837782" CI_START="-12.338106912648382" EFFECT_SIZE="-6.100000000000001" ESTIMABLE="YES" MEAN_1="47.6" MEAN_2="53.7" MODIFIED="2012-10-10 09:46:54 +0100" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="13.2" SD_2="11.5" SE="3.1827660925679098" STUDY_ID="STD-Vreeland-2006" TOTAL_1="36" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.4018373496542211" CI_START="-0.7018373496542201" DF="0" EFFECT_SIZE="0.35000000000000053" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.03" MODIFIED="2012-12-12 12:16:44 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.5142849958562727" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="45" WEIGHT="100.0" Z="0.6521801063772175">
<NAME>ILSS (high = good)</NAME>
<CONT_DATA CI_END="1.4018373496542211" CI_START="-0.7018373496542201" EFFECT_SIZE="0.35000000000000053" ESTIMABLE="YES" MEAN_1="6.41" MEAN_2="6.06" MODIFIED="2012-10-10 09:54:18 +0100" MODIFIED_BY="[Empty name]" ORDER="366" SD_1="2.66" SD_2="2.19" SE="0.5366615702895458" STUDY_ID="STD-Kopelowicz-2003" TOTAL_1="39" TOTAL_2="45" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.8659334077733087" CI_END="7.249369477857303" CI_START="-4.036096427965165" DF="2" EFFECT_SIZE="1.6066365249460688" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.04" MODIFIED="2012-12-12 12:16:55 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6485821075714622" P_Z="0.5768075095329497" STUDIES="1" TAU2="0.0" TOTAL_1="122" TOTAL_2="102" WEIGHT="100.0" Z="0.5580540052876785">
<NAME>Time budget interview (high = good)</NAME>
<CONT_DATA CI_END="22.403163821464933" CI_START="-9.903163821464933" EFFECT_SIZE="6.25" ESTIMABLE="YES" MEAN_1="59.79" MEAN_2="53.54" MODIFIED="2012-07-16 10:52:02 +0100" MODIFIED_BY="[Empty name]" ORDER="97" SD_1="20.03" SD_2="23.7" SE="8.241561553619876" STUDY_ID="STD-Garety-2008" TOTAL_1="19" TOTAL_2="12" WEIGHT="12.20292099665995">
<FOOTNOTE>Carer pathway, family intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="6.576805515559651" CI_START="-6.496805515559639" EFFECT_SIZE="0.04000000000000625" ESTIMABLE="YES" MEAN_1="56.45" MEAN_2="56.41" MODIFIED="2012-07-16 10:51:31 +0100" MODIFIED_BY="[Empty name]" ORDER="95" SD_1="18.37" SD_2="23.38" SE="3.335166139337831" STUDY_ID="STD-Garety-2008" TOTAL_1="82" TOTAL_2="78" WEIGHT="74.51571396141097">
<FOOTNOTE>No carer pathway</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="21.613464425592028" CI_START="-9.353464425592023" EFFECT_SIZE="6.130000000000003" ESTIMABLE="YES" MEAN_1="59.67" MEAN_2="53.54" MODIFIED="2012-07-17 09:09:54 +0100" MODIFIED_BY="[Empty name]" ORDER="96" SD_1="18.1" SD_2="23.7" SE="7.899871909751208" STUDY_ID="STD-Garety-2008" TOTAL_1="21" TOTAL_2="12" WEIGHT="13.28136504192908">
<FOOTNOTE>Carer pathway, patient intervention</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.07764330601324308" CI_END="5.1305089382119355" CI_START="-2.7096483477351145" DF="2" EFFECT_SIZE="1.2104302952384103" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.05" MODIFIED="2012-12-12 12:17:04 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9619222505015985" P_Z="0.54505151020245" STUDIES="1" TAU2="0.0" TOTAL_1="126" TOTAL_2="110" WEIGHT="100.0" Z="0.6051918852995041">
<NAME>SOFAS (high = good)</NAME>
<CONT_DATA CI_END="13.983284508997425" CI_START="-8.60328450899743" EFFECT_SIZE="2.6899999999999977" ESTIMABLE="YES" MEAN_1="59.73" MEAN_2="57.04" MODIFIED="2012-07-17 09:17:17 +0100" MODIFIED_BY="[Empty name]" ORDER="99" SD_1="14.53" SD_2="16.83" SE="5.76198572936922" STUDY_ID="STD-Garety-2008" TOTAL_1="22" TOTAL_2="12" WEIGHT="12.04894496727138">
<FOOTNOTE>Carer pathway, patient intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="5.387931909210983" CI_START="-3.4479319092109852" EFFECT_SIZE="0.9699999999999989" ESTIMABLE="YES" MEAN_1="53.04" MEAN_2="52.07" MODIFIED="2012-07-17 09:16:37 +0100" MODIFIED_BY="[Empty name]" ORDER="98" SD_1="13.31" SD_2="15.96" SE="2.2540883118562722" STUDY_ID="STD-Garety-2008" TOTAL_1="85" TOTAL_2="85" WEIGHT="78.73204342124419">
<FOOTNOTE>No carer pathway</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="14.24078350654503" CI_START="-11.580783506545034" EFFECT_SIZE="1.3299999999999983" ESTIMABLE="YES" MEAN_1="58.37" MEAN_2="57.04" MODIFIED="2012-07-17 09:17:03 +0100" MODIFIED_BY="[Empty name]" ORDER="100" SD_1="20.26" SD_2="16.83" SE="6.587255484480146" STUDY_ID="STD-Garety-2008" TOTAL_1="19" TOTAL_2="13" WEIGHT="9.219011611484436">
<FOOTNOTE>Carer pathway, family intervention</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="37.96568226322495" CI_START="17.03431773677505" DF="0" EFFECT_SIZE="27.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.06" MODIFIED="2012-12-12 12:17:15 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="2.6038749057004583E-7" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="31" WEIGHT="100.0" Z="5.15007127287302">
<NAME>SLOF (high = good)</NAME>
<CONT_DATA CI_END="37.96568226322495" CI_START="17.03431773677505" EFFECT_SIZE="27.5" ESTIMABLE="YES" MEAN_1="145.5" MEAN_2="118.0" MODIFIED="2012-10-10 09:54:35 +0100" MODIFIED_BY="[Empty name]" ORDER="351" SD_1="21.4" SD_2="21.3" SE="5.339731926595036" STUDY_ID="STD-Chien-2004" TOTAL_1="33" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.7579401474232934E-33" CI_END="1.3448162473103582" CI_START="-2.2048162473103585" DF="0" EFFECT_SIZE="-0.4300000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-001.12.07" MODIFIED="2013-01-07 11:05:31 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.634888664899813" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.4748573350223831">
<NAME>SAS (high = good)</NAME>
<CONT_DATA CI_END="1.3448162473103586" CI_START="-2.2048162473103585" EFFECT_SIZE="-0.43000000000000005" ESTIMABLE="YES" MEAN_1="0.66" MEAN_2="1.09" MODIFIED="2012-10-10 09:54:41 +0100" MODIFIED_BY="[Empty name]" ORDER="356" SD_1="3.9212" SD_2="4.1742" SE="0.9055351329462595" STUDY_ID="STD-Liberman-1998" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0">
<FOOTNOTE>Change data; number of participants in each group not reported, assumed to be 40.</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="211.50789619001216" CI_END="4.808681659375688" CI_START="0.1646650580644371" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_SIZE="2.4866733587200627" ESTIMABLE="YES" I2="97.16322647613602" I2_Q="64.88017516270286" ID="CMP-001.13" LOG_CI_END="0.6820260271980157" LOG_CI_START="-0.7833985483698062" LOG_DATA="NO" LOG_EFFECT_SIZE="0.3956187415135768" MODIFIED="2012-12-12 12:17:51 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="4.440892098500626E-16" P_Q="0.057995286328281215" P_Z="0.03582089465682351" Q="5.694789223082929" RANDOM="YES" SCALE="48.91" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="273.6947790846353" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="300.0" Z="2.09895469496403">
<NAME>Social functioning: 2b. Average scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours EWS + TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="11.959973081167899" CI_START="-3.159973081167897" DF="0" EFFECT_SIZE="4.4" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.01" LOG_CI_END="1.0777302021679942" LOG_CI_START="NaN" LOG_EFFECT_SIZE="0.6434526764861874" MODIFIED="2012-12-12 12:17:33 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.253984881144786" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.1407238411282796">
<NAME>SFS (high = good)</NAME>
<IV_DATA CI_END="11.959973081167899" CI_START="-3.159973081167897" EFFECT_SIZE="4.4" ESTIMABLE="YES" ESTIMATE="4.4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 09:56:03 +0100" MODIFIED_BY="[Empty name]" ORDER="264" SE="3.8572" STUDY_ID="STD-Harris-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.8403161730414175" CI_END="4.3787626159915805" CI_START="-0.5403259355069172" DF="2" EFFECT_SIZE="1.9192183402423317" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.02" LOG_CI_END="0.641351401606967" LOG_CI_START="NaN" LOG_EFFECT_SIZE="0.28312438514109134" MODIFIED="2012-12-12 12:17:44 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.39845609768138024" P_Z="0.12616815208771454" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.5293885385323334">
<NAME>GAS (high = good)</NAME>
<IV_DATA CI_END="7.040018737000125" CI_START="-2.2400187370001245" EFFECT_SIZE="2.4" ESTIMABLE="YES" ESTIMATE="2.4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 09:56:05 +0100" MODIFIED_BY="[Empty name]" ORDER="138" SE="2.3674" STUDY_ID="STD-Buchkremer-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="28.09763854543443"/>
<IV_DATA CI_END="17.216067341885022" CI_START="-1.57606734188502" EFFECT_SIZE="7.82" ESTIMABLE="YES" ESTIMATE="7.82" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 09:56:07 +0100" MODIFIED_BY="[Empty name]" ORDER="139" SE="4.794" STUDY_ID="STD-Li-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.851995175291831">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="4.139507963545871" CI_START="-1.9595079635458703" EFFECT_SIZE="1.09" ESTIMABLE="YES" ESTIMATE="1.09" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 09:56:09 +0100" MODIFIED_BY="[Empty name]" ORDER="354" SE="1.5559" STUDY_ID="STD-Liberman-1998" TOTAL_1="0" TOTAL_2="0" WEIGHT="65.05036627927375">
<FOOTNOTE>Change data; number of participants in each group not reported, assumed to be 40.</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="50.7465672165528" CI_END="44.4840867310032" CI_START="5.748338474123603" DF="2" EFFECT_SIZE="25.1162126025634" ESTIMABLE="YES" I2="96.05884671673391" ID="CMP-001.13.03" LOG_CI_END="1.6482046788256683" LOG_CI_START="0.759542332377342" LOG_EFFECT_SIZE="1.3999541505978632" MODIFIED="2012-12-12 12:17:51 +0000" MODIFIED_BY="[Empty name]" NO="3" NOTES="&lt;p&gt;data look like change and endpoint together - &lt;/p&gt;" NOTES_MODIFIED="2012-12-12 12:17:51 +0000" NOTES_MODIFIED_BY="[Empty name]" P_CHI2="9.561462732676773E-12" P_Z="0.01103222034413606" STUDIES="3" TAU2="280.48041011665873" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.5416765827071606">
<NAME>NOSIE (high = good)</NAME>
<IV_DATA CI_END="40.25992251238667" CI_START="30.520077487613328" EFFECT_SIZE="35.39" ESTIMABLE="YES" ESTIMATE="35.39" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 09:56:11 +0100" MODIFIED_BY="[Empty name]" ORDER="140" SE="2.4847" STUDY_ID="STD-Chen-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="34.06508689308773"/>
<IV_DATA CI_END="10.464684089073895" CI_START="-6.504684089073894" EFFECT_SIZE="1.98" ESTIMABLE="YES" ESTIMATE="1.98" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 09:56:14 +0100" MODIFIED_BY="[Empty name]" ORDER="141" SE="4.329" STUDY_ID="STD-Li-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="32.63443981630947">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="44.280011370784806" CI_START="30.279988629215197" EFFECT_SIZE="37.28" ESTIMABLE="YES" ESTIMATE="37.28" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 09:56:15 +0100" MODIFIED_BY="[Empty name]" ORDER="142" SE="3.5715" STUDY_ID="STD-Zhan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="33.30047329060281"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="5.703315383426757" CI_END="0.32532715666733847" CI_START="-0.2974535329486332" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="0.013936811859352666" ESTIMABLE="YES" I2="12.331693692944254" I2_Q="30.235826298063433" ID="CMP-001.14" MODIFIED="2012-12-12 12:18:34 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.3361662293458896" P_Q="0.23081951975720993" P_Z="0.9300979769304034" Q="4.300201436940009" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="197" TOTAL_2="183" UNITS="" WEIGHT="400.0" Z="0.0877215679904453">
<NAME>Quality of life: Average scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours EWS + TAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.017811760549391" CI_START="-16.117811760549387" DF="0" EFFECT_SIZE="-5.049999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.01" MODIFIED="2012-12-12 12:18:03 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3711674962284477" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="21" WEIGHT="100.0" Z="0.8942886214606127">
<NAME>QLS (high = good)</NAME>
<CONT_DATA CI_END="6.017811760549391" CI_START="-16.117811760549387" EFFECT_SIZE="-5.049999999999997" ESTIMABLE="YES" MEAN_1="58.17" MEAN_2="63.22" MODIFIED="2012-10-10 09:59:02 +0100" MODIFIED_BY="[Empty name]" ORDER="338" SD_1="14.25" SD_2="22.34" SE="5.646946498941243" STUDY_ID="STD-Bradley-2006" TOTAL_1="25" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4990589303197668" CI_START="-1.2990589303197657" DF="0" EFFECT_SIZE="-0.39999999999999947" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.02" MODIFIED="2012-12-12 12:18:13 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3832046206768164" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="24" WEIGHT="100.0" Z="0.8720069034153103">
<NAME>LQLP (high = good)</NAME>
<CONT_DATA CI_END="0.4990589303197668" CI_START="-1.2990589303197657" EFFECT_SIZE="-0.39999999999999947" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="5.3" MODIFIED="2012-10-10 09:59:10 +0100" MODIFIED_BY="[Empty name]" ORDER="341" SD_1="1.9" SD_2="1.2" SE="0.4587119648174295" STUDY_ID="STD-Bauml-2007" TOTAL_1="24" TOTAL_2="24" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4031139464867488" CI_END="1.1902529513049327" CI_START="-10.789496850168598" DF="2" EFFECT_SIZE="-4.799621949431833" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.03" MODIFIED="2012-12-12 12:18:24 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.49581279581391957" P_Z="0.1162993145160682" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="98" WEIGHT="100.0" Z="1.5704979346291905">
<NAME>EuroQoL (high = good)</NAME>
<CONT_DATA CI_END="8.466063103280902" CI_START="-27.0460631032809" EFFECT_SIZE="-9.29" ESTIMABLE="YES" MEAN_1="54.38" MEAN_2="63.67" MODIFIED="2012-10-10 10:00:09 +0100" MODIFIED_BY="[Empty name]" ORDER="103" SD_1="29.28" SD_2="18.49" SE="9.059382337297247" STUDY_ID="STD-Garety-2008" TOTAL_1="16" TOTAL_2="12" WEIGHT="11.379996927187406">
<FOOTNOTE>Carer pathway, family intervention</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="4.596177659871075" CI_START="-9.61617765987107" EFFECT_SIZE="-2.509999999999998" ESTIMABLE="YES" MEAN_1="60.17" MEAN_2="62.68" MODIFIED="2012-10-10 09:59:18 +0100" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="22.99" SD_2="20.54" SE="3.6256674693635675" STUDY_ID="STD-Garety-2008" TOTAL_1="71" TOTAL_2="74" WEIGHT="71.04988550604722">
<FOOTNOTE>No carer pathway</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="3.1399404325513522" CI_START="-25.43994043255135" EFFECT_SIZE="-11.149999999999999" ESTIMABLE="YES" MEAN_1="52.52" MEAN_2="63.67" MODIFIED="2012-10-10 10:00:05 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="22.76" SD_2="18.49" SE="7.290919907339409" STUDY_ID="STD-Garety-2008" TOTAL_1="21" TOTAL_2="12" WEIGHT="17.57011756676538">
<FOOTNOTE>Carer pathway, patient intervention</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4225964780217839" CI_START="-0.24259647802178386" DF="0" EFFECT_SIZE="0.09000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.04" MODIFIED="2012-12-12 12:18:34 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.5958605000136703" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="0.5303626774936913">
<NAME>LQoLS (high = good)</NAME>
<CONT_DATA CI_END="0.4225964780217839" CI_START="-0.24259647802178386" EFFECT_SIZE="0.09000000000000002" ESTIMABLE="YES" MEAN_1="0.38" MEAN_2="0.29" MODIFIED="2012-09-20 10:49:00 +0100" MODIFIED_BY="[Empty name]" ORDER="357" SD_1="0.7589" SD_2="0.7589" SE="0.16969519881245904" STUDY_ID="STD-Liberman-1998" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0">
<FOOTNOTE>Change data; number of participants in each group not reported, assumed to be 40.</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="2.0629903147762194" CI_END="0.34836042326234035" CI_START="0.07778643173471211" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_SIZE="0.21307342749852623" ESTIMABLE="YES" I2="51.52667499999999" I2_Q="51.52667499999999" ID="CMP-001.15" LOG_CI_END="-0.45797119044706747" LOG_CI_START="-1.1090961502678678" LOG_DATA="NO" LOG_EFFECT_SIZE="-0.6714707080067198" MODIFIED="2012-12-12 12:18:53 +0000" MODIFIED_BY="[Empty name]" NO="15" NOTES="&lt;p&gt;perhaps change but when put alongside 1.17 which also is change really looks wrong - probably because of ridiculous standard error in 1.17 - is it really 6?&lt;/p&gt;&lt;p&gt;please let us know if you have addressed this&lt;/p&gt;" NOTES_MODIFIED="2012-12-12 12:18:53 +0000" NOTES_MODIFIED_BY="[Empty name]" P_CHI2="0.1509138093069825" P_Q="0.1509138093069825" P_Z="0.0020226157561627936" Q="2.0629903147762194" RANDOM="NO" SCALE="0.39" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="3.0868912536774635">
<NAME>Satisfaction with care: 1a. Average endpoint scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours EWS + TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="0.47992469378077696" CI_START="0.120075306219223" DF="0" EFFECT_SIZE="0.3" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.01" LOG_CI_END="-0.3188269035436756" LOG_CI_START="-0.9205462971383093" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2012-12-12 12:18:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.001083203710001295" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="3.26797385620915">
<NAME>CALPAS (high = good)</NAME>
<IV_DATA CI_END="0.47992469378077696" CI_START="0.120075306219223" EFFECT_SIZE="0.3" ESTIMABLE="YES" ESTIMATE="0.3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 10:02:52 +0100" MODIFIED_BY="[Empty name]" ORDER="266" SE="0.0918" STUDY_ID="STD-Harris-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.3052082291813437" CI_START="-0.10520822918134368" DF="0" EFFECT_SIZE="0.1" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.02" LOG_CI_END="-0.5154037608879722" LOG_CI_START="NaN" LOG_EFFECT_SIZE="-1.0" MODIFIED="2012-12-12 12:18:53 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3395221663670238" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.9551098376313276">
<NAME>IAPSRS (high = good)</NAME>
<IV_DATA CI_END="0.3052082291813437" CI_START="-0.10520822918134368" EFFECT_SIZE="0.1" ESTIMABLE="YES" ESTIMATE="0.1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-09-04 10:40:44 +0100" MODIFIED_BY="[Empty name]" ORDER="181" SE="0.1047" STUDY_ID="STD-Vreeland-2006" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="13.964466902408994" CI_START="-9.664466902408993" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="2.15" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="1.1450243610351456" LOG_CI_START="NaN" LOG_DATA="NO" LOG_EFFECT_SIZE="0.33243845991560533" MODIFIED="2012-12-12 12:19:06 +0000" MODIFIED_BY="Clive E Adams" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="0.7213352770494849" Q="0.0" RANDOM="NO" SCALE="16.69" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.35667479553409975">
<NAME>Satisfaction with care: 1b. Average change scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours EWS + TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="13.964466902408994" CI_START="-9.664466902408993" DF="0" EFFECT_SIZE="2.15" ESTIMABLE="YES" I2="0.0" ID="CMP-001.16.01" LOG_CI_END="1.1450243610351456" LOG_CI_START="NaN" LOG_EFFECT_SIZE="0.33243845991560533" MODIFIED="2012-12-12 12:19:06 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7213352770494849" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.35667479553409975">
<NAME>VSSS (high = good)</NAME>
<IV_DATA CI_END="13.964466902408994" CI_START="-9.664466902408993" EFFECT_SIZE="2.15" ESTIMABLE="YES" ESTIMATE="2.15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 11:07:39 +0100" MODIFIED_BY="[Empty name]" ORDER="182" SE="6.0279" STUDY_ID="STD-Merinder-1999" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Change data</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<DICH_OUTCOME CHI2="10.094852104414787" CI_END="1.2797964703378426" CI_START="0.716335299138545" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="RR" EFFECT_SIZE="0.957477617187949" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="78" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="0.10714090805614487" LOG_CI_START="-0.14488364741269869" LOG_EFFECT_SIZE="-0.018871369678276878" METHOD="MH" MODIFIED="2012-10-10 11:13:52 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.8137314421865238" P_Q="1.0" P_Z="0.7691242228090563" Q="0.0" RANDOM="NO" SCALE="3.5804146565855475" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="752" TOTAL_2="743" WEIGHT="100.0" Z="0.29352064396706334">
<NAME>Adverse events: 1. Lost to follow-up</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.1178990744020965" CI_START="0.37944106248569703" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6146756982879912" LOG_CI_START="-0.42085567227187837" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2011-05-17 11:35:04 +0100" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.608276253029822" STUDY_ID="STD-Bradley-2006" TOTAL_1="25" TOTAL_2="25" VAR="0.37000000000000005" WEIGHT="5.17785599898677"/>
<DICH_DATA CI_END="7.888578229356675" CI_START="0.014085061703212953" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8969987366967316" LOG_CI_START="-1.8512412461360563" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2012-07-17 08:26:10 +0100" MODIFIED_BY="[Empty name]" ORDER="105" O_E="0.0" SE="1.6143297699232972" STUDY_ID="STD-Chen-2003" TOTAL_1="32" TOTAL_2="32" VAR="2.606060606060606" WEIGHT="1.9416959996200387"/>
<DICH_DATA CI_END="5.152906476246514" CI_START="0.3044533246324721" EFFECT_SIZE="1.2525252525252526" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7120522602141011" LOG_CI_START="-0.5164792790847307" LOG_EFFECT_SIZE="0.09778649056468518" MODIFIED="2011-05-17 11:36:00 +0100" MODIFIED_BY="[Empty name]" ORDER="140" O_E="0.0" SE="0.7216455075133317" STUDY_ID="STD-Chien-2004" TOTAL_1="33" TOTAL_2="31" VAR="0.520772238514174" WEIGHT="4.00474799921633"/>
<DICH_DATA CI_END="1.6470458268562231" CI_START="0.42163031114316724" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.21670568300333048" LOG_CI_START="-0.3750681750985801" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2011-05-17 11:52:14 +0100" MODIFIED_BY="[Empty name]" ORDER="141" O_E="0.0" SE="0.3476108935769035" STUDY_ID="STD-Drury-1996" TOTAL_1="32" TOTAL_2="32" VAR="0.12083333333333335" WEIGHT="15.53356799696031"/>
<DICH_DATA CI_END="4.239447624041166" CI_START="0.17835900672739244" EFFECT_SIZE="0.8695652173913043" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6273092741732559" LOG_CI_START="-0.7487049548804794" LOG_EFFECT_SIZE="-0.0606978403536117" MODIFIED="2012-07-16 10:24:12 +0100" MODIFIED_BY="[Empty name]" ORDER="105" O_E="0.0" SE="0.8082775695264505" STUDY_ID="STD-Garety-2008" TOTAL_1="161" TOTAL_2="140" VAR="0.6533126293995859" WEIGHT="4.154326324768455">
<FOOTNOTE>Patients with and without carers reported combined in the study</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="3.414240253111331" CI_START="0.3796143734686236" EFFECT_SIZE="1.1384615384615384" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5332940782694318" LOG_CI_START="-0.4206573520931906" LOG_EFFECT_SIZE="0.0563183630881206" MODIFIED="2011-05-17 11:52:37 +0100" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.5603557923307423" STUDY_ID="STD-Granholm-2005" TOTAL_1="39" TOTAL_2="37" VAR="0.313998613998614" WEIGHT="6.642644209226448"/>
<DICH_DATA CI_END="3.755788331044886" CI_START="0.3834081883947337" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5747011082880159" LOG_CI_START="-0.4163386161927662" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2011-05-17 11:56:12 +0100" MODIFIED_BY="[Empty name]" ORDER="143" O_E="0.0" SE="0.5821416398857661" STUDY_ID="STD-Gumley-2003" TOTAL_1="72" TOTAL_2="72" VAR="0.3388888888888889" WEIGHT="6.472319998733463"/>
<DICH_DATA CI_END="5.009074665946237" CI_START="0.04990941774128532" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6997575053902041" LOG_CI_START="-1.3018174967181666" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2012-07-12 09:41:10 +0100" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="1.1757350641945108" STUDY_ID="STD-Horan-2009" TOTAL_1="17" TOTAL_2="17" VAR="1.3823529411764706" WEIGHT="2.588927999493385"/>
<DICH_DATA CI_END="2.3311987931415663" CI_START="0.0328630624973049" EFFECT_SIZE="0.2767857142857143" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.36757930959231255" LOG_CI_START="-1.4832919672641305" LOG_EFFECT_SIZE="-0.5578563288359089" MODIFIED="2011-05-17 12:03:25 +0100" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="1.0872109499860574" STUDY_ID="STD-Kopelowicz-1998a" TOTAL_1="28" TOTAL_2="31" VAR="1.1820276497695852" WEIGHT="4.914575185478968"/>
<DICH_DATA CI_END="14.721546927534659" CI_START="0.6668985145450277" EFFECT_SIZE="3.1333333333333333" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1679534476912712" LOG_CI_START="-0.1759402499311986" LOG_EFFECT_SIZE="0.49600659888003623" MODIFIED="2011-05-17 12:05:44 +0100" MODIFIED_BY="[Empty name]" ORDER="145" O_E="0.0" SE="0.7894098103645302" STUDY_ID="STD-Kopelowicz-2003" TOTAL_1="45" TOTAL_2="47" VAR="0.6231678486997635" WEIGHT="2.5326469560261375"/>
<DICH_DATA CI_END="1.9993072787819177" CI_START="0.2133183665454121" EFFECT_SIZE="0.6530612244897959" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.30087954710649467" LOG_CI_START="-0.67097175052371" LOG_EFFECT_SIZE="-0.18504610170860772" MODIFIED="2011-05-17 12:06:28 +0100" MODIFIED_BY="[Empty name]" ORDER="146" O_E="0.0" SE="0.5708702629694922" STUDY_ID="STD-Kuipers-1997" TOTAL_1="28" TOTAL_2="32" VAR="0.32589285714285715" WEIGHT="8.457164798345056"/>
<DICH_DATA CI_END="1.4688089653911636" CI_START="0.24122156003338296" EFFECT_SIZE="0.5952380952380952" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.16696531473409218" LOG_CI_START="-0.617583878185818" LOG_EFFECT_SIZE="-0.22530928172586287" MODIFIED="2012-07-23 11:40:19 +0100" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.46084807950229373" STUDY_ID="STD-Li-2003" TOTAL_1="21" TOTAL_2="25" VAR="0.21238095238095242" WEIGHT="11.819019128121974">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="7.3452862810482" CI_START="0.8508858281161646" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.8660087269957921" LOG_CI_START="-0.0701287096517169" LOG_EFFECT_SIZE="0.3979400086720376" MODIFIED="2012-09-19 15:17:04 +0100" MODIFIED_BY="[Empty name]" ORDER="494" O_E="0.0" SE="0.5498917642417936" STUDY_ID="STD-Liberman-1998" TOTAL_1="42" TOTAL_2="42" VAR="0.3023809523809523" WEIGHT="5.17785599898677"/>
<DICH_DATA CI_END="1.8204828623723552" CI_START="0.3089839578423607" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.2601865949359053" LOG_CI_START="-0.5100640681525053" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2011-05-17 12:19:57 +0100" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.4524490523004067" STUDY_ID="STD-Merinder-1999" TOTAL_1="23" TOTAL_2="23" VAR="0.2047101449275362" WEIGHT="10.35571199797354"/>
<DICH_DATA CI_END="2.934846631194213" CI_START="0.2319116074978841" EFFECT_SIZE="0.825" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.46758541087617345" LOG_CI_START="-0.6346775137763234" LOG_EFFECT_SIZE="-0.08354605145007493" MODIFIED="2011-05-17 12:24:52 +0100" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.6474746982303516" STUDY_ID="STD-Norman-2002" TOTAL_1="64" TOTAL_2="66" VAR="0.4192234848484849" WEIGHT="6.372745844906794"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-05-17 12:26:50 +0100" MODIFIED_BY="[Empty name]" ORDER="149" O_E="0.0" SE="0.0" STUDY_ID="STD-Shin-2002" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.9203548053253483" CI_START="0.11682985624039921" EFFECT_SIZE="0.6767676767676768" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5933253739138007" LOG_CI_START="-0.9324461577072476" LOG_EFFECT_SIZE="-0.16956039189672345" MODIFIED="2012-07-17 09:58:27 +0100" MODIFIED_BY="[Empty name]" ORDER="114" O_E="0.0" SE="0.8962457503650936" STUDY_ID="STD-Xiang-2001" TOTAL_1="66" TOTAL_2="67" VAR="0.8032564450474897" WEIGHT="3.8541935631555657"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.1164670079263477" CI_END="2.8876690145982673" CI_START="0.2877084525971905" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9114860305034419" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="3.737148753063269" I2_Q="100.0" ID="CMP-001.18" LOG_CI_END="0.4605474127995055" LOG_CI_START="-0.5410473787687179" LOG_EFFECT_SIZE="-0.04024998298460619" METHOD="MH" MODIFIED="2012-10-10 11:13:55 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.3740147891985932" P_Q="0.0" P_Z="0.8748304658964468" Q="5.5639237116686575E-34" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="244" TOTAL_2="218" WEIGHT="100.00000000000001" Z="0.15752581321765924">
<NAME>Adverse events: 2. Death</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<DICH_DATA CI_END="70.16470334946774" CI_START="0.1282696223366598" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8461186933890088" LOG_CI_START="-0.891876183949684" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2011-05-15 10:01:20 +0100" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="1.6083117442419756" STUDY_ID="STD-Bauml-2007" TOTAL_1="24" TOTAL_2="24" VAR="2.5866666666666664" WEIGHT="8.588203536239709"/>
<DICH_DATA CI_END="70.29633525231901" CI_START="0.12802943379190032" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8469326846047245" LOG_CI_START="-0.8926901751653995" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2011-05-15 09:56:59 +0100" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="1.6092680291808414" STUDY_ID="STD-Bradley-2006" TOTAL_1="25" TOTAL_2="25" VAR="2.58974358974359" WEIGHT="8.588203536239709"/>
<DICH_DATA CI_END="2.3865040459918228" CI_START="0.006478134209907185" EFFECT_SIZE="0.12433862433862433" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3777621749898944" LOG_CI_START="-2.1885500587929103" LOG_EFFECT_SIZE="-0.9053939419015079" MODIFIED="2012-07-16 10:23:36 +0100" MODIFIED_BY="[Empty name]" ORDER="104" O_E="0.0" SE="1.5074645095744552" STUDY_ID="STD-Garety-2008" TOTAL_1="161" TOTAL_2="140" VAR="2.2724492476265525" WEIGHT="64.28397894452694">
<FOOTNOTE>Patients with and without carers reported combined in the study</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="17.865234991166414" CI_START="0.16288812341483394" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2520087330878946" LOG_CI_START="-0.7881105800465303" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2011-05-16 15:34:28 +0100" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="1.1983761832886317" STUDY_ID="STD-Xiong-1994" TOTAL_1="34" TOTAL_2="29" VAR="1.436105476673428" WEIGHT="18.539613982993657"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="36.894115268465654" CI_END="2.5720642619048" CI_START="0.13776636012641053" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="1.3549153110156054" ESTIMABLE="YES" I2="91.86862192474317" I2_Q="45.60107757538091" ID="CMP-001.19" MODIFIED="2012-12-12 12:21:32 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="4.844981527085679E-8" P_Q="0.15909222682562196" P_Z="0.029123712373294704" Q="3.6765434145711473" RANDOM="YES" SCALE="15.82" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="12.36557486585743" TOTALS="SUB" TOTAL_1="143" TOTAL_2="124" UNITS="" WEIGHT="300.0" Z="2.1818079124600325">
<NAME>Knowledge: 1a. Average scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours EWS + TAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.038989486518545" CI_START="-0.8389894865185457" DF="0" EFFECT_SIZE="1.5999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.01" MODIFIED="2012-12-12 12:19:22 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.1985286586396253" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="25" WEIGHT="100.0" Z="1.2857547736871893">
<NAME>KASQ (patients, high = good)</NAME>
<CONT_DATA CI_END="4.038989486518545" CI_START="-0.8389894865185457" EFFECT_SIZE="1.5999999999999996" ESTIMABLE="YES" MEAN_1="16.2" MEAN_2="14.6" MODIFIED="2012-10-10 11:14:54 +0100" MODIFIED_BY="[Empty name]" ORDER="74" SD_1="4.1" SD_2="5.2" SE="1.2444052573195135" STUDY_ID="STD-Vreeland-2006" TOTAL_1="36" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.4011757485942886" CI_START="-0.48117574859428835" DF="0" EFFECT_SIZE="0.9600000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.02" MODIFIED="2012-12-12 12:21:19 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.19169656066754667" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="18" WEIGHT="100.0" Z="1.3055766633554002">
<NAME>IS (patients, high = good)</NAME>
<CONT_DATA CI_END="2.4011757485942886" CI_START="-0.48117574859428835" EFFECT_SIZE="0.9600000000000001" ESTIMABLE="YES" MEAN_1="1.09" MEAN_2="0.13" MODIFIED="2012-10-10 11:14:58 +0100" MODIFIED_BY="[Empty name]" ORDER="75" SD_1="2.19" SD_2="2.41" SE="0.7353072607262678" STUDY_ID="STD-Merinder-1999" TOTAL_1="22" TOTAL_2="18" WEIGHT="100.0">
<FOOTNOTE>Change data</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.40693616482113" CI_END="13.478237500755041" CI_START="0.9395527471541598" DF="1" EFFECT_SIZE="7.2088951239546" ESTIMABLE="YES" I2="92.54117430182198" ID="CMP-001.19.03" MODIFIED="2012-12-12 12:21:32 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="2.506970302234013E-4" P_Z="0.024215470149186374" STUDIES="2" TAU2="18.952432497013156" TOTAL_1="85" TOTAL_2="81" WEIGHT="100.0" Z="2.2536932842529254">
<NAME>ITAQ (patients, high = good)</NAME>
<CONT_DATA CI_END="13.347443008839475" CI_START="7.6525569911605285" EFFECT_SIZE="10.500000000000002" ESTIMABLE="YES" MEAN_1="16.35" MEAN_2="5.85" MODIFIED="2012-10-10 11:15:04 +0100" MODIFIED_BY="[Empty name]" ORDER="109" SD_1="6.87" SD_2="4.27" SE="1.4528037409359253" STUDY_ID="STD-Chen-2003" TOTAL_1="31" TOTAL_2="31" WEIGHT="48.576486311790624"/>
<CONT_DATA CI_END="6.004794904581683" CI_START="2.195205095418318" EFFECT_SIZE="4.1000000000000005" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="6.2" MODIFIED="2012-10-10 11:15:07 +0100" MODIFIED_BY="[Empty name]" ORDER="398" SD_1="6.8" SD_2="2.1" SE="0.9718519929990863" STUDY_ID="STD-Zhang-2004" TOTAL_1="54" TOTAL_2="50" WEIGHT="51.42351368820938"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.09879533725920076" CI_START="-2.458795337259202" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.1800000000000006" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.20" MODIFIED="2012-12-12 12:21:59 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Q="1.0" P_Z="0.07052189134289194" Q="0.0" RANDOM="YES" SCALE="15.82" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="44" TOTAL_2="37" UNITS="" WEIGHT="100.0" Z="1.808543896253266">
<NAME>Knowledge: 1b. Average scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.09879533725920076" CI_START="-2.458795337259202" DF="0" EFFECT_SIZE="-1.1800000000000006" ESTIMABLE="YES" I2="0.0" ID="CMP-001.20.01" MODIFIED="2012-12-12 12:21:59 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.07052189134289194" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="37" WEIGHT="100.0" Z="1.808543896253266">
<NAME>SUMD (patients, high = bad)</NAME>
<CONT_DATA CI_END="0.09879533725920076" CI_START="-2.458795337259202" EFFECT_SIZE="-1.1800000000000006" ESTIMABLE="YES" MEAN_1="6.77" MEAN_2="7.95" MODIFIED="2012-06-25 09:09:29 +0100" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="2.56" SD_2="3.2" SE="0.6524585897221458" STUDY_ID="STD-Chan-2007" TOTAL_1="44" TOTAL_2="37" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="0.8523298109647602" CI_END="3.752618131514641" CI_START="0.7903839820665575" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_SIZE="2.271501056790599" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.5743343726161534" LOG_CI_START="-0.10216186974962285" LOG_DATA="NO" LOG_EFFECT_SIZE="0.3563129432013686" MODIFIED="2012-12-12 12:22:25 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.35589416165019194" P_Q="0.35589416165019194" P_Z="0.002648134407608968" Q="0.8523298109647602" RANDOM="NO" SCALE="6.97" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="3.0058800469799083">
<NAME>Knowledge: 1c. Average scores (various scales)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours EWS + TAU</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="3.7699884501058336" CI_START="-0.9699884501058338" DF="0" EFFECT_SIZE="1.4" ESTIMABLE="YES" I2="0.0" ID="CMP-001.21.01" LOG_CI_END="0.5763400196851067" LOG_CI_START="NaN" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2012-12-12 12:22:14 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.24694965302707617" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999" Z="1.1577902745616935">
<NAME>DAI (patients, high = good)</NAME>
<IV_DATA CI_END="3.7699884501058336" CI_START="-0.9699884501058338" EFFECT_SIZE="1.4" ESTIMABLE="YES" ESTIMATE="1.4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 11:15:54 +0100" MODIFIED_BY="[Empty name]" ORDER="265" SE="1.2092" STUDY_ID="STD-Harris-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="4.727245137034773" CI_START="0.9327548629652276" DF="0" EFFECT_SIZE="2.83" ESTIMABLE="YES" I2="0.0" ID="CMP-001.21.02" LOG_CI_END="0.6746081237543873" LOG_CI_START="-0.0302324780647172" LOG_EFFECT_SIZE="0.45178643552429026" MODIFIED="2012-12-12 12:22:25 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.003460605068370983" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.9235537190082646">
<NAME>KASI (relatives, high = good)</NAME>
<IV_DATA CI_END="4.727245137034773" CI_START="0.9327548629652276" EFFECT_SIZE="2.83" ESTIMABLE="YES" ESTIMATE="2.83" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-10 11:15:55 +0100" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.968" STUDY_ID="STD-Li-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.3049352643770975" CI_START="-7.104935264377095" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.3999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.22" MODIFIED="2012-12-12 12:22:44 +0000" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="1.0" P_Q="1.0" P_Z="0.3174156230991778" Q="0.0" RANDOM="YES" SCALE="50.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="33" TOTAL_2="31" UNITS="" WEIGHT="100.0" Z="0.9997828447314239">
<NAME>Burden of care: 1. Average scores (FBIS, high = bad)</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.3049352643770975" CI_START="-7.104935264377095" EFFECT_SIZE="-2.3999999999999986" ESTIMABLE="YES" MEAN_1="26.8" MEAN_2="29.2" MODIFIED="2012-07-24 11:33:40 +0100" MODIFIED_BY="[Empty name]" ORDER="154" SD_1="10.1" SD_2="9.1" SE="2.400521285844549" STUDY_ID="STD-Chien-2004" TOTAL_1="33" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.288659431174752" CI_END="0.768408938126063" CI_START="0.4202280800933831" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5682490763699583" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="-0.11440759207133923" LOG_CI_START="-0.37651493093493055" LOG_EFFECT_SIZE="-0.2454612615031349" METHOD="MH" MODIFIED="2012-10-10 11:22:13 +0100" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.5146970619614198" P_Q="1.0" P_Z="2.416234554630335E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="186" TOTAL_2="188" WEIGHT="100.0" Z="3.670978723692199">
<NAME>Medication compliance: Not compliant to medication</NAME>
<GROUP_LABEL_1>EWS + TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EWS + TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TAU</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7316528481862554" CI_START="0.2767817702782713" EFFECT_SIZE="0.6923076923076923" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.23846083154481243" LOG_CI_START="-0.5578625172798363" LOG_EFFECT_SIZE="-0.1597008428675119" MODIFIED="2011-05-20 11:57:19 +0100" MODIFIED_BY="[Empty name]" ORDER="156" O_E="0.0" SE="0.4677642769637489" STUDY_ID="STD-Kopelowicz-2003" TOTAL_1="39" TOTAL_2="45" VAR="0.2188034188034188" WEIGHT="12.219977826341605"/>
<DICH_DATA CI_END="1.6827494066117772" CI_START="0.32264833132928994" EFFECT_SIZE="0.7368421052631579" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.22601944608347005" LOG_CI_START="-0.4912705766326519" LOG_EFFECT_SIZE="-0.13262556527459096" MODIFIED="2012-07-23 11:39:19 +0100" MODIFIED_BY="[Empty name]" ORDER="81" O_E="0.0" SE="0.4213397099863265" STUDY_ID="STD-Li-2003" TOTAL_1="19" TOTAL_2="21" VAR="0.17752715121136176" WEIGHT="11.251779583177617">
<FOOTNOTE>Cluster trial</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.8685023355674888" CI_START="0.4177136601356037" EFFECT_SIZE="0.6023166023166023" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="42" LOG_CI_END="-0.06122900931508793" LOG_CI_START="-0.3791213221384926" LOG_EFFECT_SIZE="-0.22017516572679022" MODIFIED="2012-07-22 12:34:31 +0100" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="0.1867315181447949" STUDY_ID="STD-Zhan-2003" TOTAL_1="74" TOTAL_2="72" VAR="0.03486865986865987" WEIGHT="56.029049017889974"/>
<DICH_DATA CI_END="0.7871004891978464" CI_START="0.12102631141736685" EFFECT_SIZE="0.30864197530864196" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.10396981768145148" LOG_CI_START="-0.9171202027317729" LOG_EFFECT_SIZE="-0.5105450102066121" MODIFIED="2012-07-17 13:49:38 +0100" MODIFIED_BY="[Empty name]" ORDER="403" O_E="0.0" SE="0.4776485613378817" STUDY_ID="STD-Zhang-2004" TOTAL_1="54" TOTAL_2="50" VAR="0.22814814814814816" WEIGHT="20.499193572590798"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-01-07 11:15:34 +0000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-05-21 14:46:16 +0100" MODIFIED_BY="[Empty name]">Details of contact with authors</TITLE>
<APPENDIX_BODY MODIFIED="2013-01-07 11:15:35 +0000" MODIFIED_BY="[Empty name]">
<P>Details regarding intervention in the study were provided by <LINK REF="STD-Turkington-2006" TYPE="STUDY">Turkington 2006</LINK>: confirmed that all participants received one hour at least on training in recognising early waring signs; <LINK REF="STD-Hogarty-1997a" TYPE="STUDY">Hogarty 1997a</LINK>: suggested clarifying the process of recognising early waring sings of schizophrenia in the book &#8216; A Guide to Individualised Treatment&#8217; by Gerard E Hogarty; <LINK REF="STD-Vreeland-2006" TYPE="STUDY">Vreeland 2006</LINK>: wrote and explained that their Team Solutions study involved approximately  five to six hours of recognition of early warning signs. Two hours in Workbook No.1 and three to four hours in Workbook No.7. The manual is free and can be downloaded from www.partners4excellence.org ; <LINK REF="STD-Kopelowicz-1998a" TYPE="STUDY">Kopelowicz 1998a</LINK>: confirmed that the first eight sessions of the Community Re-entry module included teaching patients early warning signs of psychotic relapse; Cunningham <LINK REF="STD-Owens-2001" TYPE="STUDY">Owens 2001</LINK>: confirmed that their study did not focus on early relapse symptom recognition but compliance; <LINK REF="STD-Hahlweg-1999" TYPE="STUDY">Hahlweg 1999</LINK>: confirmed that the behavioural family intervention in their study had recognition of early warning signs as part of the psychoeducation and it lasted for about one session including the patient and family. This was assessed at the beginning of every family session over the course of about 20 sessions (one year).</P>
<P>Details regarding diagnoses were provided by <LINK REF="STD-Jumnoodoo-2008" TYPE="STUDY">Jumnoodoo 2008</LINK>: confirmed that ICD-10 criteria were not used for diagnoses and less than 50% of patients had a diagnosis of schizophrenia, also, separate data for schizophrenia were not available to hand; <LINK REF="STD-Nordentoft-1998" TYPE="STUDY">Nordentoft 1998</LINK>: OPUS STUDY: clarified that it was a first episode study, so none had a previous diagnosis in the schizophrenia spectrum.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>